
<html lang="en"     class="pb-page"  data-request-id="4ca01441-d2dc-452e-b8ec-88edd3cc8a8c"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/jm2007326;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2011.54.issue-24;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Structure-Guided Evolution of Potent and Selective CHK1 Inhibitors through Scaffold Morphing" /></meta><meta name="dc.Creator" content="John C.  Reader" /></meta><meta name="dc.Creator" content="Thomas P.  Matthews" /></meta><meta name="dc.Creator" content="Suki  Klair" /></meta><meta name="dc.Creator" content="Kwai-Ming J.  Cheung" /></meta><meta name="dc.Creator" content="Jane  Scanlon" /></meta><meta name="dc.Creator" content="Nicolas  Proisy" /></meta><meta name="dc.Creator" content="Glynn  Addison" /></meta><meta name="dc.Creator" content="John  Ellard" /></meta><meta name="dc.Creator" content="Nelly  Piton" /></meta><meta name="dc.Creator" content="Suzanne  Taylor" /></meta><meta name="dc.Creator" content="Michael  Cherry" /></meta><meta name="dc.Creator" content="Martin  Fisher" /></meta><meta name="dc.Creator" content="Kathy  Boxall" /></meta><meta name="dc.Creator" content="Samantha  Burns" /></meta><meta name="dc.Creator" content="Michael I.  Walton" /></meta><meta name="dc.Creator" content="Isaac M.  Westwood" /></meta><meta name="dc.Creator" content="Angela  Hayes" /></meta><meta name="dc.Creator" content="Paul  Eve" /></meta><meta name="dc.Creator" content="Melanie  Valenti" /></meta><meta name="dc.Creator" content="Alexis  de Haven Brandon" /></meta><meta name="dc.Creator" content="Gary  Box" /></meta><meta name="dc.Creator" content="Rob L. M.  van Montfort" /></meta><meta name="dc.Creator" content="David H.  Williams" /></meta><meta name="dc.Creator" content="G. Wynne  Aherne" /></meta><meta name="dc.Creator" content="Florence I.  Raynaud" /></meta><meta name="dc.Creator" content="Suzanne A.  Eccles" /></meta><meta name="dc.Creator" content="Michelle D.  Garrett" /></meta><meta name="dc.Creator" content="Ian  Collins" /></meta><meta name="dc.Description" content="Pyrazolopyridine inhibitors with low micromolar potency for CHK1 and good selectivity against CHK2 were previously identified by fragment-based screening. The optimization of the pyrazolopyridines ..." /></meta><meta name="Description" content="Pyrazolopyridine inhibitors with low micromolar potency for CHK1 and good selectivity against CHK2 were previously identified by fragment-based screening. The optimization of the pyrazolopyridines ..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 23, 2011" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm2007326" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2011 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm2007326" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm2007326" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm2007326" /></link>
        
    
    

<title>Structure-Guided Evolution of Potent and Selective CHK1 Inhibitors through Scaffold Morphing | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm2007326" /></meta><meta property="og:title" content="Structure-Guided Evolution of Potent and Selective CHK1 Inhibitors through Scaffold Morphing" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0003.jpeg" /></meta><meta property="og:description" content="Pyrazolopyridine inhibitors with low micromolar potency for CHK1 and good selectivity against CHK2 were previously identified by fragment-based screening. The optimization of the pyrazolopyridines to a series of potent and CHK1-selective isoquinolines demonstrates how fragment-growing and scaffold morphing strategies arising from a structure-based understanding of CHK1 inhibitor binding can be combined to successfully progress fragment-derived hit matter to compounds with activity in vivo. The challenges of improving CHK1 potency and selectivity, addressing synthetic tractability, and achieving novelty in the crowded kinase inhibitor chemical space were tackled by multiple scaffold morphing steps, which progressed through tricyclic pyrimido[2,3-b]azaindoles to N-(pyrazin-2-yl)pyrimidin-4-amines and ultimately to imidazo[4,5-c]pyridines and isoquinolines. A potent and highly selective isoquinoline CHK1 inhibitor (SAR-020106) was identified, which potentiated the efficacies of irinotecan and gemcitabine in SW620 human colon carcinoma xenografts in nude mice." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm2007326"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm2007326">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm2007326&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm2007326&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm2007326&amp;href=/doi/10.1021/jm2007326" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2011</span><span class="cit-fg-volume">, 54</span><span class="cit-fg-issue">, 24</span><span class="cit-fg-pageRange">, 8328-8342</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/54/24" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm200718m" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm200762g" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Structure-Guided Evolution of Potent and Selective CHK1 Inhibitors through Scaffold Morphing</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+C.++Reader">John C. Reader</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+P.++Matthews">Thomas P. Matthews</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Suki++Klair">Suki Klair</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kwai-Ming+J.++Cheung">Kwai-Ming J. Cheung</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jane++Scanlon">Jane Scanlon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicolas++Proisy">Nicolas Proisy</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Glynn++Addison">Glynn Addison</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Ellard">John Ellard</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nelly++Piton">Nelly Piton</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Suzanne++Taylor">Suzanne Taylor</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Cherry">Michael Cherry</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Martin++Fisher">Martin Fisher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kathy++Boxall">Kathy Boxall</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Samantha++Burns">Samantha Burns</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+I.++Walton">Michael I. Walton</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Isaac+M.++Westwood">Isaac M. Westwood</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Angela++Hayes">Angela Hayes</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Eve">Paul Eve</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Melanie++Valenti">Melanie Valenti</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alexis++de+Haven+Brandon">Alexis de Haven Brandon</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gary++Box">Gary Box</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rob+L.+M.++van+Montfort">Rob L. M. van Montfort</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+H.++Williams">David H. Williams</a></span><span class="author-xref-symbol author-aff-symbol"><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=G.+Wynne++Aherne">G. Wynne Aherne</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Florence+I.++Raynaud">Florence I. Raynaud</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Suzanne+A.++Eccles">Suzanne A. Eccles</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michelle+D.++Garrett">Michelle D. Garrett</a></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ian++Collins">Ian Collins</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>â </sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>â </sup>Cancer Research UK Cancer Therapeutics Unit and <sup>â¡</sup>Division of Structural Biology, The Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span></div><div class="aff-info" id="aff2"><span class="aff-text">Sareum Ltd., 2a Langford Arch, London Road, Cambridge CB22 3FX, U.K.</span></div><div class="corresp-info">J.R.: Telephone, +44 (0)1223 497700; e-mail, <a href="/cdn-cgi/l/email-protection#076d686f69297562666362754774667562726a29646829726c"><span class="__cf_email__" data-cfemail="4d27222523633f282c29283f0d3e2c3f283820632e22633826">[emailÂ protected]</span></a>. I.C.: Telephone, +44 (0)20 8722 4317; fax, +44 (0)20 8722 4126; e-mail, <a href="/cdn-cgi/l/email-protection#86efe7e8a8e5e9eaeaefe8f5c6efe5f4a8e7e5a8f3ed"><span class="__cf_email__" data-cfemail="93faf2fdbdf0fcfffffafde0d3faf0e1bdf2f0bde6f8">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm2007326&amp;href=/doi/10.1021%2Fjm2007326" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2011</span></span><span class="cit-volume">, 54</span><span class="cit-issue">, 24</span><span class="cit-pageRange">, 8328â8342</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 23, 2011</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 June 2011</li><li><span class="item_label"><b>Published</b> online</span>23 November 2011</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 22 December 2011</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm2007326" title="DOI URL">https://doi.org/10.1021/jm2007326</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2011 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice_termsofuse.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm2007326"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5190</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">39</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm2007326" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Structure-Guided Evolution of Potent and Selective CHK1 Inhibitors through Scaffold Morphing&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;C. Reader&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;P. Matthews&quot;},{&quot;first_name&quot;:&quot;Suki&quot;,&quot;last_name&quot;:&quot;Klair&quot;},{&quot;first_name&quot;:&quot;Kwai-Ming&quot;,&quot;last_name&quot;:&quot;J. Cheung&quot;},{&quot;first_name&quot;:&quot;Jane&quot;,&quot;last_name&quot;:&quot;Scanlon&quot;},{&quot;first_name&quot;:&quot;Nicolas&quot;,&quot;last_name&quot;:&quot;Proisy&quot;},{&quot;first_name&quot;:&quot;Glynn&quot;,&quot;last_name&quot;:&quot;Addison&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Ellard&quot;},{&quot;first_name&quot;:&quot;Nelly&quot;,&quot;last_name&quot;:&quot;Piton&quot;},{&quot;first_name&quot;:&quot;Suzanne&quot;,&quot;last_name&quot;:&quot;Taylor&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Cherry&quot;},{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;Fisher&quot;},{&quot;first_name&quot;:&quot;Kathy&quot;,&quot;last_name&quot;:&quot;Boxall&quot;},{&quot;first_name&quot;:&quot;Samantha&quot;,&quot;last_name&quot;:&quot;Burns&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;I. Walton&quot;},{&quot;first_name&quot;:&quot;Isaac&quot;,&quot;last_name&quot;:&quot;M. Westwood&quot;},{&quot;first_name&quot;:&quot;Angela&quot;,&quot;last_name&quot;:&quot;Hayes&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Eve&quot;},{&quot;first_name&quot;:&quot;Melanie&quot;,&quot;last_name&quot;:&quot;Valenti&quot;},{&quot;first_name&quot;:&quot;Alexis&quot;,&quot;last_name&quot;:&quot;de Haven Brandon&quot;},{&quot;first_name&quot;:&quot;Gary&quot;,&quot;last_name&quot;:&quot;Box&quot;},{&quot;first_name&quot;:&quot;Rob&quot;,&quot;last_name&quot;:&quot;L. M. van Montfort&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;H. Williams&quot;},{&quot;first_name&quot;:&quot;G.&quot;,&quot;last_name&quot;:&quot;Wynne Aherne&quot;},{&quot;first_name&quot;:&quot;Florence&quot;,&quot;last_name&quot;:&quot;I. Raynaud&quot;},{&quot;first_name&quot;:&quot;Suzanne&quot;,&quot;last_name&quot;:&quot;A. Eccles&quot;},{&quot;first_name&quot;:&quot;Michelle&quot;,&quot;last_name&quot;:&quot;D. Garrett&quot;},{&quot;first_name&quot;:&quot;Ian&quot;,&quot;last_name&quot;:&quot;Collins&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2011&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;24&quot;,&quot;volume&quot;:&quot;54&quot;,&quot;pages&quot;:&quot;8328-8342&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm2007326&quot;},&quot;abstract&quot;:&quot;Pyrazolopyridine inhibitors with low micromolar potency for CHK1 and good selectivity against CHK2 were previously identified by fragment-based screening. The optimization of the pyrazolopyridines to a series of potent and CHK1-selective isoquinolines demonstrates how fragment-growing and scaffold morphing strategies arising from a structure-based understanding of CHK1 inhibitor binding can be combined to successfully progress fragment-derived hit matter to compounds with activity in vivo. The challenges of improving CHK1 potency and selectivity, addressing synthetic tractability, and achieving novelty in the crowded kinase inhibitor chemical space were tackled by multiple scaffold morphing steps, which progressed through tricyclic pyrimido[2,3-b]azaindoles to N-(pyrazin-2-yl)pyrimidin-4-amines and ultimately to imidazo[4,5-c]pyridines and isoquinolines. A potent and highly selective isoquinoline CHK1 inhibitor (SAR-020106) was identified, which potentiated the efficacies of irinotecan and gemcitabine in SW62&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm2007326&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2007326" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm2007326&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2007326" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm2007326&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2007326" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm2007326&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm2007326&amp;href=/doi/10.1021/jm2007326" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm2007326" /></input><a href="/doi/pdf/10.1021/jm2007326" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm2007326&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm2007326%26sid%3Dliteratum%253Aachs%26pmid%3D22111927%26genre%3Darticle%26aulast%3DReader%26date%3D2011%26atitle%3DStructure-Guided%2BEvolution%2Bof%2BPotent%2Band%2BSelective%2BCHK1%2BInhibitors%2Bthrough%2BScaffold%2BMorphing%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D54%26issue%3D24%26spage%3D8328%26epage%3D8342%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a>,</li><li><a href="/action/doSearch?ConceptID=292201" title="Scaffolds">Scaffolds</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/54/24" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jmcmar.2011.54.issue-24/production/jmcmar.2011.54.issue-24.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/medium/jm-2011-007326_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007326&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Pyrazolopyridine inhibitors with low micromolar potency for CHK1 and good selectivity against CHK2 were previously identified by fragment-based screening. The optimization of the pyrazolopyridines to a series of potent and CHK1-selective isoquinolines demonstrates how fragment-growing and scaffold morphing strategies arising from a structure-based understanding of CHK1 inhibitor binding can be combined to successfully progress fragment-derived hit matter to compounds with activity in vivo. The challenges of improving CHK1 potency and selectivity, addressing synthetic tractability, and achieving novelty in the crowded kinase inhibitor chemical space were tackled by multiple scaffold morphing steps, which progressed through tricyclic pyrimido[2,3-<i>b</i>]azaindoles to <i>N</i>-(pyrazin-2-yl)pyrimidin-4-amines and ultimately to imidazo[4,5-<i>c</i>]pyridines and isoquinolines. A potent and highly selective isoquinoline CHK1 inhibitor (SAR-020106) was identified, which potentiated the efficacies of irinotecan and gemcitabine in SW620 human colon carcinoma xenografts in nude mice.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div class="extra-info-sec articleNote"><h4><span>â¥</span>Â Author Contributions</h4><p class="last">These authors contributed equally to this work.</p></div><div class="extra-info-sec articleNote withdrawn"><h4><span></span>Â Accession Codes</h4><p class="last">PDB ID Codes: 2ym3, 2ym4, 2ym5, 2ym6, 2ym7, 2ym8.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_40074" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_40074" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The DNA damage response network ensures the fidelity of DNA replication and controls the repair of damage arising during cellular replication or from exogenous agents such as genotoxic drugs. Checkpoint kinase 1 (CHK1) is a serine/threonine kinase occupying a central position in this complex network of cell regulatory and DNA repair mechanisms.<a onclick="showRef(event, 'ref1 ref2 ref3'); return false;" href="javascript:void(0);" class="ref ref1 ref2 ref3">(1-3)</a> CHK1 is predominantly activated through phosphorylation on amino acid residues Ser317 and Ser345 by the upstream kinase Ataxia Telangiectasia and Rad3 Related (ATR) in response to single strand breaks in DNA,<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4, 5)</a> and it undergoes autophosphorylation on Ser296.<a onclick="showRef(event, 'ref6 ref7'); return false;" href="javascript:void(0);" class="ref ref6 ref7">(6, 7)</a> G1/S, S, or G2/M cell cycle checkpoints are activated in response to genotoxic antitumor drugs to provide an opportunity for repair of damaged DNA or to activate apoptotic pathways.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> CHK1 is involved in the S-phase checkpoint and stabilizing replication forks, and in the G2/M checkpoint through regulating the stability of the CDC25 phosphatases which control cell cycle progression by regulation of CDK1.<a onclick="showRef(event, 'ref9 ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11 ref12">(9-12)</a> Human cancers frequently have functional defects in the tumor suppressor p53, with consequent loss of G1/S checkpoint control<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> and greater reliance on S and G2/M checkpoints. Thus, S or G2/M checkpoint inhibitors will selectively sensitize p53 deficient cancer cells to DNA damaging agents.<a onclick="showRef(event, 'ref1 ref8 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref1 ref8 ref15 ref16">(1, 8, 15, 16)</a> CHK1 inhibition by siRNA and several small molecule inhibitors, including the lead compound resulting from the studies reported herein,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> has confirmed this in preclinical studies.<a onclick="showRef(event, 'ref18 ref19 ref20 ref21 ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref18 ref19 ref20 ref21 ref22 ref23">(18-23)</a></div><div class="NLM_p last">A range of adenosine 5â²-triphosphate (ATP) competitive CHK1 inhibitors have been reported, with varying selectivity for the target enzyme over other kinases.<a onclick="showRef(event, 'ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref23 ref24 ref25 ref26">(23-26)</a> Inhibitor development has been assisted by structural biology studies of the enzyme, in particular crystallographic analysis of inhibitor binding to the protein.<a onclick="showRef(event, 'ref27 ref28 ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref27 ref28 ref29 ref30">(27-30)</a> As well as ATP-competitive inhibitors, allosteric modulators of CHK1 have been identified.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Some ATP-competitive CHK1 inhibitors have reached early clinical trials in combination with DNA-damaging agents, although the therapeutic outcomes remain to be determined.<a onclick="showRef(event, 'ref2 ref15 ref23 ref32'); return false;" href="javascript:void(0);" class="ref ref2 ref15 ref23 ref32">(2, 15, 23, 32)</a></div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46584" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46584" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Previously we have shown how a fragment-based screening strategy identified several low molecular weight, ligand efficient templates which were developed into early stage CHK1 inhibitors.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(33, 34)</a> The purine template hit <b>1</b> was initially elaborated to the pyrazolopyridine lead <b>2</b>.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Here we describe how structure-based design led, through several scaffold morphing steps, to the evolution of <b>2</b> into a potent and selective CHK1 inhibitor <b>(</b><i><b>R</b></i><b>)-3</b> (SAR-020106,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/medium/jm-2011-007326_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of the template hit <b>1</b>, early stage lead <b>2</b>, and <b>(</b><i><b>R</b></i><b>)-3</b> (SAR-020106). Features conserved in the elaboration of the template hit and early stage lead into a potent and selective CHK1 inhibitor are highlighted in blue and red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007326&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The crystal structure of <b>2</b> bound to CHK1 confirmed that the ligand occupied the ATP pocket and interacted with the hinge region of the kinase. The predicted hydrogen bonds were observed between N1 and N7 of the pyrazolo[3,4-<i>b</i>]pyridine with the backbone amides of Glu85 and Cys87, respectively (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A). The 2-(aminomethyl)morpholine group was located in the ribose pocket, though no specific polar interactions were observed, while the ethyl ester was directed out onto the solvent exposed surface. The area around the gatekeeper and interior pocket was unexplored, and our initial synthetic effort concentrated on probing this area. CHK1 contains a polar amino acid (Asn59; see Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>A) in the interior pocket beyond the gatekeeper residue, which differentiates the enzyme from many other protein kinases where a hydrophobic amino acid is located at the equivalent position.<a onclick="showRef(event, 'ref27 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref29">(27, 29)</a> As a result, the interior pocket of CHK1, defined by Asn59, Glu55, and the Lys38-Asp148 salt bridge, is often observed in crystal structures to contain between 1 and 3 protein bound water molecules (see Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>AâE). Ligand interactions with these protein bound water molecules have been shown to be important in conferring both CHK1 potency and selectivity against other kinases.<a onclick="showRef(event, 'ref27 ref29'); return false;" href="javascript:void(0);" class="ref ref27 ref29">(27, 29)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/medium/jm-2011-007326_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0006.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structures of <b>2</b> (panel A, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ym3">2ym3</a>), <b>4</b> (panel B, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ym4">2ym4</a>), <b>6</b> (panel C, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ym5">2ym5</a>), <b>8</b> (panel D, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ym6">2ym6</a>), <b>20</b> (panel E, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ym7">2ym7</a>), and <b>(</b><i><b>R</b></i><b>)-3</b> (panel F, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ym8">2ym8</a>) bound to the CHK1 kinase domain. Red spheres represent water molecules modeled in the refinement. Dashed gray lines represent hydrogen bonds. Panel G: Plan view of the overlay of CHK1 inhibitors <b>2</b> (cyan), <b>8</b> (gray), <b>20</b> (blue), and <b>(</b><i><b>R</b></i><b>)-3</b> (gold) relative to the hinge region of CHK1 (cartoon).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007326&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Examination of the crystal structure of <b>2</b> suggested that a pendant phenyl at the 3-position of the pyrazolo[3,4-<i>b</i>]pyridine could provide a suitable vector toward the interior pocket. Alternatively, fusing a third ring to the core to form a tricycle could also provide a platform for substitution to contact the protein-bound water molecules. Accordingly, sets of analogues exploring these hypotheses were prepared and evaluated. We focused on substitution with functional groups having the potential to form hydrogen bonding interactions with the bound water molecules or the polar residues comprising the Asp148-Lys38 salt bridge in CHK1. Inhibition data for selected compounds tested against CHK1 are described in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>. In addition, we investigated the ability of the compounds to inhibit the functionally distinct checkpoint kinase 2 (CHK2).<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> Selectivity for inhibition of CHK1 over CHK2 is desirable, since simultaneous ablation of both CHK1 and CHK2 by RNAi has been shown to be inferior to selective depletion of CHK1 alone in overriding the S-phase checkpoint.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> The interior pocket of CHK2 contains a hydrophobic leucine residue at the equivalent site to Asn59 in CHK1, providing a less favorable environment for the binding of water molecules or polar ligand functionality. Thus, successful targeting of the interior pocket in CHK1 with polar functionality is predicted to lead to selectivity against CHK2.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Inhibition of CHK1 and CHK2 by Bicyclic and Tricyclic Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/medium/jm-2011-007326_0014.gif" alt="" id="GRAPHIC-d891e665-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center" char=".">CHK1 Inhibition IC<sub>50</sub> (Î¼M)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">CHK2Â Inhibition IC<sub>50</sub> (Î¼M)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">Selectivity (CHK2/CHK1)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">LE (kcalÂ mol<sup>â1</sup>Â non-HÂ atom<sup>â1</sup>)<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">1.0â(0.86,â1.2)</td><td class="colsep0 rowsep0" align="left">50 (26, 74)</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">0.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">1.5â(1.3,â1.8)</td><td class="colsep0 rowsep0" align="left">n.d.<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">0.27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">3.2â(2.2,â4.2)</td><td class="colsep0 rowsep0" align="left">28 (13, 43)</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">0.31</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char=".">0.43â(0.26,â0.60)</td><td class="colsep0 rowsep0" align="left">3.4 (Â±1.16)<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">0.36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i><b>rac</b></i><b>-7</b></td><td class="colsep0 rowsep0" align="char" char=".">3.2â(2.4,â3.9)</td><td class="colsep0 rowsep0" align="left">12 (11, 13)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">0.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(</b><i><b>R</b></i><b>)-7</b></td><td class="colsep0 rowsep0" align="char" char=".">3.0â(2.9,â3.2)</td><td class="colsep0 rowsep0" align="left">13 (11, 16)</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">0.37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(</b><i><b>S</b></i><b>)-7</b></td><td class="colsep0 rowsep0" align="char" char=".">2.3â(1.55,â3.0)</td><td class="colsep0 rowsep0" align="left">3.5 (2.3, 4.6)</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">0.38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char=".">0.88â(Â±0.21)â<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">19 (16, 23)</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="char" char=".">0.40</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="char" char=".">3.7â(3.2,â4.2)</td><td class="colsep0 rowsep0" align="left">10 (9.3, 11)</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">0.33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="char" char=".">1.7â(1.7,â1.8)</td><td class="colsep0 rowsep0" align="left">23 (22, 24)</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="char" char=".">0.47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char=".">1.7â(1.7,â1.8)</td><td class="colsep0 rowsep0" align="left">11 (8.1, 14)</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">0.45</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="char" char=".">0.67â(0.53,â0.80)</td><td class="colsep0 rowsep0" align="left">16 (10, 21)</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">0.43</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char=".">0.29â(Â±0.02)<a class="ref internalNav" href="#t1fn5" aria-label="e">e</a></td><td class="colsep0 rowsep0" align="left">12 (6.8, 16)</td><td class="colsep0 rowsep0" align="char" char=".">41</td><td class="colsep0 rowsep0" align="char" char=".">0.43</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">IC<sub>50</sub> determined in a dissociation-enhanced lanthanide fluorescent immunoassay (DELFIA).<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Mean of two independent determinations; individual values in parentheses. Standard inhibitor staurosporine gave CHK1 IC<sub>50</sub> = 2.1 (Â±1.8) nM and CHK2 IC<sub>50</sub> = 27 (Â±8) nM.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Ratio of IC<sub>50</sub> values (CHK2/CHK1).</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Ligand efficiency (LE) calculated using LE = [â1.4 log<sub>10</sub>(IC<sub>50</sub> (M))]/(number of heavy atoms).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></p></div><div class="footnote" id="t1fn4"><sup>d</sup><p class="last">Not determined.</p></div><div class="footnote" id="t1fn5"><sup>e</sup><p class="last">Mean (Â±SD) of at least three independent determinations.</p></div></div></div><div class="NLM_p">Among several analogues prepared,<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> the trisubstituted pyrazolopyridine analogue <b>4</b> retained the potency of <b>2</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) and was shown by X-ray crystallography to hydrogen bond to a water in the interior pocket through the nitrile group (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>B). However, the crystal structure also indicated that the ligand was unable to simultaneously position all three substituents optimally in the ATP-binding site due to steric congestion. The 2-(aminomethyl)morpholine and ethyl ester were both twisted into potentially undesirable conformations compared to <b>2</b>, with the ester oriented orthogonal to the bicycle. The ligand attained only equivalent potency to <b>2</b> despite the addition of extra interacting functionality, reflected in the reduced ligand efficiency. We attempted to resolve the overcrowding by reverting to a pyrrolo[2,3-<i>d</i>]pyrimidine core<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> and removing the pendant ethoxycarbonyl group. Substitution with the 3-(3-cyanophenyl) group resulted in compound <b>5</b>, having slightly reduced CHK1 potency relative to <b>4</b>, while the 3-(3-(hydroxymethyl)phenyl) analogue <b>6</b> gave a 3-fold increase in activity. However, the selectivities for CHK1 against CHK2 were reduced for both <b>5</b> and <b>6</b> compared to <b>2</b>.</div><div class="NLM_p">The crystal structure of <b>6</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>C) showed that although steric crowding around the core was reduced, the 3-hydroxymethyl substituent had adopted an alternative orientation along a vector into the ribose pocket and away from the interior pocket. The selectivity of compound <b>2</b> for CHK1 over CHK2 indicates that, in common with many ATP-competitive inhibitors binding to active kinase conformations,<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> some specificity for inhibition can be obtained through interactions with the selectivity (or solvent-exposed) surface at the entrance to the ATP-binding cleft. The amino acid residues comprising this region vary between kinases and thus alter the properties of the surface. In CHK1 the surface includes contributions from Tyr86, Cys87, and Ser88 (see Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>F), while in CHK2 the equivalent residues are leucine, methionine, and glutamate, respectively. In compound <b>6</b> the absence of the pendant ethoxycarbonyl group and the failure of the hydroxymethyl group to engage with the water-filled pocket removed the potential contributions to CHK1 selectivity.</div><div class="NLM_p">One possible approach to restoring selectivity was to replace the morpholine substituent with a less bulky, unbranched alkylamine and reintroduce the 5-substituent to the pyrazolo[3,4-<i>b</i>]pyridine core. Less bulky alkylamine 4-substituents would be anticipated to relieve the crowding seen in <b>4</b> and permit both the 3- and 5-substituents to be present in favorable conformations for binding to CHK1. However, the 2-(aminomethyl)morpholine or similar cyclic 4-substituents on the 3-aryl substituted bicyclic cores were important in establishing novelty to provide patentable compounds in an area which has been intensively exemplified as kinase inhibitor scaffolds.<a onclick="showRef(event, 'ref40 ref41 ref42 ref43 ref44 ref45 ref46'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42 ref43 ref44 ref45 ref46">(40-46)</a> Instead, we maintained the morpholine substituent but elaborated the bicyclic core by the addition of a fused ring.</div><div class="NLM_p">Initial compounds prepared from a commercially available pyrimidoindole tricyclic core (<b>7</b>) gave compounds with similar CHK1 potencies and ligand efficiencies to <b>2</b>. No preference was seen for the enantiomers of the 2-(aminomethyl)morpholine group, <b>(</b><i><b>R</b></i><b>)-7</b> and <b>(</b><i><b>S</b></i><b>)-7</b>. The requirement for the inclusion of a suitable H-bond donor or acceptor capable of interacting with the protein-bound water molecules led to a more involved synthetic effort, resulting in both the nitrile substituted analogue <b>9</b> and the introduction of a nitrogen into the fused ring to give the 9H-pyrimido[2,3-<i>b</i>]azaindole <b>8</b>. While addition of the nitrile group <b>9</b> led to a drop in LE, the more compact <b>8</b> gave equivalent potency and LE to <b>2</b> and restored some of the selectivity over CHK2. X-ray crystallography confirmed that the azaindole nitrogen effectively contacted the network of bound waters in the interior pocket of CHK1, providing a rationale for the recovery of the selectivity in the absence of a substituent directed toward Ser88 and the selectivity surface (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>D).</div><div class="NLM_p">Importantly, the pyrimido[2,3-<i>b</i>]azaindole core of <b>8</b> provided the opportunity to introduce a more varied range of alkylamino substituents to replace the 2-(aminomethyl)morpholine while still generating novel inhibitors.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> The influence of the alkylamino group was probed with an array of analogues, including <b>10</b>â<b>13</b>, resulting in the identification of the 4-(aminomethyl)piperidine <b>13</b> as a more potent and selective alternative. However, the rigid planar nature of the tricyclic scaffold and synthetic challenges to further elaboration prompted us to consider another scaffold morphing step and to disconnect the middle ring of the tricycle. This was envisaged to introduce a degree of flexibility into the core hinge-binding pharmacophore, potentially allowing the ligand to adopt a better conformation for simultaneous interaction with the hinge region and the water-filled pocket. An efficient synthesis of a small array of compounds allowed this variation to be quickly assessed (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Inhibition of CHK1 and CHK2 by <i>N</i>-(Pyridin-3-yl)- or <i>N</i>-(Pyrazin-2-yl)pyrimidin-4-amines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/medium/jm-2011-007326_0015.gif" alt="" id="GRAPHIC-d891e1089-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/medium/jm-2011-007326_0016.gif" alt="" id="GRAPHIC-d891e1090-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> determined in DELFIA.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Mean of two independent determinations; individual values in parentheses. Standard inhibitor staurosporine gave CHK1 IC<sub>50</sub> = 2.1 (Â±1.8) nM and CHK2 IC<sub>50</sub> = 27 (Â±8) nM.</p></div><div class="footnote" id="t2fn2"><sup>Table b</sup><p class="last">Ratio of IC<sub>50</sub> values (CHK2/CHK1).</p></div><div class="footnote" id="t2fn3"><sup>Table c</sup><p class="last">LE = [â1.4 log<sub>10</sub>(IC<sub>50</sub> (M))]/(number of heavy atoms).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></p></div><div class="footnote" id="t2fn4"><sup>Table d</sup><p class="last">Not determined.</p></div><div class="footnote" id="t2fn5"><sup>Table e</sup><p class="last">Mean (Â±SD) of at least three independent determinations.</p></div><div class="footnote" id="t2fn6"><sup>Table f</sup><p class="last">Single determination.</p></div></div><div></div></div><div class="NLM_p">The potency of simple <i>N</i>-(pyridin-3-yl)pyrimidin-4-amines (see representative example 14) suffered, presumably as the steric clash between the pyrimidine 5-H and pyridine 4â²-H would force the core to adopt too extreme a nonplanar conformation. By switching the pyridine to a pyrazine ring, this was overcome, and the first âring openedâ adaptation, <i>N</i>-(pyrazin-2-yl)pyrimidin-4-amine (<b>15</b>), showed some activity, though disappointingly 75-fold less than that of the parent compound, <b>13</b>. The incorporation of pyrazine substitution into CHK1 inhibitors has been reported previously for a series of pyrazin-2-yl ureas,<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48, 49)</a> where the additional nitrogen atom in the pyrazine ring was shown by crystallographic studies to be important in restraining the urea moiety in the bioactive conformation.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Comparisons with these CHK1 inhibitors suggested that appending a nitrile in the 2-position of the pyrazine could be beneficial through achieving additional interactions with the protein in the region of the water-filled pocket. Comparing <b>15</b> with <b>16</b>, the addition of the nitrile increased the CHK1 potency 15-fold. Optimization of the diamine substituent proved fruitful, as 4-(aminomethyl)piperidine gave excellent CHK1 potency while retaining selectivity over CHK2 when incorporated into the <i>N</i>-(pyrazin-2-yl)pyrimidin-4-amine <b>20</b>.</div><div class="NLM_p">Crystallographic data explained the increased activity and selectivity of the 2-cyanopyrazines, as there was a clear interaction of the nitrile with the conserved Lys38 and the water network filling the interior pocket (see Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>E). Interestingly, a sharp loss of activity was seen when the terminal amine (<b>19â20</b>) was replaced with structurally similar but nonbasic polar groups (<b>21</b>â<b>22</b>). This structureâactivity relationship is in contrast with that demonstrated for (6-cyanopyrazin-2-yl)urea CHK1 inhibitors,<a onclick="showRef(event, 'ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref48 ref49">(48, 49)</a> where replacement of a pendant amine with nonbasic polar groups was tolerated. Thus, although occupying similar space within the ATP-binding site, as shown by the crystallographic data, and interacting with some similar points on the CHK1 protein, the two series did not have identical structureâactivity relationships.</div><div class="NLM_p">With limited points of substitution that would enable us to probe the solvent-exposed selectivity surface, we sought to exchange the pyrimidine for a pyridine. Consistent with the structureâactivity relationships discussed above, the reintroduction of the ester 5-substituent in <b>23</b> increased CHK1 affinity by 4-fold (<b>23</b> vs <b>20</b>) and CHK1 vs CHK2 selectivity to approximately 300-fold. The 4,5-disubstituted pyridine scaffold presented one opportunity for optimization of the inhibitors, which will be reported separately. We also pursued a further scaffold morphing step, seeking to combine the 4- and 5-substituents into a fused ring to give imidazo[4,5-<i>c</i>]pyridines and isoquinolines. This gave the micromolar inhibitors <b>24</b> and <b>27</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>), with encouraging ligand efficiencies (>0.3 kcal mol<sup>â1</sup> heavy atom<sup>â1</sup>) for the unsubstituted scaffolds.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Inhibition of CHK1 and CHK2 by Imidazo[4,5-<i>c</i>]pyridines and Isoquinolines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/medium/jm-2011-007326_0012.gif" alt="" id="GRAPHIC-d891e1233-autogenerated" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/medium/jm-2011-007326_0013.gif" alt="" id="GRAPHIC-d891e1234-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>Table a</sup><p class="last">IC<sub>50</sub> determined in DELFIA.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Mean of two independent determinations; individual values in parentheses. Standard inhibitor staurosporine gave CHK1 IC<sub>50</sub> = 2.1 (Â±1.8) nM and CHK2 IC<sub>50</sub> = 27 (Â±8) nM.</p></div><div class="footnote" id="t3fn2"><sup>Table b</sup><p class="last">LE = [â1.4 log<sub>10</sub>(IC<sub>50</sub> (M))]/(number of heavy atoms).<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></p></div><div class="footnote" id="t3fn3"><sup>Table c</sup><p class="last">Not determined.</p></div><div class="footnote" id="t3fn4"><sup>Table d</sup><p class="last">Mean (Â±SD) of at least three independent determinations.</p></div><div class="footnote" id="t3fn5"><sup>Table e</sup><p class="last">Single determination.</p></div><div class="footnote" id="t3fn6"><sup>Table f</sup><p class="last">Poor solubility gave variability for this analogue in this assay.</p></div></div><div></div></div><div class="NLM_p">We explored the reintroduction of basic amine substituents to mimic the substitution of <b>20</b> and <b>23</b>, originating either from the imidazole nitrogen of the imidazo[4,5-<i>c</i>]pyridines or through tethering via an ether linkage to the pyrazine portion of the scaffolds.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> As shown by the representative example <b>25</b>, the analogues with the side chain originating from the imidazo[4,5-<i>c</i>]pyridines had substantially decreased affinity (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Moving the basic amine substituent to the pyrazine in <b>26</b> and <b>28</b> gave much improved activity against CHK1 with good selectivity over CHK2. While both imidazo[4,5-<i>c</i>]pyridines (e.g., <b>26</b>) and isoquinolines (e.g., <b>28</b>) were potent and selective CHK1 inhibitors, the cellular activities of the imidazo[4,5-<i>c</i>]pyridines were substantially lower than those of the corresponding isoquinolines (see Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> and discussion below), and thus, further optimization concentrated on the latter heterocycle.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. G2 Checkpoint Abrogation and Potentiation of SN38 Cytotoxicity in Human Colon Cancer Cells by Selected Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Â </th><th class="colsep0 rowsep0" align="center" char=".">CHK1 IC<sub>50</sub> (Î¼M)<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">SRB (HT29) GI<sub>50</sub> (Î¼M)<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">Checkpoint abrogation (HT29) IC<sub>50</sub> (Î¼M)<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">Potentiation of SN38 cytotoxicity (HT29) P.I.<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">ALogP<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center" char=".">TPSA<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="left">64<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">18.5<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">â0.22</td><td class="colsep0 rowsep0" align="char" char=".">106</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char=".">0.88</td><td class="colsep0 rowsep0" align="left">62<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">13.5<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">â0.44</td><td class="colsep0 rowsep0" align="char" char=".">93</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char=".">0.29</td><td class="colsep0 rowsep0" align="left">17.5<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">3.1<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">84</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="char" char=".">0.40</td><td class="colsep0 rowsep0" align="left">24<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">â0.21</td><td class="colsep0 rowsep0" align="char" char=".">125</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="left">76.5<a class="ref internalNav" href="#t4fn6" aria-label="f">f</a></td><td class="colsep0 rowsep0" align="left">n.d.</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">0.077</td><td class="colsep0 rowsep0" align="char" char=".">111</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="left">46 (Â±39, <i>n</i>Â =Â 3)</td><td class="colsep0 rowsep0" align="left">23 (Â±22, <i>n</i>Â =Â 3)</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">0.19</td><td class="colsep0 rowsep0" align="char" char=".">103</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="char" char=".">0.049</td><td class="colsep0 rowsep0" align="left">125 (120, 130)</td><td class="colsep0 rowsep0" align="left">128 (120, 135)</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">124</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="left">26 (21, 30)</td><td class="colsep0 rowsep0" align="left">>100, >100</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">74</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="char" char=".">0.017</td><td class="colsep0 rowsep0" align="left">1.2 (1.1, 1.2)</td><td class="colsep0 rowsep0" align="left">0.17 (0.16, 0.17)</td><td class="colsep0 rowsep0" align="char" char=".">3.3</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">96</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="char" char=".">0.74</td><td class="colsep0 rowsep0" align="left">120 (120, 120)</td><td class="colsep0 rowsep0" align="left">2.7 (2.0, 3.3)</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">74</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="char" char=".">0.022</td><td class="colsep0 rowsep0" align="left">0.53 (0.52, 0.53)</td><td class="colsep0 rowsep0" align="left">0.18, 0.008<a class="ref internalNav" href="#t4fn7" aria-label="g">g</a></td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">2.9</td><td class="colsep0 rowsep0" align="char" char=".">96</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>(</b><i><b>R</b></i><b>)-3</b></td><td class="colsep0 rowsep0" align="char" char=".">0.013</td><td class="colsep0 rowsep0" align="left">0.47 (Â±0.19, <i>n</i>Â =Â 11)</td><td class="colsep0 rowsep0" align="left">0.055 (Â±0.019, <i>n</i>Â =Â 5)</td><td class="colsep0 rowsep0" align="char" char=".">3.1â(Â±1.6,â<i>n</i>Â =Â 5)</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">87</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>a</sup><p class="last">IC<sub>50</sub> determined in DELFIA. Mean of at least two independent determinations.</p></div><div class="footnote" id="t4fn2"><sup>b</sup><p class="last">SRB cytotoxicity assay; mean of two independent determinations unless otherwise stated.</p></div><div class="footnote" id="t4fn3"><sup>c</sup><p class="last">G<sub>2</sub> checkpoint abrogation assay.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></p></div><div class="footnote" id="t4fn4"><sup>d</sup><p class="last">PI; ratio of SRB GI<sub>50</sub> for CHK1 inhibitor alone to GI<sub>50</sub> for the combination of CHK1 inhibitor and SN38 (see ref <a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">17</a>).</p></div><div class="footnote" id="t4fn5"><sup>e</sup><p class="last">ALogP<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> and TPSA<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> calculated with Pipeline Pilot (v7).<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a></p></div><div class="footnote" id="t4fn6"><sup>f</sup><p class="last">Single determination.</p></div><div class="footnote" id="t4fn7"><sup>g</sup><p class="last">Poor aqueous solubility gave variability for this analogue in this assay.</p></div></div></div><div class="NLM_p">Several published urea-based CHK1 inhibitors<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> direct a chlorine substituent toward the selectivity surface. Overlays of our isoquinoline scaffold with these ureas showed that a chlorine in the 8-position could be similarly positioned and have the potential to make a short oxygenâhalogen interaction with the carbonyl oxygen of Ser88.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> To explore this, reoptimization of the basic amine substituent was conducted on isoquinolines with and without 8-chloro substitution (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). In the main, the chlorinated analogues retained CHK1 activity, and this set of compounds led us to the potent and selective compound <b>(</b><i><b>rac</b></i><b>)-3</b>. The CHK1 enzyme inhibitory activity of (<i><b>rac</b></i><b>)-3</b> could be attributed, on testing of the enantiomeric pair, to the <i>R</i>-enantiomer, (<i><b>R</b></i><b>)-3</b>.</div><div class="NLM_p">X-ray crystallography of <b>(</b><i><b>R</b></i><b>)-3</b> in the CHK1 enzyme (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>F) showed binding through hydrogen-bonding to Glu85 and Cys87 in the hinge region, the hydrogen-bonding of the nitrile to Lys38, and the dimethylamine nestled in the ribose pocket. The branched methyl on the side chain fitted closely to Val23 while the isoquinoline chloro substituent was close to the specificity surface without projecting too far toward solvent. The distance from the chlorine to the carbonyl oxygen of Ser88 measured in the 2.1 Ã resolution crystal structure was 3.44 Ã, greater than the sum of the Cl and O van der Waals radii. The potency of <b>(</b><i><b>rac</b></i><b>)-3</b> was only approximately twice that of the des-chloro analogue <b>34</b>, suggesting that an oxygenâhalogen interaction was not strongly contributing to the binding energy of <b>(</b><i><b>R</b></i><b>)-3</b>. However, comparison of <b>34</b> and <b>(</b><i><b>rac</b></i>)<b>-3</b> showed that selectivity against CHK2 was improved from 120-fold to greater than 3000-fold by the addition of the 8-chloro substituent.</div><div class="NLM_p">Selected compounds were investigated for activity in cellular assays during optimization of CHK1 potency. Cytotoxicity was measured with a sulforhodamine B (SRB) assay<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> using the human colon carcinoma cell line HT29. A cell based enzyme-linked immunosorbent assay (ELISA) was developed to measure G<sub>2</sub> checkpoint abrogation by quantifying the level of M-phase phosphoprotein 2 (MPM2) expression (a measure of mitosis) in HT29 cells that passed through an etoposide-induced G<sub>2</sub> arrest into mitosis, where they were trapped using nocodazole.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> The ratio of SRB cytoxicity to cellular ELISA activity gave an activity index (AI), which we found to be a useful indicator of selective inhibition of CHK1 in cells.<a onclick="showRef(event, 'ref17 ref48'); return false;" href="javascript:void(0);" class="ref ref17 ref48">(17, 48)</a></div><div class="NLM_p">As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> with selected examples of the scaffolds described above, the cytotoxity was generally weak, with only <b>30</b> and <b>(</b><i><b>R</b></i><b>)-3</b> giving GI<sub>50</sub> values in the nanomolar range. The potency in the G2 checkpoint abrogation assay in general tracked the CHK1 activity. Isoquinolines <b>28</b>, <b>30</b>, and <b>(</b><i><b>R</b></i><b>)-3</b>, three compounds with CHK1 IC<sub>50</sub> <100 nM, abrogated the etoposide-induced G2 checkpoint with IC<sub>50</sub> < 200 nM. Conversely, the imidazo[4,5-<i>c</i>]pyridines, e.g. <b>26</b>, demonstrated good potency in the enzyme assay but showed minimal activity in both the G2 checkpoint abrogation and SRB assays. We attributed this to poor permeability of the imidazo[4,5-<i>c</i>]pyridine core scaffold when paired with the piperidine, consistent with the high polar surface area calculated for <b>26</b>.</div><div class="NLM_p">Compounds abrogating the G<sub>2</sub> checkpoint at nanomolar concentrations while remaining relatively noncytotoxic (AI > 4) were assessed further to gauge the enhanced efficacy when used in combination with a cytotoxic drug. HT29 colon cancer cells were exposed to a fixed concentration of SN38 (the active metabolite of the DNA topoisomerase I inhibitor irinotecan<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a>) that inhibited growth by 50% relative to untreated controls, and they were additionally exposed to increasing concentrations of the CHK1 inhibitor in a 96 h SRB assay. The ability of the CHK1 inhibitor to enhance the cytotoxicity of SN38 was expressed as a potentiation index (PI), which was the ratio of GI<sub>50</sub> for the CHK1 inhibitor alone and the GI<sub>50</sub> for the CHK1 inhibitor in combination with SN38.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Potentiation was observed for <b>27</b>, <b>28</b>, <b>29</b>, and <b>(</b><i><b>R</b></i><b>)-3</b>, with all except <b>27</b> giving a greater than 2-fold potentiation. The two analogues having the most favorable properties overall were <b>28</b> and <b>(</b><i><b>R</b></i><b>)-3</b>, which had GI<sub>50</sub> values of 345 nM and 190 nM, respectively, in the presence of SN38. These encouraging cellular assay data led to further profiling of <b>(</b><i><b>R</b></i><b>)-3</b>.</div><div class="NLM_p">The inhibitory activity of <b>(</b><i><b>R</b></i><b>)-3</b> was assessed at 1 Î¼M concentration against a representative sample of 124 kinases from across the human kinome, using radiometric assay format<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> at [ATP] â¼ <i>K</i><sub>m,ATP</sub> for all the enzymes (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). Only CHK1 and 6 other kinases out of 124 showed >80% inhibition at 1 Î¼M. A further 8 kinases showed some inhibition (40â80%) at 1 Î¼M, but the majority of kinases tested (109/124) showed less than 40% inhibition at 1 Î¼M concentration of <b>(R)-3</b>, indicative of >100-fold selectivity. The kinase inhibitory activities of <b>(</b><i><b>R</b></i><b>)-3</b> were also determined in a smaller panel at the higher concentration of 10 Î¼M (see <a class="ref internalNav" href="#notes-3" aria-label="Supporting Information">Supporting Information</a>). The compound also displayed good selectivity at this higher concentration, where only CHK1 and 8 other kinases out of 50 tested showed >80% inhibition.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/medium/jm-2011-007326_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0008.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Selectivity profile of <b>(</b><i><b>R</b></i><b>)-3</b> against a panel of 124 kinases measured at 1 Î¼M concentration of the test compound with [ATP] â¼ <i>K</i><sub>m,ATP</sub> for each kinase. Kinase dendrogram<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> reproduced courtesy of Cell Signaling Technology, Inc. (<a href="http://www.cellsignal.com" class="extLink">www.cellsignal.com</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007326&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Metabolic turnover of <b>(</b><i><b>R</b></i><b>)-3</b> in mouse and rat liver microsomes was high (80% and 92% metabolized at 30 min, respectively), but the compound was appreciably more stable in human liver microsomes (35% metabolized at 30 min). Good permeability was seen for a monolayer of human intestinal epithelial cells (CaCo-2; A to B Pe 1.43 Ã 10<sup>â6</sup> cm s<sup>â1</sup>) with no active efflux observed (ratio A â B/B â A 0.25).</div><div class="NLM_p"><b>(</b><i><b>R</b></i><b>)-3</b> was studied in vivo as previously described,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> including pharmacodynamic and efficacy determinations in SW620 human colon carcinoma xenografts in nude mice.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Although having minimal oral bioavailability in mice (<i>F</i> = 5%), distribution of <b>(</b><i><b>R</b></i><b>)-3</b> following i.p. dosing (40 mg/kg) was sufficient to inhibit CHK1 in the tumors, as shown by inhibition of the irinotecan-induced CHK1 pS296 autophosphorylation (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>A).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> At doses giving inhibition of CHK1 activity in vivo, the selective CHK1 inhibitor <b>(</b><i><b>R</b></i><b>)-3</b> showed no single agent activity in the SW620 xenograft model, and tumors grew at similar rates to the vehicle-treated controls. When dosed (i.p.) in combination with irinotecan, <b>(</b><i><b>R</b></i><b>)-3</b> was observed to potentiate the antitumor activity of the genotoxic drug in the SW620 xenograft model. Tumor growth was delayed when compared to the vehicle-treated control, CHK1 inhibitor alone, or cytotoxic drug alone. Similar data were obtained for the combination of <b>(</b><i><b>R</b></i><b>)-3</b> with gemcitabine<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>B and see ref <a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">17</a>). These experiments demonstrated that the in vitro cellular potency and potentiation of genotoxic cytotoxicity by <b>(</b><i><b>R</b></i><b>)-3</b> translated into in vivo biomarker modulation and potentiation of genotoxic drug efficacy expected for a selective CHK1 inhibitor.<a onclick="showRef(event, 'ref17 ref23'); return false;" href="javascript:void(0);" class="ref ref17 ref23">(17, 23)</a></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/medium/jm-2011-007326_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0009.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Status of pS296 CHK1 autophosphorylation in SW620 tumor xenografts following treatment with either irinotecan alone or in combination with <b>(</b><i><b>R</b></i><b>)</b><b>-(3)</b>.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Tumor bearing animals were administered either vehicle alone, irinotecan alone (25 or 50 mg/kg ip), or irinotecan combined with a fixed dose of <b>(</b><i><b>R</b></i><b>)</b><b>-(3)</b> (40 mg kg<sup>â1</sup> ip) 1 h prior to irinotecan administration. Tumors were collected 6 or 24 h following treatment (6 or 24 after administration of the first agent for combinations) and snap frozen. Tumor protein expression was characterized by Western blotting using 50 Î¼g of sample per lane. (B) Antitumor effects of combining <b>(</b><i><b>R</b></i><b>)-3</b> with irinotecan in nude mice bearing SW620 xenograft tumors.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Symbols: (â) dose administered; (â ) vehicle alone; (shaded up triangles) irinotecan alone (12.5 mg/kg ip); (shaded down triangles) <b>(</b><i><b>R</b></i><b>)-3</b> alone (40 mg/kg ip); (â§«) irinotecan and <b>(</b><i><b>R</b></i><b>)-3</b> combined (<b>(</b><i><b>R</b></i><b>)-3</b> dosed 1 h prior to and 24 h after irinotecan). Values are mean Â± SEM; <i>n</i> = 9â11.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007326&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64170" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64170" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The evolution of pyrazolopyridine <b>2</b>, a micromolar inhibitor of CHK1, to the potent and selective isoquinoline inhibitor <b>(</b><i><b>R</b></i><b>)-3</b> demonstrates how fragment-growing and scaffold morphing strategies can be combined to successfully progress fragment-derived hit matter to compounds with appropriate activity in vivo. By incorporating inhibitor selectivity against CHK2 as a goal from the start of the medicinal chemistry, and guided by determinants of CHK1 selectivity apparent from the structural biology of the enzyme, the promising selectivity for CHK1 in the early fragment-derived leads was maintained and improved. Fragment-growing identified two productive vectors for enhancing the potency and selectivity of the initial bicyclic inhibitors: an extension to contact the water-filled pocket of CHK1, best achieved with a tricyclic heteroaromatic framework, and substitution to bind at the specificity surface of the ATP site. The determination of multiple proteinâligand structures during the optimization confirmed the introduction of productive new binding interactions and allowed a rationalization of the poor affinity of sterically crowded bicycles which adopted energetically unfavorable conformations on binding.</div><div class="NLM_p">Scaffold modification, or morphing, is a common strategy for improvement and diversification of lead molecules derived from screening approaches. In this case, breaking up the tricyclic scaffold to a series of <i>N</i>-(pyrazin-2-yl)pyrimidin-4-amines, followed by optimization of a basic amino-substituted side-chain, maintained the hinge-binding hydrogen bonds and other key interactions for CHK1 potency and selectivity, while addressing challenges of synthetic tractability and crowded intellectual property space encountered with the tricyclic and bicyclic inhibitors, respectively. A further scaffold morphing step was achieved through translocation of the basic amine side-chain, allowing diversification of the hinge-binding group to include a series of 2-amino-isoquinolines. This approach led to the isoquinoline <b>(</b><i><b>R</b></i><b>)-3</b> (SAR-020106), a potent inhibitor of CHK1 with excellent selectivity with respect to CHK2 and a broader sample of the kinome, representing one of the most selective CHK1 inhibitors reported to date. Despite the extensive scaffold modification, the isoquinoline <b>(</b><i><b>R</b></i><b>)-3</b> (MW = 382) retained the good ligand efficiency of the original template hit, 6-(morpholin-4-yl)purine <b>1</b>.</div><div class="NLM_p last">Cell-based assays for selective CHK1 inhibition, through measuring the abrogation of an etoposide-induced G2 checkpoint, and for nonselective cytotoxicity were used to confirm that the observed kinase selectivity translated into the expected CHK1-selective pharmacology in cells. The pharmacokinetic properties of the optimized isoquinoline <b>(</b><i><b>R</b></i><b>)-3</b> were sufficient to demonstrate inhibition of CHK1 in vivo on i.p. dosing. Pharmacodynamic biomarkers showing the activation of CHK1 by genotoxic drugs were inhibited in human tumor xenografts. At a pharmacodynamically active dose, the inhibitor potentiated the antiproliferative efficacy of the genotoxic agents irinotecan and gemcitabine toward human SW620 colon cancer xenografts in nude mice, and minimal effects of the selective CHK1 inhibitor alone were shown. While optimization of pharmacokinetic properties is desirable to generate compounds suitable for development, the isoquinoline <b>(</b><i><b>R</b></i><b>)-3</b> is a useful in vitro and in vivo chemical tool to investigate the effects of selective CHK1 inhibition.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_71524" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_71524" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Synthetic Chemistry</h3><div class="NLM_p">The synthetic procedures for the four scaffolds and the analogues discussed in this paper (<b>3</b>â<b>34</b>) are outlined in Schemes <a class="ref internalNav" href="#sch1" aria-label="1">1</a>â<a class="ref internalNav" href="#sch4" aria-label="4">4</a>. The previously described pyrazolopyridine <b>35</b><a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> was brominated at the 3-position using NBS (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). A SuzukiâMiyaura coupling and deprotection of the amine gave the pyrazolopyridine <b>4</b>. For the pyrrolopyrimidine analogues commercially available 4-chloro-7H-pyrrolo[2,3-<i>d</i>]pyrimidine <b>37</b> was first brominated followed by SEM protection of the pyrazole nitrogen to give <b>38</b>. Displacement of the chlorine substituent with Boc-protected 2-(aminomethyl)morpholine at 100 Â°C in <i>n</i>-butanol gave an advanced intermediate <b>39</b>, which was elaborated using SuzukiâMiyaura couplings. Dual deprotection using TBAF and ethylenediamine in DMF followed by HCl in dioxane/MeOH gave <b>5</b> and <b>6</b>.</div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/medium/jm-2011-007326_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007326&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NBS, DMF, rt, 77%; (ii) PdCl<sub>2</sub>(dppf)Â·CH<sub>2</sub>Cl<sub>2</sub>, 3-cyanophenylboronic acid, Na<sub>2</sub>CO<sub>3</sub>, DME/H<sub>2</sub>O, 140 Â°C, 2 h, microwave, 48%; (iii) TFA, MeOH, 80 Â°C, 62%; (iv) NBS, CH<sub>2</sub>Cl<sub>2</sub>, rt, 83%; (v) NaH, SEM-Cl, DMF, 0 Â°C to rt, 93%; (vi) Boc-amine, TEA, <i>n</i>-BuOH, 100 Â°C, 68%; (vii) Pd(PPh<sub>3</sub>)<sub>4</sub>, phenylboronic acid, Na<sub>2</sub>CO<sub>3</sub>, DME/H<sub>2</sub>O, 120 Â°C, 30 min, microwave, 49â59%; (viii) TBAF, ethane-1,2-diamine, DMF, 60 Â°C, 7 h and then TFA, MeOH, 80 Â°C, 21%; (ix) TBAF, ethane-1,2-diamine, DMF, 60 Â°C, 7 h and then 4 M HClâdioxane, MeOH, 24 h, rt, 17%.</p></p></figure><div class="NLM_p">(4-(9<i>H</i>-Pyrimido[4,5-<i>b</i>]indol-4-yl)-morpholin-2-yl)methanamines <b>7</b> were synthesized by reacting the racemic or single enantiomer<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> Cbz-protected 2-(aminomethyl)morpholine with commercially available 4-chloro-9<i>H</i>-pyrimido[4,5-<i>b</i>]indole (<b>48</b>) and subsequent acid-mediated removal of the Cbz protecting group (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). The pyrido[4â²,3â²:4,5]pyrrolo[2,3-<i>d</i>]pyrimidine and pyrimido[4,5-<i>b</i>]indole-7-carbonitrile tricyclic cores <b>49</b> and <b>50</b> were constructed from 4-chloro-5-nitropyridine (<b>40</b>) and 4-chloro-3-nitrobenzonitrile (<b>41</b>), respectively (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Nucleophilic aromatic subsitution of the starting material with the anion of ethylcyanoacetate and reduction of the nitro group with zinc in acetic acid allowed an intramolecular cyclization which provided the ethyl 2-amino-1<i>H</i>-indole-3-carboxylate <b>45</b> or its 6-aza analogue <b>44</b>. Condensation with formamide completed the tricyclic cores (<b>46</b>, <b>47</b>), and chlorination with phosphorus oxychloride installed the reactive chloride functionality of <b>49</b> and <b>50</b>. The diamines were introduced as described for the previous examples to provide <b>7</b>â<b>13</b>.</div><figure id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/medium/jm-2011-007326_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0010.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007326&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NaH, NCCH<sub>2</sub>CO<sub>2</sub>Et, DMF, 0 Â°C to rt and then <b>40</b> or <b>41</b>, 2 h, rt, 48%; (ii) Zn/AcOH, 95 Â°C, 1 h 15 min, 88%; (iii) formamide, ammonium formate, 170 Â°C, 18 h, 45%; (iv) POCl<sub>3</sub>, 75 Â°C, 18 h, 100%; (v) amine, TEA, DMF, 120 Â°C, 1 h, microwave and then 4 M HCl, dioxane/MeOH, 2.5 h, 3â46%; (vi) amine, TEA, NMP, 140 Â°C, microwave and then MP-TsOH column, 29%.</p></p></figure><div class="NLM_p">The <i>N</i>-(pyridin-2-yl)pyrimidine-4,6-diamines and <i>N</i>-(pyrazin-2-yl)pyrimidine-4,6-diamines were assembled via a palladium-mediated amination of 4,6-dichloropyrimidine (<b>51</b>) with 3-aminopyridine (<b>52</b>), 2-aminopyrazine (<b>53</b>), or 2-amino-5-cyanopyrazine (<b>54</b>) (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). The resulting intermediates <b>55</b>â<b>57</b> were derivatized by S<sub>N</sub>Ar reactions with amines followed by a deprotection step, where required, to yield <b>14</b>â<b>22</b>.</div><figure id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/medium/jm-2011-007326_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007326&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span><sup></sup>Reagents and conditions: (i) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, LiHMDS, THF, 135 Â°C, 20 min, 19%â22%; or when X = CH(<sup>t</sup>Bu<sub>3</sub>P)<sub>2</sub>Pd(0), NaO<sup>t</sup>Bu, toluene, 80 Â°C, 2 h, 45%; (ii) amine, NMP, 145 Â°C, 20 min, (26â41%); (iii) amine, NMP, 145 Â°C, 20 min, followed by TFA, CH<sub>2</sub>Cl<sub>2</sub>, 1 h, rt, or HCl, dioxane, MP-TsOH column (3â63%).</p></p></figure><div class="NLM_p">The azabenzimidazoles <b>60</b> and <b>62</b> were prepared by first stirring 2-bromo-4-chloro-5-nitropyridine (<b>58</b>) at rt with <i>tert</i>-butyl 4-(aminomethyl)piperidine-1-carboxylate or 4-methoxybenzylamine followed by a reduction of the nitro group with tin(II) chloride dihydrate to give the diamine <b>59</b> or <b>61</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Cyclizations to the azabenzimidazoles were effected by heating with acetic anhydride and triethylorthoformate.</div><figure id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/medium/jm-2011-007326_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0005.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007326&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span><sup></sup>Reagents and conditions: (i) 4-(aminomethyl)piperidine-1-carboxylate, TEA, MeCN, 1.5 h, rt, 93%; (ii) SnCl<sub>2</sub>Â·2H<sub>2</sub>O, EtOH, 70 Â°C, 2 h, 88%; (iii) (EtO)<sub>3</sub>CH, Ac<sub>2</sub>O, 100 Â°C, 18 h, 40%â100%; (iv) 4-methoxybenzylamine, TEA, MeCN, 1.5 h, rt, 77%; (v) aryl halide (ArCl for <b>24</b>, <b>25</b>, <b>29</b>; ArI for <b>27</b>), Pd(OAc)<sub>2</sub>, (Â±)-BINAP, NaO<sup>t</sup>Bu, DMF/Tol, 150 Â°C, 30 min, microwave and then MP-TsOH column, 3â41% (11% for <b>25</b> including Boc deprotection); (vi) NHMe<sub>2</sub> (40% in H<sub>2</sub>O), 0â20 Â°C, 2 h 40%; (vii) aq NH<sub>3</sub> (28%), 100 Â°C, o/n, 91%; (viii) NBS, CH<sub>2</sub>Cl<sub>2</sub>, 0 Â°C, 1 h, 42%; (ix) CuI, 18-crown-6, Pd(PPh<sub>3</sub>)<sub>4</sub>, KCN, DMF, reflux, 3 h, 82%; (x) NaH (60% in oil), dioxane, aminoalcohol, 100 Â°C, o/n, 14â32%; (xi) Pd(OAc)<sub>2</sub>, (Â±)-BINAP, Na<sup>t</sup>Bu, DMF/toluene, microwave, 140â150 Â°C, 30 min, or Pd<sub>2</sub>(dba)<sub>3</sub>, Xantphos, Cs<sub>2</sub>CO<sub>3</sub>, toluene, microwave, 140 Â°C, 45 min (2â45%); (xii) Pd(OAc)<sub>2</sub>, (Â±)-BINAP, Na<sup>t</sup>Bu, DMF/Tol, microwave, 140â150Â Â°C, 30 min, or Pd<sub>2</sub>(dba)<sub>3</sub>, Xantphos, Cs<sub>2</sub>CO<sub>3</sub>, toluene, microwave, 140Â Â°C, 45 min followed by TFA, 80 Â°C, 30 min or TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1Â h MP-TsOH column (2â26%).</p></p></figure><div class="NLM_p">In the course of our investigations into the isoquinoline analogues, several different isoquinoline reagents were coupled using a variety of BuchwaldâHartwig conditions (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a> and <a class="ref internalNav" href="#notes-3" aria-label="Supporting Information">Supporting Information</a>). The lengthy synthesis of <b>64</b> has been previously described,<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> while 3-chloroisoquinoline <b>63</b> is commercially available and 8-chloroisoquinolin-3-yl trifluoromethanesulfonate <b>65</b> was synthesized in large quantities using the method reported by Ventura et al.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a></div><div class="NLM_p">BuchwaldâHartwig palladium mediated aminations of <b>60</b> and <b>62</b> with commercially available 2-amino-5-cyanopyrazine <b>66</b> followed by deprotection of Boc or PMB protecting groups using TFA in CH<sub>2</sub>Cl<sub>2</sub> at ambient temperature, or with neat TFA at 80 Â°C, respectively, gave analogues <b>24</b> and <b>25</b>. Similarly, palladium mediated aminations of <b>63</b> and <b>64</b> with <b>66</b> afforded analogues <b>27</b> and <b>29</b> directly.</div><div class="NLM_p last">The BuchwaldâHartwig coupling partners for the other isoquinolines and azabenzimidazoles were constructed from 2,6-dichloropyrazine.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Substitution of one chlorine using NH<sub>3</sub> followed by bromination <i>ortho</i> to the remaining chlorine gave the precursor to the desired 5-amino-3-chloropyrazine-2-carbonitrile <b>70</b>. Cyanation was achieved by heating with potassium cyanide in DMF with a crown ether and Pd(PPh<sub>3</sub>)<sub>4</sub> to complete the synthesis of <b>70</b>. S<sub><i>N</i></sub>Ar with protected or tertiary aminoalkoxides gave a range of substituted pyrazines <b>71</b>â<b>76</b> for BuchwaldâHartwig palladium mediated coupling to the haloheterocycles <b>62</b>â<b>65</b>. The single enantiomers of 1-(dimethylamino)propan-2-ol, e.g. <b>68</b>, required for the synthesis of (<i><b>R</b></i><b>)-3</b> and (<i><b>S</b></i>)<b>-3</b> were prepared by the careful addition of an aqueous solution of dimethylamine to the appropriate, neat, enantiomerically pure propylene oxide, e.g. <b>67</b> (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Palladium mediated couplings between isoquinolines <b>63</b> or <b>65</b> with the relevant substituted pyrazines <b>73</b>, <b>74</b>, <b>75</b>, or <b>76</b> afforded products <b>33</b>, <b>34</b>, <b>3</b>, <b>(</b><i><b>R</b></i><b>)-3</b>, or <b>(</b><i><b>S</b></i><b>)-3</b> directly. The optical purities of <b>(</b><i><b>R</b></i><b>)-3</b> and <b>(</b><i><b>S</b></i><b>)-3</b> were determined to be >95% ee by chiral HPLC analysis (see <a class="ref internalNav" href="#notes-3" aria-label="Supporting Information">Supporting Information</a>). Where required, Boc or PMB protecting groups were removed following coupling reactions using TFA in dichloromethane at ambient temperature, or with neat TFA at 80 Â°C, respectively, to give compounds <b>26</b>, <b>28</b>, and <b>30</b>â<b>32</b>.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General Synthetic Chemistry</h3><div class="NLM_p">Reactions were carried out under N<sub>2</sub>. Organic solutions were dried over MgSO<sub>4</sub> or Na<sub>2</sub>SO<sub>4</sub>. Starting materials and solvents were purchased from commercial suppliers and were used without further purification. Microwave reactions were carried out using Biotage Initiator 60 or CEM microwave reactors. Flash silica chromatography was performed using Merck silica gel 60 (0.025â0.04 mm). Ion exchange chromatography was performed using Isolute Flash SCX-II (acidic) or Flash NH2 (basic) resin cartridges. <sup>1</sup>H NMR spectra were recorded on a Bruker AMX500 instrument at 500 MHz or Bruker Avance instrument at 400 MHz using internal deuterium locks. Chemical shifts (Î´) are reported relative to TMS (Î´ = 0) and/or referenced to the solvent in which they were measured. Combined HPLC-MS analyses were recorded using either</div><div class="NLM_p">(1) (LCT) a Waters Alliance 2795 separations module and Waters/Micromass LCT mass detector with electrospray ionization (+ve or âve ion mode as indicated) with HPLC performed using Supelco DISCOVERY C18, 50 mm Ã 4.6 mm or 30 mm Ã 4.6 mm i.d. columns or an Agilent 6210 TOF HPLC-MS with a Phenomenex Gemini 3 Î¼m C18 (3 cm Ã 4.6 mm i.d.) column [Both were run at a temperature of 22 Â°C with gradient elution of 10â90% MeOH/0.1% aqueous formic acid at a flow rate of 1 mL/min and a run time of 3.5 or 6 min as indicated. UV detection was at 254 nm, and ionization was by positive or negative ion electrospray. The molecular weight scan range was 50â1000 amu.]</div><div class="NLM_p">(2) (ZQ) a Micromass ZQ mass spectrometer/Waters Alliance 2795 HT HPLC with a Phenomenex Gemini 5 Î¼m, C18, 30 mm Ã 4.6 mm i.d. column or a Waters X-Bridge C18, 2.5 Î¼M, 3.0 Ã 30 mm column. [Both were run at a temperature of 35 Â°C with a gradient elution of 5â95% [(0.1% ammonia in acetonitrile)/(0.1% ammonia, 5% acetonitrile, and 0.063% ammonium formate in water)] at a flow rate of 2 mL/min and a run time of 4 or 7 min as indicated. UV detection was at 220â400 nm using a Waters 996 photodiode array UV detector, and ionization was by positive or negative ion electrospray. The molecular weight scan range was 80â1000 amu.]</div><div class="NLM_p">All tested compounds gave >95% purity as determined by these methods. All purified synthetic intermediates gave >95% purity as determined by these methods except where indicated in the text. High-resolution mass spectra were measured using the Agilent TOF system described above.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> Ethyl 3-Bromo-4-(2-((<i>tert</i>-butoxycarbonyl)aminomethyl)morpholino)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-carboxylate (<b>36</b>)</h4><div class="NLM_p last"><i>N</i>-Bromosuccinimide (0.044 g, 0.25 mmol) was added in portions at rt to a solution of ethyl 4-(2-((<i>tert</i>-butoxycarbonylamino)methyl)morpholino)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-carboxylate<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> (<b>35</b>; 0.083 g, 0.20 mmol) in DMF (2 mL). After stirring for 2 h, saturated brine was added and the precipitate was collected by filtration, washed with water, and dried, to yield <b>36</b> as a pale yellow powder (0.076 g, 77%). <sup>1</sup>H NMR (500 MHz, <i>d</i><sub>4</sub>-MeOD) Î´ 1.40â1.46 (9H + 3H, m), 3.05â3.13 (1H, m), 3.13â3.29 (3H, m), 3.39â3.48 (1H, m), 3.55â3.62 (1H, m), 3.95â4.00 (2H, m), 4.02â4.07 (1H, m), 4.44 (2H, q, <i>J</i> = 7.5 Hz), 8.53 (1H, s); LC-MS (LCT, 6 min) <i>R</i><sub>t</sub> 4.83 min; <i>m</i>/<i>z</i> (ESI) 484, 486 [MH<sup>+</sup>].</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> Ethyl 4-(2-(Aminomethyl)morpholino)-3-(3-cyanophenyl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-carboxylate (<b>4</b>)</h4><div class="NLM_p last">A mixture of <b>36</b> (14 mg, 0.029 mmol), PdCl<sub>2</sub>(dppf)Â·CH<sub>2</sub>Cl<sub>2</sub> (18 mg, 10 mol %), 3-cyanophenylboronic acid (9 mg, 0.06 mmol), and Na<sub>2</sub>CO<sub>3</sub> (8 mg, 0.075 mmol) in DME (2 mL) and water (0.5 mL) was heated to 140 Â°C in a microwave reactor for 2 h. The mixture was partitioned between brine (10 mL) and EtOAc (2 Ã 8 mL). The combined organic layers were washed with brine (10 mL) and water (10 mL), dried, filtered, and concentrated. Preparative TLC, eluting with 1:2 hexane/EtOAc, gave ethyl 4-(2-((<i>tert</i>-butoxycarbonylamino)methyl)morpholino)-3-(3-cyanophenyl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-carboxylate as a light yellow oil (7 mg, 48%). <sup>1</sup>H NMR (500 MHz, <i>d</i><sub>4</sub>-MeOD) Î´ 1.44 (3H, t, <i>J</i> = 7.5 Hz), 1.46 (9H, s), 2.86â3.05 (4H, m), 3.06â3.26 (4H, m), 3.57â3.65 (1H, m), 4.45 (2H, q, <i>J</i> = 7.5 Hz), 7.75 (1H, dd, <i>J</i> = 7.5, 7.5 Hz), 7.87 (1H, d, <i>J</i> = 7.5 Hz), 8.01 (1H, d, <i>J</i> = 7.5 Hz), 8.08 (1H, s), 8.55 (1H, s); LC-MS (LCT, 6 min) <i>R</i><sub>t</sub> 4.74 min; <i>m</i>/<i>z</i> (ESI) 507 [MH<sup>+</sup>]. Ethyl 4-(2-((<i>tert</i>-butoxycarbonylamino)methyl)morpholino)-3-(3-cyanophenyl)-1<i>H</i>-pyrazolo[3,4-<i>b</i>]pyridine-5-carboxylate (2 mg, 0.004 mmol) was dissolved in MeOH (2 mL), and TFA (1 mL) was added. After being refluxed at 80 Â°C for 16 h, the solvents were evaporated and the residue was purified on SCX-II acidic resin (2 g), eluting with MeOH and then 2 M NH<sub>3</sub>/MeOH. The basic fractions were combined and concentrated. The crude oil was purified by preparative TLC, eluting with EtOAc, to give <b>4</b> as a yellow oil (1 mg, 62%). <sup>1</sup>H NMR (500 MHz, <i>d</i><sub>4</sub>-MeOD) Î´ 1.43 (3H, t, <i>J</i> = 7.5 Hz), 2.46â2.51 (2H, m), 2.85â2.91 (1H, m), 2.97â3.05 (2H, m), 3.08â3.25 (3H, m), 3.62â3.67 (1H, m), 4.44 (2H, q, <i>J</i> = 7.5 Hz), 7.75 (1H, dd, <i>J</i> = 7.5, 7.5 Hz), 7.90 (1H, d, <i>J</i> = 7.5 Hz), 8.00 (1H, d, <i>J</i> = 7.5 Hz), 8.08 (1H, s), 8.56 (1H, s); LC-MS (LCT, 6 min) <i>R</i><sub>t</sub> 2.56 min; <i>m</i>/<i>z</i> (ESI) 407 [MH<sup>+</sup>]. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>23</sub>N<sub>6</sub>O<sub>3</sub> (M + H) 407.1826, found 407.1831.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 5-Bromo-4-chloro-7-((2-(trimethylsilyl)ethoxy)methyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>38</b>)</h4><div class="NLM_p last">A suspension of 4-chloro-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (<b>37</b>; 0.49 g, 3.2 mmol) and <i>N</i>-bromosuccinimide (0.68 g, 3.8 mmol) in dry CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was stirred at rt for 2.5 h. The suspension was diluted with MeOH and evaporated onto silica. The crude product was purified using flash column chromatography, eluting with 2:1 hexanes/EtOAc, to yield 5-bromo-4-chloro-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine as an off-white solid (0.613 g, 2.64 mmol, 83%). <sup>1</sup>H NMR (500 MHz, <i>d</i><sub>4</sub>-MeOD) Î´ 7.64 (1H, s), 8.56 (1H, s); LC-MS (LCT, 6 min) <i>R</i><sub>t</sub> 3.34 min; <i>m</i>/<i>z</i> (ESI) 236, 234, 232 [MH<sup>+</sup>]. To a solution of 5-bromo-4-chloro-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidine (1.03 g, 4.43 mmol) in DMF (12 mL) at 0 Â°C was added NaH (0.21 g, 60% suspension in oil, 5.05 mmol). After the suspension was stirred at this temperature for 15 min, SEM-Cl (0.89 g, 5.34 mmol) in DMF (2 mL) was added. The resulting suspension was then stirred at 0 Â°C for 20 min and at rt for 1 h. Water (30 mL) was added; the precipitate was collected by filtration, washed with water (2 Ã 30 mL), and dried in vacuo. Compound <b>38</b> was obtained as light pink crystals (1.5 g, 93%). <sup>1</sup>H NMR (500 MHz, <i>d</i><sub>6</sub>-DMSO) Î´ 0.00 (9H, s), 0.90 (2H, t, <i>J</i> = 7.5 Hz), 3.60 (2H, t, <i>J</i> = 7.5 Hz), 5.70 (2H, s), 7.25 (1H, s), 8.70 (1H, s); LC-MS (LCT, 6 min) <i>R</i><sub>t</sub> 4.34 min; <i>m</i>/<i>z</i> (ESI) 366, 364, 362 [MH<sup>+</sup>].</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> <i>tert</i>-Butyl (4-(5-Bromo-7-((2-(trimethylsilyl)ethoxy)methyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)morpholin-2-yl)methylcarbamate (<b>39</b>)</h4><div class="NLM_p last">A solution of <i>tert</i>-butyl morpholin-2-ylmethylcarbamate (0.075 g, 0.35 mmol), <b>38</b> (0.12 g, 0.33 mmol), and Et<sub>3</sub>N (0.13 mL, 0.75 mmol) in <i>n</i>-BuOH (1.5 mL) was heated at 100 Â°C in a microwave reactor for 1 h. The solution was concentrated onto silica gel. The crude product was purified using flash column chromatography, eluting with 2:1 hexanes/EtOAc, to yield <b>39</b> as a viscous oil (0.122 g, 0.225 mmol, 68%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ â0.03 (9H, s), 0.93 (2H, t, <i>J</i> = 7 Hz), 1.27 (9H, s), 2.95 (1H, dd, <i>J</i> = 7, 7 Hz), 3.21â3.23 (2H, m), 3.40â3.45 (1H, m), 3.56 (2H, t, <i>J</i> = 7 Hz), 3.85â3.90 (2H, m), 4.02â4.16 (2H, m), 4.90â4.95 (1H, m), 5.58 (2H, s), 7.28 (1H, s), 8.43 (1H, s); LC-MS (LCT, 6 min) <i>R</i><sub>t</sub> 4.30 min; <i>m</i>/<i>z</i> (ESI) 544, 542 [MH<sup>+</sup>].</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 3-(4-(2-(Aminomethyl)morpholino)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-5-yl)benzonitrile (<b>5</b>)</h4><div class="NLM_p last">A mixture of <b>39</b> (44 mg, 0.08 mmol), Pd(PPh<sub>3</sub>)<sub>4</sub> (5 mg, 4 mol %), 3-cyanophenylboronic acid (24.5 mg, 0.22 mmol), and sodium carbonate (30 mg, 0.17 mmol) in DME (1.5 mL) and water (0.5 mL) was heated to 120 Â°C in a microwave reactor for 30 min. The mixture was partitioned between brine (10 mL) and EtOAc (2 Ã 8 mL). The combined organic layers were washed with brine (10 mL) and water (10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. Preparative TLC, eluting with EtOAc/<i>n</i>-hexane/1:1 (<i>R</i><sub>f</sub> = 0.27), gave <i>tert</i>-butyl (4-(5-bromo-7-((2-(trimethylsilyl)ethoxy)methyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)morpholin-2-yl)methylcarbamate as a yellow oil (27 mg, 59%). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 0.00 to â0.04 (9H, s), 0.95 (2H, t, <i>J</i> = 8.0 Hz), 1.45 (9H, s), 2.65â2.72 (1H, m), 2.82â2.98 (2H, m), 3.09â3.19 (1H, m), 3.35â3.50 (2H, m), 3.61 (2H, t, <i>J</i> = 8.0 Hz), 3.62â3.78 (2H, m), 4.58 (1H, m), 4.78 (1H, broad s), 5.67 (2H, s), 7.30 (1H, s), 7.51â7.53 (2H, m), 7.78 (1H, d, <i>J</i> = 7.5 Hz), 7.84 (1H, s), 8.55 (1H, s); LC-MS (LCT, 6 min) <i>R</i><sub>t</sub> 5.57 min; <i>m</i>/<i>z</i> (ESI) 565 [MH<sup>+</sup>]. A mixture of <i>tert</i>-butyl (4-((5-(3-cyanophenyl)-7-((2-(trimethylsilyl)ethoxy)methyl)-7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)morpholin-2-yl)methylcarbamate (37 mg, 0.066 mmol), 1.0 M TBAF/THF (0.55 mL, 0.55 mmol), and ethane-1,2-diamine (20 Î¼L) in DMF (1.5 mL) was stirred at 60 Â°C under N<sub>2</sub> for 16 h. It was diluted with brine (8 mL) and extracted with EtOAc (2 Ã 10 mL). The combined organic layers were washed with brine (10 mL) and water (10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The crude oil (12 mg) was purified by preparative TLC, yielding 8 mg (LC-MS <i>R</i><sub>t</sub> 4.51 min; <i>m</i>/<i>z</i> (ESI) 435 [MH<sup>+</sup>]). It was then dissolved in a mixture of MeOH (3 mL) and TFA (2 mL). The solution was stirred at 80 Â°C for 12 h. The solvents were evaporated, and the residue was purified on SCX-II acidic resin (1 g) eluting with MeOH and then 2 M NH<sub>3</sub>âMeOH. The basic fractions were combined and evaporated to give <b>5</b> as a yellow oil (4.5 mg, 21%). <sup>1</sup>H NMR (500 MHz, <i>d</i><sub>4</sub>-MeOD) Î´ 2.52â2.60 (1H, m), 2.63â2.70 (1H, m), 2.85â2.95 (2H, m), 3.41â3.51 (2H, m), 3.55â3.60 (1H, m), 3.74 (2H, d, <i>J</i> = 12 Hz), 7.48 (1H, s), 7.79â7.55 (2H, m), 7.88 (<i>J</i> = 7.7 Hz, 1H, d), 7.93 (1H, s), 8.39 (1H, s); LC-MS (LCT, 6 min) <i>R</i><sub>t</sub> 2.12 min; <i>m</i>/<i>z</i> (ESI) 335 [MH<sup>+</sup>]. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>18</sub>H<sub>19</sub>N<sub>6</sub>O (M + H) 335.1620, found 335.1618.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> C-[4-(9<i>H</i>-Pyrimido[4,5-<i>b</i>]indol-4-yl)-morpholin-2-yl]methylamine (<i><b>rac</b></i><b>-7</b>)</h4><div class="NLM_p last">A mixture of 4-chloro-9<i>H</i>-pyrimido[4,5-<i>b</i>]indole (<b>47</b>; 0.045 g, 0.221 mmol), morpholin-2-ylmethylcarbamic acid <i>tert</i>-butyl ester (0.055 g, 0.25 mmol), and Et<sub>3</sub>N (0.10 mL, 0.75 mmol) in DMF (0.70 mL) was heated to 120 Â°C in a microwave reactor for 1 h. The cooled solution was partitioned between water (20 mL) and EtOAc (20 mL). The organic extract was dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. Flash column chromatography, eluting with EtOAc, gave [4-(9<i>H</i>-pyrimido[4,5-<i>b</i>]indol-4-yl)morpholin-2-ylmethyl]carbamic acid <i>tert</i>-butyl ester as a yellow solid (0.021 g, 0.0548 mmol, 25%). LC-MS (LCT, 6 min) <i>R</i><sub>t</sub> 5.57 min; <i>m</i>/<i>z</i> (ESI) 384 [MH<sup>+</sup>]. A solution of [4-(9<i>H</i>-pyrimido[4,5-<i>b</i>]indol-4-yl)morpholin-2-ylmethyl]carbamic acid <i>tert-</i>butyl ester (0.021 g, 0.548 mmol) and 4 M HClâdioxane (1 mL) in MeOH (5 mL) was stirred at rt for 2.5 h. The solution was evaporated to dryness and purified by ion exchange on SCX-II acidic resin (2 g), eluting with MeOH and then 2 M NH<sub>3</sub>âMeOH. The basic fractions were combined. Preparative silica TLC, eluting with 1% NH<sub>3</sub>â9% MeOHâ90% CH<sub>2</sub>Cl<sub>2</sub>, gave <i><b>rac</b></i><b>-7</b> (0.007 g, 0.025 mmol, 46%) as a beige powder. <sup>1</sup>H NMR (500 MHz, <i>d</i><sub>4</sub>-MeOD) Î´ 2.75â2.80 (2H, m), 3.00â3.06 (1H, m), 3.35â3.40 (1H, m), 3.75â3.85 (1H, m), 3.90 (1H, dd, <i>J</i> = 10, 10 Hz), 4.10â4.13 (1H, m), 4.19 (1H, d, <i>J</i> = 13 Hz), 4.25 (1H, d, <i>J</i> = 13 Hz), 7.35 (1H, dd, <i>J</i> = 8.8 Hz), 7.47 (1H, dd, <i>J</i> = 8.8 Hz), 7.57 (1H, d, <i>J</i> = 8 Hz), 7.79 (1H, d, <i>J</i> = 8 Hz), 8.46 (1H, s); LC-MS (LCT, 6 min) <i>R</i><sub>t</sub> 1.98 min; <i>m</i>/<i>z</i> (ESI) 284 [MH<sup>+</sup>].</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> Ethyl 2-Cyano-2-(3-nitropyridin-4-yl)acetate (<b>42</b>)</h4><div class="NLM_p last">Ethylcyanoacetate (3.75 g, 38 mmol) in DMF (3 mL) was added dropwise at 0 Â°C to a suspension of NaH (1.5 g, 60% in mineral oil, 38 mmol) in DMF (9 mL). The reaction mixture was stirred at rt for 30 min and then cooled to 0 Â°C, and 3-nitro-4-chloropyridine (<b>41</b>; 2.63 g, 19 mmol, 1 equiv) in DMF (3 mL) was added slowly. Two molar HCl (20 mL) and EtOAc (20 mL) were added after 2 h stirring at rt, and the organic layer was washed with water and brine, dried, and concentrated to give a red-orange oil. The crude oil was triturated with EtOAc, and the resultant solid was collected by filtration to give <b>42</b> (2.88 g, 48%). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO) Î´ 1.18 (3H, t, <i>J</i> = 7.0 Hz), 4.06 (2H, q, <i>J</i> = 7.0 Hz), 7.58 (1H, br s), 7.88 (1H, dd, <i>J</i> = 1.0, 7.0 Hz), 8.70 (1H, s), 13.2 (1H, br s); LC-MS (ZQ, 4 min) <i>R</i><sub>t</sub> 1.13 min; <i>m</i>/<i>z</i> (ES<sup>â</sup>) 190 [M â EtO], 234 [M â H].</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 2-Amino-1<i>H</i>-pyrrolo[2,3-<i>c</i>]pyridine-3-carboxylic Acid Ethyl Ester (<b>44</b>)</h4><div class="NLM_p last">A solution of <b>42</b> (2.20 g, 9.35 mmol) in AcOH (20 mL) was heated to 80 Â°C under nitrogen. Zinc dust (6.12 g, 94 mmol) in 500 mg portions was added, and then the reaction mixture was heated at 95 Â°C for 1 h 15 min. Upon cooling, the insoluble material was filtered off and washed with fresh AcOH. The filtrate was concentrated, and the residue was treated with saturated NaHCO<sub>3</sub> to give a light brown solid. This was filtered, washed with water, and dried to give <b>44</b> as a light brown solid (1.69 g, 8.24 mmol, 88% yield). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO) Î´ 1.32 (3H, t, <i>J</i> = 7.0 Hz), 4.23 (2H, q, <i>J</i> = 7.0 Hz), 7.0 (2H, br s), 7.41 (1H, d, <i>J</i> = 4.5 Hz), 8.0 (1H, br), 8.31 (1H, br), 11.0 (1H, s, br). LC-MS (TOF, 4 min), <i>R</i><sub>t</sub> = 1.70 min; <i>m</i>/<i>z</i> (ES<sup>+</sup>) 206.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 9<i>H</i>-Pyrido[4â²,3â²:4,5]pyrrolo[2,3-<i>d</i>]pyrimidin-4-ol (<b>46</b>)</h4><div class="NLM_p last">A mixture of <b>44</b> (1.80 g, 8.8 mmol) and ammonium formate (0.62 g, 9.8 mmol) in formamide (10 mL) was heated at 170 Â°C for 18 h. One molar HCl was added to the cooled reaction mixture, and the resulting suspension was filtered to remove insolubles. The filtrate was then adjusted to pH 7 with saturated sodium bicarbonate solution. The resulting precipitate was collected by filtration and dried to a constant weight in a vacuum oven to give <b>46</b> (0.74 g, 45%). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO) Î´ 7.89 (1H, d, <i>J</i> = 4.0), 8.26 (1H, s), 8.37 (1H, d, <i>J</i> = 4.0), 8.83 (1H, s), 12.5 (s, br); LC-MS (ZQ, 4 min) <i>R</i><sub>t</sub> = 0.75 min; <i>m</i>/<i>z</i> (ES<sup>â</sup>) 185 [M â H].</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> 4-Chloro-9<i>H</i>-pyrido[4â²,3â²:4,5]pyrrolo[2,3-<i>d</i>]pyrimidine (<b>49</b>)</h4><div class="NLM_p last">A mixture of <b>46</b> (264 mg, 1.4 mmol) and Et<sub>3</sub>N (750 Î¼L) in POCl<sub>3</sub> (5 mL) was heated at 75 Â°C for 18 h. Toluene was added to the cooled reaction mixture, and the solvents were then removed in vacuo to give <b>49</b> as a brown oil (290 mg, 100%) used directly in the subsequent reaction. LC-MS (ZQ, 4 min) <i>R</i><sub>t</sub> 1.25 min; <i>m</i>/<i>z</i> (ES<sup>+</sup>) 205/207.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 4-(2-(Aminomethyl)morpholino)-9<i>H</i>-pyrido[4â²,3â²:4,5]pyrrolo[2,3-<i>d</i>]pyrimidine (<b>8</b>)</h4><div class="NLM_p last">A mixture of <b>49</b> (20 mg, 0.098 mmol), morpholin-2-ylmethylcarbamic acid <i>tert</i>-butyl ester (32 mg, 0.147 mmol), and Et<sub>3</sub>N (68 mL, 0.489 mmol) in NMP (1 mL) was heated in a microwave reactor at 140 Â°C for 15 min. The reaction mixture was diluted with MeOH and applied to a MP-TsOH cartridge which had been preconditioned with MeOH. The cartridge was flushed with MeOH and left for 20 min. The product was eluted using 2 M NH<sub>3</sub> in MeOH, affording a brown oil, which was purified using preparative HPLC to give 4-(2-(aminomethyl)morpholino)-9H-pyrido[4â²,3â²:4,5]pyrrolo[2,3-d]pyrimidine (11 mg, 40%). <sup>1</sup>H NMR (<i>d</i><sub>4</sub>-MeOD) Î´ 3.10â3.04 (1H, m), 3.25â3.19 (2H, m), 3.58â3.51 (1H, m), 3.83 (1 H, td, <i>J</i> = 11.6, 2.5), 4.00â3.94 (1H, m), 4.14 (1H, dd, <i>J</i> = 11.6, 2.0), 4.32 (1H, d, <i>J</i> = 13.4), 4.46 (1H, d, <i>J</i> = 12.9), 7.78 (1H, d, <i>J</i> = 5.6), 8.43 (1H, d, <i>J</i> = 5.6), 8.46 (2H, br s), 8.54 (1H, s), 8.84 (1H, s); LC-MS (ZQ, 7 min) <i>R</i><sub>t</sub> 1.78 min; <i>m</i>/<i>z</i> (ES<sup>+</sup>)285 [M + H]. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>14</sub>H<sub>17</sub>N<sub>6</sub>O (M + H) 285.1458, found 285.1457.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 5-(6-Chloropyrimidin-4-ylamino)pyrazine-2-carbonitrile (<b>57</b>)</h4><div class="NLM_p last">A mixture of 4,6-dichloropyrimidine (<b>51</b>; 1.0 g, 6.7 mmol), 2-amino-5-cyanopyrazine (<b>54</b>; 806 mg, 6.7 mmol), and bis(triphenylphosphine)palladium(II) chloride (94 mg, 0.134 mmol) in dry THF (24 mL) was degassed under a stream of nitrogen gas over 10 min with stirring. 1 M LiHMDS in THF (7.38 mL, 7.4 mmol) was added, and the mixture was heated at 135 Â°C for 20 min in a microwave reactor. The reaction mixture was adsorbed onto silica and purified by flash chromatography, eluting with 30% EtOAc in hexane, to give <b>57</b> (300 mg, 19%). LC-MS (ZQ, 4 min) <i>R</i><sub>t</sub> = 1.64; min <i>m</i>/<i>z</i> (ES<sup>â</sup>) 231 [M â H].</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> 5-(6-(Piperidin-4-ylmethylamino)pyrimidin-4-ylamino)pyrazine-2-carbonitrile (<b>20</b>)</h4><div class="NLM_p last">A mixture of <b>57</b> (124 mg, 0.533 mmol), 4-(aminomethyl)-1-<i>N</i>-Boc-piperidine (228 mg, 1.066 mmol), and Et<sub>3</sub>N (150 Î¼L, 1.07 mmol) in 1-methyl-2-pyrrolidinone (1 mL) was heated at 145 Â°C for 15 min in a microwave reactor. The mixture was concentrated <i>in vacuo</i>, and the residue was purified by preparative HPLC. The purified solid was dissolved in CH<sub>2</sub>Cl<sub>2</sub> (2 mL) and trifluoroacetic acid (3 mL) and was stirred for 1 h at rt before being applied to a MP-TsOH cartridge. After washing with MeOH, the pure product was eluted using 7 M NH<sub>3</sub> to give <b>20</b> (10 mg, 6.2%). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO, 400 MHz): Î´ 1.30 (3H, m), 1.85 (4H, m), 2.71 (2H, m), 3.18 (2H, m), 3.26 (1H, br s), 7.14 (1H, br s), 8.21 (1H, s), 8.62 (s, 1H), 8.79 (1H, br s); LCMS (LCT, 4 min) <i>R</i><sub>t</sub> = 0.78 min <i>m</i>/<i>z</i> (ES<sup>+</sup>) 311. HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>15</sub>H<sub>19</sub>N<sub>8</sub> (M + H) 311.1742, found 311.1727.</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>N</i><sup><i>4</i></sup>-(4-Methoxybenzyl)-6-bromopyridine-3,4-diamine (<b>61</b>)</h4><div class="NLM_p last">A solution of 4-methoxybenzylamine (0.756 g, 5.51 mmol) in acetonitrile (2 mL) was added to a mixture of 2-bromo-4-chloro-5-nitropyridine (<b>53</b>) (1.19 g, 5.01 mmol) and Et<sub>3</sub>N (0.768 mL, 5.51 mmol) in acetonitrile (8 mL). After stirring for 1.5 h, the solution was diluted with EtOAc (100 mL), and the resulting solution was then washed successively with water and brine before being concentrated in vacuo to a light brown oil which solidified on standing to give <i>N</i>-(4-methoxybenzyl)-2-bromo-5-nitropyridin-4-amine (1.31 g, 3.87 mmol, 77%). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO, 400 MHz) Î´ 3.70 (3H, s), 4.60 (2H, d, <i>J</i> = 6 Hz), 6.95 (2H, d, <i>J</i> = 9 Hz), 7.10 (1H, s), 7.35 (2H, d, <i>J</i> = 9 Hz), 8.80 (s, 1H), 9.00 (br t, 1H, J = 6 Hz). LC-MS (ZQ, 4 min) <i>R</i><sub>t</sub> = 2.13 min; <i>m</i>/<i>z</i> (ESI<sup>â</sup>) 336, 338 [M â H]. Tin(II) chloride dihydrate (4.37 g, 19.4 mmol) was added portionwise to <i>N</i>-(4-methoxybenzyl)-2-bromo-5-nitropyridin-4-amine (1.31 g, 3.87 mmol) in absolute EtOH (10 mL) at rt. The mixture was heated at 70 Â°C for 2 h before being concentrated in vacuo. The residue was suspended in a mixture of EtOAc and saturated sodium bicarbonate solution and filtered. The insoluble solids were washed with EtOAc. The aqueous phase was re-extracted with EtOAc, and the combined organic layers were washed with brine, dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated to give <b>61</b> as a brown solid (1.05 g, 3.41 mmol, 88%). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO, 400 MHz) Î´ 3.75 (3H, s), 4.30 (2H, d, <i>J</i> = 5.5 Hz), 4.85 (2H, br s), 6.35 (1H, br t, 5.5 Hz), 6.45 (1H, s), 6.90 (2H, d, <i>J</i> = 8.5 Hz), 7.30 (2H, d, <i>J</i> = 8.5 Hz), 7.40 (1H, s); LC-MS (ZQ, 4 min) <i>R</i><sub>t</sub> = 1.77 min; <i>m</i>/<i>z</i> (ESI<sup>â</sup>) 306, 308; (ESI<sup>+</sup>) 308, 310 [MH<sup>+</sup>].</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> 1-(4-Methoxybenzyl)-6-bromo-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridine (<b>62</b>)</h4><div class="NLM_p last">Acetic anhydride (1.28 mL, 13.6 mmol) was added to a solution of <b>61</b> (1.05 g, 3.41 mmol) in triethylorthoformate (13 mL). The mixture was heated at 100 Â°C for 18 h and then concentrated to give <b>62</b> as a brown oil (1.18 g, quantitative). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO, 400 MHz) Î´ 3.70 (3H, s), 5.45 (2H, s), 6.90 (2H, d, <i>J</i> = 9.0 Hz), 7.35 (2H, d, <i>J</i> = 9 Hz), 8.00 (1H, s), 8.60 (1H, s), 8.75 (1H, s). LC-MS (ZQ, 7 min) <i>R</i><sub>t</sub> = 2.27 min; <i>m</i>/<i>z</i> (ESI<sup>+</sup>) 318, 320 (MH<sup>+</sup>).</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 5-(1<i>H</i>-Imidazo[4,5-<i>c</i>]pyridin-6-ylamino)pyrazine-2-carbonitrile (<b>24</b>)</h4><div class="NLM_p last">Palladium(II) acetate (3.5 mg, 16 Î¼mol) was added to (Â±)-2,2â³-bis(diphenylphosphino)-1,1â³-binaphthalene (59 mg, 94 Î¼mol) in DMF/toluene (1:2), and the resulting mixture was degassed under a stream of nitrogen gas for 10 min. 2-Amino-5-cyanopyrazine (<b>66</b>; 19 mg, 0.16 mmol), sodium <i>tert</i>-butoxide (45 mg, 0.47 mmol), and <b>62</b> (50 mg, 0.16 mmol) were added, and the mixture was degassed for a further 5 min before heating at 150 Â°C for 30 min in a microwave reactor. The reaction mixture was partitioned between water and CH<sub>2</sub>Cl<sub>2</sub>. The aqueous phase was extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined organic layers were dried (Na<sub>2</sub>SO<sub>4</sub>) and concentrated. The residue was dissolved in MeOH, passed through a PS-Thiol column, and concentrated. The product was purified using preparative HPLC to give 5-(1-(4-methoxybenzyl)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-6-ylamino)pyrazine-2-carbonitrile (22.4 mg, 40%). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO, 400 MHz) Î´ 3.72 (3H, s), 5.41 (2H, s), 6.96 (2H, d, <i>J</i> = 8.8 Hz), 7.34 (2H, d, <i>J</i> = 8.8 Hz), 8.17 (1H, s), 8.49 (1H, s), 8.73â8.76 (2H, m), 8.77 (1H, d, <i>J =</i> 1.3 Hz), 10.84 (1H, br s). LC-MS (ZQ, 7 min) <i>R</i><sub>t</sub> = 2.32 min; <i>m</i>/<i>z</i> (ESI<sup>+</sup>) 358 (MH<sup>+</sup>), (ESI<sup>â</sup>) 356 (M â H). 5-(1-(4-Methoxybenzyl)-1<i>H</i>-imidazo[4,5-<i>c</i>]pyridin-6-ylamino)pyrazine-2-carbonitrile (10.6 mg, 30 Î¼mol) was treated with TFA at 80 Â°C over 30 min. Isolation by SPE on a MP-TsOH cartridge, eluting with 2M NH<sub>3</sub> in MeOH, followed by concentration, gave <b>24</b> as a white solid (7.02 mg, 100%). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO, 400 MHz) Î´ 8.26 (1H, s), 8.35 (1H, s), 8.75â8.77 (3H, m), 10.85 (1H, br s), 12.79 (1H, br s); LC-MS (ZQ, 7 min) <i>R</i><sub>t</sub> = 1.36 min; <i>m</i>/<i>z</i> (ESI<sup>+</sup>) 238 (MH<sup>+</sup>), (ESI<sup>â</sup>) 236 (M â H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>11</sub>H<sub>8</sub>N<sub>7</sub> (M + H) 238.0836, found 238.0845.</div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> (<i>R</i>)-1-(Dimethylamino)propan-2-ol (<b>68</b>)</h4><div class="NLM_p last">Dimethylamine 40% in water (11.39 mL, 90 mmol) was slowly added to (<i>R</i>)<i>-</i>propylene oxide (5.25 mL, 74.9 mmol) which had been cooled in an ice bath. This solution was stirred at rt for 2 h before being extracted with CH<sub>2</sub>Cl<sub>2</sub> (4 Ã 5 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, and the pure (<i>R</i>)-1-(dimethylamino)propan-2-ol (5.12 g, 49.6 mmol, 40.0% yield) was isolated as a clear oil using distillation under reduced pressure (50 mbar). <sup>1</sup>H NMR (CDCl<sub>3</sub>, 500 MHz) Î´ 1.12 (3H, d, <i>J</i> = 6.0 Hz), 2.16â2.12 (1H, m), 2.25â2.21 (1H, m), 2.27 (6H, s), 3.40 (1H, br s), 3.82â3.76 (1H, m).</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 5-Amino-3-chloropyrazine-2-carbonitrile (<b>70</b>)</h4><div class="NLM_p last">2,6-Dichloropyrazine (<b>69</b>; 2.89 g, 19.4 mmol) was stirred in aqueous NH<sub>3</sub> (28%, 10 mL) and heated to 100 Â°C overnight in a sealed tube. The reaction mixture was cooled, and the resultant precipitate was filtered. Trituration with water and then ether gave 6-chloropyrazin-2-amine as a white solid (2.28 g, 17.6 mmol, 91%). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO, 400 MHz) Î´ 6.9 (2H, br s), 7.70 (1H, d, <i>J</i> = 0.4 Hz), 7.80 (1H, d, <i>J</i> = 0.4 Hz); LC-MS (ZQ, 7 min) <i>R</i><sub>t</sub> = 1.05 min; <i>m</i>/<i>z</i> (ESI<sup>+</sup>) 130, 132 (MH<sup>+</sup>). 6-Chloropyrazin-2-amine (2.50 g, 19.3 mmol) was stirred in CH<sub>2</sub>Cl<sub>2</sub> (60 mL) and cooled to 0 Â°C. <i>N</i>-Bromosuccinimide (2.92 g, 16.4 mmol) was added slowly, and the reaction mixture was stirred at 0 Â°C for 60 min. The reaction mixture was filtered through Celite and concentrated to give a brown oil. Purification by flash chromatography, eluting with 0â25% EtOAcâhexanes, gave 5-bromo-6-chloropyrazin-2-amine as a yellow solid (1.69 g, 8.16 mmol, 42%). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO, 400 MHz) Î´ 7.1 (2H, br s), 7.65 (1H, s); LC-MS (ZQ, 4 min) <i>R</i><sub>t</sub> = 1.46 min; <i>m</i>/<i>z</i> (ESI<sup>â</sup>) 205 (M â H). A mixture of 5-bromo-6-chloropyrazin-2-amine (1.00 g, 4.8 mmol), copper(I) iodide (914 mg, 4.8 mmol), 18-crown-6 (95 mg, 0.36 mmol), and tetrakis(triphenylphosphine)palladium (0) (83 mg, 0.072 mmol) was suspended in dry DMF (20 mL), and a stream of nitrogen was passed through it for 5 min. Potassium cyanide (312 mg, 4.8 mmol) was added, and the mixture was stirred at rt for 30 min and then refluxed at 200 Â°C for 3 h. The mixture was cooled and diluted with EtOAc and absorbed onto silica gel (10 g). DMF was removed by evaporation. The product was purified by flash chromatography, eluting with 1:1 EtOAcâhexanes, to yield <b>70</b> as a yellow solid (607 mg, 3.93 mmol, 82%). <sup>1</sup>H NMR (<i>d</i><sub>6</sub>-DMSO, 400 MHz) Î´ 7.87 (1H, s), 8.1 (2H, br s); LC-MS (ZQ, 4 min) <i>R</i><sub>t</sub> = 1.20 min; <i>m</i>/<i>z</i> (ESI<sup>â</sup>) 153 (M â H).</div></div><div id="sec4_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> (<i>R</i>)-5-Amino-3-(1-(dimethylamino)propan-2-yloxy)pyrazine-2-carbonitrile (<b>74</b>)</h4><div class="NLM_p last">(<i>R</i>)-1-(Dimethylamino)propan-2-ol (<b>68</b>; 0.667 g, 6.47 mmol) was added dropwise to a suspension of NaH 60% (0.388 g, 9.71 mmol) in dioxane (16.18 mL) and stirred for 30 min. 5-Amino-3-chloropyrazine-2-carbonitrile (<b>70</b>; 1.000 g, 6.47 mmol) was added in one portion and heated at 90 Â°C for 14 h. After cooling water (200 mL) was added and the solution was extracted with diethyl ether (4 Ã 100 mL) and dried over MgSO<sub>4</sub>, the volatiles were removed under vacuum. Column chromatography using a gradient of MeOH in CH<sub>2</sub>Cl<sub>2</sub> (+ 1% NH<sub>3</sub>) gave <b>74</b> (0.558 g, 2.52 mmol, 39.0% yield) as a yellow solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) Î´ 1.35 (3H, d, <i>J</i> = 6.5 Hz), 2.37 (6H, s), 2.52 (1H, dd, <i>J</i> = 4.0, 13.5 Hz), 2.76 (1H, dd, <i>J</i> = 7.5, 13.5 Hz), 5.31 (2H, br s), 5.42â5.35 (1H, m), 7.54 (1H, s). LC-MS (TOF, 3.5 min) <i>R</i><sub>t</sub> = 0.80 min; <i>m</i>/<i>z</i> (ESI) 222 (M + H).</div></div><div id="sec4_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> (<i>R</i>)-5-(8-Chloroisoquinolin-3-ylamino)-3-(1-(dimethylamino)propan-2-yloxy)pyrazine-2-carbonitrile (<b>(</b><i><b>R</b></i><b>)-3</b>)</h4><div class="NLM_p last">To four microwave vials was added Xantphos (66.8 mg, 0.116 mmol), Pd<sub>2</sub>(dba)<sub>3</sub> (52.9 mg, 0.058 mmol), 8-chloroisoquinolin-3-yl trifluoromethanesulfonate (180 mg, 0.578 mmol), <b>74</b> (128 mg, 0.578 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (376 mg, 1.155 mmol) followed by dry toluene (4 mL). The vials were sealed, and dry nitrogen was bubbled through the stirred solution for 8 min. The reactions were irradiated at 130 Â°C for 45 min in a Biotage microwave. Upon cooling, the mixtures were combined, diluted with MeOH, and purified using an acidic ion exchange column which was washed with MeOH before the basic components eluted with 2 M NH<sub>3</sub> in MeOH followed by CH<sub>2</sub>Cl<sub>2</sub>/2 M NH<sub>3</sub> in MeOH. The residue was purified by column chromatography eluting with a gradient of MeOH in CH<sub>2</sub>Cl<sub>2</sub> (+1% NH<sub>3</sub>) to give <b>(</b><i><b>R</b></i><b>)-3</b> (301 mg, 0.786 mmol, 45% yield) as a light yellow powder. <sup>1</sup>H NMR (500 MHz,<i> d</i><sub>6</sub>-DMSO) Î´ 1.46 (3H, d, <i>J</i> = 6.5 Hz), 2.21 (6H, s), 2.54 (2H, dd, <i>J</i> = 5, 13 Hz), 2.66 (1H, dd, <i>J</i> = 7, 13 Hz), 5.54â5.46 (1H, m), 7.66 (1H, d, <i>J</i> = 7.5 Hz), 7.72 (1H, dd, <i>J</i> = 7.5, 8.0 Hz), 7.84 (1H, d, <i>J</i> = 8.0 Hz), 8.26 (1H, s), 8.48 (1H, s), 9.40 (1H, s), 11.16 (1H, s). LC-MS (TOF, 3.5 min) <i>R</i><sub>t</sub> = 2.58 min; <i>m</i>/<i>z</i> (ESI) 383 (M + H). HRMS (ESI) <i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>20</sub>ClN<sub>6</sub>O (M + H) 383.1382, found 383.1366.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37"><a href="/doi/suppl/10.1021/jm2007326">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00824" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00824" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental details for the preparation and characterization of compounds <b>(</b><i><b>rac</b></i><b>)-3</b>,<b> (</b><i><b>S</b></i><b>)-3</b>, <b>6</b>, <b>(</b><i><b>R</b></i><b>)-7</b>,<b> (</b><i><b>S</b></i><b>)-7</b>,<b> 9â19</b>,<b> 21</b>,<b> 22</b>, and <b>25â34</b>; experimental details for the determination of the enantiopurity of <b>(</b><i><b>R</b></i><b>)-3</b> and <b>(</b><i><b>S</b></i><b>)-3</b>; experimental details for CHK1 and CHK2 enzyme inhibition assays; summary of crystal structure determinations of CHK1 in complex with <b>2</b>, <b>4</b>, <b>6</b>, <b>8</b>, <b>20</b>, and <b>(</b><i><b>R</b></i><b>)-3</b>; and kinase inhibitory profiles of <b>(</b><i><b>R</b></i><b>)-3</b> at 1 Î¼M and 10 Î¼M test concentrations. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm2007326/suppl_file/jm2007326_si_001.pdf">jm2007326_si_001.pdf (293.06 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm2007326" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66377" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66377" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John C. Reader</span> - <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#0d67626563237f686c69687f4d7e6c7f687860236e622378662d646c63236e62616164637e4d646e7f236c6e237866"><span class="__cf_email__" data-cfemail="543e3b3c3a7a263135303126142735263121397a373b7a213f">[emailÂ protected]</span> <span class="__cf_email__" data-cfemail="9df4fcf3b3fef2f1f1f4f3eeddf4feefb3fcfeb3e8f6">[emailÂ protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ian Collins</span> - <span class="hlFld-Affiliation affiliation">â Cancer
Research UK Cancer Therapeutics Unit and â¡Division of Structural Biology, The Institute of Cancer Research, 15
Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>;Â 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span>;Â 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e18b8e898fcf938480858493a192809384948ccf828ecf948ac188808fcf828e8d8d888f92a1888293cf8082cf948a"><span class="__cf_email__" data-cfemail="73191c1b1d5d0116121716013300120116061e5d101c5d0618">[emailÂ protected]</span> <span class="__cf_email__" data-cfemail="caa3aba4e4a9a5a6a6a3a4b98aa3a9b8e4aba9e4bfa1">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas P. Matthews</span> - <span class="hlFld-Affiliation affiliation">â Cancer
Research UK Cancer Therapeutics Unit and â¡Division of Structural Biology, The Institute of Cancer Research, 15
Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>;Â 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Suki Klair</span> - <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kwai-Ming J. Cheung</span> - <span class="hlFld-Affiliation affiliation">â Cancer
Research UK Cancer Therapeutics Unit and â¡Division of Structural Biology, The Institute of Cancer Research, 15
Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>;Â 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jane Scanlon</span> - <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicolas Proisy</span> - <span class="hlFld-Affiliation affiliation">â Cancer
Research UK Cancer Therapeutics Unit and â¡Division of Structural Biology, The Institute of Cancer Research, 15
Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>;Â 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Glynn Addison</span> - <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Ellard</span> - <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nelly Piton</span> - <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Suzanne Taylor</span> - <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Cherry</span> - <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin Fisher</span> - <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kathy Boxall</span> - <span class="hlFld-Affiliation affiliation">â Cancer
Research UK Cancer Therapeutics Unit and â¡Division of Structural Biology, The Institute of Cancer Research, 15
Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>;Â 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Samantha Burns</span> - <span class="hlFld-Affiliation affiliation">â Cancer
Research UK Cancer Therapeutics Unit and â¡Division of Structural Biology, The Institute of Cancer Research, 15
Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>;Â 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael I. Walton</span> - <span class="hlFld-Affiliation affiliation">â Cancer
Research UK Cancer Therapeutics Unit and â¡Division of Structural Biology, The Institute of Cancer Research, 15
Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>;Â 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Isaac M. Westwood</span> - <span class="hlFld-Affiliation affiliation">â Cancer
Research UK Cancer Therapeutics Unit and â¡Division of Structural Biology, The Institute of Cancer Research, 15
Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>;Â 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Angela Hayes</span> - <span class="hlFld-Affiliation affiliation">â Cancer
Research UK Cancer Therapeutics Unit and â¡Division of Structural Biology, The Institute of Cancer Research, 15
Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>;Â 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Eve</span> - <span class="hlFld-Affiliation affiliation">â Cancer
Research UK Cancer Therapeutics Unit and â¡Division of Structural Biology, The Institute of Cancer Research, 15
Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>;Â 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Melanie Valenti</span> - <span class="hlFld-Affiliation affiliation">â Cancer
Research UK Cancer Therapeutics Unit and â¡Division of Structural Biology, The Institute of Cancer Research, 15
Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>;Â 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alexis de Haven Brandon</span> - <span class="hlFld-Affiliation affiliation">â Cancer
Research UK Cancer Therapeutics Unit and â¡Division of Structural Biology, The Institute of Cancer Research, 15
Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>;Â 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gary Box</span> - <span class="hlFld-Affiliation affiliation">â Cancer
Research UK Cancer Therapeutics Unit and â¡Division of Structural Biology, The Institute of Cancer Research, 15
Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>;Â 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rob L. M. van Montfort</span> - <span class="hlFld-Affiliation affiliation">â Cancer
Research UK Cancer Therapeutics Unit and â¡Division of Structural Biology, The Institute of Cancer Research, 15
Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>;Â 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David H. Williams</span> - <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">G. Wynne Aherne</span> - <span class="hlFld-Affiliation affiliation">â Cancer
Research UK Cancer Therapeutics Unit and â¡Division of Structural Biology, The Institute of Cancer Research, 15
Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>;Â 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Florence I. Raynaud</span> - <span class="hlFld-Affiliation affiliation">â Cancer
Research UK Cancer Therapeutics Unit and â¡Division of Structural Biology, The Institute of Cancer Research, 15
Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>;Â 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Suzanne A. Eccles</span> - <span class="hlFld-Affiliation affiliation">â Cancer
Research UK Cancer Therapeutics Unit and â¡Division of Structural Biology, The Institute of Cancer Research, 15
Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>;Â 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michelle D. Garrett</span> - <span class="hlFld-Affiliation affiliation">â Cancer
Research UK Cancer Therapeutics Unit and â¡Division of Structural Biology, The Institute of Cancer Research, 15
Cotswold Road, Sutton, Surrey SM2 5NG, U.K.</span>;Â 
    <span class="hlFld-Affiliation affiliation">Sareum Ltd., 2a Langford
Arch, London Road, Cambridge CB22 3FX, U.K.</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack" id="ACK-d891e4490-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i38">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55316" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55316" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. A. Mirza, M. Richards, and Dr. M. Liu for assistance in the spectroscopic characterization of test compounds and Dr. M. Lamers for the preparation of CHK1 protein. This work was supported by Cancer Research UK [CUK] grant numbers C309/A2187, C309/A8274, and C309/A8365 and by The Institute of Cancer Research. We acknowledge NHS funding to the NIHR Biomedical Research Centre.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i39" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i39"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i40" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i40"> Abbreviations Used</h2><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine 5â²-triphosphate</p></td></tr><tr><td class="NLM_term">ATR</td><td class="NLM_def"><p class="first last">ataxia telangiectasia and rad3 related</p></td></tr><tr><td class="NLM_term">CHK1</td><td class="NLM_def"><p class="first last">checkpoint kinase 1</p></td></tr><tr><td class="NLM_term">CHK2</td><td class="NLM_def"><p class="first last">checkpoint kinase 2</p></td></tr><tr><td class="NLM_term">DELFIA</td><td class="NLM_def"><p class="first last">dissociation-enhanced lanthanide fluorescent immunoassay</p></td></tr><tr><td class="NLM_term">ELISA</td><td class="NLM_def"><p class="first last">enzyme-linked immunosorbent assay</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">MPM2</td><td class="NLM_def"><p class="first last">M-phase phosphoprotein 2</p></td></tr><tr><td class="NLM_term">SRB</td><td class="NLM_def"><p class="first last">sulforhodamine B</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i41">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75004" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75004" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 61 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span> </span><span class="NLM_article-title">Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase inhibitors</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">â</span> <span class="NLM_lpage">373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1016%2Fj.coph.2005.04.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=15964238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvFKlsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=366-373&author=I.+Collinsauthor=M.+D.+Garrett&title=Targeting+the+cell+division+cycle+in+cancer%3A+CDK+and+cell+cycle+checkpoint+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase inhibitors</span></div><div class="casAuthors">Collins, Ian; Garrett, Michelle D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">366-373</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The cyclin-dependent kinase (CDK) family of serine/threonine kinases regulate progression through each stage of the cell division cycle and as such are major targets for deregulation in cancer.  This has led to the development of several small-mol. inhibitors of CDKs as potential therapeutic agents for the treatment of this disease.  Progression through the cell cycle is also monitored at several positions known as cell cycle checkpoints, 2 of which occur during G1 and G2 in response to DNA damage.  These are often defective in cancer, leading to the suggestion that inhibition of one or both of the cell cycle checkpoint kinases CHK1 and CHK2 may drive a cancer cell that already has defects in its cell cycle checkpoints towards death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlqcFxaO9gh7Vg90H21EOLACvtfcHk0lj23B2ORFwWGQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvFKlsL0%253D&md5=40607fa37e866766581683b322829a13</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2005.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2005.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26atitle%3DTargeting%2520the%2520cell%2520division%2520cycle%2520in%2520cancer%253A%2520CDK%2520and%2520cell%2520cycle%2520checkpoint%2520kinase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2005%26volume%3D5%26spage%3D366%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span> </span><span class="NLM_article-title">New insights into checkpoint kinase 1 in the DNA damage response signaling network</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">376</span><span class="NLM_x">â</span> <span class="NLM_lpage">383</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1158%2F1078-0432.CCR-09-1029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=20068082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktF2qsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=376-383&author=Y.+Daiauthor=S.+Grant&title=New+insights+into+checkpoint+kinase+1+in+the+DNA+damage+response+signaling+network"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into checkpoint kinase 1 in the DNA damage response signaling network</span></div><div class="casAuthors">Dai, Yun; Grant, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">376-383</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The DNA damage response (DDR) represents a complex network of multiple signaling pathways involving cell cycle checkpoints, DNA repair, transcriptional programs, and apoptosis, through which cells maintain genomic integrity following various endogenous (metabolic) or environmental stresses.  In cancer treatment, the DDR occurs in response to various genotoxic insults by diverse cytotoxic agents and radiation, representing an important mechanism limiting chemotherapeutic and radiotherapeutic efficacy.  This has prompted the development of agents targeting DDR signaling pathways, particularly checkpoint kinase 1 (Chk1), which contributes to all currently defined cell cycle checkpoints, including G1/S, intra-S-phase, G2/M, and the mitotic spindle checkpoint.  Although numerous agents have been developed with the primary goal of enhancing the activity of DNA-damaging agents or radiation, the therapeutic outcome of this strategy remains to be detd.  Recently, new insights into DDR signaling pathways support the notion that Chk1 represents a core component central to the entire DDR, including direct involvement in DNA repair and apoptotic events in addn. to checkpoint regulation.  Together, these new insights into the role of Chk1 in the DDR machinery could provide an opportunity for novel approaches to the development of Chk1 inhibitor strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP9oCivdYOLbVg90H21EOLACvtfcHk0lj23B2ORFwWGQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktF2qsb8%253D&md5=37b8cf16a1a136372f1c1ee6d42b6988</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-09-1029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-09-1029%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DY.%26aulast%3DGrant%26aufirst%3DS.%26atitle%3DNew%2520insights%2520into%2520checkpoint%2520kinase%25201%2520in%2520the%2520DNA%2520damage%2520response%2520signaling%2520network%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2010%26volume%3D16%26spage%3D376%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Kastan, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartek, J.</span><span> </span><span class="NLM_article-title">Cell-cycle checkpoints and cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">432</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">â</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1038%2Fnature03097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=15549093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpvVCjtLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=432&publication_year=2004&pages=316-323&author=M.+B.+Kastanauthor=J.+Bartek&title=Cell-cycle+checkpoints+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-cycle checkpoints and cancer</span></div><div class="casAuthors">Kastan, Michael B.; Bartek, Jiri</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">432</span>
        (<span class="NLM_cas:issue">7015</span>),
    <span class="NLM_cas:pages">316-323</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with refs.  All life on earth must cope with const. exposure to DNA-damaging agents such as the Sun's radiation.  Highly conserved DNA-repair and cell-cycle checkpoint pathways allow cells to deal with both endogenous and exogenous sources of DNA damage.  How much an individual is exposed to these agents and how their cells respond to DNA damage are crit. determinants of whether that individual will develop cancer.  These cellular responses are also important for detg. toxicities and responses to current cancer therapies, most of which target the DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpONns98smbebVg90H21EOLACvtfcHk0lj23B2ORFwWGQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpvVCjtLo%253D&md5=23577cd35313a3a11afee151281c3fd4</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature03097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03097%26sid%3Dliteratum%253Aachs%26aulast%3DKastan%26aufirst%3DM.%2BB.%26aulast%3DBartek%26aufirst%3DJ.%26atitle%3DCell-cycle%2520checkpoints%2520and%2520cancer%26jtitle%3DNature%26date%3D2004%26volume%3D432%26spage%3D316%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumagai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunphy, W. G.</span><span> </span><span class="NLM_article-title">Requirement for Atr in phosphorylation of Chk1 and cell cycle regulation in response to DNA replication blocks and UV-damaged DNA in Xenopus egg extracts</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2745</span><span class="NLM_x">â</span> <span class="NLM_lpage">2756</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2000&pages=2745-2756&author=Z.+Guoauthor=A.+Kumagaiauthor=S.+X.+Wangauthor=W.+G.+Dunphy&title=Requirement+for+Atr+in+phosphorylation+of+Chk1+and+cell+cycle+regulation+in+response+to+DNA+replication+blocks+and+UV-damaged+DNA+in+Xenopus+egg+extracts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DKumagai%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DS.%2BX.%26aulast%3DDunphy%26aufirst%3DW.%2BG.%26atitle%3DRequirement%2520for%2520Atr%2520in%2520phosphorylation%2520of%2520Chk1%2520and%2520cell%2520cycle%2520regulation%2520in%2520response%2520to%2520DNA%2520replication%2520blocks%2520and%2520UV-damaged%2520DNA%2520in%2520Xenopus%2520egg%2520extracts%26jtitle%3DGenes%2520Dev.%26date%3D2000%26volume%3D14%26spage%3D2745%26epage%3D2756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwnica-Worms, H.</span><span> </span><span class="NLM_article-title">ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4129</span><span class="NLM_x">â</span> <span class="NLM_lpage">4139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1128%2FMCB.21.13.4129-4139.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=11390642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksVOrtrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=4129-4139&author=H.+Zhaoauthor=H.+Piwnica-Worms&title=ATR-mediated+checkpoint+pathways+regulate+phosphorylation+and+activation+of+human+Chk1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1</span></div><div class="casAuthors">Zhao, Hui; Piwnica-Worms, Helen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4129-4139</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Chk1 is an evolutionarily conserved protein kinase that regulates cell cycle progression in response to checkpoint activation.  In this study, we demonstrated that agents that block DNA replication or cause certain forms of DNA damage induce the phosphorylation of human Chk1.  The phosphorylated form of Chk1 possessed higher intrinsic protein kinase activity and eluted more quickly on gel filtration columns.  Serines 317 and 345 were identified as sites of phosphorylation in vivo, and ATR (the ATM- and Rad3-related protein kinase) phosphorylated both of these sites in vitro.  Furthermore, phosphorylation of Chk1 on serines 317 and 345 in vivo was ATR dependent.  Mutants of Chk1 contg. alanine in place of serines 317 and 345 were poorly activated in response to replication blocks or genotoxic stress in vivo, were poorly phosphorylated by ATR in vitro, and were not found in faster-eluting fractions by gel filtration.  These findings demonstrate that the activation of Chk1 in response to replication blocks and certain forms of genotoxic stress involves phosphorylation of serines 317 and 345.  In addn., this study implicates ATR as a direct upstream activator of Chk1 in human cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC8wdmNW0hyLVg90H21EOLACvtfcHk0ljBxnCmM0G3sg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksVOrtrw%253D&md5=91810bc5ec14229fd93ca55f25630d8b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1128%2FMCB.21.13.4129-4139.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.21.13.4129-4139.2001%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DPiwnica-Worms%26aufirst%3DH.%26atitle%3DATR-mediated%2520checkpoint%2520pathways%2520regulate%2520phosphorylation%2520and%2520activation%2520of%2520human%2520Chk1%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2001%26volume%3D21%26spage%3D4129%26epage%3D4139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Clarke, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. R.</span><span> </span><span class="NLM_article-title">DNA-dependent phosphorylation of Chk1 and Claspin in a human cell-free system</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">388</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">â</span> <span class="NLM_lpage">712</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2005&pages=705-712&author=C.+A.+Clarkeauthor=P.+R.+Clarke&title=DNA-dependent+phosphorylation+of+Chk1+and+Claspin+in+a+human+cell-free+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DC.%2BA.%26aulast%3DClarke%26aufirst%3DP.%2BR.%26atitle%3DDNA-dependent%2520phosphorylation%2520of%2520Chk1%2520and%2520Claspin%2520in%2520a%2520human%2520cell-free%2520system%26jtitle%3DBiochem.%2520J.%26date%3D2005%26volume%3D388%26spage%3D705%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Smits, V. A. J.</span><span> </span><span class="NLM_article-title">Spreading the signal. Dissociation of Chk1 from chromatin</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1039</span><span class="NLM_x">â</span> <span class="NLM_lpage">1043</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=1039-1043&author=V.+A.+J.+Smits&title=Spreading+the+signal.+Dissociation+of+Chk1+from+chromatin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmits%26aufirst%3DV.%2BA.%2BJ.%26atitle%3DSpreading%2520the%2520signal.%2520Dissociation%2520of%2520Chk1%2520from%2520chromatin%26jtitle%3DCell%2520Cycle%26date%3D2006%26volume%3D5%26spage%3D1039%26epage%3D1043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Zhou, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elledge, S. J.</span><span> </span><span class="NLM_article-title">The DNA damage response: Putting checkpoints in perspective</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">â</span> <span class="NLM_lpage">439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1038%2F35044005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=11100718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD3cXos1Srsb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=433-439&author=B.+B.+Zhouauthor=S.+J.+Elledge&title=The+DNA+damage+response%3A+Putting+checkpoints+in+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The DNA damage response: putting checkpoints in perspective</span></div><div class="casAuthors">Zhou, Bin-Bing S.; Elledge, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6811</span>),
    <span class="NLM_cas:pages">433-439</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review, with 96 refs.  The inability to repair DNA damage properly in mammals leads to various disorders and enhanced rates of tumor development.  Organisms respond to chromosomal insults by activating a complex damage response pathway.  This pathway regulates known responses such as cell-cycle arrest and apoptosis (programmed cell death), and has recently been shown to control addnl. processes including direct activation of DNA repair networks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokbilF0_EQubVg90H21EOLACvtfcHk0ljBxnCmM0G3sg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXos1Srsb0%253D&md5=bedb1b7569ab0f8267bc37cda4ce59d8</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F35044005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35044005%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DB.%2BB.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520DNA%2520damage%2520response%253A%2520Putting%2520checkpoints%2520in%2520perspective%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D433%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Feijoo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall-Jackson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smythe, C.</span><span> </span><span class="NLM_article-title">Activation of mammalian Chk1 during DNA replication arrest: A role for Chk1 in the intra-S phase checkpoint monitoring replication origin firing</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">913</span><span class="NLM_x">â</span> <span class="NLM_lpage">923</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2001&pages=913-923&author=C.+Feijooauthor=C.+Hall-Jacksonauthor=R.+Wuauthor=D.+Jenkinsauthor=J.+Leitchauthor=D.+M.+Gilbertauthor=C.+Smythe&title=Activation+of+mammalian+Chk1+during+DNA+replication+arrest%3A+A+role+for+Chk1+in+the+intra-S+phase+checkpoint+monitoring+replication+origin+firing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeijoo%26aufirst%3DC.%26aulast%3DHall-Jackson%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DR.%26aulast%3DJenkins%26aufirst%3DD.%26aulast%3DLeitch%26aufirst%3DJ.%26aulast%3DGilbert%26aufirst%3DD.%2BM.%26aulast%3DSmythe%26aufirst%3DC.%26atitle%3DActivation%2520of%2520mammalian%2520Chk1%2520during%2520DNA%2520replication%2520arrest%253A%2520A%2520role%2520for%2520Chk1%2520in%2520the%2520intra-S%2520phase%2520checkpoint%2520monitoring%2520replication%2520origin%2520firing%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2001%26volume%3D154%26spage%3D913%26epage%3D923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Peng, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoma, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwnica-Worms, H.</span><span> </span><span class="NLM_article-title">Mitotic and G2 checkpoint control: Regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">1501</span><span class="NLM_x">â</span> <span class="NLM_lpage">1505</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1126%2Fscience.277.5331.1501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=9278512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADyaK2sXlvVGlu74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=1997&pages=1501-1505&author=C.+Y.+Pengauthor=P.+R.+Gravesauthor=R.+S.+Thomaauthor=Z.+Wuauthor=A.+S.+Shawauthor=H.+Piwnica-Worms&title=Mitotic+and+G2+checkpoint+control%3A+Regulation+of+14-3-3+protein+binding+by+phosphorylation+of+Cdc25C+on+serine-216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216</span></div><div class="casAuthors">Peng, Cheng-Yuan; Graves, Paul R.; Thoma, Richard S.; Wu, Zhiqi; Shaw, Andrey S.; Piwnica-Worms, Helen</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">5331</span>),
    <span class="NLM_cas:pages">1501-1505</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Human Cdc25C is a dual-specificity protein phosphatase that controls entry into mitosis by dephosphorylating the protein kinase Cdc2.  Throughout interphase, but not in mitosis, Cdc25C was phosphorylated on serine-216 and bound to members of the highly conserved and ubiquitously expressed family of 14-3-3 proteins.  A mutation preventing phosphorylation of serine-216 abrogated 14-3-3 binding.  Conditional overexpression of this mutant perturbed mitotic timing and allowed cells to escape the G2 checkpoint arrest induced by either unreplicated DNA or radiation-induced damage.  Chk1, a fission yeast kinase involved in the DNA damage checkpoint response, phosphorylated Cdc25C in vitro on serine-216.  These results indicate that serine-216 phosphorylation and 14-3-3 binding neg. regulate Cdc25C and identify Cdc25C as a potential target of checkpoint control in human cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozK2EquaM1ibVg90H21EOLACvtfcHk0ljBxnCmM0G3sg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlvVGlu74%253D&md5=a7ad063199580208875235588070cd4c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1126%2Fscience.277.5331.1501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.277.5331.1501%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DC.%2BY.%26aulast%3DGraves%26aufirst%3DP.%2BR.%26aulast%3DThoma%26aufirst%3DR.%2BS.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DShaw%26aufirst%3DA.%2BS.%26aulast%3DPiwnica-Worms%26aufirst%3DH.%26atitle%3DMitotic%2520and%2520G2%2520checkpoint%2520control%253A%2520Regulation%2520of%252014-3-3%2520protein%2520binding%2520by%2520phosphorylation%2520of%2520Cdc25C%2520on%2520serine-216%26jtitle%3DScience%26date%3D1997%26volume%3D277%26spage%3D1501%26epage%3D1505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Sanchez, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoma, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwnica-Worms, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elledge, S. J.</span><span> </span><span class="NLM_article-title">Conservation of the Chk1 checkpoint pathway in mammals: Linkage of DNA damage to Cdk regulation through cdc25</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">1497</span><span class="NLM_x">â</span> <span class="NLM_lpage">1501</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=1997&pages=1497-1501&author=Y.+Sanchezauthor=C.+Wongauthor=R.+S.+Thomaauthor=R.+Richmanauthor=Z.+Wuauthor=H.+Piwnica-Wormsauthor=S.+J.+Elledge&title=Conservation+of+the+Chk1+checkpoint+pathway+in+mammals%3A+Linkage+of+DNA+damage+to+Cdk+regulation+through+cdc25"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez%26aufirst%3DY.%26aulast%3DWong%26aufirst%3DC.%26aulast%3DThoma%26aufirst%3DR.%2BS.%26aulast%3DRichman%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DPiwnica-Worms%26aufirst%3DH.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26atitle%3DConservation%2520of%2520the%2520Chk1%2520checkpoint%2520pathway%2520in%2520mammals%253A%2520Linkage%2520of%2520DNA%2520damage%2520to%2520Cdk%2520regulation%2520through%2520cdc25%26jtitle%3DScience%26date%3D1997%26volume%3D277%26spage%3D1497%26epage%3D1501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Xiao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunasekera, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span> </span><span class="NLM_article-title">Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">21767</span><span class="NLM_x">â</span> <span class="NLM_lpage">21773</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=21767-21773&author=Z.+Xiaoauthor=Z.+Chenauthor=A.+H.+Gunasekeraauthor=T.+J.+Sowinauthor=S.+H.+Rosenbergauthor=S.+Fesikauthor=H.+Zhang&title=Chk1+mediates+S+and+G2+arrests+through+Cdc25A+degradation+in+response+to+DNA-damaging+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DGunasekera%26aufirst%3DA.%2BH.%26aulast%3DSowin%26aufirst%3DT.%2BJ.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DFesik%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DChk1%2520mediates%2520S%2520and%2520G2%2520arrests%2520through%2520Cdc25A%2520degradation%2520in%2520response%2520to%2520DNA-damaging%2520agents%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D21767%26epage%3D21773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Hollstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidransky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. C.</span><span> </span><span class="NLM_article-title">p53 mutations in human cancers</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">253</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">â</span> <span class="NLM_lpage">53</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1991&pages=49-53&author=M.+Hollsteinauthor=D.+Sidranskyauthor=B.+Vogelsteinauthor=C.+C.+Harris&title=p53+mutations+in+human+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHollstein%26aufirst%3DM.%26aulast%3DSidransky%26aufirst%3DD.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DHarris%26aufirst%3DC.%2BC.%26atitle%3Dp53%2520mutations%2520in%2520human%2520cancers%26jtitle%3DScience%26date%3D1991%26volume%3D253%26spage%3D49%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Oren, M.</span><span> </span><span class="NLM_article-title">Regulation of the p53 tumor suppressor protein</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">36031</span><span class="NLM_x">â</span> <span class="NLM_lpage">36034</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=36031-36034&author=M.+Oren&title=Regulation+of+the+p53+tumor+suppressor+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOren%26aufirst%3DM.%26atitle%3DRegulation%2520of%2520the%2520p53%2520tumor%2520suppressor%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D36031%26epage%3D36034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Bucher, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britten, C. D.</span><span> </span><span class="NLM_article-title">G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">â</span> <span class="NLM_lpage">528</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1038%2Fsj.bjc.6604208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=18231106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1KrsLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2008&pages=523-528&author=N.+Bucherauthor=C.+D.+Britten&title=G2+checkpoint+abrogation+and+checkpoint+kinase-1+targeting+in+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer</span></div><div class="casAuthors">Bucher, N.; Britten, C. D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">523-528</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Rigorous quality control steps, termed checkpoints, tightly regulate progression through the cell cycle.  DNA-damaging chemotherapy and radiation activate functional cellular checkpoints.  These checkpoints can facilitate DNA repair and promote cell death in unrepaired cells.  There are at least three DNA damage checkpoints - at G1/S, S, and G2/M - as well as a mitotic spindle checkpoint.  Most cancer cells harbor mutations in tumor suppressors and/or oncogenes, which impair certain cell checkpoints.  Inhibiting the remaining cell checkpoints - particularly after exposure of cancer cells to chemotherapy and/or radiation - allows cell death, a strategy now being employed in cancer therapeutics.  With our increasing knowledge of cell cycle regulation, many compds. have been developed to inhibit specific checkpoint components, particularly at the G2/M transition.  One such target is checkpoint kinase-1 (Chk1).  We review here the mol. framework of the cell cycle, the rationale for targeting Chk1, the preclin. concepts related to the development of Chk1 inhibitors, and the efficacy and safety results from Chk1 inhibitors now in phase I/II trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKqRg9PDH1B7Vg90H21EOLACvtfcHk0liOyY9NYP15Og"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1KrsLc%253D&md5=607123f2a15cbe76fbd2aba55da7d289</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6604208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6604208%26sid%3Dliteratum%253Aachs%26aulast%3DBucher%26aufirst%3DN.%26aulast%3DBritten%26aufirst%3DC.%2BD.%26atitle%3DG2%2520checkpoint%2520abrogation%2520and%2520checkpoint%2520kinase-1%2520targeting%2520in%2520the%2520treatment%2520of%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2008%26volume%3D98%26spage%3D523%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Kawabe, T.</span><span> </span><span class="NLM_article-title">G2 checkpoint abrogators as anticancer drugs</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">â</span> <span class="NLM_lpage">519</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=15078995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivFygsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=513-519&author=T.+Kawabe&title=G2+checkpoint+abrogators+as+anticancer+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">G2 checkpoint abrogators as anticancer drugs</span></div><div class="casAuthors">Kawabe, Takumi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">513-519</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Many conventional anticancer treatments kill cells irresp. of whether they are normal or cancerous, so patients suffer from adverse side effects due to the loss of healthy cells.  Anticancer insights derived from cell cycle research has given birth to the idea of cell cycle G2 checkpoint abrogation as a cancer cell specific therapy, based on the discovery that many cancer cells have a defective G1 checkpoint resulting in a dependence on the G2 checkpoint during cell replication.  Damaged DNA in humans is detected by sensor proteins (such as hHUS1, hRAD1, hRAD9, hRAD17, and hRAD26) that transmit a signal via ATR to CHK1, or by another sensor complex (that may include Î³H2AX, 53BP1, BRCA1, NBS1, hMRE11, and hRAD50), the signal of which is relayed by ATM to CHK2.  Most of the damage signals originated by the sensor complexes for the G2 checkpoint are conducted to CDC25C, the activity of which is modulated by 14-3-3.  There are also less extensively explored pathways involving p53, p38, PCNA, HDAC, PP2A, PLK1, WEE1, CDC25B, and CDC25A.  This review will examine the available inhibitors of CHK1 (Staurosporin, UCN-01, Go6976, SB-218078, ICP-1, and CEP-3891), both CHK1 and CHK2 (TAT-S216A and debromohymenialdisine), CHK2 (CEP-6367), WEE1 (PD0166285), and PP2A (okadaic acid and fostriecin), as well as the unknown checkpoint inhibitors 13-hydroxy-15-ozoapathin (sic) and the isogranulatimides.  Among these targets, CHK1 seems to be the most suitable target for therapeutic G2 abrogation to date, although an unexplored target such as 14-3-3 or the strategy of targeting multiple proteins at once may be of interest in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_oPLSt8XxXbVg90H21EOLACvtfcHk0liOyY9NYP15Og"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivFygsr0%253D&md5=2efedfd30a7560c908c3857fa387d870</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKawabe%26aufirst%3DT.%26atitle%3DG2%2520checkpoint%2520abrogators%2520as%2520anticancer%2520drugs%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2004%26volume%3D3%26spage%3D513%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Walton, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eve, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Haven Brandon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reader, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span> </span><span class="NLM_article-title">The preclinical pharmacology and therapeutic activity of the novel CHK1 inhibitor SAR-020106</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">â</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1158%2F1535-7163.MCT-09-0938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=20053762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktVOhuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=89-100&author=M.+I.+Waltonauthor=P.+D.+Eveauthor=A.+Hayesauthor=M.+Valentiauthor=A.+De+Haven+Brandonauthor=G.+Boxauthor=K.+J.+Boxallauthor=G.+W.+Aherneauthor=S.+A.+Ecclesauthor=F.+I.+Raynaudauthor=D.+H.+Williamsauthor=J.+C.+Readerauthor=I.+Collinsauthor=M.+D.+Garrett&title=The+preclinical+pharmacology+and+therapeutic+activity+of+the+novel+CHK1+inhibitor+SAR-020106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The Preclinical Pharmacology and Therapeutic Activity of the Novel CHK1 Inhibitor SAR-020106</span></div><div class="casAuthors">Walton, Michael I.; Eve, Paul D.; Hayes, Angela; Valenti, Melanie; De Haven Brandon, Alexis; Box, Gary; Boxall, Kathy J.; Aherne, G. Wynne; Eccles, Suzanne A.; Raynaud, Florence I.; Williams, David H.; Reader, John C.; Collins, Ian; Garrett, Michelle D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-100</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Genotoxic antitumor agents continue to be the mainstay of current cancer chemotherapy.  These drugs cause DNA damage and activate numerous cell cycle checkpoints facilitating DNA repair and the maintenance of genomic integrity.  Most human tumors lack functional p53 and consequently have compromised G1-S checkpoint control.  This has led to the hypothesis that S and G2-M checkpoint abrogation may selectively enhance genotoxic cell killing in a p53-deficient background, as normal cells would be rescued at the G1-S checkpoint.  CHK1 is a serine/threonine kinase assocd. with DNA damage-linked S and G2-M checkpoint control.  SAR-020106 is an ATP-competitive, potent, and selective CHK1 inhibitor with an IC50 of 13.3 nmol/L on the isolated human enzyme.  This compd. abrogates an etoposide-induced G2 arrest with an IC50 of 55 nmol/L in HT29 cells, and significantly enhances the cell killing of gemcitabine and SN38 by 3.0- to 29-fold in several colon tumor lines in vitro and in a p53-dependent fashion.  Biomarker studies have shown that SAR-020106 inhibits cytotoxic drug-induced autophosphorylation of CHK1 at S296 and blocks the phosphorylation of CDK1 at Y15 in a dose-dependent fashion both in vitro and in vivo.  Cytotoxic drug combinations were assocd. with increased Î³H2AX and poly ADP ribose polymerase cleavage consistent with the SAR-020106-enhanced DNA damage and tumor cell death.  Irinotecan and gemcitabine antitumor activity was enhanced by SAR-020106 in vivo with minimal toxicity.  SAR-020106 represents a novel class of CHK1 inhibitors that can enhance antitumor activity with selected anticancer drugs in vivo and may therefore have clin. utility.  Mol Cancer Ther; 9(1); 89-100.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodRgZ8gsmTGbVg90H21EOLACvtfcHk0lgi3DADj-nBKw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktVOhuw%253D%253D&md5=395ce9fc39b4a465597e82d59e413f14</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0938%26sid%3Dliteratum%253Aachs%26aulast%3DWalton%26aufirst%3DM.%2BI.%26aulast%3DEve%26aufirst%3DP.%2BD.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DDe%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DBoxall%26aufirst%3DK.%2BJ.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DWilliams%26aufirst%3DD.%2BH.%26aulast%3DReader%26aufirst%3DJ.%2BC.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26atitle%3DThe%2520preclinical%2520pharmacology%2520and%2520therapeutic%2520activity%2520of%2520the%2520novel%2520CHK1%2520inhibitor%2520SAR-020106%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D89%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Blasina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arango, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraynov, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Register, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ninkovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâConnor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderes, K.</span><span> </span><span class="NLM_article-title">Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2394</span><span class="NLM_x">â</span> <span class="NLM_lpage">2404</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1158%2F1535-7163.MCT-07-2391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=18723486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWksL%252FP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=2394-2404&author=A.+Blasinaauthor=J.+Hallinauthor=E.+Chenauthor=M.+E.+Arangoauthor=E.+Kraynovauthor=J.+Registerauthor=S.+Grantauthor=S.+Ninkovicauthor=P.+Chenauthor=T.+Nicholsauthor=P.+O%E2%80%99Connorauthor=K.+Anderes&title=Breaching+the+DNA+damage+checkpoint+via+PF-00477736%2C+a+novel+small-molecule+inhibitor+of+checkpoint+kinase+1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1</span></div><div class="casAuthors">Blasina, Alessandra; Hallin, Jill; Chen, Enhong; Arango, Maria Elena; Kraynov, Eugenia; Register, James; Grant, Stephan; Ninkovic, Sacha; Chen, Ping; Nichols, Tim; O'Connor, Patrick; Anderes, Kenna</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2394-2404</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Checkpoints are present in all phases of the cell cycle and are regarded as the gatekeepers maintaining the integrity of the genome.  Many conventional agents used to treat cancer impart damage to the genome and activate cell cycle checkpoints.  Many tumors are defective in the tumor suppressor p53 and therefore lack a functional G1 checkpoint.  In these tumors, however, the S-G2 checkpoints remain intact and, in response to DNA damage, arrest cell cycle progression allowing time for DNA repair.  Checkpoint kinase 1 (Chk1) is a key element in the DNA damage response pathway and plays a crucial role in the S-G2-phase checkpoints.  Inhibiting Chk1 represents a therapeutic strategy for creating a "synthetic lethal" response by overriding the last checkpoint defense of tumor cells against the lethal damage induced by DNA-directed chemotherapeutic agents.  Chk1 inhibition is consistent with emerging targeted therapies aiming to exploit mol. differences between normal and cancer cells.  Adding a Chk1 inhibitor to DNA-damaging cytotoxic therapy selectively targets tumors with intrinsic checkpoint defects while minimizing toxicity in checkpoint-competent normal cells.  PF-00477736 was identified as a potent, selective ATP-competitive small-mol. inhibitor that inhibits Chk1 with a Ki of 0.49 nM.  PF-00477736 abrogates cell cycle arrest induced by DNA damage and enhances cytotoxicity of clin. important chemotherapeutic agents, including gemcitabine and carboplatin.  In xenografts, PF-00477736 enhanced the antitumor activity of gemcitabine in a dose-dependent manner.  PF-00477736 combinations were well tolerated with no exacerbation of side effects commonly assocd. with cytotoxic agents. [Mol Cancer Ther 2008;7(8):2394-404].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCAlkcnouhLrVg90H21EOLACvtfcHk0lgi3DADj-nBKw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWksL%252FP&md5=fc3f9cf9121c207c6fa284b2090ed1c3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-2391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-2391%26sid%3Dliteratum%253Aachs%26aulast%3DBlasina%26aufirst%3DA.%26aulast%3DHallin%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DE.%26aulast%3DArango%26aufirst%3DM.%2BE.%26aulast%3DKraynov%26aufirst%3DE.%26aulast%3DRegister%26aufirst%3DJ.%26aulast%3DGrant%26aufirst%3DS.%26aulast%3DNinkovic%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DNichols%26aufirst%3DT.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%26aulast%3DAnderes%26aufirst%3DK.%26atitle%3DBreaching%2520the%2520DNA%2520damage%2520checkpoint%2520via%2520PF-00477736%252C%2520a%2520novel%2520small-molecule%2520inhibitor%2520of%2520checkpoint%2520kinase%25201%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D2394%26epage%3D2404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Ganzinelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrassa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crippa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavecchio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broggini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damia, G.</span><span> </span><span class="NLM_article-title">Checkpoint kinase 1 down-regulation by an inducible small interfering RNA expression system sensitized in vivo tumors to treatment with 5-fluorouracil</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5131</span><span class="NLM_x">â</span> <span class="NLM_lpage">5141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1158%2F1078-0432.CCR-08-0304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=18698031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpslKgtb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=5131-5141&author=M.+Ganzinelliauthor=L.+Carrassaauthor=F.+Crippaauthor=M.+Tavecchioauthor=M.+Brogginiauthor=G.+Damia&title=Checkpoint+kinase+1+down-regulation+by+an+inducible+small+interfering+RNA+expression+system+sensitized+in+vivo+tumors+to+treatment+with+5-fluorouracil"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Checkpoint kinase 1 down-regulation by an inducible small interfering RNA expression system sensitized in vivo tumors to treatment with 5-fluorouracil</span></div><div class="casAuthors">Ganzinelli, Monica; Carrassa, Laura; Crippa, Francesca; Tavecchio, Michele; Broggini, Massimo; Damia, Giovanna</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5131-5141</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: After DNA damage, checkpoints pathways are activated in the cells to halt the cell cycle, thus ensuring repair or inducing cell death.  To better investigate the role of checkpoint kinase 1 (Chk1) in cellular response to different anticancer agents, Chk1 was knocked down in HCT-116 cell line and in its p53-deficient subline by using small interfering RNAs (siRNA).  Exptl. Design: Chk1 was abrogated by transient transfection of specific siRNA against it, and stable tetracycline-inducible Chk1 siRNA clones were obtained transfecting cells with a plasmid expressing two siRNA against Chk1.  The validated inducible system was then translated in an in vivo setting by transplanting the inducible clones in nude mice.  RESULTS: Transient Chk1 down-regulation sensitized HCT-116 cells, p53-/- more than the p53 wild-type counterpart, to DNA-damaging agents 5-fluorouracil (5-FU), doxorubicin, and etoposide treatments, with no modification of Taxol and PS341 cytotoxic activities.  Inhibition of Chk1 protein levels in inducible clones on induction with doxycycline correlated with an increased cisplatin and 5-FU activity.  Such effect was more evident in a p53-deficient background.  These clones were transplanted in nude mice and a clear Chk1 down-regulation was shown in tumor samples of mice given tetracycline in the drinking water by immunohistochem. detection of Chk1 protein.  More importantly, an increased 5-FU antitumor activity was found in tumors with the double Chk1 and p53 silencing.  CONCLUSIONS: These findings corroborate the fact that Chk1 protein is a mol. target to be inhibited in tumors with a defective G1 checkpoint to increase the selectivity of anticancer treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe9DwgiSQdlLVg90H21EOLACvtfcHk0lgi3DADj-nBKw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpslKgtb8%253D&md5=3605a0e485bac9da9dc0f056a7fbd95b</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0304%26sid%3Dliteratum%253Aachs%26aulast%3DGanzinelli%26aufirst%3DM.%26aulast%3DCarrassa%26aufirst%3DL.%26aulast%3DCrippa%26aufirst%3DF.%26aulast%3DTavecchio%26aufirst%3DM.%26aulast%3DBroggini%26aufirst%3DM.%26aulast%3DDamia%26aufirst%3DG.%26atitle%3DCheckpoint%2520kinase%25201%2520down-regulation%2520by%2520an%2520inducible%2520small%2520interfering%2520RNA%2520expression%2520system%2520sensitized%2520in%2520vivo%2520tumors%2520to%2520treatment%2520with%25205-fluorouracil%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D5131%26epage%3D5141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Tse, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rendahl, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheikh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheema, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aardalen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moler, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopes de Menezes, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesner, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, G. K.</span><span> </span><span class="NLM_article-title">CHIR-124, a novel potent inhibitor of Chk1, potentiates the cytotoxicity of topoisomerase I poisons in vitro and in vivo</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span><span class="NLM_x">â</span> <span class="NLM_lpage">602</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1158%2F1078-0432.CCR-06-1424" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=17255282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD2sXoslSktQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=591-602&author=A.+N.+Tseauthor=K.+G.+Rendahlauthor=T.+Sheikhauthor=H.+Cheemaauthor=K.+Aardalenauthor=M.+Embryauthor=S.+Maauthor=E.+J.+Molerauthor=Z.+J.+Niauthor=D.+E.+Lopes+de+Menezesauthor=B.+Hibnerauthor=T.+G.+Gesnerauthor=G.+K.+Schwartz&title=CHIR-124%2C+a+novel+potent+inhibitor+of+Chk1%2C+potentiates+the+cytotoxicity+of+topoisomerase+I+poisons+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">CHIR-124, a novel potent inhibitor of Chk1, potentiates the cytotoxicity of topoisomerase I poisons in vitro and in vivo</span></div><div class="casAuthors">Tse, Archie N.; Rendahl, Katherine G.; Sheikh, Tahir; Cheema, Haider; Aardalen, Kim; Embry, Millicent; Ma, Sylvia; Moler, Edward J.; Ni, Zhi Jie; Lopes de Menezes, Daniel E.; Hibner, Barbara; Gesner, Thomas G.; Schwartz, Gary K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2, Pt. 1</span>),
    <span class="NLM_cas:pages">591-602</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Chk1 kinase is a crit. regulator of both S and G2-M phase cell cycle checkpoints in response to DNA damage.  This study aimed to evaluate the biochem., cellular, and antitumor effects of a novel Chk1 inhibitor, CHIR124.  CHIR-124 was evaluated for its ability to abrogate cell cycle checkpoints, to potentiate cytotoxicity, and to inhibit Chk1-mediated signaling induced by topoisomerase I poisons in human tumor cell line and xenograft models.  CHIR-124 is a quinolone-based small mol. that is structurally unrelated to other known inhibitors of Chk1.  It potently and selectively inhibits Chk1 in vitro (IC50 = 0.0003 Î¼mol/L).  CHIR-124 interacts synergistically with topoisomerase poisons (e.g., camptothecin or SN-38) in causing growth inhibition in several p53-mutant solid tumor cell lines as detd. by isobologram or response surface anal.  CHIR-124 abrogates the SN-38-induced S and G2-M checkpoints and potentiates apoptosis in MDA-MD-435 breast cancer cells.  The abrogation of the G2-M checkpoint and induction of apoptosis by CHIR-124 are enhanced by the loss of p53.  We have also shown that CHIR-124 treatment can restore the level of cdc25A protein, which is normally targeted by Chk1 for degrdn. following DNA damage, indicating that Chk1 signaling is suppressed in the presence of CHIR-124.  Finally, in an orthotopic breast cancer xenograft model, CHIR-124 potentiates the growth inhibitory effects of irinotecan by abrogating the G2-M checkpoint and increasing tumor apoptosis.  CHIR-124 is a novel and potent Chk1 inhibitor with promising antitumor activities when used in combination with topoisomerase I poisons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8tD5w3RW7tbVg90H21EOLACvtfcHk0ljs8JX-jeU3Sg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXoslSktQ%253D%253D&md5=59760855db149f99eba0e10828042816</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-1424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-1424%26sid%3Dliteratum%253Aachs%26aulast%3DTse%26aufirst%3DA.%2BN.%26aulast%3DRendahl%26aufirst%3DK.%2BG.%26aulast%3DSheikh%26aufirst%3DT.%26aulast%3DCheema%26aufirst%3DH.%26aulast%3DAardalen%26aufirst%3DK.%26aulast%3DEmbry%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DMoler%26aufirst%3DE.%2BJ.%26aulast%3DNi%26aufirst%3DZ.%2BJ.%26aulast%3DLopes%2Bde%2BMenezes%26aufirst%3DD.%2BE.%26aulast%3DHibner%26aufirst%3DB.%26aulast%3DGesner%26aufirst%3DT.%2BG.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26atitle%3DCHIR-124%252C%2520a%2520novel%2520potent%2520inhibitor%2520of%2520Chk1%252C%2520potentiates%2520the%2520cytotoxicity%2520of%2520topoisomerase%2520I%2520poisons%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D591%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Xiao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span> </span><span class="NLM_article-title">Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1935</span><span class="NLM_x">â</span> <span class="NLM_lpage">1943</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1158%2F1535-7163.MCT-06-0077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=16928813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVans7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=1935-1943&author=Z.+Xiaoauthor=J.+Xueauthor=T.+J.+Sowinauthor=H.+Zhang&title=Differential+roles+of+checkpoint+kinase+1%2C+checkpoint+kinase+2%2C+and+mitogen-activated+protein+kinase-activated+protein+kinase+2+in+mediating+DNA+damage-induced+cell+cycle+arrest%3A+implications+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy</span></div><div class="casAuthors">Xiao, Zhan; Xue, John; Sowin, Thomas J.; Zhang, Haiying</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1935-1943</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Mammalian cells initiate cell cycle arrest at different phases of the cell cycle in response to various forms of genotoxic stress to allow time for DNA repair, and thus preserving their genomic integrity.  The protein kinases checkpoint kinase 1 (Chk1), checkpoint kinase 2 (Chk2), and mitogen-activated protein kinase-activated protein kinase 2 (MK2) have all been shown to be involved in cell cycle checkpoint control.  Recently, cell cycle checkpoint abrogation has been proposed as one way to sensitize cancer cells to DNA-damaging agents due to the expected induction of mitotic catastrophe.  Due to their overlapping substrate spectra and redundant functions, it is still not clear which kinase is mainly responsible for the cell cycle arrests conferred by clin. relevant chemotherapeutics.  Thus, the issue remains about which kinase is the most therapeutically relevant target and, more importantly, whether multiple kinases might need to be targeted to achieve the best efficacy in light of recent studies showing superior efficacy for pan-receptor tyrosine kinase inhibitors.  To clarify this issue, we investigated the roles of the three kinases in response to different genotoxic stresses through small interfering RNA-mediated specific target knockdowns.  Our result showed that only the down-regulation of Chk1, but not of Chk2 or MK2, abrogated camptothecin- or 5-fluorouracil-induced S-phase arrest or doxorubicin-induced G2-phase arrest.  This was followed by mitotic catastrophe and apoptosis.  Moreover, double inhibition of Chk1 and Chk2 failed to achieve better efficacy than Chk1 inhibition alone; surprisingly, inhibition of MK2, in addn. to Chk1 suppression, partially reversed the checkpoint abrogation and negated mitotic catastrophe.  We further showed that this is due to the fact that in MK2-deficient cells, Cdc25A protein, which is critically required for the mitotic progression following checkpoint abrogation, becomes greatly depleted.  In summary, our findings show that Chk1 is the only relevant checkpoint kinase as a cancer drug target and inhibition of other checkpoint kinases in addn. to Chk1 would be nonproductive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-Au13f9gHdLVg90H21EOLACvtfcHk0ljs8JX-jeU3Sg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVans7o%253D&md5=2144e703cacac5049bc937e35fca8713</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0077%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DSowin%26aufirst%3DT.%2BJ.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DDifferential%2520roles%2520of%2520checkpoint%2520kinase%25201%252C%2520checkpoint%2520kinase%25202%252C%2520and%2520mitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520in%2520mediating%2520DNA%2520damage-induced%2520cell%2520cycle%2520arrest%253A%2520implications%2520for%2520cancer%2520therapy%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D1935%26epage%3D1943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Zabludoff, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grondine, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehy, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caleb, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haye, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horn, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janetka, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouchet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ready, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Queva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A. M.</span><span> </span><span class="NLM_article-title">AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2955</span><span class="NLM_x">â</span> <span class="NLM_lpage">2966</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1158%2F1535-7163.MCT-08-0492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=18790776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSmsL7O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=2955-2966&author=S.+D.+Zabludoffauthor=C.+Dengauthor=M.+R.+Grondineauthor=A.+M.+Sheehyauthor=S.+Ashwellauthor=B.+L.+Calebauthor=S.+Greenauthor=H.+R.+Hayeauthor=C.+L.+Hornauthor=J.+W.+Janetkaauthor=D.+Liuauthor=E.+Mouchetauthor=S.+Readyauthor=J.+L.+Rosenthalauthor=C.+Quevaauthor=G.+K.+Schwartzauthor=K.+J.+Taylorauthor=A.+N.+Tseauthor=G.+E.+Walkerauthor=A.+M.+White&title=AZD7762%2C+a+novel+checkpoint+kinase+inhibitor%2C+drives+checkpoint+abrogation+and+potentiates+DNA-targeted+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies</span></div><div class="casAuthors">Zabludoff, Sonya D.; Deng, Chun; Grondine, Michael R.; Sheehy, Adam M.; Ashwell, Susan; Caleb, Benjamin L.; Green, Stephen; Haye, Heather R.; Horn, Candice L.; Janetka, James W.; Liu, Dongfang; Mouchet, Elizabeth; Ready, Shannon; Rosenthal, Judith L.; Queva, Christophe; Schwartz, Gary K.; Taylor, Karen J.; Tse, Archie N.; Walker, Graeme E.; White, Anne M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2955-2966</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Insights from cell cycle research have led to the hypothesis that tumors may be selectively sensitized to DNA-damaging agents resulting in improved antitumor activity and a wider therapeutic margin.  The theory relies on the observation that the majority of tumors are deficient in the G1-DNA damage checkpoint pathway resulting in reliance on S and G2 checkpoints for DNA repair and cell survival.  The S and G2 checkpoints are regulated by checkpoint kinase 1, a serine/threonine kinase that is activated in response to DNA damage; thus, inhibition of checkpoint kinase 1 signaling impairs DNA repair and increases tumor cell death.  Normal tissues, however, have a functioning G1 checkpoint signaling pathway allowing for DNA repair and cell survival.  Here, we describe the preclin. profile of AZD7762, a potent ATP-competitive checkpoint kinase inhibitor in clin. trials.  AZD7762 has been profiled extensively in vitro and in vivo in combination with DNA-damaging agents and has been shown to potentiate response in several different settings where inhibition of checkpoint kinase results in the abrogation of DNA damage-induced cell cycle arrest.  Dose-dependent potentiation of antitumor activity, when AZD7762 is administered in combination with DNA-damaging agents, has been obsd. in multiple xenograft models with several DNA-damaging agents, further supporting the potential of checkpoint kinase inhibitors to enhance the efficacy of both conventional chemotherapy and radiotherapy and increase patient response rates in a variety of settings. [Mol Cancer Ther 2008;7(9):2955-66].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTXvjs3OaUFrVg90H21EOLACvtfcHk0lhdnzRcsPLzqg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSmsL7O&md5=b33ff697c6592c9823e85c9bb265c02d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0492%26sid%3Dliteratum%253Aachs%26aulast%3DZabludoff%26aufirst%3DS.%2BD.%26aulast%3DDeng%26aufirst%3DC.%26aulast%3DGrondine%26aufirst%3DM.%2BR.%26aulast%3DSheehy%26aufirst%3DA.%2BM.%26aulast%3DAshwell%26aufirst%3DS.%26aulast%3DCaleb%26aufirst%3DB.%2BL.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DHaye%26aufirst%3DH.%2BR.%26aulast%3DHorn%26aufirst%3DC.%2BL.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMouchet%26aufirst%3DE.%26aulast%3DReady%26aufirst%3DS.%26aulast%3DRosenthal%26aufirst%3DJ.%2BL.%26aulast%3DQueva%26aufirst%3DC.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26aulast%3DTaylor%26aufirst%3DK.%2BJ.%26aulast%3DTse%26aufirst%3DA.%2BN.%26aulast%3DWalker%26aufirst%3DG.%2BE.%26aulast%3DWhite%26aufirst%3DA.%2BM.%26atitle%3DAZD7762%252C%2520a%2520novel%2520checkpoint%2520kinase%2520inhibitor%252C%2520drives%2520checkpoint%2520abrogation%2520and%2520potentiates%2520DNA-targeted%2520therapies%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D2955%26epage%3D2966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span> </span><span class="NLM_article-title">Anticancer therapy with checkpoint inhibitors: What, where and when?</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">308</span><span class="NLM_x">â</span> <span class="NLM_lpage">316</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=308-316&author=M.+D.+Garrettauthor=I.+Collins&title=Anticancer+therapy+with+checkpoint+inhibitors%3A+What%2C+where+and+when%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DAnticancer%2520therapy%2520with%2520checkpoint%2520inhibitors%253A%2520What%252C%2520where%2520and%2520when%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2011%26volume%3D32%26spage%3D308%26epage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Janetka, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwell, S.</span><span> </span><span class="NLM_article-title">Checkpoint kinase inhibitors: A review of the patent literature</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">â</span> <span class="NLM_lpage">197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1517%2F13543770802653622" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=19441917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVClu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=165-197&author=J.+W.+Janetkaauthor=S.+Ashwell&title=Checkpoint+kinase+inhibitors%3A+A+review+of+the+patent+literature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Checkpoint kinase inhibitors: a review of the patent literature</span></div><div class="casAuthors">Janetka, James W.; Ashwell, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">165-197</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The checkpoint kinases, Chk1 and Chk2 are Ser/Thr protein kinases, which function as key regulatory kinases in cellular DNA damage response pathways limiting cell-cycle progression in the presence of DNA damage.  The development of checkpoint kinase inhibitors for the treatment of cancer has been a major objective in drug discovery over the past decade, as evidenced by three checkpoint kinase inhibitors entering clinic trials since late 2005.  This review describes and discusses the most recent inhibitors of checkpoint kinases Chk1 and Chk2, as reported in the patent literature, including an evaluation of chem. structure and biol. activity.  Using a variety of approaches, we searched and analyzed all patent applications claiming chem. matter in which Chk1 or Chk2 were stated as targets of inhibition from Jan. 2006 through August 2008.  Conclusions: A large no. of chem. diverse Chk1 and Chk2 kinase inhibitors have appeared in the recent patent literature.  Common structural motifs of the checkpoint kinase inhibitors were identified.  There are currently three checkpoint kinase inhibitors in clin. development, a continuing effort by the pharmaceutical industry to identify novel scaffolds for checkpoint kinase inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvPfYmTA3VFrVg90H21EOLACvtfcHk0lhdnzRcsPLzqg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVClu7c%253D&md5=bb53a2a82402796d1eb61a9addbdc7c3</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1517%2F13543770802653622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770802653622%26sid%3Dliteratum%253Aachs%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DAshwell%26aufirst%3DS.%26atitle%3DCheckpoint%2520kinase%2520inhibitors%253A%2520A%2520review%2520of%2520the%2520patent%2520literature%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D165%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Janetka, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabludoff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyne, P.</span><span> </span><span class="NLM_article-title">Inhibitors of checkpoint kinases: From discovery to the clinic</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">â</span> <span class="NLM_lpage">486</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=473-486&author=J.+W.+Janetkaauthor=S.+Ashwellauthor=S.+Zabludoffauthor=P.+Lyne&title=Inhibitors+of+checkpoint+kinases%3A+From+discovery+to+the+clinic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DAshwell%26aufirst%3DS.%26aulast%3DZabludoff%26aufirst%3DS.%26aulast%3DLyne%26aufirst%3DP.%26atitle%3DInhibitors%2520of%2520checkpoint%2520kinases%253A%2520From%2520discovery%2520to%2520the%2520clinic%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2007%26volume%3D10%26spage%3D473%26epage%3D486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Prudhomme, M.</span><span> </span><span class="NLM_article-title">Novel checkpoint 1 inhibitors</span> <span class="citation_source-journal">Recent Pat. Anti-Cancer Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">â</span> <span class="NLM_lpage">68</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=55-68&author=M.+Prudhomme&title=Novel+checkpoint+1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrudhomme%26aufirst%3DM.%26atitle%3DNovel%2520checkpoint%25201%2520inhibitors%26jtitle%3DRecent%2520Pat.%2520Anti-Cancer%2520Drug%2520Discovery%26date%3D2006%26spage%3D55%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Tao, Z.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judge, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span> </span><span class="NLM_article-title">Structure-based design, synthesis, and biological evaluation of potent and selective macrocyclic checkpoint kinase 1 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1514</span><span class="NLM_x">â</span> <span class="NLM_lpage">1527</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061247v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1514-1527&author=Z.-F.+Taoauthor=L.+Wangauthor=K.+D.+Stewartauthor=Z.+Chenauthor=W.+Guauthor=M.-H.+Buiauthor=P.+Mertaauthor=H.+Zhangauthor=P.+Kovarauthor=E.+Johnsonauthor=C.+Parkauthor=R.+Judgeauthor=S.+Rosenbergauthor=T.+Sowinauthor=N.-H.+Lin&title=Structure-based+design%2C+synthesis%2C+and+biological+evaluation+of+potent+and+selective+macrocyclic+checkpoint+kinase+1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm061247v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061247v%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DZ.-F.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DGu%26aufirst%3DW.%26aulast%3DBui%26aufirst%3DM.-H.%26aulast%3DMerta%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DJohnson%26aufirst%3DE.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DJudge%26aufirst%3DR.%26aulast%3DRosenberg%26aufirst%3DS.%26aulast%3DSowin%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DN.-H.%26atitle%3DStructure-based%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520potent%2520and%2520selective%2520macrocyclic%2520checkpoint%2520kinase%25201%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1514%26epage%3D1527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Register, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margosiak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tempczyk-Russell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâConnor, P. M.</span><span> </span><span class="NLM_article-title">The 1.7 A crystal structure of human cell cycle checkpoint kinase Chk1: implications for Chk1 regulation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">681</span><span class="NLM_x">â</span> <span class="NLM_lpage">692</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=681-692&author=P.+Chenauthor=C.+Luoauthor=Y.+Dengauthor=K.+Ryanauthor=J.+Registerauthor=S.+Margosiakauthor=A.+Tempczyk-Russellauthor=B.+Nguyenauthor=P.+Myersauthor=K.+Lundgrenauthor=C.+C.+Kanauthor=P.+M.+O%E2%80%99Connor&title=The+1.7+A+crystal+structure+of+human+cell+cycle+checkpoint+kinase+Chk1%3A+implications+for+Chk1+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DRegister%26aufirst%3DJ.%26aulast%3DMargosiak%26aufirst%3DS.%26aulast%3DTempczyk-Russell%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DB.%26aulast%3DMyers%26aufirst%3DP.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DKan%26aufirst%3DC.%2BC.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%2BM.%26atitle%3DThe%25201.7%2520A%2520crystal%2520structure%2520of%2520human%2520cell%2520cycle%2520checkpoint%2520kinase%2520Chk1%253A%2520implications%2520for%2520Chk1%2520regulation%26jtitle%3DCell%26date%3D2000%26volume%3D100%26spage%3D681%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Foloppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kierstan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, A.</span><span> </span><span class="NLM_article-title">Identification of a buried pocket for potent and selective inhibition of Chk1: Prediction and verification</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1792</span><span class="NLM_x">â</span> <span class="NLM_lpage">1804</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=1792-1804&author=N.+Foloppeauthor=L.+M.+Fisherauthor=G.+Francisauthor=R.+Howesauthor=P.+Kierstanauthor=A.+Potter&title=Identification+of+a+buried+pocket+for+potent+and+selective+inhibition+of+Chk1%3A+Prediction+and+verification"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DFisher%26aufirst%3DL.%2BM.%26aulast%3DFrancis%26aufirst%3DG.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DKierstan%26aufirst%3DP.%26aulast%3DPotter%26aufirst%3DA.%26atitle%3DIdentification%2520of%2520a%2520buried%2520pocket%2520for%2520potent%2520and%2520selective%2520inhibition%2520of%2520Chk1%253A%2520Prediction%2520and%2520verification%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D1792%26epage%3D1804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Foloppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kierstan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A. E.</span><span> </span><span class="NLM_article-title">Structure-based design of novel Chk1 inhibitors: Insights into hydrogen bonding and protein-ligand affinity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4332</span><span class="NLM_x">â</span> <span class="NLM_lpage">4345</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049022c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4332-4345&author=N.+Foloppeauthor=L.+M.+Fisherauthor=R.+Howesauthor=P.+Kierstanauthor=A.+Potterauthor=A.+G.+Robertsonauthor=A.+E.+Surgenor&title=Structure-based+design+of+novel+Chk1+inhibitors%3A+Insights+into+hydrogen+bonding+and+protein-ligand+affinity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm049022c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049022c%26sid%3Dliteratum%253Aachs%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DFisher%26aufirst%3DL.%2BM.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DKierstan%26aufirst%3DP.%26aulast%3DPotter%26aufirst%3DA.%26aulast%3DRobertson%26aufirst%3DA.%2BG.%26aulast%3DSurgenor%26aufirst%3DA.%2BE.%26atitle%3DStructure-based%2520design%2520of%2520novel%2520Chk1%2520inhibitors%253A%2520Insights%2520into%2520hydrogen%2520bonding%2520and%2520protein-ligand%2520affinity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4332%26epage%3D4345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Converso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartingh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbaccio, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasber, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreatsoulas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stirdivant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drakas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrams, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepp-Lorenzino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zugay-Murphy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sardana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jezequel-Sur, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuck, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span> </span><span class="NLM_article-title">Development of thioquinazolinones, allosteric Chk1 kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1240</span><span class="NLM_x">â</span> <span class="NLM_lpage">1244</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1016%2Fj.bmcl.2008.12.076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=19155174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Wrurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1240-1244&author=A.+Conversoauthor=T.+Hartinghauthor=R.+M.+Garbaccioauthor=E.+Tasberauthor=K.+Rickertauthor=M.+E.+Fraleyauthor=Y.+Yanauthor=C.+Kreatsoulasauthor=S.+Stirdivantauthor=B.+Drakasauthor=E.+S.+Walshauthor=K.+Hamiltonauthor=C.+A.+Buserauthor=X.+Maoauthor=M.+T.+Abramsauthor=S.+C.+Beckauthor=W.+Taoauthor=R.+Lobellauthor=L.+Sepp-Lorenzinoauthor=J.+Zugay-Murphyauthor=V.+Sardanaauthor=S.+K.+Munshiauthor=S.+M.+Jezequel-Surauthor=P.+D.+Zuckauthor=G.+D.+Hartman&title=Development+of+thioquinazolinones%2C+allosteric+Chk1+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Development of thioquinazolinones, allosteric Chk1 kinase inhibitors</span></div><div class="casAuthors">Converso, Antonella; Hartingh, Timothy; Garbaccio, Robert M.; Tasber, Edward; Rickert, Keith; Fraley, Mark E.; Yan, Youwei; Kreatsoulas, Constantine; Stirdivant, Steve; Drakas, Bob; Walsh, Eileen S.; Hamilton, Kelly; Buser, Carolyn A.; Mao, Xianzhi; Abrams, Marc T.; Beck, Stephen C.; Tao, Weikang; Lobell, Rob; Sepp-Lorenzino, Laura; Zugay-Murphy, Joan; Sardana, Vinod; Munshi, Sanjeev K.; Jezequel-Sur, Sylvie Marie; Zuck, Paul D.; Hartman, George D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1240-1244</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A high throughput screening campaign was designed to identify allosteric inhibitors of Chk1 kinase by testing compds. at high concn.  Activity was then obsd. at Km for ATP and at near-physiol. concns. of ATP.  This strategy led to the discovery of a non-ATP competitive thioquinazolinone series which was optimized for potency and stability.  An X-ray crystal structure for the complex of our best inhibitor bound to Chk1 was solved, indicating that it binds to an allosteric site â¼13 Ã from the ATP binding site.  Preliminary data is presented for several of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9bIRNnirJ4bVg90H21EOLACvtfcHk0liqpCevkUkh6w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Wrurc%253D&md5=e91440930e976b9aafcfbb1597679511</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.12.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.12.076%26sid%3Dliteratum%253Aachs%26aulast%3DConverso%26aufirst%3DA.%26aulast%3DHartingh%26aufirst%3DT.%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DTasber%26aufirst%3DE.%26aulast%3DRickert%26aufirst%3DK.%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DKreatsoulas%26aufirst%3DC.%26aulast%3DStirdivant%26aufirst%3DS.%26aulast%3DDrakas%26aufirst%3DB.%26aulast%3DWalsh%26aufirst%3DE.%2BS.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DMao%26aufirst%3DX.%26aulast%3DAbrams%26aufirst%3DM.%2BT.%26aulast%3DBeck%26aufirst%3DS.%2BC.%26aulast%3DTao%26aufirst%3DW.%26aulast%3DLobell%26aufirst%3DR.%26aulast%3DSepp-Lorenzino%26aufirst%3DL.%26aulast%3DZugay-Murphy%26aufirst%3DJ.%26aulast%3DSardana%26aufirst%3DV.%26aulast%3DMunshi%26aufirst%3DS.%2BK.%26aulast%3DJezequel-Sur%26aufirst%3DS.%2BM.%26aulast%3DZuck%26aufirst%3DP.%2BD.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26atitle%3DDevelopment%2520of%2520thioquinazolinones%252C%2520allosteric%2520Chk1%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1240%26epage%3D1244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Ma, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janetka, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwnica-Worms, H.</span><span> </span><span class="NLM_article-title">Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics</span> <span class="citation_source-journal">Trends. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">â</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1016%2Fj.molmed.2010.10.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=21087899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFWgsro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=88-96&author=C.+X.+Maauthor=J.+W.+Janetkaauthor=H.+Piwnica-Worms&title=Death+by+releasing+the+breaks%3A+CHK1+inhibitors+as+cancer+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics</span></div><div class="casAuthors">Ma, Cynthia X.; Janetka, James W.; Piwnica-Worms, Helen</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">88-96</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Defects in p53 function, which occur frequently in human cancers due to mutations in TP53 or disruptions in the p53 regulatory pathway, render cells dependent on CHK1 (Checkpoint Kinase 1) to activate cell cycle checkpoints.  In the presence of DNA damage or replication stress, inhibition of CHK1 leads to "mitotic catastrophe" and cell death in p53-deficient tumors while sparing p53-proficient cells.  CHK1 inhibitors sensitize tumors to a variety of DNA-damaging agents or antimetabolites in preclin. models and are being evaluated in early phase clin. trials.  In this review, we summarize recent advances and controversies in the development and application of CHK1 inhibitors as cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAxtqrXv9ZqbVg90H21EOLACvtfcHk0ljLC3ALChCbQg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFWgsro%253D&md5=e53c01cf0016d5be069913a041d67a08</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2010.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2010.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DC.%2BX.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DPiwnica-Worms%26aufirst%3DH.%26atitle%3DDeath%2520by%2520releasing%2520the%2520breaks%253A%2520CHK1%2520inhibitors%2520as%2520cancer%2520therapeutics%26jtitle%3DTrends.%2520Mol.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D88%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klair, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwood, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHardy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K.-M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Montfort, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span> </span><span class="NLM_article-title">Identification of inhibitors of checkpoint kinase 1 through template screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4810</span><span class="NLM_x">â</span> <span class="NLM_lpage">4819</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900314j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4810-4819&author=T.+P.+Matthewsauthor=S.+Klairauthor=S.+Burnsauthor=K.+Boxallauthor=M.+Cherryauthor=M.+Fisherauthor=I.+M.+Westwoodauthor=M.+I.+Waltonauthor=T.+McHardyauthor=K.-M.+J.+Cheungauthor=R.+Van+Montfortauthor=D.+Williamsauthor=G.+W.+Aherneauthor=M.+D.+Garrettauthor=J.+Readerauthor=I.+Collins&title=Identification+of+inhibitors+of+checkpoint+kinase+1+through+template+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm900314j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900314j%26sid%3Dliteratum%253Aachs%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DKlair%26aufirst%3DS.%26aulast%3DBurns%26aufirst%3DS.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DCherry%26aufirst%3DM.%26aulast%3DFisher%26aufirst%3DM.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3DWalton%26aufirst%3DM.%2BI.%26aulast%3DMcHardy%26aufirst%3DT.%26aulast%3DCheung%26aufirst%3DK.-M.%2BJ.%26aulast%3DVan%2BMontfort%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DD.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DReader%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DIdentification%2520of%2520inhibitors%2520of%2520checkpoint%2520kinase%25201%2520through%2520template%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4810%26epage%3D4819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHardy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klair, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Addison, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwood, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montfort, R. v.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reader, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span> </span><span class="NLM_article-title">Design and evaluation of 3,6-di(hetero)aryl imidazo[1,2-<i>a</i>]pyrazines as inhibitors of checkpoint and other kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4045</span><span class="NLM_x">â</span> <span class="NLM_lpage">4049</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4045-4049&author=T.+P.+Matthewsauthor=T.+McHardyauthor=S.+Klairauthor=K.+Boxallauthor=M.+Fisherauthor=M.+Cherryauthor=C.+E.+Allenauthor=G.+J.+Addisonauthor=J.+Ellardauthor=G.+W.+Aherneauthor=I.+M.+Westwoodauthor=R.+v.+Montfortauthor=M.+D.+Garrettauthor=J.+C.+Readerauthor=I.+Collins&title=Design+and+evaluation+of+3%2C6-di%28hetero%29aryl+imidazo%5B1%2C2-a%5Dpyrazines+as+inhibitors+of+checkpoint+and+other+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DMcHardy%26aufirst%3DT.%26aulast%3DKlair%26aufirst%3DS.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DFisher%26aufirst%3DM.%26aulast%3DCherry%26aufirst%3DM.%26aulast%3DAllen%26aufirst%3DC.%2BE.%26aulast%3DAddison%26aufirst%3DG.%2BJ.%26aulast%3DEllard%26aufirst%3DJ.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3DMontfort%26aufirst%3DR.%2Bv.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DReader%26aufirst%3DJ.%2BC.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DDesign%2520and%2520evaluation%2520of%25203%252C6-di%2528hetero%2529aryl%2520imidazo%255B1%252C2-a%255Dpyrazines%2520as%2520inhibitors%2520of%2520checkpoint%2520and%2520other%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4045%26epage%3D4049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Antoni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sodha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span> </span><span class="NLM_article-title">CHK2 kinase: cancer susceptibility and cancer therapyâtwo sides of the same coin?</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">925</span><span class="NLM_x">â</span> <span class="NLM_lpage">936</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1038%2Fnrc2251" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=18004398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlCrsLbI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=925-936&author=L.+Antoniauthor=N.+Sodhaauthor=I.+Collinsauthor=M.+D.+Garrett&title=CHK2+kinase%3A+cancer+susceptibility+and+cancer+therapy%E2%80%94two+sides+of+the+same+coin%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">CHK2 kinase: cancer susceptibility and cancer therapy - two sides of the same coin?</span></div><div class="casAuthors">Antoni, Laurent; Sodha, Nayanta; Collins, Ian; Garrett, Michelle D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">925-936</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In the past decade, CHK2 has emerged as an important multifunctional player in the DNA-damage response signalling pathway.  Parallel studies of the human CHEK2 gene have also highlighted its role as a candidate multiorgan tumor susceptibility gene rather than a highly penetrant predisposition gene for Li-Fraumeni syndrome.  As discussed here, the current understanding of CHK2 function in tumor cells, in both a biol. and genetic context, suggests that targeted modulation of the active kinase or exploitation of its loss in tumors could prove to be effective anti-cancer strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsWURyq9JQfLVg90H21EOLACvtfcHk0lj9Dj8Tvib5Bg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlCrsLbI&md5=b0ad4a7db909590234fb8e2656e949d1</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnrc2251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2251%26sid%3Dliteratum%253Aachs%26aulast%3DAntoni%26aufirst%3DL.%26aulast%3DSodha%26aufirst%3DN.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26atitle%3DCHK2%2520kinase%253A%2520cancer%2520susceptibility%2520and%2520cancer%2520therapy%25E2%2580%2594two%2520sides%2520of%2520the%2520same%2520coin%253F%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2007%26volume%3D7%26spage%3D925%26epage%3D936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Guzi, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paruch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labroli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanahan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taricani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiswell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seghezzi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penaflor, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhagwat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parry, D.</span><span> </span><span class="NLM_article-title">Targeting the replication checkpoint using SCH 900776, a potent and functionally selective CHK1 inhibitor identified via high content screening</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span><span class="NLM_x">â</span> <span class="NLM_lpage">602</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1158%2F1535-7163.MCT-10-0928" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=21321066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSrt7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=591-602&author=T.+J.+Guziauthor=K.+Paruchauthor=M.+P.+Dwyerauthor=M.+Labroliauthor=F.+Shanahanauthor=N.+Davisauthor=L.+Taricaniauthor=D.+Wiswellauthor=W.+Seghezziauthor=E.+Penaflorauthor=B.+Bhagwatauthor=W.+Wangauthor=D.+Guauthor=Y.+Hsiehauthor=S.+Leeauthor=M.+Liuauthor=D.+Parry&title=Targeting+the+replication+checkpoint+using+SCH+900776%2C+a+potent+and+functionally+selective+CHK1+inhibitor+identified+via+high+content+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Replication Checkpoint Using SCH 900776, a Potent and Functionally Selective CHK1 Inhibitor Identified via High Content Screening</span></div><div class="casAuthors">Guzi, Timothy J.; Paruch, Kamil; Dwyer, Michael P.; Labroli, Marc; Shanahan, Frances; Davis, Nicole; Taricani, Lorena; Wiswell, Derek; Seghezzi, Wolfgang; Penaflor, Ervin; Bhagwat, Bhagyashree; Wang, Wei; Gu, Danling; Hsieh, Yunsheng; Lee, Suining; Liu, Ming; Parry, David</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">591-602</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Checkpoint kinase 1 (CHK1) is an essential serine/threonine kinase that responds to DNA damage and stalled DNA replication.  CHK1 is essential for maintenance of replication fork viability during exposure to DNA antimetabolites.  In human tumor cell lines, ablation of CHK1 function during antimetabolite exposure led to accumulation of double-strand DNA breaks and cell death.  Here, we extend these observations and confirm ablation of CHK2 does not contribute to these phenotypes and may diminish them.  Furthermore, concomitant suppression of cyclin-dependent kinase (CDK) activity is sufficient to completely antagonize the desired CHK1 ablation phenotypes.  These mechanism-based observations prompted the development of a high-content, cell-based screen for Î³-H2AX induction, a surrogate marker for double-strand DNA breaks.  This mechanism-based functional approach was used to optimize small mol. inhibitors of CHK1.  Specifically, the assay was used to mechanistically define the optimal in-cell profile with compds. exhibiting varying degrees of CHK1, CHK2, and CDK selectivity.  Using this approach, SCH 900776 was identified as a highly potent and functionally optimal CHK1 inhibitor with minimal intrinsic antagonistic properties.  SCH 900776 exposure phenocopies short interfering RNA-mediated CHK1 ablation and interacts synergistically with DNA antimetabolite agents in vitro and in vivo to selectively induce dsDNA breaks and cell death in tumor cell backgrounds.  Mol Cancer Ther; 10(4); 591-602.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_DnP2RPokHLVg90H21EOLACvtfcHk0lh30yXShTGI9Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSrt7o%253D&md5=884137ebd69d0959b583a6338a89b87a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-0928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-0928%26sid%3Dliteratum%253Aachs%26aulast%3DGuzi%26aufirst%3DT.%2BJ.%26aulast%3DParuch%26aufirst%3DK.%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DLabroli%26aufirst%3DM.%26aulast%3DShanahan%26aufirst%3DF.%26aulast%3DDavis%26aufirst%3DN.%26aulast%3DTaricani%26aufirst%3DL.%26aulast%3DWiswell%26aufirst%3DD.%26aulast%3DSeghezzi%26aufirst%3DW.%26aulast%3DPenaflor%26aufirst%3DE.%26aulast%3DBhagwat%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DGu%26aufirst%3DD.%26aulast%3DHsieh%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DParry%26aufirst%3DD.%26atitle%3DTargeting%2520the%2520replication%2520checkpoint%2520using%2520SCH%2520900776%252C%2520a%2520potent%2520and%2520functionally%2520selective%2520CHK1%2520inhibitor%2520identified%2520via%2520high%2520content%2520screening%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D591%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficency: A useful tool for metric lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">â</span> <span class="NLM_lpage">431</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficency%3A+A+useful+tool+for+metric+lead+selection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficency%253A%2520A%2520useful%2520tool%2520for%2520metric%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Collins, I.; Reader, J. C.; Cheung, K. M.; Matthews, T. P.; Proisy, N.; Klair, S. S.</span><span> </span><span class="NLM_article-title">Morpholino-bicyclo-heteroaryl compounds as CHK1 kinase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of cancer</span>. Patent Appl. WO2008075007, 2008; Chem Abstr.<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">104737</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=I.+Collins&author=J.+C.+Reader&author=K.+M.+Cheung&author=T.+P.+Matthews&author=N.+Proisy&author=S.+S.+Klair&title=Morpholino-bicyclo-heteroaryl+compounds+as+CHK1+kinase+inhibitors+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DMorpholino-bicyclo-heteroaryl%2520compounds%2520as%2520CHK1%2520kinase%2520inhibitors%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520cancer%26jtitle%3DChem%2520Abstr.%26date%3D2008%26volume%3D149%26spage%3D104737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Cherry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. H.</span><span> </span><span class="NLM_article-title">Recent kinase and kinase inhibitor X-ray structures: Mechanisms of inhibition and selectivity insights</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">â</span> <span class="NLM_lpage">673</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.2174%2F0929867043455792" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=15032722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFWgs7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=663-673&author=M.+Cherryauthor=D.+H.+Williams&title=Recent+kinase+and+kinase+inhibitor+X-ray+structures%3A+Mechanisms+of+inhibition+and+selectivity+insights"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Recent kinase and kinase inhibitor x-ray structures: mechanisms of inhibition and selectivity insights</span></div><div class="casAuthors">Cherry, M.; Williams, D. H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">663-673</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent years have seen an explosion in the no. of publicly available x-ray crystal structures of protein kinases.  These structures have provided a wealth of information on the regulatory mechanisms, conformational plasticity and drugability of this important family of enzymes.  Drawing upon structural information, new insights into the development of protein kinase inhibitors are discussed including de-novo design, mol. templates for ATP competitive inhibitors and alternative mechanisms of inhibition.  The highly conserved nature of the ATP binding site is of central concern to drug development and the concept of a selectivity profile has arisen with structure-based design emerging as a key tool for addressing the challenges of specificity.  In addn., protein-ligand complexes, where the enzyme is in an inactive conformation, signify an alternate approach to protein kinase inhibition.  The belief that an inactive kinase presents a less conserved target is reviewed using observations on the structural changes occurring during protein kinase regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB19ovXBL1mrVg90H21EOLACvtfcHk0lh30yXShTGI9Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFWgs7w%253D&md5=63c621c012a6e1cc9f795565580d7492</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.2174%2F0929867043455792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043455792%26sid%3Dliteratum%253Aachs%26aulast%3DCherry%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DD.%2BH.%26atitle%3DRecent%2520kinase%2520and%2520kinase%2520inhibitor%2520X-ray%2520structures%253A%2520Mechanisms%2520of%2520inhibition%2520and%2520selectivity%2520insights%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D663%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Anand, N. K.; Blazey, C. M.; Bowles, O. J.; Bussenius, J.; Canne Bannen, L.; Chan, D. S.-M.; Chen, B.; Co, E. W.; Costanzo, S.; Defina, S. C.; Dubenko, L.; Franzini, M.; Huang, P.; Jammalamadaka, V.; Khoury, R. G.; Kim, M. H.; Klein, R. R.; Le, D. T.; Mac, M. B.; Nuss, J. M.; Parks, J. J.; Rice, K. D.; Tsang, T. H.; Tsuhako, A. L.; Wang, Y.; Xu, W.</span><span> </span><span class="NLM_article-title">Preparation and structure activity of pyrazolo-pyrimidine derivatives as antitumor agents and kinase modulators</span>. Patent WO 2005117909, 2005; Chem Abstr.<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">104737</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=N.+K.+Anand&author=C.+M.+Blazey&author=O.+J.+Bowles&author=J.+Bussenius&author=L.+Canne+Bannen&author=D.+S.-M.+Chan&author=B.+Chen&author=E.+W.+Co&author=S.+Costanzo&author=S.+C.+Defina&author=L.+Dubenko&author=M.+Franzini&author=P.+Huang&author=V.+Jammalamadaka&author=R.+G.+Khoury&author=M.+H.+Kim&author=R.+R.+Klein&author=D.+T.+Le&author=M.+B.+Mac&author=J.+M.+Nuss&author=J.+J.+Parks&author=K.+D.+Rice&author=T.+H.+Tsang&author=A.+L.+Tsuhako&author=Y.+Wang&author=W.+Xu&title=Preparation+and+structure+activity+of+pyrazolo-pyrimidine+derivatives+as+antitumor+agents+and+kinase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAnand%26aufirst%3DN.%2BK.%26atitle%3DPreparation%2520and%2520structure%2520activity%2520of%2520pyrazolo-pyrimidine%2520derivatives%2520as%2520antitumor%2520agents%2520and%2520kinase%2520modulators%26jtitle%3DChem%2520Abstr.%26date%3D2006%26volume%3D144%26spage%3D104737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Bold, G.; Frei, J.; Lang, M.; Traxler, P.; Furet, P.</span><span> </span><span class="NLM_article-title">Preparation of pyrazolo[3,4-<i>d</i>]pyrimidines as antitumor agents</span>. Patent WO 9814449, 1998; Chem Abstr.<span class="NLM_x"> </span><span class="NLM_year">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">282843</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=G.+Bold&author=J.+Frei&author=M.+Lang&author=P.+Traxler&author=P.+Furet&title=Preparation+of+pyrazolo%5B3%2C4-d%5Dpyrimidines+as+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBold%26aufirst%3DG.%26atitle%3DPreparation%2520of%2520pyrazolo%255B3%252C4-d%255Dpyrimidines%2520as%2520antitumor%2520agents%26jtitle%3DChem%2520Abstr.%26date%3D1998%26volume%3D128%26spage%3D282843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Caldwell, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donald, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHardy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlands, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruddle, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdonk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span> </span><span class="NLM_article-title">Identification of 4-(4-aminopiperidin-1-yl)-7H-pyrrolo[2,3-<i>d</i>]pyrimidines as selective inhibitors of protein kinase B through fragment elaboration</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2147</span><span class="NLM_x">â</span> <span class="NLM_lpage">2157</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701437d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2147-2157&author=J.+J.+Caldwellauthor=T.+G.+Daviesauthor=A.+Donaldauthor=T.+McHardyauthor=M.+G.+Rowlandsauthor=G.+W.+Aherneauthor=L.+K.+Hunterauthor=K.+Taylorauthor=R.+Ruddleauthor=F.+I.+Raynaudauthor=M.+Verdonkauthor=P.+Workmanauthor=M.+D.+Garrettauthor=I.+Collins&title=Identification+of+4-%284-aminopiperidin-1-yl%29-7H-pyrrolo%5B2%2C3-d%5Dpyrimidines+as+selective+inhibitors+of+protein+kinase+B+through+fragment+elaboration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm701437d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701437d%26sid%3Dliteratum%253Aachs%26aulast%3DCaldwell%26aufirst%3DJ.%2BJ.%26aulast%3DDavies%26aufirst%3DT.%2BG.%26aulast%3DDonald%26aufirst%3DA.%26aulast%3DMcHardy%26aufirst%3DT.%26aulast%3DRowlands%26aufirst%3DM.%2BG.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DHunter%26aufirst%3DL.%2BK.%26aulast%3DTaylor%26aufirst%3DK.%26aulast%3DRuddle%26aufirst%3DR.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DVerdonk%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DIdentification%2520of%25204-%25284-aminopiperidin-1-yl%2529-7H-pyrrolo%255B2%252C3-d%255Dpyrimidines%2520as%2520selective%2520inhibitors%2520of%2520protein%2520kinase%2520B%2520through%2520fragment%2520elaboration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2147%26epage%3D2157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Hoehn, H.; Denzel, T.</span><span> </span><span class="NLM_article-title">1H-Pyrazolo[3,4-<i>b</i>]pyridines</span>. Patent DE 2301268, 1973; Chem Abstr.<span class="NLM_x"> </span><span class="NLM_year">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">115578</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1973&author=H.+Hoehn&author=T.+Denzel&title=1H-Pyrazolo%5B3%2C4-b%5Dpyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHoehn%26aufirst%3DH.%26atitle%3D1H-Pyrazolo%255B3%252C4-b%255Dpyridines%26jtitle%3DChem%2520Abstr.%26date%3D1973%26volume%3D79%26spage%3D115578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">McHardy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlands, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruddle, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Haven Brandon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seavers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span> </span><span class="NLM_article-title">Discovery of 4-amino-1-(7H-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)piperidine-4-carboxamides as selective, orally active inhibitors of protein kinase B (Akt)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2239</span><span class="NLM_x">â</span> <span class="NLM_lpage">2249</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901788j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2239-2249&author=T.+McHardyauthor=J.+J.+Caldwellauthor=K.+M.+Cheungauthor=L.+J.+Hunterauthor=K.+Taylorauthor=M.+Rowlandsauthor=R.+Ruddleauthor=A.+Henleyauthor=A.+de+Haven+Brandonauthor=M.+Valentiauthor=T.+G.+Daviesauthor=L.+Fazalauthor=L.+Seaversauthor=F.+I.+Raynaudauthor=S.+A.+Ecclesauthor=G.+W.+Aherneauthor=M.+D.+Garrettauthor=I.+Collins&title=Discovery+of+4-amino-1-%287H-pyrrolo%5B2%2C3-d%5Dpyrimidin-4-yl%29piperidine-4-carboxamides+as+selective%2C+orally+active+inhibitors+of+protein+kinase+B+%28Akt%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm901788j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901788j%26sid%3Dliteratum%253Aachs%26aulast%3DMcHardy%26aufirst%3DT.%26aulast%3DCaldwell%26aufirst%3DJ.%2BJ.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DHunter%26aufirst%3DL.%2BJ.%26aulast%3DTaylor%26aufirst%3DK.%26aulast%3DRowlands%26aufirst%3DM.%26aulast%3DRuddle%26aufirst%3DR.%26aulast%3DHenley%26aufirst%3DA.%26aulast%3Dde%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DDavies%26aufirst%3DT.%2BG.%26aulast%3DFazal%26aufirst%3DL.%26aulast%3DSeavers%26aufirst%3DL.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DDiscovery%2520of%25204-amino-1-%25287H-pyrrolo%255B2%252C3-d%255Dpyrimidin-4-yl%2529piperidine-4-carboxamides%2520as%2520selective%252C%2520orally%2520active%2520inhibitors%2520of%2520protein%2520kinase%2520B%2520%2528Akt%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2239%26epage%3D2249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Traxler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bold, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lydon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mett, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchdunger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span> </span><span class="NLM_article-title">Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(Phenylamino)pyrazolo[3,4-d]pyrimidines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">3601</span><span class="NLM_x">â</span> <span class="NLM_lpage">3616</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970124v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=3601-3616&author=P.+Traxlerauthor=G.+Boldauthor=J.+Freiauthor=M.+Langauthor=N.+Lydonauthor=H.+Mettauthor=E.+Buchdungerauthor=T.+Meyerauthor=M.+Muellerauthor=P.+Furet&title=Use+of+a+pharmacophore+model+for+the+design+of+EGF-R+tyrosine+kinase+inhibitors%3A+4-%28Phenylamino%29pyrazolo%5B3%2C4-d%5Dpyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm970124v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970124v%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP.%26aulast%3DBold%26aufirst%3DG.%26aulast%3DFrei%26aufirst%3DJ.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DLydon%26aufirst%3DN.%26aulast%3DMett%26aufirst%3DH.%26aulast%3DBuchdunger%26aufirst%3DE.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DMueller%26aufirst%3DM.%26aulast%3DFuret%26aufirst%3DP.%26atitle%3DUse%2520of%2520a%2520pharmacophore%2520model%2520for%2520the%2520design%2520of%2520EGF-R%2520tyrosine%2520kinase%2520inhibitors%253A%25204-%2528Phenylamino%2529pyrazolo%255B3%252C4-d%255Dpyrimidines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D3601%26epage%3D3616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Traxler, P.; Furet, P.; Bold, G.; Frei, J.; Lang, M.</span><span> </span><span class="NLM_article-title">Preparation of 4-amino-1H-pyrazolo[3,4-<i>d</i>]pyrimidines as EGF-receptor-specific protein tyrosine kinase inhibitors</span>. Patent WO 9631510, 1996; Chem Abstr.<span class="NLM_x"> </span><span class="NLM_year">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">8129</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=P.+Traxler&author=P.+Furet&author=G.+Bold&author=J.+Frei&author=M.+Lang&title=Preparation+of+4-amino-1H-pyrazolo%5B3%2C4-d%5Dpyrimidines+as+EGF-receptor-specific+protein+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP.%26atitle%3DPreparation%2520of%25204-amino-1H-pyrazolo%255B3%252C4-d%255Dpyrimidines%2520as%2520EGF-receptor-specific%2520protein%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DChem%2520Abstr.%26date%3D1997%26volume%3D126%26spage%3D8129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Collins, I.; Reader, J. C.; Klair, S.; Scanlon, J.; Addison, G.; Cherry, M.</span><span> </span><span class="NLM_article-title">Preparation of 9H-pyrimido[4,5-<i>b</i>]indole, 9H-pyrido[4â²,3â²:4,5]pyrrolo[2,3-<i>d</i>]pyridine and 9H-1,3,6,9-tetraazafluorene derivatives as CHK1 kinase inhibitors</span>. Patent WO 2009004329, 2009; Chem Abstr.<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">150</span><span class="NLM_x">, </span> <span class="NLM_fpage">98355</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=I.+Collins&author=J.+C.+Reader&author=S.+Klair&author=J.+Scanlon&author=G.+Addison&author=M.+Cherry&title=Preparation+of+9H-pyrimido%5B4%2C5-b%5Dindole%2C+9H-pyrido%5B4%E2%80%B2%2C3%E2%80%B2%3A4%2C5%5Dpyrrolo%5B2%2C3-d%5Dpyridine+and+9H-1%2C3%2C6%2C9-tetraazafluorene+derivatives+as+CHK1+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DPreparation%2520of%25209H-pyrimido%255B4%252C5-b%255Dindole%252C%25209H-pyrido%255B4%25E2%2580%25B2%252C3%25E2%2580%25B2%253A4%252C5%255Dpyrrolo%255B2%252C3-d%255Dpyridine%2520and%25209H-1%252C3%252C6%252C9-tetraazafluorene%2520derivatives%2520as%2520CHK1%2520kinase%2520inhibitors%26jtitle%3DChem%2520Abstr.%26date%3D2009%26volume%3D150%26spage%3D98355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Wang, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantei, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span> </span><span class="NLM_article-title">1-(5-Chloro-2-alkoxyphenyl)-3-(5-cyano-pyrazin-2-yl)ureas as potent and selective inhibitors of Chk1 kinase: Synthesis, preliminary SAR, and biological activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3118</span><span class="NLM_x">â</span> <span class="NLM_lpage">3121</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm048989d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3118-3121&author=G.+T.+Wangauthor=G.+Liauthor=R.+A.+Manteiauthor=Z.+Chenauthor=P.+Kovarauthor=W.+Guauthor=Z.+Xiaoauthor=H.+Zhangauthor=H.+L.+Shamauthor=T.+Sowinauthor=S.+H.+Rosenbergauthor=N.-H.+Lin&title=1-%285-Chloro-2-alkoxyphenyl%29-3-%285-cyano-pyrazin-2-yl%29ureas+as+potent+and+selective+inhibitors+of+Chk1+kinase%3A+Synthesis%2C+preliminary+SAR%2C+and+biological+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm048989d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm048989d%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DG.%2BT.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DMantei%26aufirst%3DR.%2BA.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DGu%26aufirst%3DW.%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DSowin%26aufirst%3DT.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DLin%26aufirst%3DN.-H.%26atitle%3D1-%25285-Chloro-2-alkoxyphenyl%2529-3-%25285-cyano-pyrazin-2-yl%2529ureas%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520Chk1%2520kinase%253A%2520Synthesis%252C%2520preliminary%2520SAR%252C%2520and%2520biological%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3118%26epage%3D3121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasvold, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, Z.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwaltney, S. L.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Credo, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 1-(2,4,5-trisubstituted phenyl)-3-(5-cyanopyrazin-2-yl)ureas as potent Chk1 kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2293</span><span class="NLM_x">â</span> <span class="NLM_lpage">2298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2293-2298&author=G.+Liauthor=L.+A.+Hasvoldauthor=Z.-F.+Taoauthor=G.+T.+Wangauthor=S.+L.+Gwaltneyauthor=J.+Patelauthor=P.+Kovarauthor=R.+B.+Credoauthor=Z.+Chenauthor=H.+Zhangauthor=C.+Parkauthor=H.+L.+Shamauthor=T.+Sowinauthor=S.+H.+Rosenbergauthor=N.-H.+Lin&title=Synthesis+and+biological+evaluation+of+1-%282%2C4%2C5-trisubstituted+phenyl%29-3-%285-cyanopyrazin-2-yl%29ureas+as+potent+Chk1+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%26aulast%3DHasvold%26aufirst%3DL.%2BA.%26aulast%3DTao%26aufirst%3DZ.-F.%26aulast%3DWang%26aufirst%3DG.%2BT.%26aulast%3DGwaltney%26aufirst%3DS.%2BL.%26aulast%3DPatel%26aufirst%3DJ.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DCredo%26aufirst%3DR.%2BB.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DSowin%26aufirst%3DT.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DLin%26aufirst%3DN.-H.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25201-%25282%252C4%252C5-trisubstituted%2520phenyl%2529-3-%25285-cyanopyrazin-2-yl%2529ureas%2520as%2520potent%2520Chk1%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2293%26epage%3D2298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Auffinger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hays, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westhof, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, P. S.</span><span> </span><span class="NLM_article-title">Halogen bonds in biological molecules</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">16789</span><span class="NLM_x">â</span> <span class="NLM_lpage">16794</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1073%2Fpnas.0407607101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=15557000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFansr3P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=16789-16794&author=P.+Auffingerauthor=F.+A.+Haysauthor=E.+Westhofauthor=P.+S.+Ho&title=Halogen+bonds+in+biological+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Halogen bonds in biological molecules</span></div><div class="casAuthors">Auffinger, Pascal; Hays, Franklin A.; Westhof, Eric; Ho, P. Shing</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">16789-16794</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Short oxygen-halogen interactions have been known in org. chem. since the 1950s and recently have been exploited in the design of supramol. assemblies.  The present survey of protein and nucleic acid structures reveals similar halogen bonds as potentially stabilizing inter- and intramol. interactions that can affect ligand binding and mol. folding.  A halogen bond in biomols. can be defined as a short C-XÂ·Â·Â·O-Y interaction (C-X is a carbon-bonded chlorine, bromine, or iodine, and O-Y is a carbonyl, hydroxyl, charged carboxylate, or phosphate group), where the XÂ·Â·Â·O distance is less than or equal to the sums of the resp. van der Waals radii (3.27 Ã for ClÂ·Â·Â·O, 3.37 Ã for BrÂ·Â·Â·O, and 3.50 Ã for IÂ·Â·Â·O) and can conform to the geometry seen in small mols., with the C-XÂ·Â·Â·O angle â165Â° (consistent with a strong directional polarization of the halogen) and the XÂ·Â·Â·O-Y angle â120Â°.  Alternative geometries can be imposed by the more complex environment found in biomols., depending on which of the two types of donor systems are involved in the interaction: (i) the lone pair electrons of oxygen (and, to a lesser extent, nitrogen and sulfur) atoms or (ii) the delocalized Ï-electrons of peptide bonds or carboxylate or amide groups.  Thus, the specific geometry and diversity of the interacting partners of halogen bonds offer new and versatile tools for the design of ligands as drugs and materials in nanotechnol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPMdZU91iT77Vg90H21EOLACvtfcHk0lieBogZNeA1ug"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFansr3P&md5=dfcce25d4e336c66294f6ab8ce412154</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0407607101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0407607101%26sid%3Dliteratum%253Aachs%26aulast%3DAuffinger%26aufirst%3DP.%26aulast%3DHays%26aufirst%3DF.%2BA.%26aulast%3DWesthof%26aufirst%3DE.%26aulast%3DHo%26aufirst%3DP.%2BS.%26atitle%3DHalogen%2520bonds%2520in%2520biological%2520molecules%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26spage%3D16789%26epage%3D16794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Skehan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storeng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vistica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bokesch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M. R.</span><span> </span><span class="NLM_article-title">New colorimetric cytotoxicity assay for anticancer-drug screening</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">â</span> <span class="NLM_lpage">1112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1093%2Fjnci%2F82.13.1107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=2359136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADyaK3cXltVylsL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1990&pages=1107-1112&author=P.+Skehanauthor=R.+Storengauthor=D.+Scudieroauthor=A.+Monksauthor=J.+McMahonauthor=D.+Visticaauthor=J.+T.+Warrenauthor=H.+Bokeschauthor=S.+Kenneyauthor=M.+R.+Boyd&title=New+colorimetric+cytotoxicity+assay+for+anticancer-drug+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">New colorimetric cytotoxicity assay for anticancer-drug screening</span></div><div class="casAuthors">Skehan, Philip; Storeng, Ritsa; Scudiero, Dominic; Monks, Anne; McMahon, James; Vistica, David; Warren, Jonathan T.; Bokesch, Heidi; Kenney, Susan; Boyd, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1107-12</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">A rapid, sensitive, and inexpensive method was developed for measuring the cellular protein content of adherent and suspension cultures in 96-well microtiter plates.  The method is suitable for ordinary lab. purposes and for very large-scale applications, such as the National Cancer Institute's disease-oriented in vitro anticancer-drug discovery screen, which requires the use of several million culture wells per yr.  Cultures fixed with trichloroacetic acid were stained for 30 min with 0.4% (wt/vol) sulforhodamine B (SRB) dissolved in 1% acetic acid.  Unbound dye was removed by four washes with 1% acetic acid, and protein-bound dye was extd. with 10 mM unbuffered Tris base [tris(hydroxymethyl)aminomethane] for detn. of optical d. in a computer-interfaced, 96-well microtiter plate reader.  The SRB assay results were linear with the no. of cells and with values for cellular protein measured by both the Lowry and Bradford assays at densities ranging from sparse subconfluence to multilayered supraconfluence.  The signal-to-noise ratio at 564 nm was approx. 1.5 with 1,000 cells per well.  The sensitivity of the SRB assay compared favorably with sensitivities of several fluorescence assays and was superior to those of both the Lowry and Bradford assays and to those of 20 other visible dyes.  The SRB assay provides a colorimetric end point that is nondestructive, indefinitely stable, and visible to the naked eye.  It provides a sensitive measure of drug-induced cytotoxicity, is useful in quantitating clonogenicity, and is well suited to high-vol., automated drug screening.  SRB fluoresces strongly with laser excitation at 488 nm and can be measured quant. at the single-cell level by static fluorescence cytometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA1MIZ3rkcqLVg90H21EOLACvtfcHk0lieBogZNeA1ug"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXltVylsL8%253D&md5=d7bc1784a1f181842d2999efa7fa870c</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F82.13.1107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F82.13.1107%26sid%3Dliteratum%253Aachs%26aulast%3DSkehan%26aufirst%3DP.%26aulast%3DStoreng%26aufirst%3DR.%26aulast%3DScudiero%26aufirst%3DD.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DMcMahon%26aufirst%3DJ.%26aulast%3DVistica%26aufirst%3DD.%26aulast%3DWarren%26aufirst%3DJ.%2BT.%26aulast%3DBokesch%26aufirst%3DH.%26aulast%3DKenney%26aufirst%3DS.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DNew%2520colorimetric%2520cytotoxicity%2520assay%2520for%2520anticancer-drug%2520screening%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1990%26volume%3D82%26spage%3D1107%26epage%3D1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Kunimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nitta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uehara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokokura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyasaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutai, M.</span><span> </span><span class="NLM_article-title">Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, a novel water-soluble derivative of camptothecin, against murine tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5944</span><span class="NLM_x">â</span> <span class="NLM_lpage">5947</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1987&pages=5944-5947&author=T.+Kunimotoauthor=K.+Nittaauthor=T.+Tanakaauthor=N.+Ueharaauthor=H.+Babaauthor=M.+Takeuchiauthor=T.+Yokokuraauthor=S.+Sawadaauthor=T.+Miyasakaauthor=M.+Mutai&title=Antitumor+activity+of+7-ethyl-10-%5B4-%281-piperidino%29-1-piperidino%5Dcarbonyloxy-camptothecin%2C+a+novel+water-soluble+derivative+of+camptothecin%2C+against+murine+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKunimoto%26aufirst%3DT.%26aulast%3DNitta%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DUehara%26aufirst%3DN.%26aulast%3DBaba%26aufirst%3DH.%26aulast%3DTakeuchi%26aufirst%3DM.%26aulast%3DYokokura%26aufirst%3DT.%26aulast%3DSawada%26aufirst%3DS.%26aulast%3DMiyasaka%26aufirst%3DT.%26aulast%3DMutai%26aufirst%3DM.%26atitle%3DAntitumor%2520activity%2520of%25207-ethyl-10-%255B4-%25281-piperidino%2529-1-piperidino%255Dcarbonyloxy-camptothecin%252C%2520a%2520novel%2520water-soluble%2520derivative%2520of%2520camptothecin%252C%2520against%2520murine%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D1987%26volume%3D47%26spage%3D5944%26epage%3D5947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viswanadhan, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendoloski, J. J.</span><span> </span><span class="NLM_article-title">Prediction of hydrophobic (lipophilic) properties of small organic molecules using fragmental methods: an analysis of ALOGP and CLOGP methods</span> <span class="citation_source-journal">J. Phys. Chem. A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">3762</span><span class="NLM_x">â</span> <span class="NLM_lpage">3772</span></span><div class="citationLinks">[<a href="/doi/10.1021/jp980230o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADyaK1cXis12rsrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1998&pages=3762-3772&author=A.+K.+Ghoseauthor=V.+N.+Viswanadhanauthor=J.+J.+Wendoloski&title=Prediction+of+hydrophobic+%28lipophilic%29+properties+of+small+organic+molecules+using+fragmental+methods%3A+an+analysis+of+ALOGP+and+CLOGP+methods"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods</span></div><div class="casAuthors">Ghose, Arup K.; Viswanadhan, Vellarkad N.; Wendoloski, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry A</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3762-3772</span>CODEN:
                <span class="NLM_cas:coden">JPCAFH</span>;
        ISSN:<span class="NLM_cas:issn">1089-5639</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. hydrophobicity (lipophilicity), usually quantified as log P (the logarithm of 1-octanol/water partition coeff.), is an important mol. characteristic in drug discovery.  ALOGP and CLOGP are two of the most widely used methods for the estn. of log P.  This work describes an extensive reparametrization of the at. log P values and a detailed comparison of the performance of ALOGP and CLOGP methods on the Pomona Medchem database.  Only the "star list" compds. having precisely measured log P values were used in this anal.  While the overall results with both methods are similar, anal. shows that the CLOGP method is better for very small mols. in the range of 1-20 atoms.  The two methods are almost comparable in the range of 21-45 atoms, while the ALOGP method has better accuracy for mols. with more than 45 atoms.  Although the rms deviation and the correlation coeff. for CLOGP predictions were marginally better than those for corresponding ALOGP predictions, the latter showed a very stable performance for all classes of org. compds. analyzed.  Importantly, the ALOGP method can be used to compute ests. for all mols. in the database, whereas the CLOGP method fails to offer ests. for a substantial part of the database.  Finally, unlike CLOGP and other methods of predicting lipophilicity, the ALOGP method has multiple uses, such as the estn. of local hydrophobicity, the visualization of mol. hydrophobicity maps, and the evaluation of hydrophobic interactions in protein-ligand complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXdn8wsqV3frVg90H21EOLACvtfcHk0liQj7Z62IarCg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXis12rsrY%253D&md5=ef58841437913e164dc2d6e73eb5c87d</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjp980230o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp980230o%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DViswanadhan%26aufirst%3DV.%2BN.%26aulast%3DWendoloski%26aufirst%3DJ.%2BJ.%26atitle%3DPrediction%2520of%2520hydrophobic%2520%2528lipophilic%2529%2520properties%2520of%2520small%2520organic%2520molecules%2520using%2520fragmental%2520methods%253A%2520an%2520analysis%2520of%2520ALOGP%2520and%2520CLOGP%2520methods%26jtitle%3DJ.%2520Phys.%2520Chem.%2520A%26date%3D1998%26volume%3D102%26spage%3D3762%26epage%3D3772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Ertl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohde, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selzer, P.</span><span> </span><span class="NLM_article-title">Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3714</span><span class="NLM_x">â</span> <span class="NLM_lpage">3717</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000942e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3714-3717&author=P.+Ertlauthor=B.+Rohdeauthor=P.+Selzer&title=Fast+calculation+of+molecular+polar+surface+area+as+a+sum+of+fragment-based+contributions+and+its+application+to+the+prediction+of+drug+transport+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties</span></div><div class="casAuthors">Ertl, Peter; Rohde, Bernhard; Selzer, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3714-3717</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. polar surface area (PSA), i.e., surface belonging to polar atoms, is a descriptor that was shown to correlate well with passive mol. transport through membranes and, therefore, allows prediction of transport properties of drugs.  The calcn. of PSA, however, is rather time-consuming because of the necessity to generate a reasonable 3D mol. geometry and the calcn. of the surface itself.  A new approach for the calcn. of the PSA is presented here, based on the summation of tabulated surface contributions of polar fragments.  The method, termed topol. PSA (TPSA), provides results which are practically identical with the 3D PSA (the correlation coeff. between 3D PSA and fragment-based TPSA for 34 810 mols. from the World Drug Index is 0.99), while the computation speed is 2-3 orders of magnitude faster.  The new methodol. may, therefore, be used for fast bioavailability screening of virtual libraries having millions of mols.  This article describes the new methodol. and shows the results of validation studies based on sets of published absorption data, including intestinal absorption, Caco-2 monolayer penetration, and blood-brain barrier penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhP6Qncx_h6LVg90H21EOLACvtfcHk0liQj7Z62IarCg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D&md5=23ae4e7708bd8ddeb4a24ad160a29bd6</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm000942e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000942e%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26aulast%3DRohde%26aufirst%3DB.%26aulast%3DSelzer%26aufirst%3DP.%26atitle%3DFast%2520calculation%2520of%2520molecular%2520polar%2520surface%2520area%2520as%2520a%2520sum%2520of%2520fragment-based%2520contributions%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520drug%2520transport%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3714%26epage%3D3717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span>PipelinePilot, version 7.0; Accelrys: San Diego, CA, USA, <a href="http://accelrys.com" class="extLink">http://accelrys.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=PipelinePilot%2C+version+7.0%3B+Accelrys%3A+San+Diego%2C+CA%2C+USA%2C+http%3A%2F%2Faccelrys.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DPipelinePilot" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span>The National Centre for Protein Kinase Profiling, MRC Protein Phosphorylation Unit, University of Dundee, U.K. (<a href="http://www.kinase-screen.mrc.ac.uk" class="extLink">http://www.kinase-screen.mrc.ac.uk</a>)</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+National+Centre+for+Protein+Kinase+Profiling%2C+MRC+Protein+Phosphorylation+Unit%2C+University+of+Dundee%2C+U.K.+%28http%3A%2F%2Fwww.kinase-screen.mrc.ac.uk%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">Matthews, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakes, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornheim, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clary, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karnitz, L. M.</span><span> </span><span class="NLM_article-title">Pharmacological abrogation of S-phase checkpoint enhances the anti-tumor activity of gemcitabine in vivo</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">104</span><span class="NLM_x">â</span> <span class="NLM_lpage">110</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=104-110&author=D.+J.+Matthewsauthor=F.+M.+Yakesauthor=J.+Chenauthor=M.+Tadanoauthor=L.+Bornheimauthor=D.+O.+Claryauthor=A.+Taiauthor=J.+M.+Wagnerauthor=N.+Millerauthor=Y.+D.+Kimauthor=S.+Robertsonauthor=L.+Murrayauthor=L.+M.+Karnitz&title=Pharmacological+abrogation+of+S-phase+checkpoint+enhances+the+anti-tumor+activity+of+gemcitabine+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatthews%26aufirst%3DD.%2BJ.%26aulast%3DYakes%26aufirst%3DF.%2BM.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DTadano%26aufirst%3DM.%26aulast%3DBornheim%26aufirst%3DL.%26aulast%3DClary%26aufirst%3DD.%2BO.%26aulast%3DTai%26aufirst%3DA.%26aulast%3DWagner%26aufirst%3DJ.%2BM.%26aulast%3DMiller%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DY.%2BD.%26aulast%3DRobertson%26aufirst%3DS.%26aulast%3DMurray%26aufirst%3DL.%26aulast%3DKarnitz%26aufirst%3DL.%2BM.%26atitle%3DPharmacological%2520abrogation%2520of%2520S-phase%2520checkpoint%2520enhances%2520the%2520anti-tumor%2520activity%2520of%2520gemcitabine%2520in%2520vivo%26jtitle%3DCell%2520Cycle%26date%3D2007%26volume%3D6%26spage%3D104%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Manning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whyte, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudarsanam, S.</span><span> </span><span class="NLM_article-title">The protein kinase complement of the human genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1912</span><span class="NLM_x">â</span> <span class="NLM_lpage">1934</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1126%2Fscience.1075762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=12471243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1912-1934&author=G.+Manningauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sudarsanam&title=The+protein+kinase+complement+of+the+human+genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Kinase Complement of the Human Genome</span></div><div class="casAuthors">Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5600</span>),
    <span class="NLM_cas:pages">1912-1916, 1933-1934</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We have catalogued the protein kinase complement of the human genome (the "kinome") using public and proprietary genomic, complementary DNA, and expressed sequence tag (EST) sequences.  This provides a starting point for comprehensive anal. of protein phosphorylation in normal and disease states, as well as a detailed view of the current state of human genome anal. through a focus on one large gene family.  We identify 518 putative protein kinase genes, of which 71 have not previously been reported or described as kinases, and we extend or correct the protein sequences of 56 more kinases.  New genes include members of well-studied families as well as previously unidentified families, some of which are conserved in model organisms.  Classification and comparison with model organism kinomes identified orthologous groups and highlighted expansions specific to human and other lineages.  We also identified 106 protein kinase pseudogenes.  Chromosomal mapping revealed several small clusters of kinase genes and revealed that 244 kinases map to disease loci or cancer amplicons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTj1hf_0cQcrVg90H21EOLACvtfcHk0liduJBARfOkwA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D&md5=b3def83bace52257a3252a3347b8bb92</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1126%2Fscience.1075762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1075762%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSudarsanam%26aufirst%3DS.%26atitle%3DThe%2520protein%2520kinase%2520complement%2520of%2520the%2520human%2520genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1912%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><div class="note"><p class="first last">All procedures followed U.K. Home Office and local ethical guidelines and were performed according to U.K. National Cancer Research Institute guidelines, see:</p></div><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aboagye, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balkwill, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balmain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruder, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Double, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everitt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farningham, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennie, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelland, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratford, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozer, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedge, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span> </span><span class="NLM_article-title">Committee of the National Cancer Research Institute. Guidelines for the welfare and use of animals in cancer research</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">1555</span><span class="NLM_x">â</span> <span class="NLM_lpage">1577</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1038%2Fsj.bjc.6605642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=20502460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A280%3ADC%252BC3czmvFyhsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2010&pages=1555-1577&author=P.+Workmanauthor=E.+O.+Aboagyeauthor=F.+Balkwillauthor=A.+Balmainauthor=G.+Bruderauthor=D.+J.+Chaplinauthor=J.+A.+Doubleauthor=J.+Everittauthor=D.+A.+Farninghamauthor=M.+J.+Glennieauthor=L.+R.+Kellandauthor=V.+Robinsonauthor=I.+J.+Stratfordauthor=G.+M.+Tozerauthor=S.+Watsonauthor=S.+R.+Wedgeauthor=S.+A.+Eccles&title=Committee+of+the+National+Cancer+Research+Institute.+Guidelines+for+the+welfare+and+use+of+animals+in+cancer+research"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Guidelines for the welfare and use of animals in cancer research</span></div><div class="casAuthors">Workman P; Aboagye E O; Balkwill F; Balmain A; Bruder G; Chaplin D J; Double J A; Everitt J; Farningham D A H; Glennie M J; Kelland L R; Robinson V; Stratford I J; Tozer G M; Watson S; Wedge S R; Eccles S A</div><div class="citationInfo"><span class="NLM_cas:title">British journal of cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1555-77</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Animal experiments remain essential to understand the fundamental mechanisms underpinning malignancy and to discover improved methods to prevent, diagnose and treat cancer.  Excellent standards of animal care are fully consistent with the conduct of high quality cancer research.  Here we provide updated guidelines on the welfare and use of animals in cancer research.  All experiments should incorporate the 3Rs: replacement, reduction and refinement.  Focusing on animal welfare, we present recommendations on all aspects of cancer research, including: study design, statistics and pilot studies; choice of tumour models (e.g., genetically engineered, orthotopic and metastatic); therapy (including drugs and radiation); imaging (covering techniques, anaesthesia and restraint); humane endpoints (including tumour burden and site); and publication of best practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkVD7D529OLg5nADWVYHg1fW6udTcc2eYxpqW0lnNR9Lntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czmvFyhsQ%253D%253D&md5=55f4c62e16fb1ebaa1f05d59caba3989</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6605642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6605642%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DAboagye%26aufirst%3DE.%2BO.%26aulast%3DBalkwill%26aufirst%3DF.%26aulast%3DBalmain%26aufirst%3DA.%26aulast%3DBruder%26aufirst%3DG.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DDouble%26aufirst%3DJ.%2BA.%26aulast%3DEveritt%26aufirst%3DJ.%26aulast%3DFarningham%26aufirst%3DD.%2BA.%26aulast%3DGlennie%26aufirst%3DM.%2BJ.%26aulast%3DKelland%26aufirst%3DL.%2BR.%26aulast%3DRobinson%26aufirst%3DV.%26aulast%3DStratford%26aufirst%3DI.%2BJ.%26aulast%3DTozer%26aufirst%3DG.%2BM.%26aulast%3DWatson%26aufirst%3DS.%26aulast%3DWedge%26aufirst%3DS.%2BR.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26atitle%3DCommittee%2520of%2520the%2520National%2520Cancer%2520Research%2520Institute.%2520Guidelines%2520for%2520the%2520welfare%2520and%2520use%2520of%2520animals%2520in%2520cancer%2520research%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2010%26volume%3D102%26spage%3D1555%26epage%3D1577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Collins, I.; Reader, J. C.; Williams, D. H.; Klair, S. S.; Scanlon, J. E.; Piton, N.; Cherry, M.</span><span> </span><span class="NLM_article-title">Bicyclylaryl-aryl-amine compounds, their preparation, and their use as CHK1 kinase inhibitors for treating proliferative diseases</span>. Patent WO 2009103966, 2009; Chem Abstr.<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">289187</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=I.+Collins&author=J.+C.+Reader&author=D.+H.+Williams&author=S.+S.+Klair&author=J.+E.+Scanlon&author=N.+Piton&author=M.+Cherry&title=Bicyclylaryl-aryl-amine+compounds%2C+their+preparation%2C+and+their+use+as+CHK1+kinase+inhibitors+for+treating+proliferative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DBicyclylaryl-aryl-amine%2520compounds%252C%2520their%2520preparation%252C%2520and%2520their%2520use%2520as%2520CHK1%2520kinase%2520inhibitors%2520for%2520treating%2520proliferative%2520diseases%26jtitle%3DChem%2520Abstr.%26date%3D2009%26volume%3D151%26spage%3D289187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Ventura, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barigelletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durola, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flamigni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauvage, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenger, O. S.</span><span> </span><span class="NLM_article-title">Fe(II), Ru(II) and Re(I) complexes of endotopic, sterically non-hindering, U-shaped 8,8â²-disubstituted-3,3â²-biisoquinoline ligands: syntheses and spectroscopic properties</span> <span class="citation_source-journal">Dalton Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">â</span> <span class="NLM_lpage">498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=491-498&author=B.+Venturaauthor=F.+Barigellettiauthor=F.+Durolaauthor=L.+Flamigniauthor=J.-P.+Sauvageauthor=O.+S.+Wenger&title=Fe%28II%29%2C+Ru%28II%29+and+Re%28I%29+complexes+of+endotopic%2C+sterically+non-hindering%2C+U-shaped+8%2C8%E2%80%B2-disubstituted-3%2C3%E2%80%B2-biisoquinoline+ligands%3A+syntheses+and+spectroscopic+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVentura%26aufirst%3DB.%26aulast%3DBarigelletti%26aufirst%3DF.%26aulast%3DDurola%26aufirst%3DF.%26aulast%3DFlamigni%26aufirst%3DL.%26aulast%3DSauvage%26aufirst%3DJ.-P.%26aulast%3DWenger%26aufirst%3DO.%2BS.%26atitle%3DFe%2528II%2529%252C%2520Ru%2528II%2529%2520and%2520Re%2528I%2529%2520complexes%2520of%2520endotopic%252C%2520sterically%2520non-hindering%252C%2520U-shaped%25208%252C8%25E2%2580%25B2-disubstituted-3%252C3%25E2%2580%25B2-biisoquinoline%2520ligands%253A%2520syntheses%2520and%2520spectroscopic%2520properties%26jtitle%3DDalton%2520Trans.%26date%3D2008%26spage%3D491%26epage%3D498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 39 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Lucia VeselovskÃ¡, Radek Pohl, Eva TlouÅ¡tâ²ovÃ¡, SoÅa GurskÃ¡, Petr DÅ¾ubÃ¡k, MariÃ¡n HajdÃºch, <span class="NLM_string-name hlFld-ContribAuthor">Michal Hocek</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrido-Fused Deazapurine Bases: Synthesis and Glycosylation of 4-Substituted 9H-Pyrido[2â²,3â²:4,5]- and Pyrido[4â²,3â²:4,5]pyrrolo[2,3-d]pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">ACS Omega</span><span> <strong>2020,</strong> <em>5 </em>
                                    (40)
                                     , 26278-26286. <a href="https://doi.org/10.1021/acsomega.0c04302" title="DOI URL">https://doi.org/10.1021/acsomega.0c04302</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsomega.0c04302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsomega.0c04302%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Omega%26atitle%3DPyrido-Fused%252BDeazapurine%252BBases%25253A%252BSynthesis%252Band%252BGlycosylation%252Bof%252B4-Substituted%252B9H-Pyrido%25255B2%2525E2%252580%2525B2%25252C3%2525E2%252580%2525B2%25253A4%25252C5%25255D-%252Band%252BPyrido%25255B4%2525E2%252580%2525B2%25252C3%2525E2%252580%2525B2%25253A4%25252C5%25255Dpyrrolo%25255B2%25252C3-d%25255Dpyrimidines%26aulast%3DVeselovsk%25C3%25A1%26aufirst%3DLucia%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D03092020%26date%3D24092020%26date%3D02102020%26volume%3D5%26issue%3D40%26spage%3D26278%26epage%3D26286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Marianne Fleuti, KateÅina BÃ¡rtovÃ¡, Lenka PoÅ¡tovÃ¡ SlavÄtÃ­nskÃ¡, Eva TlouÅ¡tâovÃ¡, Michal TichÃ½, SoÅa GurskÃ¡, Petr PavliÅ¡, Petr DÅ¾ubÃ¡k, MariÃ¡n HajdÃºch, <span class="NLM_string-name hlFld-ContribAuthor">Michal Hocek</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Profiling of Pyrazolo-Fused 7-Deazapurine Nucleosides. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2020,</strong> <em>85 </em>
                                    (16)
                                     , 10539-10551. <a href="https://doi.org/10.1021/acs.joc.0c00928" title="DOI URL">https://doi.org/10.1021/acs.joc.0c00928</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.0c00928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.0c00928%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Band%252BBiological%252BProfiling%252Bof%252BPyrazolo-Fused%252B7-Deazapurine%252BNucleosides%26aulast%3DFleuti%26aufirst%3DMarianne%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D15042020%26date%3D06082020%26date%3D21072020%26volume%3D85%26issue%3D16%26spage%3D10539%26epage%3D10551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bin  Yang</span>, <span class="hlFld-ContribAuthor ">Melissa M.  Vasbinder</span>, <span class="hlFld-ContribAuthor ">Alexander W.  Hird</span>, <span class="hlFld-ContribAuthor ">Qibin  Su</span>, <span class="hlFld-ContribAuthor ">Haixia  Wang</span>, <span class="hlFld-ContribAuthor ">Yan  Yu</span>, <span class="hlFld-ContribAuthor ">Dorin  Toader</span>, <span class="hlFld-ContribAuthor ">Paul D.  Lyne</span>, <span class="hlFld-ContribAuthor ">Jon A.  Read</span>, <span class="hlFld-ContribAuthor ">Jason  Breed</span>, <span class="hlFld-ContribAuthor ">Stephanos  Ioannidis</span>, <span class="hlFld-ContribAuthor ">Chun  Deng</span>, <span class="hlFld-ContribAuthor ">Michael  Grondine</span>, <span class="hlFld-ContribAuthor ">Nancy  DeGrace</span>, <span class="hlFld-ContribAuthor ">David  Whitston</span>, <span class="hlFld-ContribAuthor ">Patrick  Brassil</span>, and <span class="hlFld-ContribAuthor ">James W.  Janetka</span>  . </span><span class="cited-content_cbyCitation_article-title">Adventures in Scaffold Morphing: Discovery of Fused Ring Heterocyclic Checkpoint Kinase 1 (CHK1) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 1061-1073. <a href="https://doi.org/10.1021/acs.jmedchem.7b01490" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01490</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01490%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAdventures%252Bin%252BScaffold%252BMorphing%25253A%252BDiscovery%252Bof%252BFused%252BRing%252BHeterocyclic%252BCheckpoint%252BKinase%252B1%252B%252528CHK1%252529%252BInhibitors%26aulast%3DYang%26aufirst%3DBin%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D10102017%26date%3D19012018%26date%3D08022018%26date%3D04012018%26volume%3D61%26issue%3D3%26spage%3D1061%26epage%3D1073" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James D.  Osborne</span>, <span class="hlFld-ContribAuthor ">Thomas P.  Matthews</span>, <span class="hlFld-ContribAuthor ">Tatiana  McHardy</span>, <span class="hlFld-ContribAuthor ">Nicolas  Proisy</span>, <span class="hlFld-ContribAuthor ">Kwai-Ming J.  Cheung</span>, <span class="hlFld-ContribAuthor ">Michael  Lainchbury</span>, <span class="hlFld-ContribAuthor ">Nathan  Brown</span>, <span class="hlFld-ContribAuthor ">Michael I.  Walton</span>, <span class="hlFld-ContribAuthor ">Paul D.  Eve</span>, <span class="hlFld-ContribAuthor ">Katherine J.  Boxall</span>, <span class="hlFld-ContribAuthor ">Angela  Hayes</span>, <span class="hlFld-ContribAuthor ">Alan T.  Henley</span>, <span class="hlFld-ContribAuthor ">Melanie R.  Valenti</span>, <span class="hlFld-ContribAuthor ">Alexis K.  De Haven Brandon</span>, <span class="hlFld-ContribAuthor ">Gary  Box</span>, <span class="hlFld-ContribAuthor ">Yann  Jamin</span>, <span class="hlFld-ContribAuthor ">Simon P.  Robinson</span>, <span class="hlFld-ContribAuthor ">Isaac M.  Westwood</span>, <span class="hlFld-ContribAuthor ">Rob L. M.  van Montfort</span>, <span class="hlFld-ContribAuthor ">Philip M.  Leonard</span>, <span class="hlFld-ContribAuthor ">Marieke B. A. C.  Lamers</span>, <span class="hlFld-ContribAuthor ">John C.  Reader</span>, <span class="hlFld-ContribAuthor ">G. Wynne  Aherne</span>, <span class="hlFld-ContribAuthor ">Florence I.  Raynaud</span>, <span class="hlFld-ContribAuthor ">Suzanne A.  Eccles</span>, <span class="hlFld-ContribAuthor ">Michelle D.  Garrett</span>, and <span class="hlFld-ContribAuthor ">Ian  Collins</span>  . </span><span class="cited-content_cbyCitation_article-title">Multiparameter Lead Optimization to Give an Oral Checkpoint Kinase 1 (CHK1) Inhibitor Clinical Candidate: (R)-5-((4-((Morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile (CCT245737). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (11)
                                     , 5221-5237. <a href="https://doi.org/10.1021/acs.jmedchem.5b01938" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01938</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01938%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMultiparameter%252BLead%252BOptimization%252Bto%252BGive%252Ban%252BOral%252BCheckpoint%252BKinase%252B1%252B%252528CHK1%252529%252BInhibitor%252BClinical%252BCandidate%25253A%252B%252528R%252529-5-%252528%2525284-%252528%252528Morpholin-2-ylmethyl%252529amino%252529-5-%252528trifluoromethyl%252529pyridin-2-yl%252529amino%252529pyrazine-2-carbonitrile%252B%252528CCT245737%252529%26aulast%3DOsborne%26aufirst%3DJames%2BD.%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D15122015%26date%3D23052016%26date%3D09062016%26date%3D11052016%26volume%3D59%26issue%3D11%26spage%3D5221%26epage%3D5237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian G.  Lawhorn</span>, <span class="hlFld-ContribAuthor ">Joanne  Philp</span>, <span class="hlFld-ContribAuthor ">Yongdong  Zhao</span>, <span class="hlFld-ContribAuthor ">Christopher  Louer</span>, <span class="hlFld-ContribAuthor ">Marlys  Hammond</span>, <span class="hlFld-ContribAuthor ">Mui  Cheung</span>, <span class="hlFld-ContribAuthor ">Harvey  Fries</span>, <span class="hlFld-ContribAuthor ">Alan P.  Graves</span>, <span class="hlFld-ContribAuthor ">Lisa  Shewchuk</span>, <span class="hlFld-ContribAuthor ">Liping  Wang</span>, <span class="hlFld-ContribAuthor ">Joshua E.  Cottom</span>, <span class="hlFld-ContribAuthor ">Hongwei  Qi</span>, <span class="hlFld-ContribAuthor ">Huizhen  Zhao</span>, <span class="hlFld-ContribAuthor ">Rachel  Totoritis</span>, <span class="hlFld-ContribAuthor ">Guofeng  Zhang</span>, <span class="hlFld-ContribAuthor ">Benjamin  Schwartz</span>, <span class="hlFld-ContribAuthor ">Hu  Li</span>, <span class="hlFld-ContribAuthor ">Sharon  Sweitzer</span>, <span class="hlFld-ContribAuthor ">Dennis A.  Holt</span>, <span class="hlFld-ContribAuthor ">Gregory J.  Gatto, Jr.</span>, and <span class="hlFld-ContribAuthor ">Lara S.  Kallander</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Purines and 7-Deazapurines as Potent and Selective Type I Inhibitors of Troponin I-Interacting Kinase (TNNI3K). </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (18)
                                     , 7431-7448. <a href="https://doi.org/10.1021/acs.jmedchem.5b00931" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00931</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00931%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BPurines%252Band%252B7-Deazapurines%252Bas%252BPotent%252Band%252BSelective%252BType%252BI%252BInhibitors%252Bof%252BTroponin%252BI-Interacting%252BKinase%252B%252528TNNI3K%252529%26aulast%3DLawhorn%26aufirst%3DBrian%2BG.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D16062015%26date%3D10092015%26date%3D24092015%26volume%3D58%26issue%3D18%26spage%3D7431%26epage%3D7448" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bernard  Pirard</span> and <span class="hlFld-ContribAuthor ">Peter  Ertl</span>  . </span><span class="cited-content_cbyCitation_article-title">Evaluation of a Semi-Automated Workflow for Fragment Growing. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2015,</strong> <em>55 </em>
                                    (1)
                                     , 180-193. <a href="https://doi.org/10.1021/ci5006355" title="DOI URL">https://doi.org/10.1021/ci5006355</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci5006355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci5006355%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DEvaluation%252Bof%252Ba%252BSemi-Automated%252BWorkflow%252Bfor%252BFragment%252BGrowing%26aulast%3DPirard%26aufirst%3DBernard%26date%3D2015%26date%3D2015%26date%3D2014%26date%3D22102014%26date%3D06012015%26date%3D26012015%26date%3D16122014%26volume%3D55%26issue%3D1%26spage%3D180%26epage%3D193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Lainchbury</span>, <span class="hlFld-ContribAuthor ">Thomas P.  Matthews</span>, <span class="hlFld-ContribAuthor ">Tatiana  McHardy</span>, <span class="hlFld-ContribAuthor ">Kathy J.  Boxall</span>, <span class="hlFld-ContribAuthor ">Michael I.  Walton</span>, <span class="hlFld-ContribAuthor ">Paul D.  Eve</span>, <span class="hlFld-ContribAuthor ">Angela  Hayes</span>, <span class="hlFld-ContribAuthor ">Melanie R.  Valenti</span>, <span class="hlFld-ContribAuthor ">Alexis K.  de Haven Brandon</span>, <span class="hlFld-ContribAuthor ">Gary  Box</span>, <span class="hlFld-ContribAuthor ">G. Wynne  Aherne</span>, <span class="hlFld-ContribAuthor ">John C.  Reader</span>, <span class="hlFld-ContribAuthor ">Florence I.  Raynaud</span>, <span class="hlFld-ContribAuthor ">Suzanne A.  Eccles</span>, <span class="hlFld-ContribAuthor ">Michelle D.  Garrett</span>, and <span class="hlFld-ContribAuthor ">Ian  Collins</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of 3-Alkoxyamino-5-(pyridin-2-ylamino)pyrazine-2-carbonitriles as Selective, Orally Bioavailable CHK1 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (22)
                                     , 10229-10240. <a href="https://doi.org/10.1021/jm3012933" title="DOI URL">https://doi.org/10.1021/jm3012933</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm3012933&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm3012933%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B3-Alkoxyamino-5-%252528pyridin-2-ylamino%252529pyrazine-2-carbonitriles%252Bas%252BSelective%25252C%252BOrally%252BBioavailable%252BCHK1%252BInhibitors%26aulast%3DLainchbury%26aufirst%3DMichael%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D07092012%26date%3D19102012%26date%3D26112012%26volume%3D55%26issue%3D22%26spage%3D10229%26epage%3D10240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nguyen Thi  Mai</span>, <span class="hlFld-ContribAuthor ">Ngo Thi  Lan</span>, <span class="hlFld-ContribAuthor ">Thien Y  Vu</span>, <span class="hlFld-ContribAuthor ">Phuong Thi Mai  Duong</span>, <span class="hlFld-ContribAuthor ">Nguyen Thanh  Tung</span>, <span class="hlFld-ContribAuthor ">Huong Thi Thu  Phung</span>. </span><span class="cited-content_cbyCitation_article-title">Estimation of the ligand-binding free energy of checkpoint kinase 1 via non-equilibrium MD simulations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2020,</strong> <em>100 </em>, 107648. <a href="https://doi.org/10.1016/j.jmgm.2020.107648" title="DOI URL">https://doi.org/10.1016/j.jmgm.2020.107648</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2020.107648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2020.107648%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DEstimation%252Bof%252Bthe%252Bligand-binding%252Bfree%252Benergy%252Bof%252Bcheckpoint%252Bkinase%252B1%252Bvia%252Bnon-equilibrium%252BMD%252Bsimulations%26aulast%3DMai%26aufirst%3DNguyen%2BThi%26date%3D2020%26volume%3D100%26spage%3D107648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lucia  VeselovskÃ¡</span>, <span class="hlFld-ContribAuthor ">NatÃ¡lie  KudlovÃ¡</span>, <span class="hlFld-ContribAuthor ">SoÅa  GurskÃ¡</span>, <span class="hlFld-ContribAuthor ">Barbora  LiÅ¡kovÃ¡</span>, <span class="hlFld-ContribAuthor ">Martina  MedvedÃ­kovÃ¡</span>, <span class="hlFld-ContribAuthor ">OndÅej  Hodek</span>, <span class="hlFld-ContribAuthor ">Eva  TlouÅ¡Å¥ovÃ¡</span>, <span class="hlFld-ContribAuthor ">Nemanja  Milisavljevic</span>, <span class="hlFld-ContribAuthor ">Michal  TichÃ½</span>, <span class="hlFld-ContribAuthor ">Pavla  PerlÃ­kovÃ¡</span>, <span class="hlFld-ContribAuthor ">Helena  MertlÃ­kovÃ¡âKaiserovÃ¡</span>, <span class="hlFld-ContribAuthor ">Jana  TrylÄovÃ¡</span>, <span class="hlFld-ContribAuthor ">Radek  Pohl</span>, <span class="hlFld-ContribAuthor ">Blanka  KlepetÃ¡ÅovÃ¡</span>, <span class="hlFld-ContribAuthor ">Petr  DÅ¾ubÃ¡k</span>, <span class="hlFld-ContribAuthor ">MariÃ¡n  HajdÃºch</span>, <span class="hlFld-ContribAuthor ">Michal  Hocek</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Cytotoxic and Antiviral Activity Profiling of AllâFour Isomeric Series of PyridoâFused 7âDeazapurine Ribonucleosides. </span><span class="cited-content_cbyCitation_journal-name">Chemistry â A European Journal</span><span> <strong>2020,</strong> <em>26 </em>
                                    (57)
                                     , 13002-13015. <a href="https://doi.org/10.1002/chem.202001124" title="DOI URL">https://doi.org/10.1002/chem.202001124</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.202001124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.202001124%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DSynthesis%252Band%252BCytotoxic%252Band%252BAntiviral%252BActivity%252BProfiling%252Bof%252BAll%2525E2%252580%252590Four%252BIsomeric%252BSeries%252Bof%252BPyrido%2525E2%252580%252590Fused%252B7%2525E2%252580%252590Deazapurine%252BRibonucleosides%26aulast%3DVeselovsk%25C3%25A1%26aufirst%3DLucia%26date%3D2020%26date%3D2020%26volume%3D26%26issue%3D57%26spage%3D13002%26epage%3D13015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Aaron  Mailman</span>, <span class="hlFld-ContribAuthor ">Rakesh  Puttreddy</span>, <span class="hlFld-ContribAuthor ">Manu  Lahtinen</span>, <span class="hlFld-ContribAuthor ">Noora  Svahn</span>, <span class="hlFld-ContribAuthor ">Kari  Rissanen</span>. </span><span class="cited-content_cbyCitation_article-title">Hydrogen and Halogen Bond Mediated Coordination Polymers of Chloro-Substituted Pyrazin-2-Amine Copper(I) Bromide Complexes. </span><span class="cited-content_cbyCitation_journal-name">Chemistry</span><span> <strong>2020,</strong> <em>2 </em>
                                    (3)
                                     , 700-713. <a href="https://doi.org/10.3390/chemistry2030045" title="DOI URL">https://doi.org/10.3390/chemistry2030045</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/chemistry2030045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fchemistry2030045%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%26atitle%3DHydrogen%252Band%252BHalogen%252BBond%252BMediated%252BCoordination%252BPolymers%252Bof%252BChloro-Substituted%252BPyrazin-2-Amine%252BCopper%252528I%252529%252BBromide%252BComplexes%26aulast%3DMailman%26aufirst%3DAaron%26date%3D2020%26date%3D2020%26volume%3D2%26issue%3D3%26spage%3D700%26epage%3D713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shinya  Ohashi</span>, <span class="hlFld-ContribAuthor ">Osamu  Kikuchi</span>, <span class="hlFld-ContribAuthor ">Yukie  Nakai</span>, <span class="hlFld-ContribAuthor ">Tomomi  Ida</span>, <span class="hlFld-ContribAuthor ">Tomoki  Saito</span>, <span class="hlFld-ContribAuthor ">Yuki  Kondo</span>, <span class="hlFld-ContribAuthor ">Yoshihiro  Yamamoto</span>, <span class="hlFld-ContribAuthor ">Yosuke  Mitani</span>, <span class="hlFld-ContribAuthor ">Trang H.  Nguyen Vu</span>, <span class="hlFld-ContribAuthor ">Keita  Fukuyama</span>, <span class="hlFld-ContribAuthor ">Hiroshi  Tsukihara</span>, <span class="hlFld-ContribAuthor ">Norihiko  Suzuki</span>, <span class="hlFld-ContribAuthor ">Manabu  Muto</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Lethality with Trifluridine/Tipiracil and Checkpoint Kinase 1 Inhibitor for Esophageal Squamous Cell Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Therapeutics</span><span> <strong>2020,</strong> <em>19 </em>
                                    (6)
                                     , 1363-1372. <a href="https://doi.org/10.1158/1535-7163.MCT-19-0918" title="DOI URL">https://doi.org/10.1158/1535-7163.MCT-19-0918</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1535-7163.MCT-19-0918&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1535-7163.MCT-19-0918%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Therapeutics%26atitle%3DSynthetic%252BLethality%252Bwith%252BTrifluridine%25252FTipiracil%252Band%252BCheckpoint%252BKinase%252B1%252BInhibitor%252Bfor%252BEsophageal%252BSquamous%252BCell%252BCarcinoma%26aulast%3DOhashi%26aufirst%3DShinya%26date%3D2020%26date%3D2020%26volume%3D19%26issue%3D6%26spage%3D1363%26epage%3D1372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lyudmila A.  Sviridova</span>, <span class="hlFld-ContribAuthor ">Polina S.  Protopopova</span>, <span class="hlFld-ContribAuthor ">Mikhail G.  Akimov</span>, <span class="hlFld-ContribAuthor ">Maria S.  Dudina</span>, <span class="hlFld-ContribAuthor ">Elizaveta K.  Melnikova</span>, <span class="hlFld-ContribAuthor ">Konstantin A.  Kochetkov</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of new physiologically active (2-oxoimidazolidin-5-yl)indoles. </span><span class="cited-content_cbyCitation_journal-name">Mendeleev Communications</span><span> <strong>2020,</strong> <em>30 </em>
                                    (3)
                                     , 347-349. <a href="https://doi.org/10.1016/j.mencom.2020.05.029" title="DOI URL">https://doi.org/10.1016/j.mencom.2020.05.029</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.mencom.2020.05.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.mencom.2020.05.029%26sid%3Dliteratum%253Aachs%26jtitle%3DMendeleev%2520Communications%26atitle%3DSynthesis%252Bof%252Bnew%252Bphysiologically%252Bactive%252B%2525282-oxoimidazolidin-5-yl%252529indoles%26aulast%3DSviridova%26aufirst%3DLyudmila%2BA.%26date%3D2020%26volume%3D30%26issue%3D3%26spage%3D347%26epage%3D349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong-Xin  Bo</span>, <span class="hlFld-ContribAuthor ">Rong  Xiang</span>, <span class="hlFld-ContribAuthor ">Yu  Xu</span>, <span class="hlFld-ContribAuthor ">Shu-Yi  Hao</span>, <span class="hlFld-ContribAuthor ">Xing-Rong  Wang</span>, <span class="hlFld-ContribAuthor ">Shi-Wu  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, biological evaluation and molecular modeling study of 2-amino-3,5-disubstituted-pyrazines as Aurora kinases inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (5)
                                     , 115351. <a href="https://doi.org/10.1016/j.bmc.2020.115351" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115351</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115351%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%25252C%252Bbiological%252Bevaluation%252Band%252Bmolecular%252Bmodeling%252Bstudy%252Bof%252B2-amino-3%25252C5-disubstituted-pyrazines%252Bas%252BAurora%252Bkinases%252Binhibitors%26aulast%3DBo%26aufirst%3DYong-Xin%26date%3D2020%26volume%3D28%26issue%3D5%26spage%3D115351" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Janos  Sapi</span>, <span class="hlFld-ContribAuthor ">StÃ©phane  GÃ©rard</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 5-6 Systems: Three Heteroatoms 2:1. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00021-4" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00021-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00021-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00021-4%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252B5-6%252BSystems%25253A%252BThree%252BHeteroatoms%252B2%25253A1%26aulast%3DSapi%26aufirst%3DJanos%26date%3D2020%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2020%26volume%3Dvol.%252010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ina  Patties</span>, <span class="hlFld-ContribAuthor ">Sonja  Kallendrusch</span>, <span class="hlFld-ContribAuthor ">Lisa  BÃ¶hme</span>, <span class="hlFld-ContribAuthor ">Eva  Kendzia</span>, <span class="hlFld-ContribAuthor ">Henry  Oppermann</span>, <span class="hlFld-ContribAuthor ">Frank  Gaunitz</span>, <span class="hlFld-ContribAuthor ">Rolf-Dieter  Kortmann</span>, <span class="hlFld-ContribAuthor ">Annegret  Glasow</span>. </span><span class="cited-content_cbyCitation_article-title">The Chk1 inhibitor SAR-020106 sensitizes human glioblastoma cells to irradiation, to temozolomide, and to decitabine treatment. </span><span class="cited-content_cbyCitation_journal-name">Journal of Experimental & Clinical Cancer Research</span><span> <strong>2019,</strong> <em>38 </em>
                                    (1)
                                     <a href="https://doi.org/10.1186/s13046-019-1434-2" title="DOI URL">https://doi.org/10.1186/s13046-019-1434-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1186/s13046-019-1434-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1186%2Fs13046-019-1434-2%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Experimental%2520%2526%2520Clinical%2520Cancer%2520Research%26atitle%3DThe%252BChk1%252Binhibitor%252BSAR-020106%252Bsensitizes%252Bhuman%252Bglioblastoma%252Bcells%252Bto%252Birradiation%25252C%252Bto%252Btemozolomide%25252C%252Band%252Bto%252Bdecitabine%252Btreatment%26aulast%3DPatties%26aufirst%3DIna%26date%3D2019%26date%3D2019%26volume%3D38%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lexian  Tong</span>, <span class="hlFld-ContribAuthor ">Pinrao  Song</span>, <span class="hlFld-ContribAuthor ">Kailong  Jiang</span>, <span class="hlFld-ContribAuthor ">Lei  Xu</span>, <span class="hlFld-ContribAuthor ">Tingting  Jin</span>, <span class="hlFld-ContribAuthor ">Peipei  Wang</span>, <span class="hlFld-ContribAuthor ">Xiaobei  Hu</span>, <span class="hlFld-ContribAuthor ">Sui  Fang</span>, <span class="hlFld-ContribAuthor ">Anhui  Gao</span>, <span class="hlFld-ContribAuthor ">Yubo  Zhou</span>, <span class="hlFld-ContribAuthor ">Tao  Liu</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Yongzhou  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of (R)-5-((5-(1-methyl-1H-pyrazol-4-yl)-4-(methylamino)pyrimidin-2-yl)amino)-3-(piperidin-3-yloxy)picolinonitrile, a novel CHK1 inhibitor for hematologic malignancies. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>173 </em>, 44-62. <a href="https://doi.org/10.1016/j.ejmech.2019.03.062" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.03.062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.03.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.03.062%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B%252528R%252529-5-%252528%2525285-%2525281-methyl-1H-pyrazol-4-yl%252529-4-%252528methylamino%252529pyrimidin-2-yl%252529amino%252529-3-%252528piperidin-3-yloxy%252529picolinonitrile%25252C%252Ba%252Bnovel%252BCHK1%252Binhibitor%252Bfor%252Bhematologic%252Bmalignancies%26aulast%3DTong%26aufirst%3DLexian%26date%3D2019%26volume%3D173%26spage%3D44%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Stanislav  Andreev</span>, <span class="hlFld-ContribAuthor ">Tatu  Pantsar</span>, <span class="hlFld-ContribAuthor ">Francesco  Ansideri</span>, <span class="hlFld-ContribAuthor ">Mark  Kudolo</span>, <span class="hlFld-ContribAuthor ">Michael  Forster</span>, <span class="hlFld-ContribAuthor ">Dieter  Schollmeyer</span>, <span class="hlFld-ContribAuthor ">Stefan A.  Laufer</span>, <span class="hlFld-ContribAuthor ">Pierre  Koch</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and Biological Evaluation of 7-Chloro-9H-pyrimido[4,5-b]indole-based Glycogen Synthase Kinase-3Î² Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (12)
                                     , 2331. <a href="https://doi.org/10.3390/molecules24122331" title="DOI URL">https://doi.org/10.3390/molecules24122331</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24122331&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24122331%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDesign%25252C%252BSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252B7-Chloro-9H-pyrimido%25255B4%25252C5-b%25255Dindole-based%252BGlycogen%252BSynthase%252BKinase-3%2525CE%2525B2%252BInhibitors%26aulast%3DAndreev%26aufirst%3DStanislav%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D12%26spage%3D2331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Philipp  Kirchner</span>, <span class="hlFld-ContribAuthor ">Mathieu  Bourdenx</span>, <span class="hlFld-ContribAuthor ">Julio  Madrigal-Matute</span>, <span class="hlFld-ContribAuthor ">Simoni  Tiano</span>, <span class="hlFld-ContribAuthor ">Antonio  Diaz</span>, <span class="hlFld-ContribAuthor ">Boris A.  Bartholdy</span>, <span class="hlFld-ContribAuthor ">Britta  Will</span>, <span class="hlFld-ContribAuthor ">Ana Maria  Cuervo</span>, . </span><span class="cited-content_cbyCitation_article-title">Proteome-wide analysis of chaperone-mediated autophagy targeting motifs. </span><span class="cited-content_cbyCitation_journal-name">PLOS Biology</span><span> <strong>2019,</strong> <em>17 </em>
                                    (5)
                                     , e3000301. <a href="https://doi.org/10.1371/journal.pbio.3000301" title="DOI URL">https://doi.org/10.1371/journal.pbio.3000301</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.pbio.3000301&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.pbio.3000301%26sid%3Dliteratum%253Aachs%26jtitle%3DPLOS%2520Biology%26atitle%3DProteome-wide%252Banalysis%252Bof%252Bchaperone-mediated%252Bautophagy%252Btargeting%252Bmotifs%26aulast%3DKirchner%26aufirst%3DPhilipp%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D5%26spage%3De3000301" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhaojun  Qiu</span>, <span class="hlFld-ContribAuthor ">Nancy L.  Oleinick</span>, <span class="hlFld-ContribAuthor ">Junran  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">ATR/CHK1 inhibitors and cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Radiotherapy and Oncology</span><span> <strong>2018,</strong> <em>126 </em>
                                    (3)
                                     , 450-464. <a href="https://doi.org/10.1016/j.radonc.2017.09.043" title="DOI URL">https://doi.org/10.1016/j.radonc.2017.09.043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.radonc.2017.09.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.radonc.2017.09.043%26sid%3Dliteratum%253Aachs%26jtitle%3DRadiotherapy%2520and%2520Oncology%26atitle%3DATR%25252FCHK1%252Binhibitors%252Band%252Bcancer%252Btherapy%26aulast%3DQiu%26aufirst%3DZhaojun%26date%3D2018%26volume%3D126%26issue%3D3%26spage%3D450%26epage%3D464" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ian  Collins</span>, <span class="hlFld-ContribAuthor ">Michelle D.  Garrett</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical Profiles and Contexts for CHK1 and CHK2 Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 241-276. <a href="https://doi.org/10.1007/978-3-319-75836-7_10" title="DOI URL">https://doi.org/10.1007/978-3-319-75836-7_10</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-3-319-75836-7_10&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-3-319-75836-7_10%26sid%3Dliteratum%253Aachs%26atitle%3DPreclinical%252BProfiles%252Band%252BContexts%252Bfor%252BCHK1%252Band%252BCHK2%252BInhibitors%26aulast%3DCollins%26aufirst%3DIan%26date%3D2018%26date%3D2018%26spage%3D241%26epage%3D276%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DTargeting%252Bthe%252BDNA%252BDamage%252BResponse%252Bfor%252BAnti-Cancer%252BTherapy%26aulast%3DPollard%26aufirst%3DJohn%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea Ghelli Luserna Di  RorÃ </span>, <span class="hlFld-ContribAuthor ">Ilaria  Iacobucci</span>, <span class="hlFld-ContribAuthor ">Enrica  Imbrogno</span>, <span class="hlFld-ContribAuthor ">Cristina  Papayannidis</span>, <span class="hlFld-ContribAuthor ">Enrico  Derenzini</span>, <span class="hlFld-ContribAuthor ">Anna  Ferrari</span>, <span class="hlFld-ContribAuthor ">Viviana  Guadagnuolo</span>, <span class="hlFld-ContribAuthor ">Valentina  Robustelli</span>, <span class="hlFld-ContribAuthor ">Sarah  Parisi</span>, <span class="hlFld-ContribAuthor ">Chiara  Sartor</span>, <span class="hlFld-ContribAuthor ">Maria Chiara  Abbenante</span>, <span class="hlFld-ContribAuthor ">Stefania  Paolini</span>, <span class="hlFld-ContribAuthor ">Giovanni  Martinelli</span>. </span><span class="cited-content_cbyCitation_article-title">Prexasertib, a Chk1/Chk2 inhibitor, increases the effectiveness of conventional therapy in B-/T- cell progenitor acute lymphoblastic leukemia. </span><span class="cited-content_cbyCitation_journal-name">Oncotarget</span><span> <strong>2016,</strong> <em>7 </em>
                                    (33)
                                     , 53377-53391. <a href="https://doi.org/10.18632/oncotarget.10535" title="DOI URL">https://doi.org/10.18632/oncotarget.10535</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.18632/oncotarget.10535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.18632%2Foncotarget.10535%26sid%3Dliteratum%253Aachs%26jtitle%3DOncotarget%26atitle%3DPrexasertib%25252C%252Ba%252BChk1%25252FChk2%252Binhibitor%25252C%252Bincreases%252Bthe%252Beffectiveness%252Bof%252Bconventional%252Btherapy%252Bin%252BB-%25252FT-%252Bcell%252Bprogenitor%252Bacute%252Blymphoblastic%252Bleukemia%26aulast%3DRor%25C3%25A0%26aufirst%3DAndrea%2BGhelli%2BLuserna%2BDi%26date%3D2016%26date%3D2016%26volume%3D7%26issue%3D33%26spage%3D53377%26epage%3D53391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">D.  Dube</span>, <span class="hlFld-ContribAuthor ">P.  Tiwari</span>, <span class="hlFld-ContribAuthor ">P.  Kaur</span>. </span><span class="cited-content_cbyCitation_article-title">The hunt for antimitotic agents: an overview of structure-based design strategies. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2016,</strong> <em>11 </em>
                                    (6)
                                     , 579-597. <a href="https://doi.org/10.1080/17460441.2016.1174689" title="DOI URL">https://doi.org/10.1080/17460441.2016.1174689</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17460441.2016.1174689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17460441.2016.1174689%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DThe%252Bhunt%252Bfor%252Bantimitotic%252Bagents%25253A%252Ban%252Boverview%252Bof%252Bstructure-based%252Bdesign%252Bstrategies%26aulast%3DDube%26aufirst%3DD.%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D6%26spage%3D579%26epage%3D597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xuewu  Liang</span>, <span class="hlFld-ContribAuthor ">Yongxue  Huang</span>, <span class="hlFld-ContribAuthor ">Jie  Zang</span>, <span class="hlFld-ContribAuthor ">Qianwen  Gao</span>, <span class="hlFld-ContribAuthor ">Binghe  Wang</span>, <span class="hlFld-ContribAuthor ">Wenfang  Xu</span>, <span class="hlFld-ContribAuthor ">Yingjie  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and preliminary biological evaluation of 4-aminopyrazole derivatives as novel and potent JAKs inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (12)
                                     , 2660-2672. <a href="https://doi.org/10.1016/j.bmc.2016.04.030" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.04.030</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.04.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.04.030%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bpreliminary%252Bbiological%252Bevaluation%252Bof%252B4-aminopyrazole%252Bderivatives%252Bas%252Bnovel%252Band%252Bpotent%252BJAKs%252Binhibitors%26aulast%3DLiang%26aufirst%3DXuewu%26date%3D2016%26volume%3D24%26issue%3D12%26spage%3D2660%26epage%3D2672" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gwenola  Manic</span>, <span class="hlFld-ContribAuthor ">Florine  Obrist</span>, <span class="hlFld-ContribAuthor ">Antonella  Sistigu</span>, <span class="hlFld-ContribAuthor ">Ilio  Vitale</span>. </span><span class="cited-content_cbyCitation_article-title">Trial Watch: Targeting ATMâCHK2 and ATRâCHK1 pathways for anticancer therapy. </span><span class="cited-content_cbyCitation_journal-name">Molecular & Cellular Oncology</span><span> <strong>2015,</strong> <em>2 </em>
                                    (4)
                                     , e1012976. <a href="https://doi.org/10.1080/23723556.2015.1012976" title="DOI URL">https://doi.org/10.1080/23723556.2015.1012976</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/23723556.2015.1012976&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F23723556.2015.1012976%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520%2526%2520Cellular%2520Oncology%26atitle%3DTrial%252BWatch%25253A%252BTargeting%252BATM%2525E2%252580%252593CHK2%252Band%252BATR%2525E2%252580%252593CHK1%252Bpathways%252Bfor%252Banticancer%252Btherapy%26aulast%3DManic%26aufirst%3DGwenola%26date%3D2015%26date%3D2015%26volume%3D2%26issue%3D4%26spage%3De1012976" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nour Jamal  Jaradat</span>, <span class="hlFld-ContribAuthor ">Mohammad A.  Khanfar</span>, <span class="hlFld-ContribAuthor ">Maha  Habash</span>, <span class="hlFld-ContribAuthor ">Mutasem Omar  Taha</span>. </span><span class="cited-content_cbyCitation_article-title">Combining docking-based comparative intermolecular contacts analysis and k-nearest neighbor correlation for the discovery of new check point kinase 1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2015,</strong> <em>29 </em>
                                    (6)
                                     , 561-581. <a href="https://doi.org/10.1007/s10822-015-9848-1" title="DOI URL">https://doi.org/10.1007/s10822-015-9848-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-015-9848-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-015-9848-1%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DCombining%252Bdocking-based%252Bcomparative%252Bintermolecular%252Bcontacts%252Banalysis%252Band%252Bk-nearest%252Bneighbor%252Bcorrelation%252Bfor%252Bthe%252Bdiscovery%252Bof%252Bnew%252Bcheck%252Bpoint%252Bkinase%252B1%252Binhibitors%26aulast%3DJaradat%26aufirst%3DNour%2BJamal%26date%3D2015%26date%3D2015%26volume%3D29%26issue%3D6%26spage%3D561%26epage%3D581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alberto  Cuzzolin</span>, <span class="hlFld-ContribAuthor ">Mattia  Sturlese</span>, <span class="hlFld-ContribAuthor ">Ivana  Malvacio</span>, <span class="hlFld-ContribAuthor ">Antonella  Ciancetta</span>, <span class="hlFld-ContribAuthor ">Stefano  Moro</span>. </span><span class="cited-content_cbyCitation_article-title">DockBench: An Integrated Informatic Platform Bridging the Gap between the Robust Validation of Docking Protocols and Virtual Screening Simulations. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2015,</strong> <em>20 </em>
                                    (6)
                                     , 9977-9993. <a href="https://doi.org/10.3390/molecules20069977" title="DOI URL">https://doi.org/10.3390/molecules20069977</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules20069977&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules20069977%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DDockBench%25253A%252BAn%252BIntegrated%252BInformatic%252BPlatform%252BBridging%252Bthe%252BGap%252Bbetween%252Bthe%252BRobust%252BValidation%252Bof%252BDocking%252BProtocols%252Band%252BVirtual%252BScreening%252BSimulations%26aulast%3DCuzzolin%26aufirst%3DAlberto%26date%3D2015%26date%3D2015%26volume%3D20%26issue%3D6%26spage%3D9977%26epage%3D9993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sobhi M.  Gomha</span>, <span class="hlFld-ContribAuthor ">Mohamed M.  Abdulla</span>, <span class="hlFld-ContribAuthor ">Sahar M.  Abou-Seri</span>. </span><span class="cited-content_cbyCitation_article-title">RETRACTED: Identification of novel aminothiazole and aminothiadiazole conjugated cyanopyridines as selective CHK1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>92 </em>, 459-470. <a href="https://doi.org/10.1016/j.ejmech.2015.01.019" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.01.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.01.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.01.019%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRETRACTED%25253A%252BIdentification%252Bof%252Bnovel%252Baminothiazole%252Band%252Baminothiadiazole%252Bconjugated%252Bcyanopyridines%252Bas%252Bselective%252BCHK1%252Binhibitors%26aulast%3DGomha%26aufirst%3DSobhi%2BM.%26date%3D2015%26volume%3D92%26spage%3D459%26epage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jon A.  Erickson</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment-Based Design of Kinase Inhibitors: A Practical Guide. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 157-183. <a href="https://doi.org/10.1007/978-1-4939-2486-8_13" title="DOI URL">https://doi.org/10.1007/978-1-4939-2486-8_13</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-2486-8_13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-2486-8_13%26sid%3Dliteratum%253Aachs%26atitle%3DFragment-Based%252BDesign%252Bof%252BKinase%252BInhibitors%25253A%252BA%252BPractical%252BGuide%26aulast%3DErickson%26aufirst%3DJon%2BA.%26date%3D2015%26date%3D2015%26spage%3D157%26epage%3D183%26pub%3DSpringer%2520New%2520York%26atitle%3DFragment-Based%252BMethods%252Bin%252BDrug%252BDiscovery%26aulast%3DKlon%26aufirst%3DAnthony%2BE.%26date%3D2015%26volume%3D1289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">So Jeong  Lee</span>, <span class="hlFld-ContribAuthor ">Joanna S.  Fowler</span>, <span class="hlFld-ContribAuthor ">David  Alexoff</span>, <span class="hlFld-ContribAuthor ">Michael  Schueller</span>, <span class="hlFld-ContribAuthor ">Dohyun  Kim</span>, <span class="hlFld-ContribAuthor ">Alexander  Nauth</span>, <span class="hlFld-ContribAuthor ">Carina  Weber</span>, <span class="hlFld-ContribAuthor ">Sung Won  Kim</span>, <span class="hlFld-ContribAuthor ">Jacob M.  Hooker</span>, <span class="hlFld-ContribAuthor ">Ling  Ma</span>, <span class="hlFld-ContribAuthor ">Wenchao  Qu</span>. </span><span class="cited-content_cbyCitation_article-title">An efficient and practical synthesis of [2-
              11
              C]indole via superfast nucleophilic [
              11
              C]cyanation and RANEYÂ® Nickel catalyzed reductive cyclization. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2015,</strong> <em>13 </em>
                                    (46)
                                     , 11235-11243. <a href="https://doi.org/10.1039/C5OB01654A" title="DOI URL">https://doi.org/10.1039/C5OB01654A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5OB01654A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5OB01654A%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DAn%252Befficient%252Band%252Bpractical%252Bsynthesis%252Bof%252B%25255B2-%252B11%252BC%25255Dindole%252Bvia%252Bsuperfast%252Bnucleophilic%252B%25255B%252B11%252BC%25255Dcyanation%252Band%252BRANEY%2525C2%2525AE%252BNickel%252Bcatalyzed%252Breductive%252Bcyclization%26aulast%3DLee%26aufirst%3DSo%2BJeong%26date%3D2015%26date%3D2015%26volume%3D13%26issue%3D46%26spage%3D11235%26epage%3D11243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vikash  Kumar</span>, <span class="hlFld-ContribAuthor ">Saman  Khan</span>, <span class="hlFld-ContribAuthor ">Priyanka  Gupta</span>, <span class="hlFld-ContribAuthor ">Namrata  Rastogi</span>, <span class="hlFld-ContribAuthor ">Durga Prasad  Mishra</span>, <span class="hlFld-ContribAuthor ">Shakil  Ahmed</span>, <span class="hlFld-ContribAuthor ">Mohammad Imran  Siddiqi</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of novel inhibitors of human Chk1 using pharmacophore-based virtual screening and their evaluation as potential anti-cancer agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2014,</strong> <em>28 </em>
                                    (12)
                                     , 1247-1256. <a href="https://doi.org/10.1007/s10822-014-9800-9" title="DOI URL">https://doi.org/10.1007/s10822-014-9800-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-014-9800-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-014-9800-9%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DIdentification%252Bof%252Bnovel%252Binhibitors%252Bof%252Bhuman%252BChk1%252Busing%252Bpharmacophore-based%252Bvirtual%252Bscreening%252Band%252Btheir%252Bevaluation%252Bas%252Bpotential%252Banti-cancer%252Bagents%26aulast%3DKumar%26aufirst%3DVikash%26date%3D2014%26date%3D2014%26volume%3D28%26issue%3D12%26spage%3D1247%26epage%3D1256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hai-Kui  Yang</span>, <span class="hlFld-ContribAuthor ">Wen-Wei  You</span>, <span class="hlFld-ContribAuthor ">Guang-Hua  Yan</span>, <span class="hlFld-ContribAuthor ">Zhi-Hong  Jiang</span>, <span class="hlFld-ContribAuthor ">Pei-Liang  Zhao</span>, <span class="hlFld-ContribAuthor ">Zhong-Zhen  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient One-Pot Synthesis of 3-Amino-7-azaindoles Under Microwave Irradiation. </span><span class="cited-content_cbyCitation_journal-name">Synthetic Communications</span><span> <strong>2014,</strong> <em>44 </em>
                                    (8)
                                     , 1165-1171. <a href="https://doi.org/10.1080/00397911.2013.858360" title="DOI URL">https://doi.org/10.1080/00397911.2013.858360</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00397911.2013.858360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00397911.2013.858360%26sid%3Dliteratum%253Aachs%26jtitle%3DSynthetic%2520Communications%26atitle%3DEfficient%252BOne-Pot%252BSynthesis%252Bof%252B3-Amino-7-azaindoles%252BUnder%252BMicrowave%252BIrradiation%26aulast%3DYang%26aufirst%3DHai-Kui%26date%3D2014%26date%3D2014%26volume%3D44%26issue%3D8%26spage%3D1165%26epage%3D1171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Charlotte E.  Allen</span>, <span class="hlFld-ContribAuthor ">Amanda J.  Welford</span>, <span class="hlFld-ContribAuthor ">Thomas P.  Matthews</span>, <span class="hlFld-ContribAuthor ">John J.  Caldwell</span>, <span class="hlFld-ContribAuthor ">Ian  Collins</span>. </span><span class="cited-content_cbyCitation_article-title">Fragment growing to retain or alter the selectivity of anchored kinase hinge-binding fragments. </span><span class="cited-content_cbyCitation_journal-name">Med. Chem. Commun.</span><span> <strong>2014,</strong> <em>5 </em>
                                    (2)
                                     , 180-185. <a href="https://doi.org/10.1039/C3MD00308F" title="DOI URL">https://doi.org/10.1039/C3MD00308F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C3MD00308F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC3MD00308F%26sid%3Dliteratum%253Aachs%26jtitle%3DMed.%2520Chem.%2520Commun.%26atitle%3DFragment%252Bgrowing%252Bto%252Bretain%252Bor%252Balter%252Bthe%252Bselectivity%252Bof%252Banchored%252Bkinase%252Bhinge-binding%252Bfragments%26aulast%3DAllen%26aufirst%3DCharlotte%2BE.%26date%3D2014%26date%3D2014%26volume%3D5%26issue%3D2%26spage%3D180%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bradley J.  Newhouse</span>, <span class="hlFld-ContribAuthor ">Steve  Wenglowsky</span>, <span class="hlFld-ContribAuthor ">Jonas  Grina</span>, <span class="hlFld-ContribAuthor ">Ellen R.  Laird</span>, <span class="hlFld-ContribAuthor ">Walter C.  Voegtli</span>, <span class="hlFld-ContribAuthor ">Li  Ren</span>, <span class="hlFld-ContribAuthor ">Kateri  Ahrendt</span>, <span class="hlFld-ContribAuthor ">Alex  Buckmelter</span>, <span class="hlFld-ContribAuthor ">Susan L.  Gloor</span>, <span class="hlFld-ContribAuthor ">Nathalie  Klopfenstein</span>, <span class="hlFld-ContribAuthor ">Joachim  Rudolph</span>, <span class="hlFld-ContribAuthor ">Zhaoyang  Wen</span>, <span class="hlFld-ContribAuthor ">Xianfeng  Li</span>, <span class="hlFld-ContribAuthor ">Bainian  Feng</span>. </span><span class="cited-content_cbyCitation_article-title">Imidazo[4,5-b]pyridine inhibitors of B-Raf kinase. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (21)
                                     , 5896-5899. <a href="https://doi.org/10.1016/j.bmcl.2013.08.086" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.08.086</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.08.086&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.08.086%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DImidazo%25255B4%25252C5-b%25255Dpyridine%252Binhibitors%252Bof%252BB-Raf%252Bkinase%26aulast%3DNewhouse%26aufirst%3DBradley%2BJ.%26date%3D2013%26volume%3D23%26issue%3D21%26spage%3D5896%26epage%3D5899" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas P  Matthews</span>, <span class="hlFld-ContribAuthor ">Alan M  Jones</span>, <span class="hlFld-ContribAuthor ">Ian  Collins</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design, discovery and development of checkpoint kinase inhibitors as potential anticancer therapies. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2013,</strong> <em>8 </em>
                                    (6)
                                     , 621-640. <a href="https://doi.org/10.1517/17460441.2013.788496" title="DOI URL">https://doi.org/10.1517/17460441.2013.788496</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2013.788496&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2013.788496%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DStructure-based%252Bdesign%25252C%252Bdiscovery%252Band%252Bdevelopment%252Bof%252Bcheckpoint%252Bkinase%252Binhibitors%252Bas%252Bpotential%252Banticancer%252Btherapies%26aulast%3DMatthews%26aufirst%3DThomas%2BP%26date%3D2013%26date%3D2013%26volume%3D8%26issue%3D6%26spage%3D621%26epage%3D640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yann  Touchefeu</span>, <span class="hlFld-ContribAuthor ">Aadil A.  Khan</span>, <span class="hlFld-ContribAuthor ">Gerben  Borst</span>, <span class="hlFld-ContribAuthor ">Shane H.  Zaidi</span>, <span class="hlFld-ContribAuthor ">Martin  McLaughlin</span>, <span class="hlFld-ContribAuthor ">Victoria  Roulstone</span>, <span class="hlFld-ContribAuthor ">David  Mansfield</span>, <span class="hlFld-ContribAuthor ">Joan  Kyula</span>, <span class="hlFld-ContribAuthor ">Tim  Pencavel</span>, <span class="hlFld-ContribAuthor ">Eleni M.  Karapanagiotou</span>, <span class="hlFld-ContribAuthor ">Jamie  Clayton</span>, <span class="hlFld-ContribAuthor ">Mark J.  Federspiel</span>, <span class="hlFld-ContribAuthor ">Steve J.  Russell</span>, <span class="hlFld-ContribAuthor ">Michelle  Garrett</span>, <span class="hlFld-ContribAuthor ">Ian  Collins</span>, <span class="hlFld-ContribAuthor ">Kevin J.  Harrington</span>. </span><span class="cited-content_cbyCitation_article-title">Optimising measles virus-guided radiovirotherapy with external beam radiotherapy and specific checkpoint kinase 1 inhibition. </span><span class="cited-content_cbyCitation_journal-name">Radiotherapy and Oncology</span><span> <strong>2013,</strong> <em>108 </em>
                                    (1)
                                     , 24-31. <a href="https://doi.org/10.1016/j.radonc.2013.05.036" title="DOI URL">https://doi.org/10.1016/j.radonc.2013.05.036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.radonc.2013.05.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.radonc.2013.05.036%26sid%3Dliteratum%253Aachs%26jtitle%3DRadiotherapy%2520and%2520Oncology%26atitle%3DOptimising%252Bmeasles%252Bvirus-guided%252Bradiovirotherapy%252Bwith%252Bexternal%252Bbeam%252Bradiotherapy%252Band%252Bspecific%252Bcheckpoint%252Bkinase%252B1%252Binhibition%26aulast%3DTouchefeu%26aufirst%3DYann%26date%3D2013%26volume%3D108%26issue%3D1%26spage%3D24%26epage%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Se-Ho  Kim</span>, <span class="hlFld-ContribAuthor ">Benjamin  Markovitz</span>, <span class="hlFld-ContribAuthor ">Richard  Trovato</span>, <span class="hlFld-ContribAuthor ">Brett R.  Murphy</span>, <span class="hlFld-ContribAuthor ">Harry  Austin</span>, <span class="hlFld-ContribAuthor ">Adam J.  Willardsen</span>, <span class="hlFld-ContribAuthor ">Vijay  Baichwal</span>, <span class="hlFld-ContribAuthor ">Scott  Morham</span>, <span class="hlFld-ContribAuthor ">Ashok  Bajji</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a new HIV-1 inhibitor scaffold and synthesis of potential prodrugs of indazoles. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2013,</strong> <em>23 </em>
                                    (10)
                                     , 2888-2892. <a href="https://doi.org/10.1016/j.bmcl.2013.03.075" title="DOI URL">https://doi.org/10.1016/j.bmcl.2013.03.075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2013.03.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2013.03.075%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252Bnew%252BHIV-1%252Binhibitor%252Bscaffold%252Band%252Bsynthesis%252Bof%252Bpotential%252Bprodrugs%252Bof%252Bindazoles%26aulast%3DKim%26aufirst%3DSe-Ho%26date%3D2013%26volume%3D23%26issue%3D10%26spage%3D2888%26epage%3D2892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John M.  Furgason</span>, <span class="hlFld-ContribAuthor ">El Mustapha  Bahassi</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting DNA repair mechanisms in cancer. </span><span class="cited-content_cbyCitation_journal-name">Pharmacology & Therapeutics</span><span> <strong>2013,</strong> <em>137 </em>
                                    (3)
                                     , 298-308. <a href="https://doi.org/10.1016/j.pharmthera.2012.10.009" title="DOI URL">https://doi.org/10.1016/j.pharmthera.2012.10.009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.pharmthera.2012.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.pharmthera.2012.10.009%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacology%2520%2526%2520Therapeutics%26atitle%3DTargeting%252BDNA%252Brepair%252Bmechanisms%252Bin%252Bcancer%26aulast%3DFurgason%26aufirst%3DJohn%2BM.%26date%3D2013%26volume%3D137%26issue%3D3%26spage%3D298%26epage%3D308" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">. </span><span class="cited-content_cbyCitation_article-title">Radiation Induced DNA Damage, Repair and Therapeutics. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 110-110. <a href="https://doi.org/10.1201/b14587-14" title="DOI URL">https://doi.org/10.1201/b14587-14</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1201/b14587-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1201%2Fb14587-14%26sid%3Dliteratum%253Aachs%26atitle%3DRadiation%252BInduced%252BDNA%252BDamage%25252C%252BRepair%252Band%252BTherapeutics%26date%3D2013%26spage%3D110%26epage%3D110%26pub%3DCRC%2520Press%26atitle%3DDNA%252BRepair%252Band%252BCancer%26aulast%3DMadhusudan%26aufirst%3DSrinivasan%26date%3D2013%26date%3D2013%26volume%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mike I.  Walton</span>, <span class="hlFld-ContribAuthor ">Paul D.  Eve</span>, <span class="hlFld-ContribAuthor ">Angela  Hayes</span>, <span class="hlFld-ContribAuthor ">Melanie R.  Valenti</span>, <span class="hlFld-ContribAuthor ">Alexis K.  De Haven Brandon</span>, <span class="hlFld-ContribAuthor ">Gary  Box</span>, <span class="hlFld-ContribAuthor ">Albert  Hallsworth</span>, <span class="hlFld-ContribAuthor ">Elizabeth L.  Smith</span>, <span class="hlFld-ContribAuthor ">Kathy J.  Boxall</span>, <span class="hlFld-ContribAuthor ">Michael  Lainchbury</span>, <span class="hlFld-ContribAuthor ">Thomas P.  Matthews</span>, <span class="hlFld-ContribAuthor ">Yann  Jamin</span>, <span class="hlFld-ContribAuthor ">Simon P.  Robinson</span>, <span class="hlFld-ContribAuthor ">G. Wynne  Aherne</span>, <span class="hlFld-ContribAuthor ">John C.  Reader</span>, <span class="hlFld-ContribAuthor ">Louis  Chesler</span>, <span class="hlFld-ContribAuthor ">Florence I.  Raynaud</span>, <span class="hlFld-ContribAuthor ">Suzanne A.  Eccles</span>, <span class="hlFld-ContribAuthor ">Ian  Collins</span>, <span class="hlFld-ContribAuthor ">Michelle D.  Garrett</span>. </span><span class="cited-content_cbyCitation_article-title">CCT244747 Is a Novel Potent and Selective CHK1 Inhibitor with Oral Efficacy Alone and in Combination with Genotoxic Anticancer Drugs. </span><span class="cited-content_cbyCitation_journal-name">Clinical Cancer Research</span><span> <strong>2012,</strong> <em>18 </em>
                                    (20)
                                     , 5650-5661. <a href="https://doi.org/10.1158/1078-0432.CCR-12-1322" title="DOI URL">https://doi.org/10.1158/1078-0432.CCR-12-1322</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1078-0432.CCR-12-1322&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1078-0432.CCR-12-1322%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Cancer%2520Research%26atitle%3DCCT244747%252BIs%252Ba%252BNovel%252BPotent%252Band%252BSelective%252BCHK1%252BInhibitor%252Bwith%252BOral%252BEfficacy%252BAlone%252Band%252Bin%252BCombination%252Bwith%252BGenotoxic%252BAnticancer%252BDrugs%26aulast%3DWalton%26aufirst%3DMike%2BI.%26date%3D2012%26date%3D2012%26volume%3D18%26issue%3D20%26spage%3D5650%26epage%3D5661" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/medium/jm-2011-007326_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007326&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/medium/jm-2011-007326_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structures of the template hit <b>1</b>, early stage lead <b>2</b>, and <b>(</b><i><b>R</b></i><b>)-3</b> (SAR-020106). Features conserved in the elaboration of the template hit and early stage lead into a potent and selective CHK1 inhibitor are highlighted in blue and red.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007326&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/medium/jm-2011-007326_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0006.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structures of <b>2</b> (panel A, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ym3">2ym3</a>), <b>4</b> (panel B, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ym4">2ym4</a>), <b>6</b> (panel C, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ym5">2ym5</a>), <b>8</b> (panel D, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ym6">2ym6</a>), <b>20</b> (panel E, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ym7">2ym7</a>), and <b>(</b><i><b>R</b></i><b>)-3</b> (panel F, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ym8">2ym8</a>) bound to the CHK1 kinase domain. Red spheres represent water molecules modeled in the refinement. Dashed gray lines represent hydrogen bonds. Panel G: Plan view of the overlay of CHK1 inhibitors <b>2</b> (cyan), <b>8</b> (gray), <b>20</b> (blue), and <b>(</b><i><b>R</b></i><b>)-3</b> (gold) relative to the hinge region of CHK1 (cartoon).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007326&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/medium/jm-2011-007326_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0008.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Selectivity profile of <b>(</b><i><b>R</b></i><b>)-3</b> against a panel of 124 kinases measured at 1 Î¼M concentration of the test compound with [ATP] â¼ <i>K</i><sub>m,ATP</sub> for each kinase. Kinase dendrogram<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> reproduced courtesy of Cell Signaling Technology, Inc. (<a href="http://www.cellsignal.com" class="extLink">www.cellsignal.com</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007326&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/medium/jm-2011-007326_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0009.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (A) Status of pS296 CHK1 autophosphorylation in SW620 tumor xenografts following treatment with either irinotecan alone or in combination with <b>(</b><i><b>R</b></i><b>)</b><b>-(3)</b>.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Tumor bearing animals were administered either vehicle alone, irinotecan alone (25 or 50 mg/kg ip), or irinotecan combined with a fixed dose of <b>(</b><i><b>R</b></i><b>)</b><b>-(3)</b> (40 mg kg<sup>â1</sup> ip) 1 h prior to irinotecan administration. Tumors were collected 6 or 24 h following treatment (6 or 24 after administration of the first agent for combinations) and snap frozen. Tumor protein expression was characterized by Western blotting using 50 Î¼g of sample per lane. (B) Antitumor effects of combining <b>(</b><i><b>R</b></i><b>)-3</b> with irinotecan in nude mice bearing SW620 xenograft tumors.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Symbols: (â) dose administered; (â ) vehicle alone; (shaded up triangles) irinotecan alone (12.5 mg/kg ip); (shaded down triangles) <b>(</b><i><b>R</b></i><b>)-3</b> alone (40 mg/kg ip); (â§«) irinotecan and <b>(</b><i><b>R</b></i><b>)-3</b> combined (<b>(</b><i><b>R</b></i><b>)-3</b> dosed 1 h prior to and 24 h after irinotecan). Values are mean Â± SEM; <i>n</i> = 9â11.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007326&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/medium/jm-2011-007326_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007326&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NBS, DMF, rt, 77%; (ii) PdCl<sub>2</sub>(dppf)Â·CH<sub>2</sub>Cl<sub>2</sub>, 3-cyanophenylboronic acid, Na<sub>2</sub>CO<sub>3</sub>, DME/H<sub>2</sub>O, 140 Â°C, 2 h, microwave, 48%; (iii) TFA, MeOH, 80 Â°C, 62%; (iv) NBS, CH<sub>2</sub>Cl<sub>2</sub>, rt, 83%; (v) NaH, SEM-Cl, DMF, 0 Â°C to rt, 93%; (vi) Boc-amine, TEA, <i>n</i>-BuOH, 100 Â°C, 68%; (vii) Pd(PPh<sub>3</sub>)<sub>4</sub>, phenylboronic acid, Na<sub>2</sub>CO<sub>3</sub>, DME/H<sub>2</sub>O, 120 Â°C, 30 min, microwave, 49â59%; (viii) TBAF, ethane-1,2-diamine, DMF, 60 Â°C, 7 h and then TFA, MeOH, 80 Â°C, 21%; (ix) TBAF, ethane-1,2-diamine, DMF, 60 Â°C, 7 h and then 4 M HClâdioxane, MeOH, 24 h, rt, 17%.</p></p></figure><figure data-id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/medium/jm-2011-007326_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0010.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007326&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) NaH, NCCH<sub>2</sub>CO<sub>2</sub>Et, DMF, 0 Â°C to rt and then <b>40</b> or <b>41</b>, 2 h, rt, 48%; (ii) Zn/AcOH, 95 Â°C, 1 h 15 min, 88%; (iii) formamide, ammonium formate, 170 Â°C, 18 h, 45%; (iv) POCl<sub>3</sub>, 75 Â°C, 18 h, 100%; (v) amine, TEA, DMF, 120 Â°C, 1 h, microwave and then 4 M HCl, dioxane/MeOH, 2.5 h, 3â46%; (vi) amine, TEA, NMP, 140 Â°C, microwave and then MP-TsOH column, 29%.</p></p></figure><figure data-id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/medium/jm-2011-007326_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007326&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span><sup></sup>Reagents and conditions: (i) PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, LiHMDS, THF, 135 Â°C, 20 min, 19%â22%; or when X = CH(<sup>t</sup>Bu<sub>3</sub>P)<sub>2</sub>Pd(0), NaO<sup>t</sup>Bu, toluene, 80 Â°C, 2 h, 45%; (ii) amine, NMP, 145 Â°C, 20 min, (26â41%); (iii) amine, NMP, 145 Â°C, 20 min, followed by TFA, CH<sub>2</sub>Cl<sub>2</sub>, 1 h, rt, or HCl, dioxane, MP-TsOH column (3â63%).</p></p></figure><figure data-id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/medium/jm-2011-007326_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0005.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. <sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2011/jmcmar.2011.54.issue-24/jm2007326/production/images/large/jm-2011-007326_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm2007326&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span><sup></sup>Reagents and conditions: (i) 4-(aminomethyl)piperidine-1-carboxylate, TEA, MeCN, 1.5 h, rt, 93%; (ii) SnCl<sub>2</sub>Â·2H<sub>2</sub>O, EtOH, 70 Â°C, 2 h, 88%; (iii) (EtO)<sub>3</sub>CH, Ac<sub>2</sub>O, 100 Â°C, 18 h, 40%â100%; (iv) 4-methoxybenzylamine, TEA, MeCN, 1.5 h, rt, 77%; (v) aryl halide (ArCl for <b>24</b>, <b>25</b>, <b>29</b>; ArI for <b>27</b>), Pd(OAc)<sub>2</sub>, (Â±)-BINAP, NaO<sup>t</sup>Bu, DMF/Tol, 150 Â°C, 30 min, microwave and then MP-TsOH column, 3â41% (11% for <b>25</b> including Boc deprotection); (vi) NHMe<sub>2</sub> (40% in H<sub>2</sub>O), 0â20 Â°C, 2 h 40%; (vii) aq NH<sub>3</sub> (28%), 100 Â°C, o/n, 91%; (viii) NBS, CH<sub>2</sub>Cl<sub>2</sub>, 0 Â°C, 1 h, 42%; (ix) CuI, 18-crown-6, Pd(PPh<sub>3</sub>)<sub>4</sub>, KCN, DMF, reflux, 3 h, 82%; (x) NaH (60% in oil), dioxane, aminoalcohol, 100 Â°C, o/n, 14â32%; (xi) Pd(OAc)<sub>2</sub>, (Â±)-BINAP, Na<sup>t</sup>Bu, DMF/toluene, microwave, 140â150 Â°C, 30 min, or Pd<sub>2</sub>(dba)<sub>3</sub>, Xantphos, Cs<sub>2</sub>CO<sub>3</sub>, toluene, microwave, 140 Â°C, 45 min (2â45%); (xii) Pd(OAc)<sub>2</sub>, (Â±)-BINAP, Na<sup>t</sup>Bu, DMF/Tol, microwave, 140â150Â Â°C, 30 min, or Pd<sub>2</sub>(dba)<sub>3</sub>, Xantphos, Cs<sub>2</sub>CO<sub>3</sub>, toluene, microwave, 140Â Â°C, 45 min followed by TFA, 80 Â°C, 30 min or TFA, CH<sub>2</sub>Cl<sub>2</sub>, rt, 1Â h MP-TsOH column (2â26%).</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i41">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00706" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00706" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 61 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span> </span><span class="NLM_article-title">Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase inhibitors</span> <span class="citation_source-journal">Curr. Opin. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">366</span><span class="NLM_x">â</span> <span class="NLM_lpage">373</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1016%2Fj.coph.2005.04.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=15964238" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD2MXlvFKlsL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=366-373&author=I.+Collinsauthor=M.+D.+Garrett&title=Targeting+the+cell+division+cycle+in+cancer%3A+CDK+and+cell+cycle+checkpoint+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase inhibitors</span></div><div class="casAuthors">Collins, Ian; Garrett, Michelle D.</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">366-373</span>CODEN:
                <span class="NLM_cas:coden">COPUBK</span>;
        ISSN:<span class="NLM_cas:issn">1471-4892</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  The cyclin-dependent kinase (CDK) family of serine/threonine kinases regulate progression through each stage of the cell division cycle and as such are major targets for deregulation in cancer.  This has led to the development of several small-mol. inhibitors of CDKs as potential therapeutic agents for the treatment of this disease.  Progression through the cell cycle is also monitored at several positions known as cell cycle checkpoints, 2 of which occur during G1 and G2 in response to DNA damage.  These are often defective in cancer, leading to the suggestion that inhibition of one or both of the cell cycle checkpoint kinases CHK1 and CHK2 may drive a cancer cell that already has defects in its cell cycle checkpoints towards death.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlqcFxaO9gh7Vg90H21EOLACvtfcHk0ljYAYlL10bypg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXlvFKlsL0%253D&md5=40607fa37e866766581683b322829a13</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1016%2Fj.coph.2005.04.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.coph.2005.04.009%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26atitle%3DTargeting%2520the%2520cell%2520division%2520cycle%2520in%2520cancer%253A%2520CDK%2520and%2520cell%2520cycle%2520checkpoint%2520kinase%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Pharmacol.%26date%3D2005%26volume%3D5%26spage%3D366%26epage%3D373" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Dai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span> </span><span class="NLM_article-title">New insights into checkpoint kinase 1 in the DNA damage response signaling network</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">376</span><span class="NLM_x">â</span> <span class="NLM_lpage">383</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1158%2F1078-0432.CCR-09-1029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=20068082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktF2qsb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=376-383&author=Y.+Daiauthor=S.+Grant&title=New+insights+into+checkpoint+kinase+1+in+the+DNA+damage+response+signaling+network"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">New insights into checkpoint kinase 1 in the DNA damage response signaling network</span></div><div class="casAuthors">Dai, Yun; Grant, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">376-383</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  The DNA damage response (DDR) represents a complex network of multiple signaling pathways involving cell cycle checkpoints, DNA repair, transcriptional programs, and apoptosis, through which cells maintain genomic integrity following various endogenous (metabolic) or environmental stresses.  In cancer treatment, the DDR occurs in response to various genotoxic insults by diverse cytotoxic agents and radiation, representing an important mechanism limiting chemotherapeutic and radiotherapeutic efficacy.  This has prompted the development of agents targeting DDR signaling pathways, particularly checkpoint kinase 1 (Chk1), which contributes to all currently defined cell cycle checkpoints, including G1/S, intra-S-phase, G2/M, and the mitotic spindle checkpoint.  Although numerous agents have been developed with the primary goal of enhancing the activity of DNA-damaging agents or radiation, the therapeutic outcome of this strategy remains to be detd.  Recently, new insights into DDR signaling pathways support the notion that Chk1 represents a core component central to the entire DDR, including direct involvement in DNA repair and apoptotic events in addn. to checkpoint regulation.  Together, these new insights into the role of Chk1 in the DDR machinery could provide an opportunity for novel approaches to the development of Chk1 inhibitor strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP9oCivdYOLbVg90H21EOLACvtfcHk0liPFjyX7E6MPw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktF2qsb8%253D&md5=37b8cf16a1a136372f1c1ee6d42b6988</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-09-1029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-09-1029%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DY.%26aulast%3DGrant%26aufirst%3DS.%26atitle%3DNew%2520insights%2520into%2520checkpoint%2520kinase%25201%2520in%2520the%2520DNA%2520damage%2520response%2520signaling%2520network%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2010%26volume%3D16%26spage%3D376%26epage%3D383" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Kastan, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartek, J.</span><span> </span><span class="NLM_article-title">Cell-cycle checkpoints and cancer</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">432</span><span class="NLM_x">, </span> <span class="NLM_fpage">316</span><span class="NLM_x">â</span> <span class="NLM_lpage">323</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1038%2Fnature03097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=15549093" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD2cXpvVCjtLo%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=432&publication_year=2004&pages=316-323&author=M.+B.+Kastanauthor=J.+Bartek&title=Cell-cycle+checkpoints+and+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Cell-cycle checkpoints and cancer</span></div><div class="casAuthors">Kastan, Michael B.; Bartek, Jiri</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">432</span>
        (<span class="NLM_cas:issue">7015</span>),
    <span class="NLM_cas:pages">316-323</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with refs.  All life on earth must cope with const. exposure to DNA-damaging agents such as the Sun's radiation.  Highly conserved DNA-repair and cell-cycle checkpoint pathways allow cells to deal with both endogenous and exogenous sources of DNA damage.  How much an individual is exposed to these agents and how their cells respond to DNA damage are crit. determinants of whether that individual will develop cancer.  These cellular responses are also important for detg. toxicities and responses to current cancer therapies, most of which target the DNA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpONns98smbebVg90H21EOLACvtfcHk0liPFjyX7E6MPw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXpvVCjtLo%253D&md5=23577cd35313a3a11afee151281c3fd4</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1038%2Fnature03097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature03097%26sid%3Dliteratum%253Aachs%26aulast%3DKastan%26aufirst%3DM.%2BB.%26aulast%3DBartek%26aufirst%3DJ.%26atitle%3DCell-cycle%2520checkpoints%2520and%2520cancer%26jtitle%3DNature%26date%3D2004%26volume%3D432%26spage%3D316%26epage%3D323" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumagai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dunphy, W. G.</span><span> </span><span class="NLM_article-title">Requirement for Atr in phosphorylation of Chk1 and cell cycle regulation in response to DNA replication blocks and UV-damaged DNA in Xenopus egg extracts</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">2745</span><span class="NLM_x">â</span> <span class="NLM_lpage">2756</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2000&pages=2745-2756&author=Z.+Guoauthor=A.+Kumagaiauthor=S.+X.+Wangauthor=W.+G.+Dunphy&title=Requirement+for+Atr+in+phosphorylation+of+Chk1+and+cell+cycle+regulation+in+response+to+DNA+replication+blocks+and+UV-damaged+DNA+in+Xenopus+egg+extracts"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DKumagai%26aufirst%3DA.%26aulast%3DWang%26aufirst%3DS.%2BX.%26aulast%3DDunphy%26aufirst%3DW.%2BG.%26atitle%3DRequirement%2520for%2520Atr%2520in%2520phosphorylation%2520of%2520Chk1%2520and%2520cell%2520cycle%2520regulation%2520in%2520response%2520to%2520DNA%2520replication%2520blocks%2520and%2520UV-damaged%2520DNA%2520in%2520Xenopus%2520egg%2520extracts%26jtitle%3DGenes%2520Dev.%26date%3D2000%26volume%3D14%26spage%3D2745%26epage%3D2756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Zhao, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwnica-Worms, H.</span><span> </span><span class="NLM_article-title">ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">4129</span><span class="NLM_x">â</span> <span class="NLM_lpage">4139</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1128%2FMCB.21.13.4129-4139.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=11390642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksVOrtrw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=4129-4139&author=H.+Zhaoauthor=H.+Piwnica-Worms&title=ATR-mediated+checkpoint+pathways+regulate+phosphorylation+and+activation+of+human+Chk1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1</span></div><div class="casAuthors">Zhao, Hui; Piwnica-Worms, Helen</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">4129-4139</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Chk1 is an evolutionarily conserved protein kinase that regulates cell cycle progression in response to checkpoint activation.  In this study, we demonstrated that agents that block DNA replication or cause certain forms of DNA damage induce the phosphorylation of human Chk1.  The phosphorylated form of Chk1 possessed higher intrinsic protein kinase activity and eluted more quickly on gel filtration columns.  Serines 317 and 345 were identified as sites of phosphorylation in vivo, and ATR (the ATM- and Rad3-related protein kinase) phosphorylated both of these sites in vitro.  Furthermore, phosphorylation of Chk1 on serines 317 and 345 in vivo was ATR dependent.  Mutants of Chk1 contg. alanine in place of serines 317 and 345 were poorly activated in response to replication blocks or genotoxic stress in vivo, were poorly phosphorylated by ATR in vitro, and were not found in faster-eluting fractions by gel filtration.  These findings demonstrate that the activation of Chk1 in response to replication blocks and certain forms of genotoxic stress involves phosphorylation of serines 317 and 345.  In addn., this study implicates ATR as a direct upstream activator of Chk1 in human cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpC8wdmNW0hyLVg90H21EOLACvtfcHk0lgnIKcHXx-UmQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksVOrtrw%253D&md5=91810bc5ec14229fd93ca55f25630d8b</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1128%2FMCB.21.13.4129-4139.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.21.13.4129-4139.2001%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DPiwnica-Worms%26aufirst%3DH.%26atitle%3DATR-mediated%2520checkpoint%2520pathways%2520regulate%2520phosphorylation%2520and%2520activation%2520of%2520human%2520Chk1%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D2001%26volume%3D21%26spage%3D4129%26epage%3D4139" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Clarke, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarke, P. R.</span><span> </span><span class="NLM_article-title">DNA-dependent phosphorylation of Chk1 and Claspin in a human cell-free system</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">388</span><span class="NLM_x">, </span> <span class="NLM_fpage">705</span><span class="NLM_x">â</span> <span class="NLM_lpage">712</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=388&publication_year=2005&pages=705-712&author=C.+A.+Clarkeauthor=P.+R.+Clarke&title=DNA-dependent+phosphorylation+of+Chk1+and+Claspin+in+a+human+cell-free+system"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClarke%26aufirst%3DC.%2BA.%26aulast%3DClarke%26aufirst%3DP.%2BR.%26atitle%3DDNA-dependent%2520phosphorylation%2520of%2520Chk1%2520and%2520Claspin%2520in%2520a%2520human%2520cell-free%2520system%26jtitle%3DBiochem.%2520J.%26date%3D2005%26volume%3D388%26spage%3D705%26epage%3D712" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Smits, V. A. J.</span><span> </span><span class="NLM_article-title">Spreading the signal. Dissociation of Chk1 from chromatin</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1039</span><span class="NLM_x">â</span> <span class="NLM_lpage">1043</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=1039-1043&author=V.+A.+J.+Smits&title=Spreading+the+signal.+Dissociation+of+Chk1+from+chromatin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSmits%26aufirst%3DV.%2BA.%2BJ.%26atitle%3DSpreading%2520the%2520signal.%2520Dissociation%2520of%2520Chk1%2520from%2520chromatin%26jtitle%3DCell%2520Cycle%26date%3D2006%26volume%3D5%26spage%3D1039%26epage%3D1043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Zhou, B. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elledge, S. J.</span><span> </span><span class="NLM_article-title">The DNA damage response: Putting checkpoints in perspective</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x">, </span> <span class="NLM_fpage">433</span><span class="NLM_x">â</span> <span class="NLM_lpage">439</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1038%2F35044005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=11100718" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD3cXos1Srsb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2000&pages=433-439&author=B.+B.+Zhouauthor=S.+J.+Elledge&title=The+DNA+damage+response%3A+Putting+checkpoints+in+perspective"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The DNA damage response: putting checkpoints in perspective</span></div><div class="casAuthors">Zhou, Bin-Bing S.; Elledge, Stephen J.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">6811</span>),
    <span class="NLM_cas:pages">433-439</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review, with 96 refs.  The inability to repair DNA damage properly in mammals leads to various disorders and enhanced rates of tumor development.  Organisms respond to chromosomal insults by activating a complex damage response pathway.  This pathway regulates known responses such as cell-cycle arrest and apoptosis (programmed cell death), and has recently been shown to control addnl. processes including direct activation of DNA repair networks.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokbilF0_EQubVg90H21EOLACvtfcHk0lhDDmI-6VEkKQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXos1Srsb0%253D&md5=bedb1b7569ab0f8267bc37cda4ce59d8</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2F35044005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252F35044005%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DB.%2BB.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26atitle%3DThe%2520DNA%2520damage%2520response%253A%2520Putting%2520checkpoints%2520in%2520perspective%26jtitle%3DNature%26date%3D2000%26volume%3D408%26spage%3D433%26epage%3D439" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Feijoo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall-Jackson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jenkins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leitch, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smythe, C.</span><span> </span><span class="NLM_article-title">Activation of mammalian Chk1 during DNA replication arrest: A role for Chk1 in the intra-S phase checkpoint monitoring replication origin firing</span> <span class="citation_source-journal">J. Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">154</span><span class="NLM_x">, </span> <span class="NLM_fpage">913</span><span class="NLM_x">â</span> <span class="NLM_lpage">923</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2001&pages=913-923&author=C.+Feijooauthor=C.+Hall-Jacksonauthor=R.+Wuauthor=D.+Jenkinsauthor=J.+Leitchauthor=D.+M.+Gilbertauthor=C.+Smythe&title=Activation+of+mammalian+Chk1+during+DNA+replication+arrest%3A+A+role+for+Chk1+in+the+intra-S+phase+checkpoint+monitoring+replication+origin+firing"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFeijoo%26aufirst%3DC.%26aulast%3DHall-Jackson%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DR.%26aulast%3DJenkins%26aufirst%3DD.%26aulast%3DLeitch%26aufirst%3DJ.%26aulast%3DGilbert%26aufirst%3DD.%2BM.%26aulast%3DSmythe%26aufirst%3DC.%26atitle%3DActivation%2520of%2520mammalian%2520Chk1%2520during%2520DNA%2520replication%2520arrest%253A%2520A%2520role%2520for%2520Chk1%2520in%2520the%2520intra-S%2520phase%2520checkpoint%2520monitoring%2520replication%2520origin%2520firing%26jtitle%3DJ.%2520Cell%2520Biol.%26date%3D2001%26volume%3D154%26spage%3D913%26epage%3D923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Peng, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graves, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoma, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwnica-Worms, H.</span><span> </span><span class="NLM_article-title">Mitotic and G2 checkpoint control: Regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">1501</span><span class="NLM_x">â</span> <span class="NLM_lpage">1505</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1126%2Fscience.277.5331.1501" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=9278512" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADyaK2sXlvVGlu74%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=1997&pages=1501-1505&author=C.+Y.+Pengauthor=P.+R.+Gravesauthor=R.+S.+Thomaauthor=Z.+Wuauthor=A.+S.+Shawauthor=H.+Piwnica-Worms&title=Mitotic+and+G2+checkpoint+control%3A+Regulation+of+14-3-3+protein+binding+by+phosphorylation+of+Cdc25C+on+serine-216"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216</span></div><div class="casAuthors">Peng, Cheng-Yuan; Graves, Paul R.; Thoma, Richard S.; Wu, Zhiqi; Shaw, Andrey S.; Piwnica-Worms, Helen</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">277</span>
        (<span class="NLM_cas:issue">5331</span>),
    <span class="NLM_cas:pages">1501-1505</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Human Cdc25C is a dual-specificity protein phosphatase that controls entry into mitosis by dephosphorylating the protein kinase Cdc2.  Throughout interphase, but not in mitosis, Cdc25C was phosphorylated on serine-216 and bound to members of the highly conserved and ubiquitously expressed family of 14-3-3 proteins.  A mutation preventing phosphorylation of serine-216 abrogated 14-3-3 binding.  Conditional overexpression of this mutant perturbed mitotic timing and allowed cells to escape the G2 checkpoint arrest induced by either unreplicated DNA or radiation-induced damage.  Chk1, a fission yeast kinase involved in the DNA damage checkpoint response, phosphorylated Cdc25C in vitro on serine-216.  These results indicate that serine-216 phosphorylation and 14-3-3 binding neg. regulate Cdc25C and identify Cdc25C as a potential target of checkpoint control in human cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozK2EquaM1ibVg90H21EOLACvtfcHk0lgMXt_UPp9K0Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXlvVGlu74%253D&md5=a7ad063199580208875235588070cd4c</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1126%2Fscience.277.5331.1501&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.277.5331.1501%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DC.%2BY.%26aulast%3DGraves%26aufirst%3DP.%2BR.%26aulast%3DThoma%26aufirst%3DR.%2BS.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DShaw%26aufirst%3DA.%2BS.%26aulast%3DPiwnica-Worms%26aufirst%3DH.%26atitle%3DMitotic%2520and%2520G2%2520checkpoint%2520control%253A%2520Regulation%2520of%252014-3-3%2520protein%2520binding%2520by%2520phosphorylation%2520of%2520Cdc25C%2520on%2520serine-216%26jtitle%3DScience%26date%3D1997%26volume%3D277%26spage%3D1501%26epage%3D1505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Sanchez, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thoma, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwnica-Worms, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elledge, S. J.</span><span> </span><span class="NLM_article-title">Conservation of the Chk1 checkpoint pathway in mammals: Linkage of DNA damage to Cdk regulation through cdc25</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">277</span><span class="NLM_x">, </span> <span class="NLM_fpage">1497</span><span class="NLM_x">â</span> <span class="NLM_lpage">1501</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=277&publication_year=1997&pages=1497-1501&author=Y.+Sanchezauthor=C.+Wongauthor=R.+S.+Thomaauthor=R.+Richmanauthor=Z.+Wuauthor=H.+Piwnica-Wormsauthor=S.+J.+Elledge&title=Conservation+of+the+Chk1+checkpoint+pathway+in+mammals%3A+Linkage+of+DNA+damage+to+Cdk+regulation+through+cdc25"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez%26aufirst%3DY.%26aulast%3DWong%26aufirst%3DC.%26aulast%3DThoma%26aufirst%3DR.%2BS.%26aulast%3DRichman%26aufirst%3DR.%26aulast%3DWu%26aufirst%3DZ.%26aulast%3DPiwnica-Worms%26aufirst%3DH.%26aulast%3DElledge%26aufirst%3DS.%2BJ.%26atitle%3DConservation%2520of%2520the%2520Chk1%2520checkpoint%2520pathway%2520in%2520mammals%253A%2520Linkage%2520of%2520DNA%2520damage%2520to%2520Cdk%2520regulation%2520through%2520cdc25%26jtitle%3DScience%26date%3D1997%26volume%3D277%26spage%3D1497%26epage%3D1501" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Xiao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunasekera, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fesik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span> </span><span class="NLM_article-title">Chk1 mediates S and G2 arrests through Cdc25A degradation in response to DNA-damaging agents</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">21767</span><span class="NLM_x">â</span> <span class="NLM_lpage">21773</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=21767-21773&author=Z.+Xiaoauthor=Z.+Chenauthor=A.+H.+Gunasekeraauthor=T.+J.+Sowinauthor=S.+H.+Rosenbergauthor=S.+Fesikauthor=H.+Zhang&title=Chk1+mediates+S+and+G2+arrests+through+Cdc25A+degradation+in+response+to+DNA-damaging+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DGunasekera%26aufirst%3DA.%2BH.%26aulast%3DSowin%26aufirst%3DT.%2BJ.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DFesik%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DChk1%2520mediates%2520S%2520and%2520G2%2520arrests%2520through%2520Cdc25A%2520degradation%2520in%2520response%2520to%2520DNA-damaging%2520agents%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D21767%26epage%3D21773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Hollstein, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sidransky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vogelstein, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harris, C. C.</span><span> </span><span class="NLM_article-title">p53 mutations in human cancers</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">253</span><span class="NLM_x">, </span> <span class="NLM_fpage">49</span><span class="NLM_x">â</span> <span class="NLM_lpage">53</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=253&publication_year=1991&pages=49-53&author=M.+Hollsteinauthor=D.+Sidranskyauthor=B.+Vogelsteinauthor=C.+C.+Harris&title=p53+mutations+in+human+cancers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHollstein%26aufirst%3DM.%26aulast%3DSidransky%26aufirst%3DD.%26aulast%3DVogelstein%26aufirst%3DB.%26aulast%3DHarris%26aufirst%3DC.%2BC.%26atitle%3Dp53%2520mutations%2520in%2520human%2520cancers%26jtitle%3DScience%26date%3D1991%26volume%3D253%26spage%3D49%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Oren, M.</span><span> </span><span class="NLM_article-title">Regulation of the p53 tumor suppressor protein</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x">, </span> <span class="NLM_fpage">36031</span><span class="NLM_x">â</span> <span class="NLM_lpage">36034</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=36031-36034&author=M.+Oren&title=Regulation+of+the+p53+tumor+suppressor+protein"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOren%26aufirst%3DM.%26atitle%3DRegulation%2520of%2520the%2520p53%2520tumor%2520suppressor%2520protein%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26spage%3D36031%26epage%3D36034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Bucher, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Britten, C. D.</span><span> </span><span class="NLM_article-title">G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">98</span><span class="NLM_x">, </span> <span class="NLM_fpage">523</span><span class="NLM_x">â</span> <span class="NLM_lpage">528</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1038%2Fsj.bjc.6604208" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=18231106" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1KrsLc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2008&pages=523-528&author=N.+Bucherauthor=C.+D.+Britten&title=G2+checkpoint+abrogation+and+checkpoint+kinase-1+targeting+in+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer</span></div><div class="casAuthors">Bucher, N.; Britten, C. D.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">523-528</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Rigorous quality control steps, termed checkpoints, tightly regulate progression through the cell cycle.  DNA-damaging chemotherapy and radiation activate functional cellular checkpoints.  These checkpoints can facilitate DNA repair and promote cell death in unrepaired cells.  There are at least three DNA damage checkpoints - at G1/S, S, and G2/M - as well as a mitotic spindle checkpoint.  Most cancer cells harbor mutations in tumor suppressors and/or oncogenes, which impair certain cell checkpoints.  Inhibiting the remaining cell checkpoints - particularly after exposure of cancer cells to chemotherapy and/or radiation - allows cell death, a strategy now being employed in cancer therapeutics.  With our increasing knowledge of cell cycle regulation, many compds. have been developed to inhibit specific checkpoint components, particularly at the G2/M transition.  One such target is checkpoint kinase-1 (Chk1).  We review here the mol. framework of the cell cycle, the rationale for targeting Chk1, the preclin. concepts related to the development of Chk1 inhibitors, and the efficacy and safety results from Chk1 inhibitors now in phase I/II trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKqRg9PDH1B7Vg90H21EOLACvtfcHk0lj1wf01bYW_Mw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1KrsLc%253D&md5=607123f2a15cbe76fbd2aba55da7d289</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6604208&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6604208%26sid%3Dliteratum%253Aachs%26aulast%3DBucher%26aufirst%3DN.%26aulast%3DBritten%26aufirst%3DC.%2BD.%26atitle%3DG2%2520checkpoint%2520abrogation%2520and%2520checkpoint%2520kinase-1%2520targeting%2520in%2520the%2520treatment%2520of%2520cancer%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2008%26volume%3D98%26spage%3D523%26epage%3D528" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Kawabe, T.</span><span> </span><span class="NLM_article-title">G2 checkpoint abrogators as anticancer drugs</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">513</span><span class="NLM_x">â</span> <span class="NLM_lpage">519</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=15078995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD2cXivFygsr0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=513-519&author=T.+Kawabe&title=G2+checkpoint+abrogators+as+anticancer+drugs"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">G2 checkpoint abrogators as anticancer drugs</span></div><div class="casAuthors">Kawabe, Takumi</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">513-519</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">A review.  Many conventional anticancer treatments kill cells irresp. of whether they are normal or cancerous, so patients suffer from adverse side effects due to the loss of healthy cells.  Anticancer insights derived from cell cycle research has given birth to the idea of cell cycle G2 checkpoint abrogation as a cancer cell specific therapy, based on the discovery that many cancer cells have a defective G1 checkpoint resulting in a dependence on the G2 checkpoint during cell replication.  Damaged DNA in humans is detected by sensor proteins (such as hHUS1, hRAD1, hRAD9, hRAD17, and hRAD26) that transmit a signal via ATR to CHK1, or by another sensor complex (that may include Î³H2AX, 53BP1, BRCA1, NBS1, hMRE11, and hRAD50), the signal of which is relayed by ATM to CHK2.  Most of the damage signals originated by the sensor complexes for the G2 checkpoint are conducted to CDC25C, the activity of which is modulated by 14-3-3.  There are also less extensively explored pathways involving p53, p38, PCNA, HDAC, PP2A, PLK1, WEE1, CDC25B, and CDC25A.  This review will examine the available inhibitors of CHK1 (Staurosporin, UCN-01, Go6976, SB-218078, ICP-1, and CEP-3891), both CHK1 and CHK2 (TAT-S216A and debromohymenialdisine), CHK2 (CEP-6367), WEE1 (PD0166285), and PP2A (okadaic acid and fostriecin), as well as the unknown checkpoint inhibitors 13-hydroxy-15-ozoapathin (sic) and the isogranulatimides.  Among these targets, CHK1 seems to be the most suitable target for therapeutic G2 abrogation to date, although an unexplored target such as 14-3-3 or the strategy of targeting multiple proteins at once may be of interest in the future.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_oPLSt8XxXbVg90H21EOLACvtfcHk0liR_jAt_Albcg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXivFygsr0%253D&md5=2efedfd30a7560c908c3857fa387d870</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKawabe%26aufirst%3DT.%26atitle%3DG2%2520checkpoint%2520abrogators%2520as%2520anticancer%2520drugs%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2004%26volume%3D3%26spage%3D513%26epage%3D519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Walton, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eve, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hayes, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Haven Brandon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Box, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reader, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span> </span><span class="NLM_article-title">The preclinical pharmacology and therapeutic activity of the novel CHK1 inhibitor SAR-020106</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">89</span><span class="NLM_x">â</span> <span class="NLM_lpage">100</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1158%2F1535-7163.MCT-09-0938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=20053762" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BC3cXktVOhuw%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2010&pages=89-100&author=M.+I.+Waltonauthor=P.+D.+Eveauthor=A.+Hayesauthor=M.+Valentiauthor=A.+De+Haven+Brandonauthor=G.+Boxauthor=K.+J.+Boxallauthor=G.+W.+Aherneauthor=S.+A.+Ecclesauthor=F.+I.+Raynaudauthor=D.+H.+Williamsauthor=J.+C.+Readerauthor=I.+Collinsauthor=M.+D.+Garrett&title=The+preclinical+pharmacology+and+therapeutic+activity+of+the+novel+CHK1+inhibitor+SAR-020106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The Preclinical Pharmacology and Therapeutic Activity of the Novel CHK1 Inhibitor SAR-020106</span></div><div class="casAuthors">Walton, Michael I.; Eve, Paul D.; Hayes, Angela; Valenti, Melanie; De Haven Brandon, Alexis; Box, Gary; Boxall, Kathy J.; Aherne, G. Wynne; Eccles, Suzanne A.; Raynaud, Florence I.; Williams, David H.; Reader, John C.; Collins, Ian; Garrett, Michelle D.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-100</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Genotoxic antitumor agents continue to be the mainstay of current cancer chemotherapy.  These drugs cause DNA damage and activate numerous cell cycle checkpoints facilitating DNA repair and the maintenance of genomic integrity.  Most human tumors lack functional p53 and consequently have compromised G1-S checkpoint control.  This has led to the hypothesis that S and G2-M checkpoint abrogation may selectively enhance genotoxic cell killing in a p53-deficient background, as normal cells would be rescued at the G1-S checkpoint.  CHK1 is a serine/threonine kinase assocd. with DNA damage-linked S and G2-M checkpoint control.  SAR-020106 is an ATP-competitive, potent, and selective CHK1 inhibitor with an IC50 of 13.3 nmol/L on the isolated human enzyme.  This compd. abrogates an etoposide-induced G2 arrest with an IC50 of 55 nmol/L in HT29 cells, and significantly enhances the cell killing of gemcitabine and SN38 by 3.0- to 29-fold in several colon tumor lines in vitro and in a p53-dependent fashion.  Biomarker studies have shown that SAR-020106 inhibits cytotoxic drug-induced autophosphorylation of CHK1 at S296 and blocks the phosphorylation of CDK1 at Y15 in a dose-dependent fashion both in vitro and in vivo.  Cytotoxic drug combinations were assocd. with increased Î³H2AX and poly ADP ribose polymerase cleavage consistent with the SAR-020106-enhanced DNA damage and tumor cell death.  Irinotecan and gemcitabine antitumor activity was enhanced by SAR-020106 in vivo with minimal toxicity.  SAR-020106 represents a novel class of CHK1 inhibitors that can enhance antitumor activity with selected anticancer drugs in vivo and may therefore have clin. utility.  Mol Cancer Ther; 9(1); 89-100.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodRgZ8gsmTGbVg90H21EOLACvtfcHk0lis0Vnmxcf-Og"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXktVOhuw%253D%253D&md5=395ce9fc39b4a465597e82d59e413f14</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0938%26sid%3Dliteratum%253Aachs%26aulast%3DWalton%26aufirst%3DM.%2BI.%26aulast%3DEve%26aufirst%3DP.%2BD.%26aulast%3DHayes%26aufirst%3DA.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DDe%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DBox%26aufirst%3DG.%26aulast%3DBoxall%26aufirst%3DK.%2BJ.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DWilliams%26aufirst%3DD.%2BH.%26aulast%3DReader%26aufirst%3DJ.%2BC.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26atitle%3DThe%2520preclinical%2520pharmacology%2520and%2520therapeutic%2520activity%2520of%2520the%2520novel%2520CHK1%2520inhibitor%2520SAR-020106%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2010%26volume%3D9%26spage%3D89%26epage%3D100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Blasina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hallin, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arango, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kraynov, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Register, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ninkovic, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nichols, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâConnor, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderes, K.</span><span> </span><span class="NLM_article-title">Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2394</span><span class="NLM_x">â</span> <span class="NLM_lpage">2404</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1158%2F1535-7163.MCT-07-2391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=18723486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVWksL%252FP" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=2394-2404&author=A.+Blasinaauthor=J.+Hallinauthor=E.+Chenauthor=M.+E.+Arangoauthor=E.+Kraynovauthor=J.+Registerauthor=S.+Grantauthor=S.+Ninkovicauthor=P.+Chenauthor=T.+Nicholsauthor=P.+O%E2%80%99Connorauthor=K.+Anderes&title=Breaching+the+DNA+damage+checkpoint+via+PF-00477736%2C+a+novel+small-molecule+inhibitor+of+checkpoint+kinase+1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1</span></div><div class="casAuthors">Blasina, Alessandra; Hallin, Jill; Chen, Enhong; Arango, Maria Elena; Kraynov, Eugenia; Register, James; Grant, Stephan; Ninkovic, Sacha; Chen, Ping; Nichols, Tim; O'Connor, Patrick; Anderes, Kenna</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2394-2404</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Checkpoints are present in all phases of the cell cycle and are regarded as the gatekeepers maintaining the integrity of the genome.  Many conventional agents used to treat cancer impart damage to the genome and activate cell cycle checkpoints.  Many tumors are defective in the tumor suppressor p53 and therefore lack a functional G1 checkpoint.  In these tumors, however, the S-G2 checkpoints remain intact and, in response to DNA damage, arrest cell cycle progression allowing time for DNA repair.  Checkpoint kinase 1 (Chk1) is a key element in the DNA damage response pathway and plays a crucial role in the S-G2-phase checkpoints.  Inhibiting Chk1 represents a therapeutic strategy for creating a "synthetic lethal" response by overriding the last checkpoint defense of tumor cells against the lethal damage induced by DNA-directed chemotherapeutic agents.  Chk1 inhibition is consistent with emerging targeted therapies aiming to exploit mol. differences between normal and cancer cells.  Adding a Chk1 inhibitor to DNA-damaging cytotoxic therapy selectively targets tumors with intrinsic checkpoint defects while minimizing toxicity in checkpoint-competent normal cells.  PF-00477736 was identified as a potent, selective ATP-competitive small-mol. inhibitor that inhibits Chk1 with a Ki of 0.49 nM.  PF-00477736 abrogates cell cycle arrest induced by DNA damage and enhances cytotoxicity of clin. important chemotherapeutic agents, including gemcitabine and carboplatin.  In xenografts, PF-00477736 enhanced the antitumor activity of gemcitabine in a dose-dependent manner.  PF-00477736 combinations were well tolerated with no exacerbation of side effects commonly assocd. with cytotoxic agents. [Mol Cancer Ther 2008;7(8):2394-404].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCAlkcnouhLrVg90H21EOLACvtfcHk0liDrC-_Nb2BUw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVWksL%252FP&md5=fc3f9cf9121c207c6fa284b2090ed1c3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-07-2391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-07-2391%26sid%3Dliteratum%253Aachs%26aulast%3DBlasina%26aufirst%3DA.%26aulast%3DHallin%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DE.%26aulast%3DArango%26aufirst%3DM.%2BE.%26aulast%3DKraynov%26aufirst%3DE.%26aulast%3DRegister%26aufirst%3DJ.%26aulast%3DGrant%26aufirst%3DS.%26aulast%3DNinkovic%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DP.%26aulast%3DNichols%26aufirst%3DT.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%26aulast%3DAnderes%26aufirst%3DK.%26atitle%3DBreaching%2520the%2520DNA%2520damage%2520checkpoint%2520via%2520PF-00477736%252C%2520a%2520novel%2520small-molecule%2520inhibitor%2520of%2520checkpoint%2520kinase%25201%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D2394%26epage%3D2404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Ganzinelli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrassa, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crippa, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tavecchio, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broggini, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damia, G.</span><span> </span><span class="NLM_article-title">Checkpoint kinase 1 down-regulation by an inducible small interfering RNA expression system sensitized in vivo tumors to treatment with 5-fluorouracil</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">5131</span><span class="NLM_x">â</span> <span class="NLM_lpage">5141</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1158%2F1078-0432.CCR-08-0304" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=18698031" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD1cXpslKgtb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2008&pages=5131-5141&author=M.+Ganzinelliauthor=L.+Carrassaauthor=F.+Crippaauthor=M.+Tavecchioauthor=M.+Brogginiauthor=G.+Damia&title=Checkpoint+kinase+1+down-regulation+by+an+inducible+small+interfering+RNA+expression+system+sensitized+in+vivo+tumors+to+treatment+with+5-fluorouracil"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Checkpoint kinase 1 down-regulation by an inducible small interfering RNA expression system sensitized in vivo tumors to treatment with 5-fluorouracil</span></div><div class="casAuthors">Ganzinelli, Monica; Carrassa, Laura; Crippa, Francesca; Tavecchio, Michele; Broggini, Massimo; Damia, Giovanna</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">5131-5141</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: After DNA damage, checkpoints pathways are activated in the cells to halt the cell cycle, thus ensuring repair or inducing cell death.  To better investigate the role of checkpoint kinase 1 (Chk1) in cellular response to different anticancer agents, Chk1 was knocked down in HCT-116 cell line and in its p53-deficient subline by using small interfering RNAs (siRNA).  Exptl. Design: Chk1 was abrogated by transient transfection of specific siRNA against it, and stable tetracycline-inducible Chk1 siRNA clones were obtained transfecting cells with a plasmid expressing two siRNA against Chk1.  The validated inducible system was then translated in an in vivo setting by transplanting the inducible clones in nude mice.  RESULTS: Transient Chk1 down-regulation sensitized HCT-116 cells, p53-/- more than the p53 wild-type counterpart, to DNA-damaging agents 5-fluorouracil (5-FU), doxorubicin, and etoposide treatments, with no modification of Taxol and PS341 cytotoxic activities.  Inhibition of Chk1 protein levels in inducible clones on induction with doxycycline correlated with an increased cisplatin and 5-FU activity.  Such effect was more evident in a p53-deficient background.  These clones were transplanted in nude mice and a clear Chk1 down-regulation was shown in tumor samples of mice given tetracycline in the drinking water by immunohistochem. detection of Chk1 protein.  More importantly, an increased 5-FU antitumor activity was found in tumors with the double Chk1 and p53 silencing.  CONCLUSIONS: These findings corroborate the fact that Chk1 protein is a mol. target to be inhibited in tumors with a defective G1 checkpoint to increase the selectivity of anticancer treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoe9DwgiSQdlLVg90H21EOLACvtfcHk0liDrC-_Nb2BUw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXpslKgtb8%253D&md5=3605a0e485bac9da9dc0f056a7fbd95b</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-0304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-0304%26sid%3Dliteratum%253Aachs%26aulast%3DGanzinelli%26aufirst%3DM.%26aulast%3DCarrassa%26aufirst%3DL.%26aulast%3DCrippa%26aufirst%3DF.%26aulast%3DTavecchio%26aufirst%3DM.%26aulast%3DBroggini%26aufirst%3DM.%26aulast%3DDamia%26aufirst%3DG.%26atitle%3DCheckpoint%2520kinase%25201%2520down-regulation%2520by%2520an%2520inducible%2520small%2520interfering%2520RNA%2520expression%2520system%2520sensitized%2520in%2520vivo%2520tumors%2520to%2520treatment%2520with%25205-fluorouracil%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2008%26volume%3D14%26spage%3D5131%26epage%3D5141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Tse, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rendahl, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheikh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheema, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aardalen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Embry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moler, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, Z. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopes de Menezes, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hibner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gesner, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, G. K.</span><span> </span><span class="NLM_article-title">CHIR-124, a novel potent inhibitor of Chk1, potentiates the cytotoxicity of topoisomerase I poisons in vitro and in vivo</span> <span class="citation_source-journal">Clin. Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span><span class="NLM_x">â</span> <span class="NLM_lpage">602</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1158%2F1078-0432.CCR-06-1424" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=17255282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD2sXoslSktQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2007&pages=591-602&author=A.+N.+Tseauthor=K.+G.+Rendahlauthor=T.+Sheikhauthor=H.+Cheemaauthor=K.+Aardalenauthor=M.+Embryauthor=S.+Maauthor=E.+J.+Molerauthor=Z.+J.+Niauthor=D.+E.+Lopes+de+Menezesauthor=B.+Hibnerauthor=T.+G.+Gesnerauthor=G.+K.+Schwartz&title=CHIR-124%2C+a+novel+potent+inhibitor+of+Chk1%2C+potentiates+the+cytotoxicity+of+topoisomerase+I+poisons+in+vitro+and+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">CHIR-124, a novel potent inhibitor of Chk1, potentiates the cytotoxicity of topoisomerase I poisons in vitro and in vivo</span></div><div class="casAuthors">Tse, Archie N.; Rendahl, Katherine G.; Sheikh, Tahir; Cheema, Haider; Aardalen, Kim; Embry, Millicent; Ma, Sylvia; Moler, Edward J.; Ni, Zhi Jie; Lopes de Menezes, Daniel E.; Hibner, Barbara; Gesner, Thomas G.; Schwartz, Gary K.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2, Pt. 1</span>),
    <span class="NLM_cas:pages">591-602</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Chk1 kinase is a crit. regulator of both S and G2-M phase cell cycle checkpoints in response to DNA damage.  This study aimed to evaluate the biochem., cellular, and antitumor effects of a novel Chk1 inhibitor, CHIR124.  CHIR-124 was evaluated for its ability to abrogate cell cycle checkpoints, to potentiate cytotoxicity, and to inhibit Chk1-mediated signaling induced by topoisomerase I poisons in human tumor cell line and xenograft models.  CHIR-124 is a quinolone-based small mol. that is structurally unrelated to other known inhibitors of Chk1.  It potently and selectively inhibits Chk1 in vitro (IC50 = 0.0003 Î¼mol/L).  CHIR-124 interacts synergistically with topoisomerase poisons (e.g., camptothecin or SN-38) in causing growth inhibition in several p53-mutant solid tumor cell lines as detd. by isobologram or response surface anal.  CHIR-124 abrogates the SN-38-induced S and G2-M checkpoints and potentiates apoptosis in MDA-MD-435 breast cancer cells.  The abrogation of the G2-M checkpoint and induction of apoptosis by CHIR-124 are enhanced by the loss of p53.  We have also shown that CHIR-124 treatment can restore the level of cdc25A protein, which is normally targeted by Chk1 for degrdn. following DNA damage, indicating that Chk1 signaling is suppressed in the presence of CHIR-124.  Finally, in an orthotopic breast cancer xenograft model, CHIR-124 potentiates the growth inhibitory effects of irinotecan by abrogating the G2-M checkpoint and increasing tumor apoptosis.  CHIR-124 is a novel and potent Chk1 inhibitor with promising antitumor activities when used in combination with topoisomerase I poisons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8tD5w3RW7tbVg90H21EOLACvtfcHk0lgOK7n231cvbg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXoslSktQ%253D%253D&md5=59760855db149f99eba0e10828042816</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-06-1424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-06-1424%26sid%3Dliteratum%253Aachs%26aulast%3DTse%26aufirst%3DA.%2BN.%26aulast%3DRendahl%26aufirst%3DK.%2BG.%26aulast%3DSheikh%26aufirst%3DT.%26aulast%3DCheema%26aufirst%3DH.%26aulast%3DAardalen%26aufirst%3DK.%26aulast%3DEmbry%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DS.%26aulast%3DMoler%26aufirst%3DE.%2BJ.%26aulast%3DNi%26aufirst%3DZ.%2BJ.%26aulast%3DLopes%2Bde%2BMenezes%26aufirst%3DD.%2BE.%26aulast%3DHibner%26aufirst%3DB.%26aulast%3DGesner%26aufirst%3DT.%2BG.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26atitle%3DCHIR-124%252C%2520a%2520novel%2520potent%2520inhibitor%2520of%2520Chk1%252C%2520potentiates%2520the%2520cytotoxicity%2520of%2520topoisomerase%2520I%2520poisons%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2007%26volume%3D13%26spage%3D591%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Xiao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span> </span><span class="NLM_article-title">Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1935</span><span class="NLM_x">â</span> <span class="NLM_lpage">1943</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1158%2F1535-7163.MCT-06-0077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=16928813" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD28XosVans7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=1935-1943&author=Z.+Xiaoauthor=J.+Xueauthor=T.+J.+Sowinauthor=H.+Zhang&title=Differential+roles+of+checkpoint+kinase+1%2C+checkpoint+kinase+2%2C+and+mitogen-activated+protein+kinase-activated+protein+kinase+2+in+mediating+DNA+damage-induced+cell+cycle+arrest%3A+implications+for+cancer+therapy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Differential roles of checkpoint kinase 1, checkpoint kinase 2, and mitogen-activated protein kinase-activated protein kinase 2 in mediating DNA damage-induced cell cycle arrest: implications for cancer therapy</span></div><div class="casAuthors">Xiao, Zhan; Xue, John; Sowin, Thomas J.; Zhang, Haiying</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1935-1943</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Mammalian cells initiate cell cycle arrest at different phases of the cell cycle in response to various forms of genotoxic stress to allow time for DNA repair, and thus preserving their genomic integrity.  The protein kinases checkpoint kinase 1 (Chk1), checkpoint kinase 2 (Chk2), and mitogen-activated protein kinase-activated protein kinase 2 (MK2) have all been shown to be involved in cell cycle checkpoint control.  Recently, cell cycle checkpoint abrogation has been proposed as one way to sensitize cancer cells to DNA-damaging agents due to the expected induction of mitotic catastrophe.  Due to their overlapping substrate spectra and redundant functions, it is still not clear which kinase is mainly responsible for the cell cycle arrests conferred by clin. relevant chemotherapeutics.  Thus, the issue remains about which kinase is the most therapeutically relevant target and, more importantly, whether multiple kinases might need to be targeted to achieve the best efficacy in light of recent studies showing superior efficacy for pan-receptor tyrosine kinase inhibitors.  To clarify this issue, we investigated the roles of the three kinases in response to different genotoxic stresses through small interfering RNA-mediated specific target knockdowns.  Our result showed that only the down-regulation of Chk1, but not of Chk2 or MK2, abrogated camptothecin- or 5-fluorouracil-induced S-phase arrest or doxorubicin-induced G2-phase arrest.  This was followed by mitotic catastrophe and apoptosis.  Moreover, double inhibition of Chk1 and Chk2 failed to achieve better efficacy than Chk1 inhibition alone; surprisingly, inhibition of MK2, in addn. to Chk1 suppression, partially reversed the checkpoint abrogation and negated mitotic catastrophe.  We further showed that this is due to the fact that in MK2-deficient cells, Cdc25A protein, which is critically required for the mitotic progression following checkpoint abrogation, becomes greatly depleted.  In summary, our findings show that Chk1 is the only relevant checkpoint kinase as a cancer drug target and inhibition of other checkpoint kinases in addn. to Chk1 would be nonproductive.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-Au13f9gHdLVg90H21EOLACvtfcHk0lgOK7n231cvbg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XosVans7o%253D&md5=2144e703cacac5049bc937e35fca8713</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0077%26sid%3Dliteratum%253Aachs%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DXue%26aufirst%3DJ.%26aulast%3DSowin%26aufirst%3DT.%2BJ.%26aulast%3DZhang%26aufirst%3DH.%26atitle%3DDifferential%2520roles%2520of%2520checkpoint%2520kinase%25201%252C%2520checkpoint%2520kinase%25202%252C%2520and%2520mitogen-activated%2520protein%2520kinase-activated%2520protein%2520kinase%25202%2520in%2520mediating%2520DNA%2520damage-induced%2520cell%2520cycle%2520arrest%253A%2520implications%2520for%2520cancer%2520therapy%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D1935%26epage%3D1943" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Zabludoff, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grondine, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sheehy, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caleb, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haye, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horn, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janetka, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mouchet, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ready, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenthal, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Queva, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, G. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tse, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walker, G. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, A. M.</span><span> </span><span class="NLM_article-title">AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">2955</span><span class="NLM_x">â</span> <span class="NLM_lpage">2966</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1158%2F1535-7163.MCT-08-0492" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=18790776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtFSmsL7O" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=2955-2966&author=S.+D.+Zabludoffauthor=C.+Dengauthor=M.+R.+Grondineauthor=A.+M.+Sheehyauthor=S.+Ashwellauthor=B.+L.+Calebauthor=S.+Greenauthor=H.+R.+Hayeauthor=C.+L.+Hornauthor=J.+W.+Janetkaauthor=D.+Liuauthor=E.+Mouchetauthor=S.+Readyauthor=J.+L.+Rosenthalauthor=C.+Quevaauthor=G.+K.+Schwartzauthor=K.+J.+Taylorauthor=A.+N.+Tseauthor=G.+E.+Walkerauthor=A.+M.+White&title=AZD7762%2C+a+novel+checkpoint+kinase+inhibitor%2C+drives+checkpoint+abrogation+and+potentiates+DNA-targeted+therapies"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">AZD7762, a novel checkpoint kinase inhibitor, drives checkpoint abrogation and potentiates DNA-targeted therapies</span></div><div class="casAuthors">Zabludoff, Sonya D.; Deng, Chun; Grondine, Michael R.; Sheehy, Adam M.; Ashwell, Susan; Caleb, Benjamin L.; Green, Stephen; Haye, Heather R.; Horn, Candice L.; Janetka, James W.; Liu, Dongfang; Mouchet, Elizabeth; Ready, Shannon; Rosenthal, Judith L.; Queva, Christophe; Schwartz, Gary K.; Taylor, Karen J.; Tse, Archie N.; Walker, Graeme E.; White, Anne M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2955-2966</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Insights from cell cycle research have led to the hypothesis that tumors may be selectively sensitized to DNA-damaging agents resulting in improved antitumor activity and a wider therapeutic margin.  The theory relies on the observation that the majority of tumors are deficient in the G1-DNA damage checkpoint pathway resulting in reliance on S and G2 checkpoints for DNA repair and cell survival.  The S and G2 checkpoints are regulated by checkpoint kinase 1, a serine/threonine kinase that is activated in response to DNA damage; thus, inhibition of checkpoint kinase 1 signaling impairs DNA repair and increases tumor cell death.  Normal tissues, however, have a functioning G1 checkpoint signaling pathway allowing for DNA repair and cell survival.  Here, we describe the preclin. profile of AZD7762, a potent ATP-competitive checkpoint kinase inhibitor in clin. trials.  AZD7762 has been profiled extensively in vitro and in vivo in combination with DNA-damaging agents and has been shown to potentiate response in several different settings where inhibition of checkpoint kinase results in the abrogation of DNA damage-induced cell cycle arrest.  Dose-dependent potentiation of antitumor activity, when AZD7762 is administered in combination with DNA-damaging agents, has been obsd. in multiple xenograft models with several DNA-damaging agents, further supporting the potential of checkpoint kinase inhibitors to enhance the efficacy of both conventional chemotherapy and radiotherapy and increase patient response rates in a variety of settings. [Mol Cancer Ther 2008;7(9):2955-66].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoTXvjs3OaUFrVg90H21EOLACvtfcHk0liFOcdprJOyjw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtFSmsL7O&md5=b33ff697c6592c9823e85c9bb265c02d</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-08-0492&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-08-0492%26sid%3Dliteratum%253Aachs%26aulast%3DZabludoff%26aufirst%3DS.%2BD.%26aulast%3DDeng%26aufirst%3DC.%26aulast%3DGrondine%26aufirst%3DM.%2BR.%26aulast%3DSheehy%26aufirst%3DA.%2BM.%26aulast%3DAshwell%26aufirst%3DS.%26aulast%3DCaleb%26aufirst%3DB.%2BL.%26aulast%3DGreen%26aufirst%3DS.%26aulast%3DHaye%26aufirst%3DH.%2BR.%26aulast%3DHorn%26aufirst%3DC.%2BL.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMouchet%26aufirst%3DE.%26aulast%3DReady%26aufirst%3DS.%26aulast%3DRosenthal%26aufirst%3DJ.%2BL.%26aulast%3DQueva%26aufirst%3DC.%26aulast%3DSchwartz%26aufirst%3DG.%2BK.%26aulast%3DTaylor%26aufirst%3DK.%2BJ.%26aulast%3DTse%26aufirst%3DA.%2BN.%26aulast%3DWalker%26aufirst%3DG.%2BE.%26aulast%3DWhite%26aufirst%3DA.%2BM.%26atitle%3DAZD7762%252C%2520a%2520novel%2520checkpoint%2520kinase%2520inhibitor%252C%2520drives%2520checkpoint%2520abrogation%2520and%2520potentiates%2520DNA-targeted%2520therapies%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2008%26volume%3D7%26spage%3D2955%26epage%3D2966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span> </span><span class="NLM_article-title">Anticancer therapy with checkpoint inhibitors: What, where and when?</span> <span class="citation_source-journal">Trends Pharmacol. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">308</span><span class="NLM_x">â</span> <span class="NLM_lpage">316</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2011&pages=308-316&author=M.+D.+Garrettauthor=I.+Collins&title=Anticancer+therapy+with+checkpoint+inhibitors%3A+What%2C+where+and+when%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DAnticancer%2520therapy%2520with%2520checkpoint%2520inhibitors%253A%2520What%252C%2520where%2520and%2520when%253F%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2011%26volume%3D32%26spage%3D308%26epage%3D316" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Janetka, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwell, S.</span><span> </span><span class="NLM_article-title">Checkpoint kinase inhibitors: A review of the patent literature</span> <span class="citation_source-journal">Expert Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">165</span><span class="NLM_x">â</span> <span class="NLM_lpage">197</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1517%2F13543770802653622" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=19441917" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVClu7c%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=165-197&author=J.+W.+Janetkaauthor=S.+Ashwell&title=Checkpoint+kinase+inhibitors%3A+A+review+of+the+patent+literature"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Checkpoint kinase inhibitors: a review of the patent literature</span></div><div class="casAuthors">Janetka, James W.; Ashwell, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">165-197</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  The checkpoint kinases, Chk1 and Chk2 are Ser/Thr protein kinases, which function as key regulatory kinases in cellular DNA damage response pathways limiting cell-cycle progression in the presence of DNA damage.  The development of checkpoint kinase inhibitors for the treatment of cancer has been a major objective in drug discovery over the past decade, as evidenced by three checkpoint kinase inhibitors entering clinic trials since late 2005.  This review describes and discusses the most recent inhibitors of checkpoint kinases Chk1 and Chk2, as reported in the patent literature, including an evaluation of chem. structure and biol. activity.  Using a variety of approaches, we searched and analyzed all patent applications claiming chem. matter in which Chk1 or Chk2 were stated as targets of inhibition from Jan. 2006 through August 2008.  Conclusions: A large no. of chem. diverse Chk1 and Chk2 kinase inhibitors have appeared in the recent patent literature.  Common structural motifs of the checkpoint kinase inhibitors were identified.  There are currently three checkpoint kinase inhibitors in clin. development, a continuing effort by the pharmaceutical industry to identify novel scaffolds for checkpoint kinase inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvPfYmTA3VFrVg90H21EOLACvtfcHk0liFOcdprJOyjw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVClu7c%253D&md5=bb53a2a82402796d1eb61a9addbdc7c3</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1517%2F13543770802653622&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770802653622%26sid%3Dliteratum%253Aachs%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DAshwell%26aufirst%3DS.%26atitle%3DCheckpoint%2520kinase%2520inhibitors%253A%2520A%2520review%2520of%2520the%2520patent%2520literature%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D165%26epage%3D197" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Janetka, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ashwell, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zabludoff, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyne, P.</span><span> </span><span class="NLM_article-title">Inhibitors of checkpoint kinases: From discovery to the clinic</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">473</span><span class="NLM_x">â</span> <span class="NLM_lpage">486</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2007&pages=473-486&author=J.+W.+Janetkaauthor=S.+Ashwellauthor=S.+Zabludoffauthor=P.+Lyne&title=Inhibitors+of+checkpoint+kinases%3A+From+discovery+to+the+clinic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DAshwell%26aufirst%3DS.%26aulast%3DZabludoff%26aufirst%3DS.%26aulast%3DLyne%26aufirst%3DP.%26atitle%3DInhibitors%2520of%2520checkpoint%2520kinases%253A%2520From%2520discovery%2520to%2520the%2520clinic%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2007%26volume%3D10%26spage%3D473%26epage%3D486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Prudhomme, M.</span><span> </span><span class="NLM_article-title">Novel checkpoint 1 inhibitors</span> <span class="citation_source-journal">Recent Pat. Anti-Cancer Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">â</span> <span class="NLM_lpage">68</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&pages=55-68&author=M.+Prudhomme&title=Novel+checkpoint+1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPrudhomme%26aufirst%3DM.%26atitle%3DNovel%2520checkpoint%25201%2520inhibitors%26jtitle%3DRecent%2520Pat.%2520Anti-Cancer%2520Drug%2520Discovery%26date%3D2006%26spage%3D55%26epage%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Tao, Z.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bui, M.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Merta, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Judge, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span> </span><span class="NLM_article-title">Structure-based design, synthesis, and biological evaluation of potent and selective macrocyclic checkpoint kinase 1 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1514</span><span class="NLM_x">â</span> <span class="NLM_lpage">1527</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm061247v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=1514-1527&author=Z.-F.+Taoauthor=L.+Wangauthor=K.+D.+Stewartauthor=Z.+Chenauthor=W.+Guauthor=M.-H.+Buiauthor=P.+Mertaauthor=H.+Zhangauthor=P.+Kovarauthor=E.+Johnsonauthor=C.+Parkauthor=R.+Judgeauthor=S.+Rosenbergauthor=T.+Sowinauthor=N.-H.+Lin&title=Structure-based+design%2C+synthesis%2C+and+biological+evaluation+of+potent+and+selective+macrocyclic+checkpoint+kinase+1+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm061247v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061247v%26sid%3Dliteratum%253Aachs%26aulast%3DTao%26aufirst%3DZ.-F.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DGu%26aufirst%3DW.%26aulast%3DBui%26aufirst%3DM.-H.%26aulast%3DMerta%26aufirst%3DP.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DJohnson%26aufirst%3DE.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DJudge%26aufirst%3DR.%26aulast%3DRosenberg%26aufirst%3DS.%26aulast%3DSowin%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DN.-H.%26atitle%3DStructure-based%2520design%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520potent%2520and%2520selective%2520macrocyclic%2520checkpoint%2520kinase%25201%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D1514%26epage%3D1527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Chen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luo, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Register, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margosiak, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tempczyk-Russell, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lundgren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kan, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâConnor, P. M.</span><span> </span><span class="NLM_article-title">The 1.7 A crystal structure of human cell cycle checkpoint kinase Chk1: implications for Chk1 regulation</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x">, </span> <span class="NLM_fpage">681</span><span class="NLM_x">â</span> <span class="NLM_lpage">692</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=681-692&author=P.+Chenauthor=C.+Luoauthor=Y.+Dengauthor=K.+Ryanauthor=J.+Registerauthor=S.+Margosiakauthor=A.+Tempczyk-Russellauthor=B.+Nguyenauthor=P.+Myersauthor=K.+Lundgrenauthor=C.+C.+Kanauthor=P.+M.+O%E2%80%99Connor&title=The+1.7+A+crystal+structure+of+human+cell+cycle+checkpoint+kinase+Chk1%3A+implications+for+Chk1+regulation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DP.%26aulast%3DLuo%26aufirst%3DC.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DRyan%26aufirst%3DK.%26aulast%3DRegister%26aufirst%3DJ.%26aulast%3DMargosiak%26aufirst%3DS.%26aulast%3DTempczyk-Russell%26aufirst%3DA.%26aulast%3DNguyen%26aufirst%3DB.%26aulast%3DMyers%26aufirst%3DP.%26aulast%3DLundgren%26aufirst%3DK.%26aulast%3DKan%26aufirst%3DC.%2BC.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DP.%2BM.%26atitle%3DThe%25201.7%2520A%2520crystal%2520structure%2520of%2520human%2520cell%2520cycle%2520checkpoint%2520kinase%2520Chk1%253A%2520implications%2520for%2520Chk1%2520regulation%26jtitle%3DCell%26date%3D2000%26volume%3D100%26spage%3D681%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Foloppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Francis, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kierstan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, A.</span><span> </span><span class="NLM_article-title">Identification of a buried pocket for potent and selective inhibition of Chk1: Prediction and verification</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x">, </span> <span class="NLM_fpage">1792</span><span class="NLM_x">â</span> <span class="NLM_lpage">1804</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2006&pages=1792-1804&author=N.+Foloppeauthor=L.+M.+Fisherauthor=G.+Francisauthor=R.+Howesauthor=P.+Kierstanauthor=A.+Potter&title=Identification+of+a+buried+pocket+for+potent+and+selective+inhibition+of+Chk1%3A+Prediction+and+verification"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DFisher%26aufirst%3DL.%2BM.%26aulast%3DFrancis%26aufirst%3DG.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DKierstan%26aufirst%3DP.%26aulast%3DPotter%26aufirst%3DA.%26atitle%3DIdentification%2520of%2520a%2520buried%2520pocket%2520for%2520potent%2520and%2520selective%2520inhibition%2520of%2520Chk1%253A%2520Prediction%2520and%2520verification%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2006%26volume%3D14%26spage%3D1792%26epage%3D1804" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Foloppe, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howes, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kierstan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Potter, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surgenor, A. E.</span><span> </span><span class="NLM_article-title">Structure-based design of novel Chk1 inhibitors: Insights into hydrogen bonding and protein-ligand affinity</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">4332</span><span class="NLM_x">â</span> <span class="NLM_lpage">4345</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm049022c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4332-4345&author=N.+Foloppeauthor=L.+M.+Fisherauthor=R.+Howesauthor=P.+Kierstanauthor=A.+Potterauthor=A.+G.+Robertsonauthor=A.+E.+Surgenor&title=Structure-based+design+of+novel+Chk1+inhibitors%3A+Insights+into+hydrogen+bonding+and+protein-ligand+affinity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm049022c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm049022c%26sid%3Dliteratum%253Aachs%26aulast%3DFoloppe%26aufirst%3DN.%26aulast%3DFisher%26aufirst%3DL.%2BM.%26aulast%3DHowes%26aufirst%3DR.%26aulast%3DKierstan%26aufirst%3DP.%26aulast%3DPotter%26aufirst%3DA.%26aulast%3DRobertson%26aufirst%3DA.%2BG.%26aulast%3DSurgenor%26aufirst%3DA.%2BE.%26atitle%3DStructure-based%2520design%2520of%2520novel%2520Chk1%2520inhibitors%253A%2520Insights%2520into%2520hydrogen%2520bonding%2520and%2520protein-ligand%2520affinity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D4332%26epage%3D4345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Converso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartingh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garbaccio, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tasber, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rickert, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fraley, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreatsoulas, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stirdivant, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drakas, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walsh, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamilton, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buser, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrams, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beck, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lobell, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sepp-Lorenzino, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zugay-Murphy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sardana, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munshi, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jezequel-Sur, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zuck, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartman, G. D.</span><span> </span><span class="NLM_article-title">Development of thioquinazolinones, allosteric Chk1 kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1240</span><span class="NLM_x">â</span> <span class="NLM_lpage">1244</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1016%2Fj.bmcl.2008.12.076" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=19155174" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD1MXit1Wrurc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1240-1244&author=A.+Conversoauthor=T.+Hartinghauthor=R.+M.+Garbaccioauthor=E.+Tasberauthor=K.+Rickertauthor=M.+E.+Fraleyauthor=Y.+Yanauthor=C.+Kreatsoulasauthor=S.+Stirdivantauthor=B.+Drakasauthor=E.+S.+Walshauthor=K.+Hamiltonauthor=C.+A.+Buserauthor=X.+Maoauthor=M.+T.+Abramsauthor=S.+C.+Beckauthor=W.+Taoauthor=R.+Lobellauthor=L.+Sepp-Lorenzinoauthor=J.+Zugay-Murphyauthor=V.+Sardanaauthor=S.+K.+Munshiauthor=S.+M.+Jezequel-Surauthor=P.+D.+Zuckauthor=G.+D.+Hartman&title=Development+of+thioquinazolinones%2C+allosteric+Chk1+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Development of thioquinazolinones, allosteric Chk1 kinase inhibitors</span></div><div class="casAuthors">Converso, Antonella; Hartingh, Timothy; Garbaccio, Robert M.; Tasber, Edward; Rickert, Keith; Fraley, Mark E.; Yan, Youwei; Kreatsoulas, Constantine; Stirdivant, Steve; Drakas, Bob; Walsh, Eileen S.; Hamilton, Kelly; Buser, Carolyn A.; Mao, Xianzhi; Abrams, Marc T.; Beck, Stephen C.; Tao, Weikang; Lobell, Rob; Sepp-Lorenzino, Laura; Zugay-Murphy, Joan; Sardana, Vinod; Munshi, Sanjeev K.; Jezequel-Sur, Sylvie Marie; Zuck, Paul D.; Hartman, George D.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1240-1244</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A high throughput screening campaign was designed to identify allosteric inhibitors of Chk1 kinase by testing compds. at high concn.  Activity was then obsd. at Km for ATP and at near-physiol. concns. of ATP.  This strategy led to the discovery of a non-ATP competitive thioquinazolinone series which was optimized for potency and stability.  An X-ray crystal structure for the complex of our best inhibitor bound to Chk1 was solved, indicating that it binds to an allosteric site â¼13 Ã from the ATP binding site.  Preliminary data is presented for several of these compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq9bIRNnirJ4bVg90H21EOLACvtfcHk0lhFNmnXrjmYJQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXit1Wrurc%253D&md5=e91440930e976b9aafcfbb1597679511</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.12.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.12.076%26sid%3Dliteratum%253Aachs%26aulast%3DConverso%26aufirst%3DA.%26aulast%3DHartingh%26aufirst%3DT.%26aulast%3DGarbaccio%26aufirst%3DR.%2BM.%26aulast%3DTasber%26aufirst%3DE.%26aulast%3DRickert%26aufirst%3DK.%26aulast%3DFraley%26aufirst%3DM.%2BE.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DKreatsoulas%26aufirst%3DC.%26aulast%3DStirdivant%26aufirst%3DS.%26aulast%3DDrakas%26aufirst%3DB.%26aulast%3DWalsh%26aufirst%3DE.%2BS.%26aulast%3DHamilton%26aufirst%3DK.%26aulast%3DBuser%26aufirst%3DC.%2BA.%26aulast%3DMao%26aufirst%3DX.%26aulast%3DAbrams%26aufirst%3DM.%2BT.%26aulast%3DBeck%26aufirst%3DS.%2BC.%26aulast%3DTao%26aufirst%3DW.%26aulast%3DLobell%26aufirst%3DR.%26aulast%3DSepp-Lorenzino%26aufirst%3DL.%26aulast%3DZugay-Murphy%26aufirst%3DJ.%26aulast%3DSardana%26aufirst%3DV.%26aulast%3DMunshi%26aufirst%3DS.%2BK.%26aulast%3DJezequel-Sur%26aufirst%3DS.%2BM.%26aulast%3DZuck%26aufirst%3DP.%2BD.%26aulast%3DHartman%26aufirst%3DG.%2BD.%26atitle%3DDevelopment%2520of%2520thioquinazolinones%252C%2520allosteric%2520Chk1%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1240%26epage%3D1244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Ma, C. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janetka, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwnica-Worms, H.</span><span> </span><span class="NLM_article-title">Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics</span> <span class="citation_source-journal">Trends. Mol. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">88</span><span class="NLM_x">â</span> <span class="NLM_lpage">96</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1016%2Fj.molmed.2010.10.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=21087899" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhvFWgsro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=88-96&author=C.+X.+Maauthor=J.+W.+Janetkaauthor=H.+Piwnica-Worms&title=Death+by+releasing+the+breaks%3A+CHK1+inhibitors+as+cancer+therapeutics"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Death by releasing the breaks: CHK1 inhibitors as cancer therapeutics</span></div><div class="casAuthors">Ma, Cynthia X.; Janetka, James W.; Piwnica-Worms, Helen</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">88-96</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Defects in p53 function, which occur frequently in human cancers due to mutations in TP53 or disruptions in the p53 regulatory pathway, render cells dependent on CHK1 (Checkpoint Kinase 1) to activate cell cycle checkpoints.  In the presence of DNA damage or replication stress, inhibition of CHK1 leads to "mitotic catastrophe" and cell death in p53-deficient tumors while sparing p53-proficient cells.  CHK1 inhibitors sensitize tumors to a variety of DNA-damaging agents or antimetabolites in preclin. models and are being evaluated in early phase clin. trials.  In this review, we summarize recent advances and controversies in the development and application of CHK1 inhibitors as cancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAxtqrXv9ZqbVg90H21EOLACvtfcHk0lhujkcFQBD3Vw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhvFWgsro%253D&md5=e53c01cf0016d5be069913a041d67a08</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2010.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2010.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DC.%2BX.%26aulast%3DJanetka%26aufirst%3DJ.%2BW.%26aulast%3DPiwnica-Worms%26aufirst%3DH.%26atitle%3DDeath%2520by%2520releasing%2520the%2520breaks%253A%2520CHK1%2520inhibitors%2520as%2520cancer%2520therapeutics%26jtitle%3DTrends.%2520Mol.%2520Med.%26date%3D2011%26volume%3D17%26spage%3D88%26epage%3D96" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klair, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwood, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walton, M. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHardy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K.-M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van Montfort, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reader, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span> </span><span class="NLM_article-title">Identification of inhibitors of checkpoint kinase 1 through template screening</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4810</span><span class="NLM_x">â</span> <span class="NLM_lpage">4819</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900314j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=4810-4819&author=T.+P.+Matthewsauthor=S.+Klairauthor=S.+Burnsauthor=K.+Boxallauthor=M.+Cherryauthor=M.+Fisherauthor=I.+M.+Westwoodauthor=M.+I.+Waltonauthor=T.+McHardyauthor=K.-M.+J.+Cheungauthor=R.+Van+Montfortauthor=D.+Williamsauthor=G.+W.+Aherneauthor=M.+D.+Garrettauthor=J.+Readerauthor=I.+Collins&title=Identification+of+inhibitors+of+checkpoint+kinase+1+through+template+screening"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1021%2Fjm900314j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900314j%26sid%3Dliteratum%253Aachs%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DKlair%26aufirst%3DS.%26aulast%3DBurns%26aufirst%3DS.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DCherry%26aufirst%3DM.%26aulast%3DFisher%26aufirst%3DM.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3DWalton%26aufirst%3DM.%2BI.%26aulast%3DMcHardy%26aufirst%3DT.%26aulast%3DCheung%26aufirst%3DK.-M.%2BJ.%26aulast%3DVan%2BMontfort%26aufirst%3DR.%26aulast%3DWilliams%26aufirst%3DD.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DReader%26aufirst%3DJ.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DIdentification%2520of%2520inhibitors%2520of%2520checkpoint%2520kinase%25201%2520through%2520template%2520screening%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D4810%26epage%3D4819" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Matthews, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHardy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klair, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cherry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Addison, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellard, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westwood, I. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montfort, R. v.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reader, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span> </span><span class="NLM_article-title">Design and evaluation of 3,6-di(hetero)aryl imidazo[1,2-<i>a</i>]pyrazines as inhibitors of checkpoint and other kinases</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">4045</span><span class="NLM_x">â</span> <span class="NLM_lpage">4049</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=4045-4049&author=T.+P.+Matthewsauthor=T.+McHardyauthor=S.+Klairauthor=K.+Boxallauthor=M.+Fisherauthor=M.+Cherryauthor=C.+E.+Allenauthor=G.+J.+Addisonauthor=J.+Ellardauthor=G.+W.+Aherneauthor=I.+M.+Westwoodauthor=R.+v.+Montfortauthor=M.+D.+Garrettauthor=J.+C.+Readerauthor=I.+Collins&title=Design+and+evaluation+of+3%2C6-di%28hetero%29aryl+imidazo%5B1%2C2-a%5Dpyrazines+as+inhibitors+of+checkpoint+and+other+kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatthews%26aufirst%3DT.%2BP.%26aulast%3DMcHardy%26aufirst%3DT.%26aulast%3DKlair%26aufirst%3DS.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DFisher%26aufirst%3DM.%26aulast%3DCherry%26aufirst%3DM.%26aulast%3DAllen%26aufirst%3DC.%2BE.%26aulast%3DAddison%26aufirst%3DG.%2BJ.%26aulast%3DEllard%26aufirst%3DJ.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DWestwood%26aufirst%3DI.%2BM.%26aulast%3DMontfort%26aufirst%3DR.%2Bv.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DReader%26aufirst%3DJ.%2BC.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DDesign%2520and%2520evaluation%2520of%25203%252C6-di%2528hetero%2529aryl%2520imidazo%255B1%252C2-a%255Dpyrazines%2520as%2520inhibitors%2520of%2520checkpoint%2520and%2520other%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D4045%26epage%3D4049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Antoni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sodha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span> </span><span class="NLM_article-title">CHK2 kinase: cancer susceptibility and cancer therapyâtwo sides of the same coin?</span> <span class="citation_source-journal">Nat. Rev. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">925</span><span class="NLM_x">â</span> <span class="NLM_lpage">936</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1038%2Fnrc2251" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=18004398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlCrsLbI" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=925-936&author=L.+Antoniauthor=N.+Sodhaauthor=I.+Collinsauthor=M.+D.+Garrett&title=CHK2+kinase%3A+cancer+susceptibility+and+cancer+therapy%E2%80%94two+sides+of+the+same+coin%3F"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">CHK2 kinase: cancer susceptibility and cancer therapy - two sides of the same coin?</span></div><div class="casAuthors">Antoni, Laurent; Sodha, Nayanta; Collins, Ian; Garrett, Michelle D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">925-936</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  In the past decade, CHK2 has emerged as an important multifunctional player in the DNA-damage response signalling pathway.  Parallel studies of the human CHEK2 gene have also highlighted its role as a candidate multiorgan tumor susceptibility gene rather than a highly penetrant predisposition gene for Li-Fraumeni syndrome.  As discussed here, the current understanding of CHK2 function in tumor cells, in both a biol. and genetic context, suggests that targeted modulation of the active kinase or exploitation of its loss in tumors could prove to be effective anti-cancer strategies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsWURyq9JQfLVg90H21EOLACvtfcHk0likErW2LN6Z3A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlCrsLbI&md5=b0ad4a7db909590234fb8e2656e949d1</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fnrc2251&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2251%26sid%3Dliteratum%253Aachs%26aulast%3DAntoni%26aufirst%3DL.%26aulast%3DSodha%26aufirst%3DN.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26atitle%3DCHK2%2520kinase%253A%2520cancer%2520susceptibility%2520and%2520cancer%2520therapy%25E2%2580%2594two%2520sides%2520of%2520the%2520same%2520coin%253F%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2007%26volume%3D7%26spage%3D925%26epage%3D936" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Guzi, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Paruch, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dwyer, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labroli, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shanahan, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taricani, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wiswell, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seghezzi, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Penaflor, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhagwat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parry, D.</span><span> </span><span class="NLM_article-title">Targeting the replication checkpoint using SCH 900776, a potent and functionally selective CHK1 inhibitor identified via high content screening</span> <span class="citation_source-journal">Mol. Cancer Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">591</span><span class="NLM_x">â</span> <span class="NLM_lpage">602</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1158%2F1535-7163.MCT-10-0928" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=21321066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslSrt7o%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2011&pages=591-602&author=T.+J.+Guziauthor=K.+Paruchauthor=M.+P.+Dwyerauthor=M.+Labroliauthor=F.+Shanahanauthor=N.+Davisauthor=L.+Taricaniauthor=D.+Wiswellauthor=W.+Seghezziauthor=E.+Penaflorauthor=B.+Bhagwatauthor=W.+Wangauthor=D.+Guauthor=Y.+Hsiehauthor=S.+Leeauthor=M.+Liuauthor=D.+Parry&title=Targeting+the+replication+checkpoint+using+SCH+900776%2C+a+potent+and+functionally+selective+CHK1+inhibitor+identified+via+high+content+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the Replication Checkpoint Using SCH 900776, a Potent and Functionally Selective CHK1 Inhibitor Identified via High Content Screening</span></div><div class="casAuthors">Guzi, Timothy J.; Paruch, Kamil; Dwyer, Michael P.; Labroli, Marc; Shanahan, Frances; Davis, Nicole; Taricani, Lorena; Wiswell, Derek; Seghezzi, Wolfgang; Penaflor, Ervin; Bhagwat, Bhagyashree; Wang, Wei; Gu, Danling; Hsieh, Yunsheng; Lee, Suining; Liu, Ming; Parry, David</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">591-602</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Checkpoint kinase 1 (CHK1) is an essential serine/threonine kinase that responds to DNA damage and stalled DNA replication.  CHK1 is essential for maintenance of replication fork viability during exposure to DNA antimetabolites.  In human tumor cell lines, ablation of CHK1 function during antimetabolite exposure led to accumulation of double-strand DNA breaks and cell death.  Here, we extend these observations and confirm ablation of CHK2 does not contribute to these phenotypes and may diminish them.  Furthermore, concomitant suppression of cyclin-dependent kinase (CDK) activity is sufficient to completely antagonize the desired CHK1 ablation phenotypes.  These mechanism-based observations prompted the development of a high-content, cell-based screen for Î³-H2AX induction, a surrogate marker for double-strand DNA breaks.  This mechanism-based functional approach was used to optimize small mol. inhibitors of CHK1.  Specifically, the assay was used to mechanistically define the optimal in-cell profile with compds. exhibiting varying degrees of CHK1, CHK2, and CDK selectivity.  Using this approach, SCH 900776 was identified as a highly potent and functionally optimal CHK1 inhibitor with minimal intrinsic antagonistic properties.  SCH 900776 exposure phenocopies short interfering RNA-mediated CHK1 ablation and interacts synergistically with DNA antimetabolite agents in vitro and in vivo to selectively induce dsDNA breaks and cell death in tumor cell backgrounds.  Mol Cancer Ther; 10(4); 591-602.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_DnP2RPokHLVg90H21EOLACvtfcHk0likErW2LN6Z3A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslSrt7o%253D&md5=884137ebd69d0959b583a6338a89b87a</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-10-0928&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-10-0928%26sid%3Dliteratum%253Aachs%26aulast%3DGuzi%26aufirst%3DT.%2BJ.%26aulast%3DParuch%26aufirst%3DK.%26aulast%3DDwyer%26aufirst%3DM.%2BP.%26aulast%3DLabroli%26aufirst%3DM.%26aulast%3DShanahan%26aufirst%3DF.%26aulast%3DDavis%26aufirst%3DN.%26aulast%3DTaricani%26aufirst%3DL.%26aulast%3DWiswell%26aufirst%3DD.%26aulast%3DSeghezzi%26aufirst%3DW.%26aulast%3DPenaflor%26aufirst%3DE.%26aulast%3DBhagwat%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DW.%26aulast%3DGu%26aufirst%3DD.%26aulast%3DHsieh%26aufirst%3DY.%26aulast%3DLee%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DM.%26aulast%3DParry%26aufirst%3DD.%26atitle%3DTargeting%2520the%2520replication%2520checkpoint%2520using%2520SCH%2520900776%252C%2520a%2520potent%2520and%2520functionally%2520selective%2520CHK1%2520inhibitor%2520identified%2520via%2520high%2520content%2520screening%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2011%26volume%3D10%26spage%3D591%26epage%3D602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficency: A useful tool for metric lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">â</span> <span class="NLM_lpage">431</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficency%3A+A+useful+tool+for+metric+lead+selection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficency%253A%2520A%2520useful%2520tool%2520for%2520metric%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Collins, I.; Reader, J. C.; Cheung, K. M.; Matthews, T. P.; Proisy, N.; Klair, S. S.</span><span> </span><span class="NLM_article-title">Morpholino-bicyclo-heteroaryl compounds as CHK1 kinase inhibitors and their preparation, pharmaceutical compositions and use in the treatment of cancer</span>. Patent Appl. WO2008075007, 2008; Chem Abstr.<span class="NLM_x"> </span><span class="NLM_year">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">149</span><span class="NLM_x">, </span> <span class="NLM_fpage">104737</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=I.+Collins&author=J.+C.+Reader&author=K.+M.+Cheung&author=T.+P.+Matthews&author=N.+Proisy&author=S.+S.+Klair&title=Morpholino-bicyclo-heteroaryl+compounds+as+CHK1+kinase+inhibitors+and+their+preparation%2C+pharmaceutical+compositions+and+use+in+the+treatment+of+cancer"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DMorpholino-bicyclo-heteroaryl%2520compounds%2520as%2520CHK1%2520kinase%2520inhibitors%2520and%2520their%2520preparation%252C%2520pharmaceutical%2520compositions%2520and%2520use%2520in%2520the%2520treatment%2520of%2520cancer%26jtitle%3DChem%2520Abstr.%26date%3D2008%26volume%3D149%26spage%3D104737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Cherry, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, D. H.</span><span> </span><span class="NLM_article-title">Recent kinase and kinase inhibitor X-ray structures: Mechanisms of inhibition and selectivity insights</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">663</span><span class="NLM_x">â</span> <span class="NLM_lpage">673</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.2174%2F0929867043455792" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=15032722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisFWgs7w%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=663-673&author=M.+Cherryauthor=D.+H.+Williams&title=Recent+kinase+and+kinase+inhibitor+X-ray+structures%3A+Mechanisms+of+inhibition+and+selectivity+insights"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Recent kinase and kinase inhibitor x-ray structures: mechanisms of inhibition and selectivity insights</span></div><div class="casAuthors">Cherry, M.; Williams, D. H.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">663-673</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent years have seen an explosion in the no. of publicly available x-ray crystal structures of protein kinases.  These structures have provided a wealth of information on the regulatory mechanisms, conformational plasticity and drugability of this important family of enzymes.  Drawing upon structural information, new insights into the development of protein kinase inhibitors are discussed including de-novo design, mol. templates for ATP competitive inhibitors and alternative mechanisms of inhibition.  The highly conserved nature of the ATP binding site is of central concern to drug development and the concept of a selectivity profile has arisen with structure-based design emerging as a key tool for addressing the challenges of specificity.  In addn., protein-ligand complexes, where the enzyme is in an inactive conformation, signify an alternate approach to protein kinase inhibition.  The belief that an inactive kinase presents a less conserved target is reviewed using observations on the structural changes occurring during protein kinase regulation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpB19ovXBL1mrVg90H21EOLACvtfcHk0liVhrNafy3Q_w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisFWgs7w%253D&md5=63c621c012a6e1cc9f795565580d7492</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.2174%2F0929867043455792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867043455792%26sid%3Dliteratum%253Aachs%26aulast%3DCherry%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DD.%2BH.%26atitle%3DRecent%2520kinase%2520and%2520kinase%2520inhibitor%2520X-ray%2520structures%253A%2520Mechanisms%2520of%2520inhibition%2520and%2520selectivity%2520insights%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2004%26volume%3D11%26spage%3D663%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Anand, N. K.; Blazey, C. M.; Bowles, O. J.; Bussenius, J.; Canne Bannen, L.; Chan, D. S.-M.; Chen, B.; Co, E. W.; Costanzo, S.; Defina, S. C.; Dubenko, L.; Franzini, M.; Huang, P.; Jammalamadaka, V.; Khoury, R. G.; Kim, M. H.; Klein, R. R.; Le, D. T.; Mac, M. B.; Nuss, J. M.; Parks, J. J.; Rice, K. D.; Tsang, T. H.; Tsuhako, A. L.; Wang, Y.; Xu, W.</span><span> </span><span class="NLM_article-title">Preparation and structure activity of pyrazolo-pyrimidine derivatives as antitumor agents and kinase modulators</span>. Patent WO 2005117909, 2005; Chem Abstr.<span class="NLM_x"> </span><span class="NLM_year">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">144</span><span class="NLM_x">, </span> <span class="NLM_fpage">104737</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=N.+K.+Anand&author=C.+M.+Blazey&author=O.+J.+Bowles&author=J.+Bussenius&author=L.+Canne+Bannen&author=D.+S.-M.+Chan&author=B.+Chen&author=E.+W.+Co&author=S.+Costanzo&author=S.+C.+Defina&author=L.+Dubenko&author=M.+Franzini&author=P.+Huang&author=V.+Jammalamadaka&author=R.+G.+Khoury&author=M.+H.+Kim&author=R.+R.+Klein&author=D.+T.+Le&author=M.+B.+Mac&author=J.+M.+Nuss&author=J.+J.+Parks&author=K.+D.+Rice&author=T.+H.+Tsang&author=A.+L.+Tsuhako&author=Y.+Wang&author=W.+Xu&title=Preparation+and+structure+activity+of+pyrazolo-pyrimidine+derivatives+as+antitumor+agents+and+kinase+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAnand%26aufirst%3DN.%2BK.%26atitle%3DPreparation%2520and%2520structure%2520activity%2520of%2520pyrazolo-pyrimidine%2520derivatives%2520as%2520antitumor%2520agents%2520and%2520kinase%2520modulators%26jtitle%3DChem%2520Abstr.%26date%3D2006%26volume%3D144%26spage%3D104737" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Bold, G.; Frei, J.; Lang, M.; Traxler, P.; Furet, P.</span><span> </span><span class="NLM_article-title">Preparation of pyrazolo[3,4-<i>d</i>]pyrimidines as antitumor agents</span>. Patent WO 9814449, 1998; Chem Abstr.<span class="NLM_x"> </span><span class="NLM_year">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">128</span><span class="NLM_x">, </span> <span class="NLM_fpage">282843</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=G.+Bold&author=J.+Frei&author=M.+Lang&author=P.+Traxler&author=P.+Furet&title=Preparation+of+pyrazolo%5B3%2C4-d%5Dpyrimidines+as+antitumor+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBold%26aufirst%3DG.%26atitle%3DPreparation%2520of%2520pyrazolo%255B3%252C4-d%255Dpyrimidines%2520as%2520antitumor%2520agents%26jtitle%3DChem%2520Abstr.%26date%3D1998%26volume%3D128%26spage%3D282843" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Caldwell, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donald, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHardy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlands, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruddle, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verdonk, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span> </span><span class="NLM_article-title">Identification of 4-(4-aminopiperidin-1-yl)-7H-pyrrolo[2,3-<i>d</i>]pyrimidines as selective inhibitors of protein kinase B through fragment elaboration</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">2147</span><span class="NLM_x">â</span> <span class="NLM_lpage">2157</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701437d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=2147-2157&author=J.+J.+Caldwellauthor=T.+G.+Daviesauthor=A.+Donaldauthor=T.+McHardyauthor=M.+G.+Rowlandsauthor=G.+W.+Aherneauthor=L.+K.+Hunterauthor=K.+Taylorauthor=R.+Ruddleauthor=F.+I.+Raynaudauthor=M.+Verdonkauthor=P.+Workmanauthor=M.+D.+Garrettauthor=I.+Collins&title=Identification+of+4-%284-aminopiperidin-1-yl%29-7H-pyrrolo%5B2%2C3-d%5Dpyrimidines+as+selective+inhibitors+of+protein+kinase+B+through+fragment+elaboration"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Fjm701437d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701437d%26sid%3Dliteratum%253Aachs%26aulast%3DCaldwell%26aufirst%3DJ.%2BJ.%26aulast%3DDavies%26aufirst%3DT.%2BG.%26aulast%3DDonald%26aufirst%3DA.%26aulast%3DMcHardy%26aufirst%3DT.%26aulast%3DRowlands%26aufirst%3DM.%2BG.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DHunter%26aufirst%3DL.%2BK.%26aulast%3DTaylor%26aufirst%3DK.%26aulast%3DRuddle%26aufirst%3DR.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DVerdonk%26aufirst%3DM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DIdentification%2520of%25204-%25284-aminopiperidin-1-yl%2529-7H-pyrrolo%255B2%252C3-d%255Dpyrimidines%2520as%2520selective%2520inhibitors%2520of%2520protein%2520kinase%2520B%2520through%2520fragment%2520elaboration%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D2147%26epage%3D2157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Hoehn, H.; Denzel, T.</span><span> </span><span class="NLM_article-title">1H-Pyrazolo[3,4-<i>b</i>]pyridines</span>. Patent DE 2301268, 1973; Chem Abstr.<span class="NLM_x"> </span><span class="NLM_year">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">79</span><span class="NLM_x">, </span> <span class="NLM_fpage">115578</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1973&author=H.+Hoehn&author=T.+Denzel&title=1H-Pyrazolo%5B3%2C4-b%5Dpyridines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHoehn%26aufirst%3DH.%26atitle%3D1H-Pyrazolo%255B3%252C4-b%255Dpyridines%26jtitle%3DChem%2520Abstr.%26date%3D1973%26volume%3D79%26spage%3D115578" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">McHardy, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caldwell, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rowlands, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruddle, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henley, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Haven Brandon, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Valenti, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, T. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fazal, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seavers, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raynaud, F. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garrett, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span> </span><span class="NLM_article-title">Discovery of 4-amino-1-(7H-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)piperidine-4-carboxamides as selective, orally active inhibitors of protein kinase B (Akt)</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2239</span><span class="NLM_x">â</span> <span class="NLM_lpage">2249</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901788j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2239-2249&author=T.+McHardyauthor=J.+J.+Caldwellauthor=K.+M.+Cheungauthor=L.+J.+Hunterauthor=K.+Taylorauthor=M.+Rowlandsauthor=R.+Ruddleauthor=A.+Henleyauthor=A.+de+Haven+Brandonauthor=M.+Valentiauthor=T.+G.+Daviesauthor=L.+Fazalauthor=L.+Seaversauthor=F.+I.+Raynaudauthor=S.+A.+Ecclesauthor=G.+W.+Aherneauthor=M.+D.+Garrettauthor=I.+Collins&title=Discovery+of+4-amino-1-%287H-pyrrolo%5B2%2C3-d%5Dpyrimidin-4-yl%29piperidine-4-carboxamides+as+selective%2C+orally+active+inhibitors+of+protein+kinase+B+%28Akt%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1021%2Fjm901788j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901788j%26sid%3Dliteratum%253Aachs%26aulast%3DMcHardy%26aufirst%3DT.%26aulast%3DCaldwell%26aufirst%3DJ.%2BJ.%26aulast%3DCheung%26aufirst%3DK.%2BM.%26aulast%3DHunter%26aufirst%3DL.%2BJ.%26aulast%3DTaylor%26aufirst%3DK.%26aulast%3DRowlands%26aufirst%3DM.%26aulast%3DRuddle%26aufirst%3DR.%26aulast%3DHenley%26aufirst%3DA.%26aulast%3Dde%2BHaven%2BBrandon%26aufirst%3DA.%26aulast%3DValenti%26aufirst%3DM.%26aulast%3DDavies%26aufirst%3DT.%2BG.%26aulast%3DFazal%26aufirst%3DL.%26aulast%3DSeavers%26aufirst%3DL.%26aulast%3DRaynaud%26aufirst%3DF.%2BI.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DGarrett%26aufirst%3DM.%2BD.%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DDiscovery%2520of%25204-amino-1-%25287H-pyrrolo%255B2%252C3-d%255Dpyrimidin-4-yl%2529piperidine-4-carboxamides%2520as%2520selective%252C%2520orally%2520active%2520inhibitors%2520of%2520protein%2520kinase%2520B%2520%2528Akt%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2239%26epage%3D2249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Traxler, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bold, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frei, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lydon, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mett, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchdunger, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meyer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mueller, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furet, P.</span><span> </span><span class="NLM_article-title">Use of a pharmacophore model for the design of EGF-R tyrosine kinase inhibitors: 4-(Phenylamino)pyrazolo[3,4-d]pyrimidines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">3601</span><span class="NLM_x">â</span> <span class="NLM_lpage">3616</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm970124v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=3601-3616&author=P.+Traxlerauthor=G.+Boldauthor=J.+Freiauthor=M.+Langauthor=N.+Lydonauthor=H.+Mettauthor=E.+Buchdungerauthor=T.+Meyerauthor=M.+Muellerauthor=P.+Furet&title=Use+of+a+pharmacophore+model+for+the+design+of+EGF-R+tyrosine+kinase+inhibitors%3A+4-%28Phenylamino%29pyrazolo%5B3%2C4-d%5Dpyrimidines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm970124v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970124v%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP.%26aulast%3DBold%26aufirst%3DG.%26aulast%3DFrei%26aufirst%3DJ.%26aulast%3DLang%26aufirst%3DM.%26aulast%3DLydon%26aufirst%3DN.%26aulast%3DMett%26aufirst%3DH.%26aulast%3DBuchdunger%26aufirst%3DE.%26aulast%3DMeyer%26aufirst%3DT.%26aulast%3DMueller%26aufirst%3DM.%26aulast%3DFuret%26aufirst%3DP.%26atitle%3DUse%2520of%2520a%2520pharmacophore%2520model%2520for%2520the%2520design%2520of%2520EGF-R%2520tyrosine%2520kinase%2520inhibitors%253A%25204-%2528Phenylamino%2529pyrazolo%255B3%252C4-d%255Dpyrimidines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1997%26volume%3D40%26spage%3D3601%26epage%3D3616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Traxler, P.; Furet, P.; Bold, G.; Frei, J.; Lang, M.</span><span> </span><span class="NLM_article-title">Preparation of 4-amino-1H-pyrazolo[3,4-<i>d</i>]pyrimidines as EGF-receptor-specific protein tyrosine kinase inhibitors</span>. Patent WO 9631510, 1996; Chem Abstr.<span class="NLM_x"> </span><span class="NLM_year">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x">, </span> <span class="NLM_fpage">8129</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1997&author=P.+Traxler&author=P.+Furet&author=G.+Bold&author=J.+Frei&author=M.+Lang&title=Preparation+of+4-amino-1H-pyrazolo%5B3%2C4-d%5Dpyrimidines+as+EGF-receptor-specific+protein+tyrosine+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DTraxler%26aufirst%3DP.%26atitle%3DPreparation%2520of%25204-amino-1H-pyrazolo%255B3%252C4-d%255Dpyrimidines%2520as%2520EGF-receptor-specific%2520protein%2520tyrosine%2520kinase%2520inhibitors%26jtitle%3DChem%2520Abstr.%26date%3D1997%26volume%3D126%26spage%3D8129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Collins, I.; Reader, J. C.; Klair, S.; Scanlon, J.; Addison, G.; Cherry, M.</span><span> </span><span class="NLM_article-title">Preparation of 9H-pyrimido[4,5-<i>b</i>]indole, 9H-pyrido[4â²,3â²:4,5]pyrrolo[2,3-<i>d</i>]pyridine and 9H-1,3,6,9-tetraazafluorene derivatives as CHK1 kinase inhibitors</span>. Patent WO 2009004329, 2009; Chem Abstr.<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">150</span><span class="NLM_x">, </span> <span class="NLM_fpage">98355</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=I.+Collins&author=J.+C.+Reader&author=S.+Klair&author=J.+Scanlon&author=G.+Addison&author=M.+Cherry&title=Preparation+of+9H-pyrimido%5B4%2C5-b%5Dindole%2C+9H-pyrido%5B4%E2%80%B2%2C3%E2%80%B2%3A4%2C5%5Dpyrrolo%5B2%2C3-d%5Dpyridine+and+9H-1%2C3%2C6%2C9-tetraazafluorene+derivatives+as+CHK1+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DPreparation%2520of%25209H-pyrimido%255B4%252C5-b%255Dindole%252C%25209H-pyrido%255B4%25E2%2580%25B2%252C3%25E2%2580%25B2%253A4%252C5%255Dpyrrolo%255B2%252C3-d%255Dpyridine%2520and%25209H-1%252C3%252C6%252C9-tetraazafluorene%2520derivatives%2520as%2520CHK1%2520kinase%2520inhibitors%26jtitle%3DChem%2520Abstr.%26date%3D2009%26volume%3D150%26spage%3D98355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Wang, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantei, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span> </span><span class="NLM_article-title">1-(5-Chloro-2-alkoxyphenyl)-3-(5-cyano-pyrazin-2-yl)ureas as potent and selective inhibitors of Chk1 kinase: Synthesis, preliminary SAR, and biological activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">3118</span><span class="NLM_x">â</span> <span class="NLM_lpage">3121</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm048989d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=3118-3121&author=G.+T.+Wangauthor=G.+Liauthor=R.+A.+Manteiauthor=Z.+Chenauthor=P.+Kovarauthor=W.+Guauthor=Z.+Xiaoauthor=H.+Zhangauthor=H.+L.+Shamauthor=T.+Sowinauthor=S.+H.+Rosenbergauthor=N.-H.+Lin&title=1-%285-Chloro-2-alkoxyphenyl%29-3-%285-cyano-pyrazin-2-yl%29ureas+as+potent+and+selective+inhibitors+of+Chk1+kinase%3A+Synthesis%2C+preliminary+SAR%2C+and+biological+activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm048989d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm048989d%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DG.%2BT.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DMantei%26aufirst%3DR.%2BA.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DGu%26aufirst%3DW.%26aulast%3DXiao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DSowin%26aufirst%3DT.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DLin%26aufirst%3DN.-H.%26atitle%3D1-%25285-Chloro-2-alkoxyphenyl%2529-3-%25285-cyano-pyrazin-2-yl%2529ureas%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520Chk1%2520kinase%253A%2520Synthesis%252C%2520preliminary%2520SAR%252C%2520and%2520biological%2520activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D3118%26epage%3D3121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Li, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasvold, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tao, Z.-F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, G. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gwaltney, S. L.,  II</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kovar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Credo, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sham, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, N.-H.</span><span> </span><span class="NLM_article-title">Synthesis and biological evaluation of 1-(2,4,5-trisubstituted phenyl)-3-(5-cyanopyrazin-2-yl)ureas as potent Chk1 kinase inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">16</span><span class="NLM_x">, </span> <span class="NLM_fpage">2293</span><span class="NLM_x">â</span> <span class="NLM_lpage">2298</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=2293-2298&author=G.+Liauthor=L.+A.+Hasvoldauthor=Z.-F.+Taoauthor=G.+T.+Wangauthor=S.+L.+Gwaltneyauthor=J.+Patelauthor=P.+Kovarauthor=R.+B.+Credoauthor=Z.+Chenauthor=H.+Zhangauthor=C.+Parkauthor=H.+L.+Shamauthor=T.+Sowinauthor=S.+H.+Rosenbergauthor=N.-H.+Lin&title=Synthesis+and+biological+evaluation+of+1-%282%2C4%2C5-trisubstituted+phenyl%29-3-%285-cyanopyrazin-2-yl%29ureas+as+potent+Chk1+kinase+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DG.%26aulast%3DHasvold%26aufirst%3DL.%2BA.%26aulast%3DTao%26aufirst%3DZ.-F.%26aulast%3DWang%26aufirst%3DG.%2BT.%26aulast%3DGwaltney%26aufirst%3DS.%2BL.%26aulast%3DPatel%26aufirst%3DJ.%26aulast%3DKovar%26aufirst%3DP.%26aulast%3DCredo%26aufirst%3DR.%2BB.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DPark%26aufirst%3DC.%26aulast%3DSham%26aufirst%3DH.%2BL.%26aulast%3DSowin%26aufirst%3DT.%26aulast%3DRosenberg%26aufirst%3DS.%2BH.%26aulast%3DLin%26aufirst%3DN.-H.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%25201-%25282%252C4%252C5-trisubstituted%2520phenyl%2529-3-%25285-cyanopyrazin-2-yl%2529ureas%2520as%2520potent%2520Chk1%2520kinase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D2293%26epage%3D2298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Auffinger, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hays, F. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Westhof, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ho, P. S.</span><span> </span><span class="NLM_article-title">Halogen bonds in biological molecules</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x">, </span> <span class="NLM_fpage">16789</span><span class="NLM_x">â</span> <span class="NLM_lpage">16794</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1073%2Fpnas.0407607101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=15557000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFansr3P" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2004&pages=16789-16794&author=P.+Auffingerauthor=F.+A.+Haysauthor=E.+Westhofauthor=P.+S.+Ho&title=Halogen+bonds+in+biological+molecules"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Halogen bonds in biological molecules</span></div><div class="casAuthors">Auffinger, Pascal; Hays, Franklin A.; Westhof, Eric; Ho, P. Shing</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">48</span>),
    <span class="NLM_cas:pages">16789-16794</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Short oxygen-halogen interactions have been known in org. chem. since the 1950s and recently have been exploited in the design of supramol. assemblies.  The present survey of protein and nucleic acid structures reveals similar halogen bonds as potentially stabilizing inter- and intramol. interactions that can affect ligand binding and mol. folding.  A halogen bond in biomols. can be defined as a short C-XÂ·Â·Â·O-Y interaction (C-X is a carbon-bonded chlorine, bromine, or iodine, and O-Y is a carbonyl, hydroxyl, charged carboxylate, or phosphate group), where the XÂ·Â·Â·O distance is less than or equal to the sums of the resp. van der Waals radii (3.27 Ã for ClÂ·Â·Â·O, 3.37 Ã for BrÂ·Â·Â·O, and 3.50 Ã for IÂ·Â·Â·O) and can conform to the geometry seen in small mols., with the C-XÂ·Â·Â·O angle â165Â° (consistent with a strong directional polarization of the halogen) and the XÂ·Â·Â·O-Y angle â120Â°.  Alternative geometries can be imposed by the more complex environment found in biomols., depending on which of the two types of donor systems are involved in the interaction: (i) the lone pair electrons of oxygen (and, to a lesser extent, nitrogen and sulfur) atoms or (ii) the delocalized Ï-electrons of peptide bonds or carboxylate or amide groups.  Thus, the specific geometry and diversity of the interacting partners of halogen bonds offer new and versatile tools for the design of ligands as drugs and materials in nanotechnol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPMdZU91iT77Vg90H21EOLACvtfcHk0lgf7D2VYn9kOg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFansr3P&md5=dfcce25d4e336c66294f6ab8ce412154</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0407607101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0407607101%26sid%3Dliteratum%253Aachs%26aulast%3DAuffinger%26aufirst%3DP.%26aulast%3DHays%26aufirst%3DF.%2BA.%26aulast%3DWesthof%26aufirst%3DE.%26aulast%3DHo%26aufirst%3DP.%2BS.%26atitle%3DHalogen%2520bonds%2520in%2520biological%2520molecules%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2004%26volume%3D101%26spage%3D16789%26epage%3D16794" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Skehan, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storeng, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scudiero, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Monks, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMahon, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vistica, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Warren, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bokesch, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenney, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boyd, M. R.</span><span> </span><span class="NLM_article-title">New colorimetric cytotoxicity assay for anticancer-drug screening</span> <span class="citation_source-journal">J. Natl. Cancer Inst.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">82</span><span class="NLM_x">, </span> <span class="NLM_fpage">1107</span><span class="NLM_x">â</span> <span class="NLM_lpage">1112</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1093%2Fjnci%2F82.13.1107" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=2359136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADyaK3cXltVylsL8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=1990&pages=1107-1112&author=P.+Skehanauthor=R.+Storengauthor=D.+Scudieroauthor=A.+Monksauthor=J.+McMahonauthor=D.+Visticaauthor=J.+T.+Warrenauthor=H.+Bokeschauthor=S.+Kenneyauthor=M.+R.+Boyd&title=New+colorimetric+cytotoxicity+assay+for+anticancer-drug+screening"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">New colorimetric cytotoxicity assay for anticancer-drug screening</span></div><div class="casAuthors">Skehan, Philip; Storeng, Ritsa; Scudiero, Dominic; Monks, Anne; McMahon, James; Vistica, David; Warren, Jonathan T.; Bokesch, Heidi; Kenney, Susan; Boyd, Michael R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the National Cancer Institute</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1107-12</span>CODEN:
                <span class="NLM_cas:coden">JNCIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0027-8874</span>.
    </div><div class="casAbstract">A rapid, sensitive, and inexpensive method was developed for measuring the cellular protein content of adherent and suspension cultures in 96-well microtiter plates.  The method is suitable for ordinary lab. purposes and for very large-scale applications, such as the National Cancer Institute's disease-oriented in vitro anticancer-drug discovery screen, which requires the use of several million culture wells per yr.  Cultures fixed with trichloroacetic acid were stained for 30 min with 0.4% (wt/vol) sulforhodamine B (SRB) dissolved in 1% acetic acid.  Unbound dye was removed by four washes with 1% acetic acid, and protein-bound dye was extd. with 10 mM unbuffered Tris base [tris(hydroxymethyl)aminomethane] for detn. of optical d. in a computer-interfaced, 96-well microtiter plate reader.  The SRB assay results were linear with the no. of cells and with values for cellular protein measured by both the Lowry and Bradford assays at densities ranging from sparse subconfluence to multilayered supraconfluence.  The signal-to-noise ratio at 564 nm was approx. 1.5 with 1,000 cells per well.  The sensitivity of the SRB assay compared favorably with sensitivities of several fluorescence assays and was superior to those of both the Lowry and Bradford assays and to those of 20 other visible dyes.  The SRB assay provides a colorimetric end point that is nondestructive, indefinitely stable, and visible to the naked eye.  It provides a sensitive measure of drug-induced cytotoxicity, is useful in quantitating clonogenicity, and is well suited to high-vol., automated drug screening.  SRB fluoresces strongly with laser excitation at 488 nm and can be measured quant. at the single-cell level by static fluorescence cytometry.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrA1MIZ3rkcqLVg90H21EOLACvtfcHk0ljkBWzPlKmrsw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXltVylsL8%253D&md5=d7bc1784a1f181842d2999efa7fa870c</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1093%2Fjnci%2F82.13.1107&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjnci%252F82.13.1107%26sid%3Dliteratum%253Aachs%26aulast%3DSkehan%26aufirst%3DP.%26aulast%3DStoreng%26aufirst%3DR.%26aulast%3DScudiero%26aufirst%3DD.%26aulast%3DMonks%26aufirst%3DA.%26aulast%3DMcMahon%26aufirst%3DJ.%26aulast%3DVistica%26aufirst%3DD.%26aulast%3DWarren%26aufirst%3DJ.%2BT.%26aulast%3DBokesch%26aufirst%3DH.%26aulast%3DKenney%26aufirst%3DS.%26aulast%3DBoyd%26aufirst%3DM.%2BR.%26atitle%3DNew%2520colorimetric%2520cytotoxicity%2520assay%2520for%2520anticancer-drug%2520screening%26jtitle%3DJ.%2520Natl.%2520Cancer%2520Inst.%26date%3D1990%26volume%3D82%26spage%3D1107%26epage%3D1112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Kunimoto, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nitta, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tanaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uehara, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baba, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takeuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokokura, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawada, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyasaka, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mutai, M.</span><span> </span><span class="NLM_article-title">Antitumor activity of 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, a novel water-soluble derivative of camptothecin, against murine tumors</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">5944</span><span class="NLM_x">â</span> <span class="NLM_lpage">5947</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1987&pages=5944-5947&author=T.+Kunimotoauthor=K.+Nittaauthor=T.+Tanakaauthor=N.+Ueharaauthor=H.+Babaauthor=M.+Takeuchiauthor=T.+Yokokuraauthor=S.+Sawadaauthor=T.+Miyasakaauthor=M.+Mutai&title=Antitumor+activity+of+7-ethyl-10-%5B4-%281-piperidino%29-1-piperidino%5Dcarbonyloxy-camptothecin%2C+a+novel+water-soluble+derivative+of+camptothecin%2C+against+murine+tumors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKunimoto%26aufirst%3DT.%26aulast%3DNitta%26aufirst%3DK.%26aulast%3DTanaka%26aufirst%3DT.%26aulast%3DUehara%26aufirst%3DN.%26aulast%3DBaba%26aufirst%3DH.%26aulast%3DTakeuchi%26aufirst%3DM.%26aulast%3DYokokura%26aufirst%3DT.%26aulast%3DSawada%26aufirst%3DS.%26aulast%3DMiyasaka%26aufirst%3DT.%26aulast%3DMutai%26aufirst%3DM.%26atitle%3DAntitumor%2520activity%2520of%25207-ethyl-10-%255B4-%25281-piperidino%2529-1-piperidino%255Dcarbonyloxy-camptothecin%252C%2520a%2520novel%2520water-soluble%2520derivative%2520of%2520camptothecin%252C%2520against%2520murine%2520tumors%26jtitle%3DCancer%2520Res.%26date%3D1987%26volume%3D47%26spage%3D5944%26epage%3D5947" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viswanadhan, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendoloski, J. J.</span><span> </span><span class="NLM_article-title">Prediction of hydrophobic (lipophilic) properties of small organic molecules using fragmental methods: an analysis of ALOGP and CLOGP methods</span> <span class="citation_source-journal">J. Phys. Chem. A</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">3762</span><span class="NLM_x">â</span> <span class="NLM_lpage">3772</span></span><div class="citationLinks">[<a href="/doi/10.1021/jp980230o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADyaK1cXis12rsrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1998&pages=3762-3772&author=A.+K.+Ghoseauthor=V.+N.+Viswanadhanauthor=J.+J.+Wendoloski&title=Prediction+of+hydrophobic+%28lipophilic%29+properties+of+small+organic+molecules+using+fragmental+methods%3A+an+analysis+of+ALOGP+and+CLOGP+methods"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragmental Methods: An Analysis of ALOGP and CLOGP Methods</span></div><div class="casAuthors">Ghose, Arup K.; Viswanadhan, Vellarkad N.; Wendoloski, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Physical Chemistry A</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">3762-3772</span>CODEN:
                <span class="NLM_cas:coden">JPCAFH</span>;
        ISSN:<span class="NLM_cas:issn">1089-5639</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. hydrophobicity (lipophilicity), usually quantified as log P (the logarithm of 1-octanol/water partition coeff.), is an important mol. characteristic in drug discovery.  ALOGP and CLOGP are two of the most widely used methods for the estn. of log P.  This work describes an extensive reparametrization of the at. log P values and a detailed comparison of the performance of ALOGP and CLOGP methods on the Pomona Medchem database.  Only the "star list" compds. having precisely measured log P values were used in this anal.  While the overall results with both methods are similar, anal. shows that the CLOGP method is better for very small mols. in the range of 1-20 atoms.  The two methods are almost comparable in the range of 21-45 atoms, while the ALOGP method has better accuracy for mols. with more than 45 atoms.  Although the rms deviation and the correlation coeff. for CLOGP predictions were marginally better than those for corresponding ALOGP predictions, the latter showed a very stable performance for all classes of org. compds. analyzed.  Importantly, the ALOGP method can be used to compute ests. for all mols. in the database, whereas the CLOGP method fails to offer ests. for a substantial part of the database.  Finally, unlike CLOGP and other methods of predicting lipophilicity, the ALOGP method has multiple uses, such as the estn. of local hydrophobicity, the visualization of mol. hydrophobicity maps, and the evaluation of hydrophobic interactions in protein-ligand complexes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXdn8wsqV3frVg90H21EOLACvtfcHk0ljkBWzPlKmrsw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXis12rsrY%253D&md5=ef58841437913e164dc2d6e73eb5c87d</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1021%2Fjp980230o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp980230o%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DViswanadhan%26aufirst%3DV.%2BN.%26aulast%3DWendoloski%26aufirst%3DJ.%2BJ.%26atitle%3DPrediction%2520of%2520hydrophobic%2520%2528lipophilic%2529%2520properties%2520of%2520small%2520organic%2520molecules%2520using%2520fragmental%2520methods%253A%2520an%2520analysis%2520of%2520ALOGP%2520and%2520CLOGP%2520methods%26jtitle%3DJ.%2520Phys.%2520Chem.%2520A%26date%3D1998%26volume%3D102%26spage%3D3762%26epage%3D3772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Ertl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohde, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selzer, P.</span><span> </span><span class="NLM_article-title">Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3714</span><span class="NLM_x">â</span> <span class="NLM_lpage">3717</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000942e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3714-3717&author=P.+Ertlauthor=B.+Rohdeauthor=P.+Selzer&title=Fast+calculation+of+molecular+polar+surface+area+as+a+sum+of+fragment-based+contributions+and+its+application+to+the+prediction+of+drug+transport+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties</span></div><div class="casAuthors">Ertl, Peter; Rohde, Bernhard; Selzer, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3714-3717</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. polar surface area (PSA), i.e., surface belonging to polar atoms, is a descriptor that was shown to correlate well with passive mol. transport through membranes and, therefore, allows prediction of transport properties of drugs.  The calcn. of PSA, however, is rather time-consuming because of the necessity to generate a reasonable 3D mol. geometry and the calcn. of the surface itself.  A new approach for the calcn. of the PSA is presented here, based on the summation of tabulated surface contributions of polar fragments.  The method, termed topol. PSA (TPSA), provides results which are practically identical with the 3D PSA (the correlation coeff. between 3D PSA and fragment-based TPSA for 34 810 mols. from the World Drug Index is 0.99), while the computation speed is 2-3 orders of magnitude faster.  The new methodol. may, therefore, be used for fast bioavailability screening of virtual libraries having millions of mols.  This article describes the new methodol. and shows the results of validation studies based on sets of published absorption data, including intestinal absorption, Caco-2 monolayer penetration, and blood-brain barrier penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhP6Qncx_h6LVg90H21EOLACvtfcHk0lg_oa7FD8s4Wg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D&md5=23ae4e7708bd8ddeb4a24ad160a29bd6</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm000942e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000942e%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26aulast%3DRohde%26aufirst%3DB.%26aulast%3DSelzer%26aufirst%3DP.%26atitle%3DFast%2520calculation%2520of%2520molecular%2520polar%2520surface%2520area%2520as%2520a%2520sum%2520of%2520fragment-based%2520contributions%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520drug%2520transport%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3714%26epage%3D3717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span>PipelinePilot, version 7.0; Accelrys: San Diego, CA, USA, <a href="http://accelrys.com" class="extLink">http://accelrys.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=PipelinePilot%2C+version+7.0%3B+Accelrys%3A+San+Diego%2C+CA%2C+USA%2C+http%3A%2F%2Faccelrys.com."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DPipelinePilot" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span>The National Centre for Protein Kinase Profiling, MRC Protein Phosphorylation Unit, University of Dundee, U.K. (<a href="http://www.kinase-screen.mrc.ac.uk" class="extLink">http://www.kinase-screen.mrc.ac.uk</a>)</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=The+National+Centre+for+Protein+Kinase+Profiling%2C+MRC+Protein+Phosphorylation+Unit%2C+University+of+Dundee%2C+U.K.+%28http%3A%2F%2Fwww.kinase-screen.mrc.ac.uk%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">Matthews, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yakes, F. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tadano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornheim, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clary, D. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tai, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robertson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karnitz, L. M.</span><span> </span><span class="NLM_article-title">Pharmacological abrogation of S-phase checkpoint enhances the anti-tumor activity of gemcitabine in vivo</span> <span class="citation_source-journal">Cell Cycle</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">104</span><span class="NLM_x">â</span> <span class="NLM_lpage">110</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=104-110&author=D.+J.+Matthewsauthor=F.+M.+Yakesauthor=J.+Chenauthor=M.+Tadanoauthor=L.+Bornheimauthor=D.+O.+Claryauthor=A.+Taiauthor=J.+M.+Wagnerauthor=N.+Millerauthor=Y.+D.+Kimauthor=S.+Robertsonauthor=L.+Murrayauthor=L.+M.+Karnitz&title=Pharmacological+abrogation+of+S-phase+checkpoint+enhances+the+anti-tumor+activity+of+gemcitabine+in+vivo"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMatthews%26aufirst%3DD.%2BJ.%26aulast%3DYakes%26aufirst%3DF.%2BM.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DTadano%26aufirst%3DM.%26aulast%3DBornheim%26aufirst%3DL.%26aulast%3DClary%26aufirst%3DD.%2BO.%26aulast%3DTai%26aufirst%3DA.%26aulast%3DWagner%26aufirst%3DJ.%2BM.%26aulast%3DMiller%26aufirst%3DN.%26aulast%3DKim%26aufirst%3DY.%2BD.%26aulast%3DRobertson%26aufirst%3DS.%26aulast%3DMurray%26aufirst%3DL.%26aulast%3DKarnitz%26aufirst%3DL.%2BM.%26atitle%3DPharmacological%2520abrogation%2520of%2520S-phase%2520checkpoint%2520enhances%2520the%2520anti-tumor%2520activity%2520of%2520gemcitabine%2520in%2520vivo%26jtitle%3DCell%2520Cycle%26date%3D2007%26volume%3D6%26spage%3D104%26epage%3D110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Manning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whyte, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudarsanam, S.</span><span> </span><span class="NLM_article-title">The protein kinase complement of the human genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1912</span><span class="NLM_x">â</span> <span class="NLM_lpage">1934</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1126%2Fscience.1075762" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=12471243" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1912-1934&author=G.+Manningauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sudarsanam&title=The+protein+kinase+complement+of+the+human+genome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The Protein Kinase Complement of the Human Genome</span></div><div class="casAuthors">Manning, G.; Whyte, D. B.; Martinez, R.; Hunter, T.; Sudarsanam, S.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">298</span>
        (<span class="NLM_cas:issue">5600</span>),
    <span class="NLM_cas:pages">1912-1916, 1933-1934</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">We have catalogued the protein kinase complement of the human genome (the "kinome") using public and proprietary genomic, complementary DNA, and expressed sequence tag (EST) sequences.  This provides a starting point for comprehensive anal. of protein phosphorylation in normal and disease states, as well as a detailed view of the current state of human genome anal. through a focus on one large gene family.  We identify 518 putative protein kinase genes, of which 71 have not previously been reported or described as kinases, and we extend or correct the protein sequences of 56 more kinases.  New genes include members of well-studied families as well as previously unidentified families, some of which are conserved in model organisms.  Classification and comparison with model organism kinomes identified orthologous groups and highlighted expansions specific to human and other lineages.  We also identified 106 protein kinase pseudogenes.  Chromosomal mapping revealed several small clusters of kinase genes and revealed that 244 kinases map to disease loci or cancer amplicons.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTj1hf_0cQcrVg90H21EOLACvtfcHk0liZF3oAeY4fnQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xpt1Wisb0%253D&md5=b3def83bace52257a3252a3347b8bb92</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1126%2Fscience.1075762&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1075762%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSudarsanam%26aufirst%3DS.%26atitle%3DThe%2520protein%2520kinase%2520complement%2520of%2520the%2520human%2520genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1912%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><div class="note"><p class="first last">All procedures followed U.K. Home Office and local ethical guidelines and were performed according to U.K. National Cancer Research Institute guidelines, see:</p></div><span class="NLM_contrib-group">Workman, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aboagye, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balkwill, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balmain, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bruder, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaplin, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Double, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Everitt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farningham, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Glennie, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kelland, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stratford, I. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozer, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watson, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wedge, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eccles, S. A.</span><span> </span><span class="NLM_article-title">Committee of the National Cancer Research Institute. Guidelines for the welfare and use of animals in cancer research</span> <span class="citation_source-journal">Br. J. Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">1555</span><span class="NLM_x">â</span> <span class="NLM_lpage">1577</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Fjm2007326&amp;key=10.1038%2Fsj.bjc.6605642" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Fjm2007326&amp;key=20502460" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Fjm2007326&amp;key=1%3ACAS%3A280%3ADC%252BC3czmvFyhsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=2010&pages=1555-1577&author=P.+Workmanauthor=E.+O.+Aboagyeauthor=F.+Balkwillauthor=A.+Balmainauthor=G.+Bruderauthor=D.+J.+Chaplinauthor=J.+A.+Doubleauthor=J.+Everittauthor=D.+A.+Farninghamauthor=M.+J.+Glennieauthor=L.+R.+Kellandauthor=V.+Robinsonauthor=I.+J.+Stratfordauthor=G.+M.+Tozerauthor=S.+Watsonauthor=S.+R.+Wedgeauthor=S.+A.+Eccles&title=Committee+of+the+National+Cancer+Research+Institute.+Guidelines+for+the+welfare+and+use+of+animals+in+cancer+research"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Guidelines for the welfare and use of animals in cancer research</span></div><div class="casAuthors">Workman P; Aboagye E O; Balkwill F; Balmain A; Bruder G; Chaplin D J; Double J A; Everitt J; Farningham D A H; Glennie M J; Kelland L R; Robinson V; Stratford I J; Tozer G M; Watson S; Wedge S R; Eccles S A</div><div class="citationInfo"><span class="NLM_cas:title">British journal of cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">102</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1555-77</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Animal experiments remain essential to understand the fundamental mechanisms underpinning malignancy and to discover improved methods to prevent, diagnose and treat cancer.  Excellent standards of animal care are fully consistent with the conduct of high quality cancer research.  Here we provide updated guidelines on the welfare and use of animals in cancer research.  All experiments should incorporate the 3Rs: replacement, reduction and refinement.  Focusing on animal welfare, we present recommendations on all aspects of cancer research, including: study design, statistics and pilot studies; choice of tumour models (e.g., genetically engineered, orthotopic and metastatic); therapy (including drugs and radiation); imaging (covering techniques, anaesthesia and restraint); humane endpoints (including tumour burden and site); and publication of best practice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkVD7D529OLg5nADWVYHg1fW6udTcc2eblR4dUQ2T5D7ntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3czmvFyhsQ%253D%253D&md5=55f4c62e16fb1ebaa1f05d59caba3989</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6605642&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6605642%26sid%3Dliteratum%253Aachs%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DAboagye%26aufirst%3DE.%2BO.%26aulast%3DBalkwill%26aufirst%3DF.%26aulast%3DBalmain%26aufirst%3DA.%26aulast%3DBruder%26aufirst%3DG.%26aulast%3DChaplin%26aufirst%3DD.%2BJ.%26aulast%3DDouble%26aufirst%3DJ.%2BA.%26aulast%3DEveritt%26aufirst%3DJ.%26aulast%3DFarningham%26aufirst%3DD.%2BA.%26aulast%3DGlennie%26aufirst%3DM.%2BJ.%26aulast%3DKelland%26aufirst%3DL.%2BR.%26aulast%3DRobinson%26aufirst%3DV.%26aulast%3DStratford%26aufirst%3DI.%2BJ.%26aulast%3DTozer%26aufirst%3DG.%2BM.%26aulast%3DWatson%26aufirst%3DS.%26aulast%3DWedge%26aufirst%3DS.%2BR.%26aulast%3DEccles%26aufirst%3DS.%2BA.%26atitle%3DCommittee%2520of%2520the%2520National%2520Cancer%2520Research%2520Institute.%2520Guidelines%2520for%2520the%2520welfare%2520and%2520use%2520of%2520animals%2520in%2520cancer%2520research%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2010%26volume%3D102%26spage%3D1555%26epage%3D1577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Collins, I.; Reader, J. C.; Williams, D. H.; Klair, S. S.; Scanlon, J. E.; Piton, N.; Cherry, M.</span><span> </span><span class="NLM_article-title">Bicyclylaryl-aryl-amine compounds, their preparation, and their use as CHK1 kinase inhibitors for treating proliferative diseases</span>. Patent WO 2009103966, 2009; Chem Abstr.<span class="NLM_x"> </span><span class="NLM_year">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">151</span><span class="NLM_x">, </span> <span class="NLM_fpage">289187</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=I.+Collins&author=J.+C.+Reader&author=D.+H.+Williams&author=S.+S.+Klair&author=J.+E.+Scanlon&author=N.+Piton&author=M.+Cherry&title=Bicyclylaryl-aryl-amine+compounds%2C+their+preparation%2C+and+their+use+as+CHK1+kinase+inhibitors+for+treating+proliferative+diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCollins%26aufirst%3DI.%26atitle%3DBicyclylaryl-aryl-amine%2520compounds%252C%2520their%2520preparation%252C%2520and%2520their%2520use%2520as%2520CHK1%2520kinase%2520inhibitors%2520for%2520treating%2520proliferative%2520diseases%26jtitle%3DChem%2520Abstr.%26date%3D2009%26volume%3D151%26spage%3D289187" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Ventura, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barigelletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durola, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flamigni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauvage, J.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wenger, O. S.</span><span> </span><span class="NLM_article-title">Fe(II), Ru(II) and Re(I) complexes of endotopic, sterically non-hindering, U-shaped 8,8â²-disubstituted-3,3â²-biisoquinoline ligands: syntheses and spectroscopic properties</span> <span class="citation_source-journal">Dalton Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_fpage">491</span><span class="NLM_x">â</span> <span class="NLM_lpage">498</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&pages=491-498&author=B.+Venturaauthor=F.+Barigellettiauthor=F.+Durolaauthor=L.+Flamigniauthor=J.-P.+Sauvageauthor=O.+S.+Wenger&title=Fe%28II%29%2C+Ru%28II%29+and+Re%28I%29+complexes+of+endotopic%2C+sterically+non-hindering%2C+U-shaped+8%2C8%E2%80%B2-disubstituted-3%2C3%E2%80%B2-biisoquinoline+ligands%3A+syntheses+and+spectroscopic+properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVentura%26aufirst%3DB.%26aulast%3DBarigelletti%26aufirst%3DF.%26aulast%3DDurola%26aufirst%3DF.%26aulast%3DFlamigni%26aufirst%3DL.%26aulast%3DSauvage%26aufirst%3DJ.-P.%26aulast%3DWenger%26aufirst%3DO.%2BS.%26atitle%3DFe%2528II%2529%252C%2520Ru%2528II%2529%2520and%2520Re%2528I%2529%2520complexes%2520of%2520endotopic%252C%2520sterically%2520non-hindering%252C%2520U-shaped%25208%252C8%25E2%2580%25B2-disubstituted-3%252C3%25E2%2580%25B2-biisoquinoline%2520ligands%253A%2520syntheses%2520and%2520spectroscopic%2520properties%26jtitle%3DDalton%2520Trans.%26date%3D2008%26spage%3D491%26epage%3D498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ym3" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ym3','PDB','2ym3'); return false;">PDB: 2ym3</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ym4" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ym4','PDB','2ym4'); return false;">PDB: 2ym4</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ym5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ym5','PDB','2ym5'); return false;">PDB: 2ym5</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ym6" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ym6','PDB','2ym6'); return false;">PDB: 2ym6</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ym7" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ym7','PDB','2ym7'); return false;">PDB: 2ym7</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ym8" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2ym8','PDB','2ym8'); return false;">PDB: 2ym8</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-3"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i37"><a href="/doi/suppl/10.1021/jm2007326">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_03534"></div></div></div></div></div><hr /></hr><p class="last">Experimental details for the preparation and characterization of compounds <b>(</b><i><b>rac</b></i><b>)-3</b>,<b> (</b><i><b>S</b></i><b>)-3</b>, <b>6</b>, <b>(</b><i><b>R</b></i><b>)-7</b>,<b> (</b><i><b>S</b></i><b>)-7</b>,<b> 9â19</b>,<b> 21</b>,<b> 22</b>, and <b>25â34</b>; experimental details for the determination of the enantiopurity of <b>(</b><i><b>R</b></i><b>)-3</b> and <b>(</b><i><b>S</b></i><b>)-3</b>; experimental details for CHK1 and CHK2 enzyme inhibition assays; summary of crystal structure determinations of CHK1 in complex with <b>2</b>, <b>4</b>, <b>6</b>, <b>8</b>, <b>20</b>, and <b>(</b><i><b>R</b></i><b>)-3</b>; and kinase inhibitory profiles of <b>(</b><i><b>R</b></i><b>)-3</b> at 1 Î¼M and 10 Î¼M test concentrations. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm2007326/suppl_file/jm2007326_si_001.pdf">jm2007326_si_001.pdf (293.06 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm2007326&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Fjm2007326%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2011.54.issue-24%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm2007326" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799b16469be2254","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
